Medical Microbiology, Virology & Immunology. Pt. 2. Medical Bacteriology & Medical Virology by Generalov, I. I.
  
 
I.I. Generalov 
 
 
MEDICAL 
MICROBIOLOGY, 
VIROLOGY & 
IMMUNOLOGY 
 
Part 2  
Medical Bacteriology & 
Medical Virology 
 
Lecture Course  
for Students of Medical Universities 
 
 
VITEBSK STATE MEDICAL UNIVERSITY 
 
2016 
 2 
Ministry of Health of the Republic of Belarus 
Higher Educational Establishment  
“Vitebsk State Order of Peoples' Friendship Medical University” 
 
 
 
I.I. Generalov 
 
 
MEDICAL 
MICROBIOLOGY, 
VIROLOGY & 
IMMUNOLOGY 
 
Part 2  
Medical Bacteriology &  
Medical Virology 
 
 
Lecture Course  
for Students of Medical Universities 
 
 
 
 
VITEBSK 
2016 
 3 
УДК [579+616.31]=111(07) 
ББК 52.64 я73+56.6 я73 
Г 34 
 
Printed according to the decision of  
Educational&Methodological Consociation on Medical Education 
(July 1, 2016) 
 
 
Reviewed by:  
D.V.Tapalsky, MD, PhD, Head of Microbiology, Virology and Immunology Dpt, 
Gomel State Medical University 
 
Microbiology, Virology and Immunology Dpt,  
Belarusian State Medical University, Minsk 
 
 
 
Generalov I.I. 
 
Г 34  Medical Microbiology, Virology and Immunology. Part 2. Medical 
Bacteriology & Medical Virology – Lecture Course for students of medical 
universities / I.I. Generalov. – Vitebsk, - VSMU. - 2016. - 392  p. 
 
 
ISBN 978-985-466-743-0 
 
 
The Lecture Course on Medical Microbiology, Virology and Immunology accumulates a broad scope 
of data covering the most of essential areas of medical microbiology. The textbook is composed 
according to the educational standard, plan and program, approved by Ministry of Education and 
Ministry of Health of the Republic of Belarus. This edition encompasses all basic sections of the 
subject – General Microbiology, Medical Immunology, Medical Bacteriology and Virology. Part 2 of 
the Lecture Course comprises Medical Bacteriology and Medical Virology sections. 
The book is directed for students of General Medicine faculties and Dentistry faculties of higher 
educational establishments. 
 
 
УДК [579+616.31]=111(07) 
ББК 52.64 я73+56.6 я73 
 
 
 
© Generalov I.I., 2016 
     © VSMU Press, 2016 
 
ISBN 978-985-466-743-0 
 
 4 
CONTENTS 
 Pages 
  
Abbreviation list 5 
  
Section 1. MEDICAL BACTERIOLOGY 8 
  
Chapter 1. Causative agents of suppurative, wound,  
and hospital-acquired infections 
 
9 
Chapter 2. Causative agents of suppurative, wound,  
and hospital-acquired anaerobic infections 
 
33 
Chapter 3. Causative agents of enteric bacterial infections: 
Escherichia coli and shigellae 
 
52 
Chapter 4.  Causative agents of enteric bacterial infections: 
salmonellae and yersiniae 
 
66 
Chapter 5. Pathogenic vibrios – causative agents of cholera. Causative 
agent of botulism. Helicobacter pylori 
 
80 
Chapter 6. Causative agents of bacterial respiratory infections: 
meningococci, Haemophilus influenzae, bordetellae, legionellae, and 
mycoplasmas 
 
 
98 
Chapter 7.  Causative agents of bacterial respiratory infections: 
pathogenic mycobacteria and corynebacteria 
 
124 
Chapter 8. Causative agents of sexually transmitted diseases 145 
Chapter 9. Causative agents of bacterial zoonozes:plague, anthrax, 
brucellosis, and tularemia 
 
163 
Chapter 10. Causative agents of leptospirosis and borrelioses 184 
Chapter 11. Causative agents of rickketsioses and Q fever 197 
Chapter 12. Infection-associated diseases of oral cavity  
(for students of Dentistry faculty) 
 
208 
  
Section 2. MEDICAL VIROLOGY 232 
  
Chapter 13. General characteristics of viruses 233 
Chapter 14. Bacteriophages 250 
Chapter 15. Causative agents of viral respiratory infections 257 
Chapter 16. Human enteric viruses: rotaviruses, picornaviruses 290 
Chapter 17. Hepatotropic viruses 303 
Chapter 18. Retroviruses: human immunodeficiency virus (HIV) 322 
Chapter 19. Herpesviruses and herpes viral infections 333 
Chapter 20. Causative agents of zoonotic viral infections 349 
Chapter 21. Prions and prion diseases 372 
Chapter 22. Infectious diseases with specific lesions in oral cavity 
(For students of Dentistry faculty) 
 
377 
 5 
ABBREVIATION LIST 
 
Ab – antibody 
ACE 2- angiotensin- converting enzyme 2  
Ag – antigen 
AIDS – acquired immunodeficiency syndrome 
ALT – alanine aminotransferase 
ANUG – acute necrotizing ulcerative gingivitis 
BCG vaccine  – bacillus Calmette-Guerin vaccine 
BCYE agar – buffered charcoal yeast extract agar 
BSE  – bovine spongiform encephalopathy  
BSK medium – Barbour-Stoenner-Kelly medium 
BSL – biosafety level 
CADIS – candida-associated denture induced stomatitis 
CagA – cytotoxin-associated gene A 
cAMP – 3',5'-cyclic AMP 
cccDNA – covalently closed circular DNA 
CJD – Creutzfeldt-Jakob disease 
CMV – cytomegalovirus 
CNS – central nervous system 
CRISPR – clustered regularly interspaced short palindromic repeats 
CRS – congenital rubella syndrome 
CSF – cerebrospinal fluid 
DAT – diphtheria antitoxin 
DFA-TP – direct fluorescent-antibody test for T. pallidum 
DIC – disseminated intravascular coagulation 
DPT vaccine – diphtheria, pertussis, and tetanus vaccine 
DST – Diaskintest 
DtxR – diphtheria toxin repressor 
EAEC – enteroaggregative E. coli 
EBV – Epstein-Barr virus  
EF – edema factor 
EHEC – enterohemorrhagic E. coli 
EIEC – enteroinvasive E. coli 
ELISA – enzyme-linked immunosorbent assay  
EMB agar – eosin-methylene blue agar 
EPEC – enteropathogenic E. coli 
ESBL – extended-spectrum beta-lactamase 
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EVD  – Ebola virus disease  
FFI – fatal familial insomnia 
GCF – gingival crevicular fluid 
GPAC – gram-positive anaerobic cocci 
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Chapter 1 
CAUSATIVE AGENTS OF SUPPURATIVE, WOUND AND 
HOSPITAL-ACQUIRED INFECTIONS 
 
 
PATHOGENIC STAPHYLOCOCCI 
 
 
The History of Discovery 
 
R. Koch discovered staphylococci in 1878. L. Pasteur obtained the 
pure culture of these bacteria in 1880. Later they were thoroughly studied 
by F. Rosenbach (1884). 
 
 
Classification of Staphylococci 
 
Staphylococci pertain to the family Staphylococcaceae, genus 
Staphylococcus. The genus Staphylococcus comprises more than 40 
species. Three most common species are Staphylococcus aureus, 
Staphylococcus epidermidis, and Staphylococcus saprophyticus. 
S. aureus is one of the major human pathogens. It causes suppurative 
lesions in different tissues, wound infections, food poisoning, septicemia 
and many other serious disorders.  
Other staphylococci are usually the representatives of normal human 
microflora of skin and mucosal tissues. Nevertheless, S. epidermidis affects 
immunocompromised patients and patients with implanted appliances 
(intravenous catheters, drains, etc.)  
The infections of prosthetic devices can be also caused by S. hominis 
and S. haemolyticus. In rare cases S. saprophyticus is able to cause urinary 
tract infections predominantly in young women.  
The rest of staphylococcal species (S. schleifeiri, S. warneri, S. capitis 
and many others) is not regarded as causing infections in humans. 
 
 
Structure and Properties of Staphylococci 
 
Morphology 
Staphylococci are small spherical microbes, 0.5-1 m in diameter. 
Microbial cells are usually grouped into irregular grape-like clusters but 
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single cells, diplococci, and short microbial chains can be readily observed. 
Under unfavorable conditions they may turn into L-forms. 
Staphylococci are gram-positive non-motile bacteria without flagella 
and spores. They can form capsule especially in the host tissues during 
infection. 
 
Cultivation 
Staphylococci easily grow on basic nutrient media at 37°C and pH of 
7.2-7.4. During cultivation they are capable of producing water-insoluble 
pigments – golden (mostly, by S. aureus), gray (S. epidermidis), and white 
or yellow (S. saprophyticus). Pigment synthesis is facilitated in milk-
supplemented media. 
Egg yolk salt agar containing up to 10% of NaCl is applied as 
selective medium for culture of staphylococci. The elevated concentrations 
of NaCl inhibit the growth of concomitant bacteria.  
All staphylococci produce pigmented smooth convex glistening 
colonies of medium sizes. When growing upon egg yolk agar, S. aureus 
renders positive lecithinase activity, degrading egg yolk lecithin. In most of 
cases other staphylococcal species don’t express lecithinase. 
Mannitol salt agar with egg yolk is also used as selective medium for 
staphylococci with additional detection of mannitol fermentation. 
Selective Baird-Parker agar for isolation of S. aureus contains lithium 
chloride and egg yolk tellurite enrichment, which prevent the growth of 
other bacteria. After overnight incubation S. aureus demonstrates shiny 
convex black colonies resulting from tellurite reduction. 
Staphylococci can cause hemolysis of rabbit, sheep and human 
erythrocytes on blood-containing media. 
In liquid nutrient media staphylococcal cultures develop diffuse 
opacity. 
 
Biochemical properties 
Staphylococci are facultative anaerobes. They ferment carbohydrates 
yielding acid metabolites (e.g., lactic acid) without gas. These bacteria 
utilize proteins with hydrogen sulfide production.  
Staphylococci (predominantly S. aureus) liquefy gelatin, coagulate 
milk, and reduce nitrates to nitrites. Also they produce catalase that 
differentiates them from streptococci as well as urease, phosphatase and 
some other enzymes. 
Coagulase production distinguishes S. aureus from other members of 
the same genus (with rare exceptions). Thus, S. aureus refers to as 
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coagulase-positive bacteria, while other staphylococci are coagulase-
negative.  
Likewise, S. aureus express thermostable nuclease. 
 
Antigenic structure 
Staphylococci possess antigenic polysaccharides and proteins in 
peptidoglycan of microbial cell wall and microcapsule. 
Cell wall teichoic acids carry additional antigenic determinants of 
staphylococci. 
 
Virulence factors 
S. aureus expresses a great variety of virulence factors, including exo- 
and endotoxins. Most of them are plasmid-controlled; some may be under 
chromosomal control. 
S. aureus produces -, -, - and -hemolysins. 
Alpha-hemolysin or -toxin has the lethal, necrotic and hemolytic 
activity. It is pore-forming toxin, capable of embedding into the target cell 
membrane with subsequent membrane impairment. This toxin readily lyses 
rabbit erythrocytes, damages platelets and smooth muscle cells, etc. It is 
lethal for rabbits on injection. 
-Toxin renders sphingomyelinase activity. It damages the 
membranes of human erythrocytes and many other cells. 
-Hemolysin can affect erythrocytes of many mammalian species as 
well as white blood cells (neutrophils and macrophages). 
-Hemolysin damages cytoplasmic membranes of various mammalian 
cells. It is able to aggregate within membrane lipid bilayer, thereby 
forming membrane channels that mediate cell lysis. 
Poreforming leukocidin (or Panton-Valentine toxin) destroys 
leukocytes and bone marrow precursors of blood cells during infection. 
S. aureus synthesizes more than 10 variations of heat-stable 
enterotoxins, causing food poisoning. They are resistant to intestinal 
proteolytic enzymes. 
Enterotoxins show high biological capacity, activating great subset of 
T-lymphocytes. The latter is followed by redundant proinflammatory 
cytokine production by T cells and macrophages (IL-1, IL-2 IL-6, IL-12, 
alpha-TNF, etc.) Cytokine release provokes systemic inflammation with 
severe tissue damage. 
Enterotoxins affect mostly the gastrointestinal tract that results in 
vomiting and diarrhea. 
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Toxic shock syndrome toxin (TSST) resembles in structure 
enterotoxins В and C. It can induce toxic shock syndrome especially in 
menstruating women that used absorbing tampons. Tampons can be 
contaminated by TSST-producing staphylococci. TSST has strong 
superantigenic activity that finally may result in systemic shock with fever, 
collapse, desquamative skin rashes and multi-organ dysfunction. 
Similar action is promoted by staphylococcal exfoliative toxins (ETA 
and ETB). Exfoliatins are absorbed from the skin primary infection site 
and carried by the blood stream to the large areas of the skin. They destroy 
deep cellular layers of the epidermis resulting in staphylococcal scalded 
skin syndrome. This disease affects mainly newborn infants and may be 
fatal. More than 50% of skin area can be damaged. The skin becomes red, 
wrinkled, and large blisters filled with clear fluid arise. General symptoms, 
such as malaise and fever are also essential for the disease. Specific 
antitoxic antibodies can prevent syndrome development. 
Staphylococcal peptidoglycan also possesses superantigenic activity. 
It stimulates inflammation and promotes chemotaxis of host leukocytes 
(endotoxin-like activity). 
Protein A is anchored within the cell wall of most of S. aureus strains. 
It binds to Fc portion of IgG molecules of different mammalian species 
including humans. Protein A is considered to hinder the complement 
activation and IgG binding to the immune cells. 
Capsule of S. aureus supports microbial survival within phagocytes. 
Besides exo- and endotoxin production, staphylococci can elaborate a 
large number of destructive enzymes. 
S. aureus coagulase is capable of converting serum prothrombin into 
thrombin that activates blood coagulation with fibrin clotting. Fibrin 
threads on the microbial surface allow staphylococci to avoid phagocyte 
attachment. 
Staphylokinase activates plasminogen thereby promoting fibrinolysis 
of blood clot within 24-48 hours. 
The staphylococci produce hyaluronidase, or spreading factor that 
breaks down hyaluronic acid of connective tissue that facilitates microbial 
invasion. 
Lecithinase of S. aureus hydrolyzes the lecithin – phospholipid 
component of cellular membranes. 
Staphylococcal -lactamases break down the bonds within the beta-
lactam ring causing microbial insusceptibility to beta-lactam antibiotics. 
Only specially designed beta-lactam drugs (e.g. methicillin, oxacillin, 
several cephalosporins and carbapenems) overcome beta-lactamase action. 
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-Lactamase production is usually under the plasmid control. 
Nevertheless, strains of methicillin resistant Staphylococcus aureus (or 
MRSA) have been appeared from chromosome-dependent alteration of 
penicillin-binding proteins (PBP). The bacteria produce modified protein 
PBP2a with low affinity to beta-lactam antibiotics. It is encoded by 
chromosomal gene mecA. 
It was found later that staphylococcal resistance to methicillin confers 
microbial insusceptibility for almost all of beta-lactams. Last decades 
MRSA has become a tremendous problem for public health as they 
provoke numerous life-threatening infections non-responsive to antibiotic 
therapy. 
 
Resistance 
Staphylococci are relatively resistant bacteria. They can propagate in 
10% sodium chloride medium. These microbes develop resistance to 
drying, freezing, heating (maintain their viability for more than 1 hour at 
70°) and some chemical substances. Boiling rapidly inactivates microbial 
cells. Also staphylococci are sensitive to chlorine-containing disinfectants 
and certain aniline dyes. 
 
Pathogenesis and Clinical Findings of Staphylococcal Infections 
 
Large number of mammalian species including humans suffers from 
staphylococcal infections. 
Nevertheless, staphylococci, especially S. epidermidis and 
S. saprophyticus, are the representatives of the normal flora of human skin 
and respiratory tract. Nasal carriage of S. aureus is revealed in 40-50% of 
humans. But great number of pathogenicity factors, including toxins and 
destructive enzymes, and considerable invasive capacity ensure 
staphylococcal virulence. 
Staphylococci, predominantly S. aureus, cause local and generalized 
(i.e, invasive) infections.  
Staphylococci enter the host through the skin and mucous tissues that 
is followed by local microbial propagation. Finally, they can overcome 
tissue barriers and infect the blood. 
Staphylococcus aureus can cause or participate in suppurative local 
lesions of all body tissues – furuncles (boils), carbuncles, paronychia, 
hidradenitis, chronic pyoderma, abscesses and phlegmons, periostitis, 
osteomyelitis, otitis, appendicitis, cholecystitis, pyelonephritis and many 
other diseases. 
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Also it causes pneumonia, peritonitis and meningitis, as well as post-
operative wound infections. Almost all of these situations can progress 
towards disseminative infection resulting in staphylococcal septicemia. 
S. aureus takes an active participation in mixed infections. 
Actions of numerous toxins produce clinical manifestations of specific 
staphylococcal infections. They should be often regarded as toxic 
infections. 
Staphylococcal food poisoning appears after ingestion of foodstuffs 
(diary products, cakes, pastry, ice cream, etc.) contaminated with 
pathogenic bacteria. Enterotoxins are thermostable and withstand heating 
at 100
o
C for 30 min. 
Scalded skin syndrome and toxic shock syndrome result from 
infections, caused by particular toxin-producing strains of staphylococci. 
Anti-toxic antibodies that appear in staphylococcal toxic infections 
can neutralize toxin action. Nevertheless, the majority of staphylococcal 
infections are shown to trigger only low-grade immune responses of short 
duration. Phagocytosis is considered to be the substantial mechanism for 
staphylococci elimination. 
S. epidermidis is generally less pathogenic, than S. aureus, but it is 
emphasized to cause highly deleterious complications in 
immunocompromised patients and in patients with implanted prosthetic 
devices (e.g. bacterial endocarditis and septicemia).  
Overall, S. aureus and S. epidermidis are from the most common 
causative agents of hospital-acquired infections. 
S. saprophyticus can affect the urogenital tract of young women and 
may be the rare cause of wound infections. 
 
 
Laboratory Diagnosis of Staphylococcal Infections 
 
Specimens are obtained from pus, wound discharge, tracheal aspirate, 
spinal fluid, sputum, urine, blood, contaminated foodstuffs, lavage fluids, 
feces, etc. 
Microscopy is used as preliminary test to validate staphylococcal 
infection. Gram-stained smear examination usually reveals gram-positive 
cocci arranged into grape-like clusters or settled separately. 
Rapid differential diagnosis of various staphylococcal species directly 
in clinical samples can be elaborated with molecular genetic tests, e.g. 
PCR. 
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For microbial culture isolation specimens are planted on blood agar 
and egg yolk salt agar. The latter medium is selective for staphylococci. In 
cases of septicemia blood is inoculated into glucose broth. 
S. aureus culture renders hemolysis on blood agar. Also it produces 
golden pigment and positive lecithinase activity in yolk salt agar. 
Catalase test allows to discern staphylococci and streptococci (the 
latter are devoid of catalase activity). 
Positive coagulase test is essential for S. aureus. The identification is 
performed by inoculation of microbial culture into citrated rabbit plasma. 
If clot forms within hours, the test is ascertained to be positive.  
Also S. aureus but not other staphylococci ferment mannitol and 
produce thermostable nuclease. These tests may be valuable for S. aureus 
discrimination. 
Serological tests are of limited value in verifying of staphylococcal 
infection. 
Susceptibility testing finalizes the investigation for staphylococci. 
Disk diffusion and broth microdilution methods are used. 
Methicillin-resistant S. aureus (i.e., MRSA strains) are determined by 
PCR. 
 
 
Treatment and Prophylaxis of Staphylococcal Infections 
 
Drugs that block cell wall synthesis are most suitable for 
staphylococcal infection treatment. Unfortunately, most of S. aureus 
isolates produce beta-lactamases, thus conferring resistance to penicillin G 
or amoxycillin. Therefore, beta-lactamase-resistant penicillins (e.g., 
oxacillin and methicillin) and cephalosporins, as well as carbapenems, are 
used here for antibacterial therapy. In combination with antibiotics, the 
specific inhibitors of -lactamases (e.g., clavulanic acid) give additional 
beneficial effect for treatment outcome. 
Resistance to oxacillin and methicillin appears in about 20% of 
S. aureus (i.e., MRSA strains) and approximately 75% of S. epidermidis 
strains. For treatment of these bacteria other inhibitors of cell wall 
synthesis – glycopeptides vancomycin or teicoplanin – are used. They 
should be administered in combination with antibiotics, blocking microbial 
protein synthesis – aminoglycosides, macrolides, lincosamides, 
tetracyclines (e.g., tigecycline), and linezolid. 
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In cases of chronic staphylococcal infections especially in 
immunocompromised patients and infants the specific passive immune 
therapy can be administered (e.g., anti-staphylococcal -globulin). 
For activation of anti-staphylococcal immunity the toxoid, derived 
from S. aureus alpha-toxin can be administered as well. Specific 
prophylaxis with staphylococcal toxoid is recommended for patients, 
supposed to be susceptible to staphylococcal infections. 
Adequate hospital disinfection and prevention of staphylococcal 
carriage among medical personnel can restrict the spread of staphylococcal 
infections. 
 
 
 
PATHOGENIC STREPTOCOCCI 
 
 
The History of Discovery 
 
T. Billroth described first streptococci in patients with wound 
infections in 1874. L. Pasteur discovered streptococci in patients with 
sepsis in 1880; F. Fehleisen in 1883 and F. Rosenbach in 1884 isolated the 
pure culture of these bacteria. 
 
 
Classification of Streptococci 
 
Streptococci belong to the family Streptococcaceae and genus 
Streptococcus. Not long ago the family contained one more genus 
Enterococcus. Later it was placed into the separate family 
Enterococcaceae. 
Streptococcus genus comprises more than 60 species.  
The main microbial species that cause pathology in humans are: 
S. pyogenes and S. agalactiae; oral streptococci S. mutans and S. sobrinus 
(causative agents of caries); causative agent of pneumonia S. pneumonia 
or pneumococcus. 
Opportunistic pathogens E. fecalis and E. faecies are the main 
representatives of genus Enterococcus. 
Historically all streptococci were divided according to their hemolytic 
activity into -hemolytic (produce green zones of hemolysis, e.g. viridans 
streptococci like S. mutans), -hemolytic that develop clear zones of 
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complete hemolysis, e.g. S. pyogenes and S. agalactiae, and non-hemolytic 
streptococci without hemolysis. 
Also streptococci are classified by their antigenic properties into 
serogroups (A-U), some groups are further divided into types. 
Serological group division proposed by R. Lancefield is based on 
polysaccharide cell wall antigens. 
S. pyogenes pertains to group A, S. agalactiae is the member of 
group B. Oral streptococcus S. sanguinis is related with group H. 
Enterococci E. fecalis and E. faecies belong to group D. 
Streptococci of A group are further divided into more than 80 
serotypes due to the structural differences of their M protein antigen. 
S. pneumoniae and viridans streptococci (e.g., numerous oral 
streptococci S. mutans, S. salivarius, S. mitis and others) are beyond of 
Lancefield classification. S. pneumoniae is subdivided into more than 90 
serotypes on the basis of specific capsular carbohydrate antigens. 
 
 
Structure and Properties of Streptococci 
 
Morphology 
Streptococci are gram-positive spherical microbes, 0.5-1 m in 
diameter, which are usually clustered into chains or pairs. They are non-
motile bacteria without flagella and spores. The cells possess pili, 
containing M protein and lipoteichoic acid. 
Pneumococci are paired cocci of lancet-like shape.  
Enterococci are the motile bacteria that carry one polar flagellum. 
Many streptococcal species of A, B and C groups as well as 
pneumococci, produce the capsule. It is composed predominantly of 
hyaluronic acid. 
 
Cultivation 
Streptococci are relatively fastidious bacteria. The temperature range 
for their growth is rather narrow within the limits of 20-40°. They are 
cultivated on blood, serum or sugar agar and broth, pH 7.2-7.4. On solid 
media streptococci develop small, gray, translucent colonies. The growth 
in the sugar broth appears as fine precipitate near the walls and bottom of 
the test tubes. 
Many strains are hemolytic (see above). Green hemolysis zone results 
from conversion of hemoglobin into methemoglobin (viridans streptococci 
and pneumococci). 
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Biochemical properties 
Streptococci are facultatively anaerobic or aerotolerant 
microorganisms. These bacteria ferment carbohydrates (e.g. glucose, 
maltose, lactose, sucrose, etc.) with acid formation without gas. They are 
lack of proteolytic activity, can’t liquefy gelatin and don’t reduce nitrates 
into nitrites.  
Streptococci are catalase-negative bacteria, whereas entrococci reveal 
minor catalase activity. Also enterococci easily grow in the presence of 
bile and 6.5% NaCl, hydrolyze esculin that distinguishes them from 
streptococci. 
Streptococci produce great variety of invasive and toxic enzymes (see 
below). 
 
Antigenic structure 
Streptococci possess a great number of antigenic determinants within 
the cell wall and capsule, which are of oligosaccharide and protein nature. 
Group-specific polysaccharide antigens of the cell wall are 
thermostable and contain different side residues of amine sugars and 
teichoic acids. 
M protein of group A S. pyogenes is presented in more than 80 
structural variations. It is heat- and acid-labile substance. 
T protein and R protein present some other streptococcal surface 
antigens. They can be used for further differentiation of streptococci. 
P substance is the nucleoprotein fraction, which is common in most 
hemolytic streptococci. 
 
Virulence factors 
Group A streptococci are able to produce a great number of toxic 
substances, agressins and invasion enzymes. 
M protein is regarded as the most significant virulence factor of 
streptococci. M proteins are divided now into class I and class II molecules 
due to the reactions with different antibodies. The patients with rheumatic 
fever are usually infected with class I M protein streptococci. 
M protein, which is encoded by emm gene, inhibits phagocytosis and 
promotes the adhesion of streptococci to the host tissues. This is the main 
mechanism of streptococcal virulence, since the lack of emm gene results 
in efficient phagocytosis of the invaded pathogen.  
It was elucidated also that M protein binds to H factor of alternative 
pathway of complement activation as well as to host fibrinogen molecules. 
Both interactions suppress complement activation and, more important, 
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severely reduce the opsonization of streptococci, thus inhibiting 
phagocytosis. Likewise, M protein is shown to activate bradykinin, 
stimulating tissue inflammation. 
Adhesive capacity of M protein facilitates streptococcal entry into 
infected cells that results in intracellular persistence of bacteria. 
Hyaluronic acid capsule is also required to withstand phagocytosis. 
Streptococcal pyrogenic exotoxins A and C (or erythrogenic toxins) 
and streptococcal mitogens work as superantigens, resembling 
staphylococcal enterotoxins. They trigger endotoxic shock with pyrogenic 
reactions that ensues from the massive release of proinflammatory 
cytokines (IL-1, IL-6, gamma interferon, -TNF, etc.) 
Streptococcal pyrogenic exotoxin B or streptococcal proteinase is an 
extracellular cysteine protease produced by all group A streptococci. It can 
directly activate IL-1 via specific intramolecular proteolysis as well as host 
tissue metalloproteases, enhancing inflammation and bacterial invasion. 
Streptococcal pyrogenic exotoxins A and C are encoded by genes of a 
lysogenic temperate bacteriophage, while exotoxin B is of chromosomal 
origin. 
Streptococcal adhesins comprise great variety of virulence factors that 
ensure streptococcal adherence and intracellular penetration. Among them 
are above mentioned M protein, lipoteichoic acid, fibronectin-binding 
protein, collagen-binding protein and many others. 
Streptococci express different IgG- and IgA-binding proteins. These 
proteins prevent antibody-mediated opsonization and deregulate mucous 
tissue immunity. 
The group of plasminogen-binding proteins contains several factors, 
including the enzyme streptokinase. They convert plasminogen into 
plasmin on the bacterial surface. Plasmin, attached to the microbial cells, 
activates extracellular metalloproteases or collagenases forwarding tissiue 
damage and enhancing invasion. 
Many other enzymes are produced by virulent streptococci. 
Streptococcal hyaluronidase destroys hyaluronic acid of connective 
tissue facilitating microbial invasion. 
C5a peptidase of streptococci splits C5a complement fragment, 
preventing efficient chemotaxis of phagocytes. 
Streptococcal streptodornase or deoxyribonuclease hydrolyzes host 
DNA. 
Different types of hemolysins are revealed in streptococci. S. pyogenes 
produces two main hemolysins (streptolysins): streptolysin O and 
streptolysin S. 
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Streptolysin O is a protein that contains free -SH groups, being 
sensitive to the oxygen. It induces high-titer synthesis of specific 
antibodies during infection. 
Streptolysin S is of peptide nature, causing the hemolytic damage of 
cellular membranes. Also it may trigger apoptosis of infected cells and 
stimulate inflammatory response. 
 
Resistance 
Streptococci are not highly resistant bacteria, but they can withstand 
low temperatures, and survive for months in pus and sputum. They are 
killed at temperature of 70°С within one hour. Conventional disinfectants 
readily destroy them (e.g., phenol in concentrations of 3-5% inactivates 
bacteria in 15 minutes). 
 
 
Pathogenesis and Clinical Findings in Streptococcal Infections 
 
Group A representative Streptococcus pyogenes is the major 
streptococcal pathogen. It affects almost any body tissue or organ, thereby 
causing great variety of pyogenic local and invasive infections. 
According to WHO data, group A streptococci account for at least 
500,000 patients’ death cases annually.  
Among local infections are streptococcal pharyngitis or sore throat, 
streptococcal pyoderma, erysipelas, cellulitis, wound infections and some 
others. These disorders can be followed by serious complications, such as 
streptococcal pneumonia, meningitis, infectious acute and subacute 
endocarditis with possible fatal outcome. 
Toxic and invasive streptococcal infections involve scarlet fever, 
necrotizing fasciitis, puerperal fever, streptococcal toxic shock syndrome 
and septicemia. 
Non-suppurative sequelae of streptococcal infections include post-
streptococcal acute glomerulonephritis and rheumatic fever. 
The infections are transmitted by air droplet route, by direct contact, 
through skin lesions, etc. 
Streptococcal sore throat is the most frequent infection caused by -
hemolytic streptococci. Bacteria attach to pharyngeal epithelium via the 
number of adhesins. The disease is characterized by throat pain, fever, 
nasopharyngitis, tonsillitis with purulent exudates, enlargement of cervical 
lymph nodes, etc. 
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Erysipelas is the specific streptococcal skin infection. Group A strains 
enter the skin through various lesions and penetrate the epidermis. The 
disease reproduces typical skin inflammatory damage with erythematous 
superficial skin layers. 
Necrotizing fasciitis is a severe painful streptococcal disorder that 
affects subcutaneous tissues and fascia. It shows evident tendency to rapid 
spread into underlying tissues resulting in their necrosis and gangrene. 
Scarlet fever is caused by group A streptococci that produce 
streptococcal pyrogenic exotoxins A, B and C. The symptoms result from 
systemic toxin action. They involve fever, generalized rash, bright 
“strawberry” tongue, skin desquamation. The disease profoundly affects 
cardiovascular system especially microcirculation. 
Streptococcal toxic shock syndrome is the highest manifestation of 
toxigenic streptococcal infections. Hyperproduction of toxins and mitogens 
with superantigenic activity leads to hypotension and deep multiple organ 
failure that may cause patient’s death. Beta-hemolytic streptococci of M 
protein types 1, 3, 11, 12, 28 are predominantly associated with shock 
appearance. 
Poststreptococcal acute glomerulonephritis is a typical immune 
complex disease that evolves 2-3 weeks after streptococcal infection. The 
nephritogenicity of group A streptococci is related to particular M protein 
serotypes of S. pyogenes, such us M 12 (predominant), 1, 2, 4, 49, 56, 57, 
and 60. Several immune mechanisms take part in disease pathogenesis. 
Among them are deposition of immune complexes on glomerular basal 
membrane, that is followed by complement activation, the production of 
antibodies, cross-reactive with streptococcal and glomerular antigens, 
direct damage of glomeruli by streptococcal enzymes and toxins. It was 
shown that renal glomerular membrane shares antigen epitopes with 
streptococcal M12 protein. This “antigen mimicry” provokes autoimmune 
reactions. 
Rheumatic fever is a most serious delayed sequel of previous 
streptococcal infection. It arises within 1-5 weeks after group A 
streptococcal pharingitis (sore throat) or scarlet fever. 
Rheumatic fever affects predominantly children or young persons. It is 
characterized by fever, mild polyarthritis without deformations, 
cardiovascular disorders that include heart inflammation (endomyocarditis 
and pericarditis) with systemic vasculitis, CNS involvement (chorea), skin 
manifestations (erythema marginatum). 
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Without adequate treatment the carditis leads to valves damage with 
chronic valvular heart disease progression. Finally the chronic heart 
failure can develop. 
Rheumatic fever is the intermittent disease. Every secondary attack 
enhances valvular injury.  
The disease is proven to be of autoimmune origin. M protein is 
accounted as a major streptococcal antigen that renders antigenic mimicry 
with host cardiac and skeletal myosin, tropomyosin, laminin, keratin and 
other substances. Thus, rheumatic fever is provoked and supported by 
autoreactive antibodies and T cells that cross-react with streptococcal 
antigens and cardiac tissues. Subsequent immune complex deposition 
induces complement activation. These autoimmune mechanisms lead to 
profound host tissue lesions. 
In certain clinical conditions some other representatives of 
Streptococcaceae family can cause the diseases in humans. 
For instance, group B Streptococcus agalactiae elicit neonatal 
meningitis and sepsis of newborns and infants. These bacteria colonize 
vaginal mucosa of 10-30% of healthy women. The newborn becomes 
infected during delivery and may develop severe meningitis with lethality 
of 30-50%. 
S. mutans as well as S. sobrinus takes part in dental plaque formation 
by synthesis of long-chain polysaccharides from sucrose thereby 
promoting caries initiation. The next progress of caries is related with 
fermentation of food-derived “table sugars” by S. mutans. It results in 
accumulation of lactic acid and tooth enamel decalcification with 
formation of caries lesion. 
S. mitis and other viridans streptococci can cause the individual cases 
of bacterial endocarditis. 
Enterococci belong to the part of normal enteric microflora; 
nevertheless, they cause urinary tract infections. Being highly resistant to 
antimicrobial agents, they may cause severe hospital-acquired 
opportunistic infections in immunocompromised persons. 
Streptococcus pneumoniae (or pneumococcus) is the major causative 
agent of community-acquired pneumonia in groups of all ages. According 
to WHO data, pneumococcal pneumonia leads to more than 1 mln death 
cases annually in children before the age of five. 
The disease severity is related with multiple virulence factors of 
pnemococci – polysaccharide capsule that protects bacteria from 
phagocytosis and opsonization; membrane-affecting exotoxin 
pneumolysin; pneumococcal C-substance from cell wall teichoic acids that 
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activates complement system and triggers host inflammatory response; 
IgA proteases suppressing mucosal immunity. 
Besides community-acquired pneumonia, S. pneumoniae plays the 
substantial role in etiology of sinusitis, acute otitis media (about 40% of 
total cases), and bacterial meningitis in adults. It is generally ascertained 
that pneumococcal meningitis demonstrates extremely severe 
manifestations with mortality rate from 15 to 60%. 
Post-streptococcal immunity is usually type-specific. Thus, it doesn’t 
prevent the reinfection with another type of bacteria. The immunity is of a 
moderate grade and duration. Antibodies and immune T cells are directed 
to all major streptococcal antigens. Hypersensitivity reactions are shown to 
be common in most of streptococcal infections. 
 
 
Laboratory Diagnosis of Streptococcal Infections 
 
Specimens are obtained from the site of streptococcal infection. A 
throat swab, pus, wound discharge, blood, urine are examined. 
Microscopy of specimens that reveals gram-positive single or short 
chain cocci is an auxiliary test, since the viridans streptococci may be 
found in clinical material as normal microflora. 
Group A bacteria can be rapidly identified by immunofluorescence. 
For cultivation the specimens are planted on blood agar and sugar 
broth. The primary growth appears in 1-2 days. Blood cultures are 
controlled within 5-7 days or even more. 
The character of blood agar hemolysis is evaluated. Group A 
streptococci produce beta-hemolytic colonies. 
Streptococci are catalase negative. 
For definitive identification serologic grouping and typing of 
streptococci according to Lancefield classification is made by slide 
agglutination and precipitation tests. 
Specific carbohydrate streptococcal antigens can be determined also 
by ELISA tests. 
S. pyogenes is the single streptococcal representative rendering 
positive PYR-test (hydrolysis of pyrrolidonyl-β-naphthylamide substrate). 
In addition, S. pyogenes is sensitive to antibiotic bacitracin. 
Serological diagnosis of group A streptococcal infections estimates 
the titer rise of antibodies to streptolysin O (basic test), streptokinase, 
hyaluronidase and DNAse (auxiliary tests). High titers of antistreptolysins 
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(> 250 units) appear mainly in rheumatic fever patients indicating recent or 
relapsing infection. 
S. agalactiae is identified by so-called CAMP test (according to 
R. Christie, N.E. Atkins, and E. Munch-Peterson, who proposed this 
method). The test includes co-cultivation of Streptococcus agalactiae with 
S. aureus on blood agar. Usually two-streak plating of S. agalactiae is 
performed perpendicular to one-streak inoculation of hemolytic 
staphylococci. As a result, butterfly-like hemolysis enhancement of 
S. agalactiae appears. 
Unlike conventional streptococci, enterococci easily grow in presence 
of bile and 6.5% NaCl. They can hydrolyze esculin that discriminates them 
from other streptococci. 
S. pneumonia or pneumococci are gram-positive lancet-shaped 
diplococci. They develop alpha-hemolysis on blood agar. Their growth is 
inhibited by anti-microbial agent optochin. Also pneumococci are readily 
lysed in bile-containing media. 
S. pneumonia is typed by capsular polysaccharide antigen into more 
than 90 serovars. 
For rapid pneumococcal identification the slide microscopical test of 
capsule swelling is used. The specimen is treated by polyvalent antiserum 
that results in swelling of polysaccharide microbial capsule. 
Streptococcal susceptibility testing is performed by disk diffusion and 
broth dilution methods. 
 
 
Treatment and Prophylaxis of Streptococcal Infections 
 
Beta-hemolytic group A streptococci are sensitive to benzylpenicillin, 
macrolides and azalides. Early treatment of streptococcal infections with 
penicillin interrupts autoimmune response against streptococcal antigens 
thus preventing poststreptococcal glomerulonephritis and rheumatic fever. 
Benzylpenicillin (penicillin G) or ampicillin remain the drugs of 
choice for treatment of pneumococcal diseases caused by fully sensitive 
pneumococcal isolates; but penicillin-resistant strains gradually arise. 
Enterococcus spp. is extremely resistant to many antibiotics. The 
bacteria display intrinsic resistance to most of beta-lactams, including 
cephalosporins. Also they are resistant to sulfonamides (co-trimoxazole) 
and develop medium resistance to fluoroquinolones and aminoglycosides. 
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Combination of penicillinase-sensitive penicillins (benzylpenicillin, 
ampicillin) or vancomycin with aminoglycosides is regarded as the optimal 
therapy of enterococcal infections. 
For specific prophylaxis of pneumococcal diseases in children and 
adults various kinds of pneumococcal vaccines are actively used now. 
The most common are pneumococcal conjugate vaccine (PCV13) 
containing antigens of 13 bacterial types and pneumococcal 
polysaccharide vaccine (PPSV23) against 23 types of pneumococci. They 
successfully prevent the development of pneumococcal infections. 
For prophylaxis of group A streptococcal infections an experimental 
chemical vaccine, containing various M proteins of group A streptococci is 
being worked out. 
 
 
 
 
PATHOGENIC PSEUDOMONADS AND  
OTHER NONFERMENTING GRAM-NEGATIVE BACTERIA 
 
 
Aerobic nonfermenting gram-negative bacteria comprise the group of 
pathogens that hold the leading positions as causative agents of human 
hospital-acquired (or nosocomial) infections. These bacteria belong to the 
related microbial families Pseudomonadacea, Xanthomonadaceae, 
Moraxellaceae, and Burkholderiaceae. 
Within this group the limited number of microbial species, namely 
Pseudomonas aeruginosa, Acinetobacter baumannii, and 
Stenotrophomonas maltophilia, demonstrate the highest clinical 
relevance.  
They provoke severe complications, suppurative and wound infections 
in patients of intensive care units, burn centers and surgery departments. 
Moreover, all of them demonstrate the extreme levels of resistance to 
antimicrobial agents. 
Pseudomonas aeruginosa is the most common life-threatening 
pathogen. Normally, it is a saprophytic microbe that can be foumd on 
human skin and mucosal tissues, but it causes serious outbreaks of 
nosocomial infections especially in patients with suppressed immunity. 
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The History of Discovery 
 
Initial description of Pseudomonas aeruginosa was presented by 
French pharmacist Carle Gessard as far back as in 1882. 
Similarly, first representatives of Acinetobacter genus were discovered 
by M.W. Beijerinck in 1911. Nevertheless, active study of multidrug-
resistant acinetobacters, e.g., Acinetobacter baumannii, commenced only 
from early 1990s. 
First type strain of Stenotrophomonas maltophilia was isolated in 1958 
by R. Hugh. 
 
 
 
Classification of Nonfermenting Gram-negative Bacteria 
 
Pseudomonas aeruginosa pertains to the family Pseudomonadacea, 
genus Pseudomonas. 
Stenotrophomonas maltophilia is the member of Xanthomonadaceae 
family. 
Pathogenic species from Acinetobacter genus A. baumannii and 
A. baylyi belong to the family Moraxellaceae. 
Finally, pathogenic representatives of Burkholderiaceae family 
Burkholderia cepacia cause hospital-acquired infections; zoonotic agents 
B. mallei cause glanders, and B. pseudomallei – melioidosis. 
 
 
 
Structure and Properties of Pseudomonas aeruginosa 
 
Morphology 
Pseudomonas aeruginosa is the major pathogen from the group of 
nonfermenting gram-negative bacteria. Pseudomonads are small gram-
negative rods measuring about 2 m. They are single non-sporeforming 
motile bacteria with one polar flagellum. Multiple pili and fimbriae 
promote microbial attachment to epithelial cells.  
Multiple mucoid strains typically isolated from patients with cystic 
fibrosis produce large amounts of alginate exopolysaccharide that 
enwrapps bacterial cells. 
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Cultivation 
Pseudomonads grow well on basic nutrient media. P. aeruginosa can 
propagate at 42°C. 
During cultivation P. aeruginosa display smooth or mucoid round 
greenish colonies. The color of colonies results from overproduction of 
non-fluorescent bluish pigment pyocyanin; in lesser extent the bacteria 
produce fluorescent green pigment pyoverdin, ruby-colored pigment 
pyorubin or the black pigment pyomelanin. 
All pseudomonads actively form biofilms on adjacent surfaces due to 
the extensive production of adhesive exopolysaccharides. 
Certain P. aeruginosa isolates can cause hemolysis. 
Selective media for culture of P. aeruginosa contain various 
substances (e.g., cetrimide or acetamide) that support selective growth of 
pseudomonads.  
 
Biochemical properties 
Pseudomonads are obligate aerobes. They don’t ferment but oxidize 
glucose. These bacteria produce oxidase and catalase. 
P. aeruginosa liquefy gelatin and hydrolyze casein without formation 
of H2S or indole, and reduce nitrates to nitrites. 
 
Antigenic structure 
Antigenic epitopes of pseudomonads are localized predominantly 
within lipopolysaccharides of the cell wall (group-specific somatic O-Ag) 
and microbial flagellar proteins (type-specific H-Ag). 
 
Virulence factors 
P. aeruginosa expresses the broad scope of virulence factors.  
The bacteria possess the structures of type II, III and VI secretion 
systems that deliver virulence proteins into affected cells. 
Multiple adhesins promote tight microbial attachment to the cells and 
tisuues. 
Bacterial exopolysaccharides protect bacteria from phagocytosis and 
create the ground for biofilm formation. 
Cell wall lipopolysaccharides possess endotoxin activity. 
P. aeruginosa synthesize exotoxin A, which blocks protein synthesis 
by ribosylation of cellular elongation factor 2 (EF-2). 
Exotoxins ExoU (phospholipase), ExoY (adenylate cyclase), ExoS and 
ExoT (ribosyltransferases) inhibit separation of cells after their division 
(cytokinesis) thereby grossly hampering the wound healing.  
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Hemolysins (phospholipase C and lipase) directly damage cell 
membranes. 
The variety of agressive exo-enzymes (collagenase, elastase, 
proteases) destroys the components of connective tissue and intercellular 
tight junctions. Neuraminidase hydrolyzes host sialic acids. 
Microbial siderophores provide iron supply for bacterial cells. 
Most of pseudomonads produce bacteriocins (pyocins). 
Finally, P. aeruginosa has remarkable and highly versatile 
mechanisms of natural multidrug resistance to antibiotics, antiseptics and 
disinfectants.  
For instance, primary mechanism of resistance rests on extremely poor 
permeability of bacterial LPS for β-lactam antibiotics. Their transport 
across the cell wall is possible only through the porin channels within 
bacterial envelope. Frequent mutations of porin proteins lead to blockade 
of β-lactam entry into microbial cells.  
Furthermore, P. aeruginosa maintain extensive reverse transport (or 
efflux) of antimicrobial agents outside to the microbial cell. At least 4 
separate systems of efflux provide active backward transportation of 
multiple antibiotic classes – β-lactams, fluoroquinolones, aminoglycosides, 
and tetracyclines.  
In addition, P. aeruginosa express β-lactamase enzymes encoded by 
chromosomal and plasmid genes. Among them there are metallo-β-
lactamases that confer resistance to all β-lactams including carbapenems. 
 
Resistance 
P. aeruginosa reveals substantial resistance in the environment. It 
stays viable in tap water for 2.5 months, in distilled water – up to 1 year, in 
home dust – for several days. P. aeruginosa can survive even in diluted 
disinfectants such as quaternary ammonium compounds as the bacterium is 
resistant to many antibiotics and antiseptics. Nevertheless, it remains 
sensitive to chlorine-contaning biocides and 2% phenol solution. Similarly, 
the cells of P. aeruginosa easily lose their viability under the routine 
sterilization by heating or autoclaving. 
 
 
Pathogenesis and Clinical Findings of P. aeruginosa Infections 
 
Pseudomonads are widely distributed in nature. They inhabit soil, 
water, and colonize plants and animals. As the external environment plays 
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a substantial role in spread of P. aeruginosa, the infections caused by these 
bacteria are referred to as sapronoses.  
Despite the presence of potent virulence factors, P. aeruginosa rarely 
cause infections in immunocompetent host. In addition, the bacteria need a 
pre-existing injury of skin and mucosal tissues for successful adherence 
and colonization like in patients with wounds, burns, traumas and other 
lesions. By production of ExoT toxin P. aeruginosa inhibits cytokinesis 
and cell proliferation, thus preventing the closure of wound edges and 
maintaining conditions for microbial propagation. 
As the result, P. aeruginosa infections evolve only in patients with 
different injuries, implanted prosthetic devices, chronic surgical diseases 
and tumors with impaired local and systemic immunity, or after 
immunosuppression. These persons usually stay in hospital intensive care 
units and departments of surgery for a long time. 
Hence, P. aeruginosa is a leading nosocomial pathogen covering 
about 15% of all hospital-acquired infections. 
P. aeruginosa colonizes integument tissues and penetrates into the 
skin or mucous membranes that can initiate bacterial dissemination. 
The most common sources of P. aeruginosa-associated nosocomial 
infections are the hospital microbial carriers (e.g., patients or medical 
personnel). 
The major transmission routs – airborne (via contaminated aerosoles) 
or by direct contact. 
Bacteria cause a plethora of local and generalized infectious processes, 
including wound suppurative infections, abscesses and phlegmons with 
blue-green purulent discharge, osteomyelitis, otitis, meningitis, urinary 
tract infections. 
Severe disseminative infections result in sepsis with septic shock, 
hemorrhagic skin necrosis, disseminated intravascular coagulation, and 
adult respiratory distress syndrome. 
P. aeruginosa is the main agent, causing so-called ventilator-
associated pneumonia (VAP) – severe lung injury in patients receiving 
mechanical lung ventilation.  
Systemic infections and VAP are characterized by high mortality rate 
in the range of 40-50%. 
A special case of P. aeruginosa infection is observed in patients with 
cystic fibrosis – inherited autosomal recessive disorder associated with 
impaired mucociliary clearance. These patients are highly sensitive to 
P. aeruginosa demonstrating deep chronic course of disease with worse 
prognosis. 
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All these clinical cases are strongly aggravated by natural multidrug 
resistance of P. aeruginosa strains. 
 
Laboratory Diagnosis of P. aeruginosa Infections 
 
The specimens are obtained from wound discharge, pus, urine, blood, 
spinal fluid, sputum, etc. 
Microscopy reveals single gram-negative rods. 
Microbial culture isolation is performed on blood agar and selective 
media with antiseptics (cetrimide, acetamide, and others). 
Identification is based on the morphology of colonies with the 
presence of characteristic pigments, biochemical and antigenic properties. 
P. aeruginosa is an oxidase-positive bacterium able to grow at 42°C. 
Differentiation from other pseudomonads is possible by biochemical tests, 
serotype determination and pyocin typing (see table 1). 
 
Table 1  
Basic differential tests for pseudomonads  
 
 
Test 
Species 
P. aeruginosa P. fluorescens P. putida 
Cytochrome oxidase  + + + 
Pyocyanin pigment + – – 
Fluorescence  + + + 
Glucose oxidation  + + + 
Acetamide culture + – + 
Growth at 5
0С – + – 
Growth at 42
0С + – – 
Gelatinase  + + – 
 
For epidemiological purposes molecular genetic typing of 
P. aeruginosa isolates is conducted by various PCR-based tests. 
 
 
Treatment and Prophylaxis of P. aeruginosa Infections 
 
The treatment of infections caused by P. aeruginosa is extremely 
difficult clinical condition that ensues from multidrug-resistant nature of 
these agents. They show the resistance actually to the most efficient 
antimicrobials (e.g., carbapenems in more than 50-60% of cases) retaining 
sensitivity only to polymyxin group members.  
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As standard treatment regimen carbapenems are applied in 
combination with respiratory fluoroquinolones (levofloxacin). Also anti-
pseudomonad cephalosporins (cefepime) and aminoglycosides (amikacin) 
can be administered.  
Multiresistant strains of P. aeruginosa are cured with polymyxin E (or 
colistin) – about 95% of strains remain sensitive. 
Specific treatment with anti-pseudomonad immunoglobulin is 
possible. For specific immunization inactivated polyvalent pseudomonad 
vaccine can be used with uncertain results. Specific prophylaxis is 
recommended for high-risk patients and in case of P. aeruginosa infection 
outbreaks. 
 
 
Other Representatives of Nonfermenting Gram-negative Bacteria 
– Acinetobacter baumannii and Stenotrophomonas maltophilia  
 
Acinetobacter baumannii is the next common nosocomial pathogen 
pertaining to the group of nonfermenting gram-negative bacteria.  
Since 1970s the number of multidrug-resistant strains of A. baumannii 
constantly arises. These bacteria are ubiquitous in nature being broadly 
found in soil and water. Also they are normal habitants of human skin. 
The bacteria don’t affect immunocompetent hosts and cause serious 
hospital-acquires infections only in immunocompromised individuals. 
These pathogens become associated with ventilator-associated pneumonia 
in patients receiving artificial lung ventilation. Also they cause nosocomial 
endocarditis, meningitis, peritonitis, urinary tract infections and 
septicemia. 
The hallmark of hospital isolates of A. baumannii is their striking 
multiple resistance to antimicrobial agents. It is encoded by the number of 
pathogenicity islands with transposable genetic elements (integrons and 
transposons). The bacteria actively exploit the basic mechanisms of drug 
resistance – poor permeability of bacterial envelope, alterations of 
ribosomal structure, intensive drug efflux and synthesis of highly active β-
lactamases including extended-spectrum beta-lactamases (ESBL) and 
metallo-β-lactamases. 
As the result, A. baumannii renders multidrug resistance to β-lactams, 
aminoglycosides, fluoroquinolones, tetracyclines and co-trimoxazole. 
Carbapenems are the current drugs of choice for treatment of 
A. baumannii infections as more than 95% of strains remain sensitive to 
them. 
 32 
Similarly, Stenotrophomonas maltophilia is one more nosocomial 
pathogen of considerable medical notoriety that develops outstanding 
multidrug resistance. 
These microorganisms are also ubiquitous in nature being present in 
soil, water, various foodstuffs. They may colonize human nasopharingeal 
cavity and intestine. 
S. maltophilia are intrinsically resistant to β-lactams including 
carbapenems, aminoglycosides, fluoroquinolones, tetracyclines, 
chloramphenicol. The mechanisms of resistance are generally similar to 
above described pathogens. 
Like acinetobacters, stenotrophomonads affect immunocompromised 
individuals resulting in severe opportunistic infections. High-risk group 
for infection comprises the patients of intensive care units, premature 
infants, cancer patients, HIV-infected persons in stage of AIDS and others. 
The bacteria are transmitted mainly by airborne route. They cause 
hospital-acquired pneumonia and systemic infection (sepsis) with high 
mortality rate. They can provoke also catheter-associated infections, 
microbial endocarditis, peritonitis, wound infections. 
The treatment of S. maltophilia-associated disorders is performed with 
co-trimoxazole, combined β-lactams (e.g. ticarcillin/clavulanic acid) and 
selected fluoroquinolones (levofloxacin or moxifloxacin). 
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Chapter 2 
CAUSATIVE AGENTS OF SUPPURATIVE, WOUND  
AND HOSPITAL-ACQUIRED ANAEROBIC INFECTIONS 
 
 
PATHOGENIC CLOSTRIDIA –  
CAUSATIVE AGENTS OF GAS GANGRENE 
 
 
Gas gangrene is the severe polymicrobial wound infection. It is 
caused by various clostridial anaerobic microflora in association with 
pathogenic facultatively anaerobic bacteria (staphylococci, streptococci, 
gram-negative rods, etc.) 
 
 
The History of Discovery 
 
The major causative agent of gas gangrene Clostridium perfringens 
was first isolated by W. Welch and G. Nuttall in 1892. 
About 15 years earlier in 1877 the first member of gas gangrene group 
Clostridium septicum was discovered by L. Pasteur and J. Joubert. Then 
R. Koch confirmed its ability to cause gas gangrene with edema. 
In 1894 F. Novy described another clostridium species, which was 
later named as Clostridium novyi. 
Finally Clostridium hystolyticum was identificated in 1916 by 
M. Weinberg and P. Seguin. 
 
Classification of Pathogenic Clostridia 
 
Clostridia of gas gangrene belong to the family Clostridiaceae, genus 
Clostridium. Among the disease causative agents are the species 
Clostridium perfringens, C. novyi, C. septicum, C. hystolyticum as well as 
C. sordelli, C.  fallax, C. ramosum and some others. 
 
Structure and Properties of Clostridia 
 
Morphology 
C. perfringens is typically gram-positive thick non-motile rod with 
rounded ends. It possesses oval spore of central or subterminal localization 
and forms capsule within the infected host. 
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C. novyi are rod-shaped motile peritrichous bacteria with subterminal 
spores. It doesn’t form capsule. 
C. septicum are polymorphic non-capsulated rods that can develop 
long filamentous forms. Microorganisms carry central or subterminal spore 
and peritrichous flagella. 
C. hystolyticum in morphology is similar with previous two 
representatives. 
 
Cultivation 
C. perfringens is found to be the most aerotolerant among all other 
clostridia. Similar to other anaerobic bacteria, it is cultured on iron sulfite 
agar, Schaedler agar and glucose blood agar in anaerobic jars, Kitt-Tarozzi 
and other anaerobic media. 
C. perfringens is able to blacken iron sulfite agar within first 6-8 h of 
cultivation. 
In Kitt-Tarozzi medium C. perfringens renders homogenous turbidity 
with gas production. 
C. novyi, C. septicum and C. hystolyticum are strictly anaerobic 
bacteria. On glucose blood agar C. novyi form rough fringed colonies with 
hemolysis. 
C. septicum is cultured readily in meat-peptone broth. The bacteria 
develop a film on glucose blood agar. In agar stab cultures the colonies 
look like balls of wool. 
 
Biochemical properties 
All clostridia are obligate anaerobes. 
C. perfringens ferments glucose, sucrose, lactose, starch, and many 
other sugars with large amounts of acid and gas end products. They liquefy 
gelatin, coagulate blood serum and milk resulting in sponge-like clot. 
These bacteria reduce nitrates to nitrites. They produce butyric and acetic 
acids and large amounts of gases CO2, H2, H2S and others. 
C. novyi ferments glucose, maltose and glycerol with acid and gas 
production. They also liquefy gelatin and coagulate milk with small flakes. 
C. septicum slowly liquefies gelatin, and utilize proteins with 
appearance of hydrogen sulfide and ammonia. Several mono- or 
disaccharides are metabolized with acid and gas formation 
C. hystolyticum doesn’t ferment sugars but reveals substantial 
proteolytic activity. 
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Antigenic structure 
Serologic differentiation of C. perfringens is based on the antigenic 
variations of microbial toxins. Six main serovars A, B, C, D, E, and F are 
known. Type A is further divided into many subtypes. Types A, C and D 
are pathogenic for humans; B, C, D, and E affect animals. 
C. novyi comprises 4 antigenic variants A, B, C, and D, where A type 
is the predominant pathogenic variant for humans. 
C. septicum can be distinguished into 6 serovars according to their 
exotoxins. 
C. hystolyticum has 5 antigenic variants, depending on toxin structure 
differences. 
 
Virulence factors 
All clostridia produce extreme variety of virulence factors that 
predominantly display potent enzymatic activity. 
-Toxin of C. perfringens or phospholipase C displays high 
lecithinase activity that damages cell membranes, enhances vascular 
permeability and develops necrotizing activity. 
-Toxin is a potent necrotizing substance; -toxin increases vascular 
permeability in the gastrointestinal tract. 
-Toxin or perfringolysin O demonstrates polyfunctional hemolytic, 
dermonecrotizing and lethal properties. 
Other minor toxins also possess enzymatic properties. For instance, -
toxin acts as collagenase, -toxin – hyaluronidase, -toxin develops 
hemolytic activity. 
In addition, C. perfringens expresses potent enterotoxin. 
C. novyi produces at least 8 distinct toxins with hemolytic, lecithinase, 
protease and hyaluronidase activities. 
C. septicum has 4 major toxins: -toxin with lethal, hemolytic and 
necrotizing activity, -toxin with DNase activity, -toxin is hyaluronidase 
and -toxin is hemolysin. 
C. hystolyticum expresses 5 toxins, among them are -toxin with 
lethal and necrotizing activity, -toxin with collagenase activity, -toxin 
with protease activity, -toxin with elastase activity, and -toxin renders 
hemolytic activity. 
 
Resistance 
The spores of C. perfringens withstand boiling for time period of 8 to 
90 minutes. The vegetative forms are most susceptible to hydrogen 
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peroxide and phenol in concentrations commonly employed for 
disinfection. 
Spores of C. novyi survive in natural surroundings for a period of 20-
25 years without losing their virulence. Direct sunlight kills them in 24 
hours, boiling destroys them in 10-15 minutes. Spores withstand exposure 
to a 3% solution of formaldehyde for 10 minutes. 
 
 
Pathogenesis and Clinical Findings in Gas Gangrene 
 
Clostridia stay in the intestine of animals and humans (as sources of 
infection) and discharge outside with feces. Spores of clostridia are 
constantly present in the soil. Hence, any contact with dust and soil 
particles inevitably results in contamination of skin and mucosal tissues 
with clostridial spores. 
Gas gangrene develops, when grossly damaged soft tissues (muscles, 
adipose or connective tissue) become infected with spores of 
С. perfringens and other clostridia; it occurs in severe trauma with tissue 
crash, after septic abortion, in case of war wounds, or other similar 
situations. 
Therefore, clostridial infection is predominantly transmitted by 
contact route. 
The causative agents of anaerobic infections require certain conditions 
for their germination and overgrowth. The basic one is the presence of 
dead or damaged tissues resulting in low oxidation-reduction potential 
(state of anaerobiosis). Characteristic type of injury (deep narrow wounds 
or contaminated crashed tissues) as well as patient state of health 
predisposes to the emergence of gas gangrene (for instance, diabetes 
mellitus strongly impairs tissue oxygenation). 
Progressive propagation of pathogenic anaerobes leads to further 
degradation of body tissues thus aggravating anaerobic conditions. 
Active spread of infection ensures relatively short incubation period – 
from several hours up to 4-5 days. 
Gas gangrene targets primarily muscles and adipose tissue as they 
harbor a lot of potential substrates for microbial toxic enzymes (e.g., 
glycogen or phospholipids). As the result, exotoxins of clostridia cause 
expanding tissue necrosis and melting. It is followed by accumulation of 
gases like СО2 and Н2 in soft tissues that is detected as gas gangrene.  
Growing edema blocks local circulation, thereby enhancing anaerobic 
conditions and toxin production. 
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Edema is characteristic for the first phase of the infection, and 
gangrene of the soft tissues progresses in the second phase. 
Microbial exotoxins generate both local and systemic devastating 
effects, being spread throughout the body. The products of tissue decay 
render additional toxicity against host tissues. 
As the result of massive edema and tissue necrosis with gas formation, 
the skin over the affected limbs becomes pale, then reddish and cyanotic 
with extensive hemorrhages. Deep destructive changes in subcutaneous 
adipose tissue, muscles, and fascias require urgent surgical treatment and 
systemic antimicrobial and antitoxic therapy. 
The immunity arisen in the course of anaerobic clostridial infections is 
maintained predominantly by antitoxic antibodies. They neutralize the 
activity of multiple microbial toxins. However, the immune response is 
non-protective being of low grade. Without complex intensive treatment it 
is impossible to prevent the rapid disease progression.  
Besides gas gangrene development, C. perfringens may cause severe 
necrotizing enteritis followed by deep damage of small intestine. It ensues 
from the action of clostridial β-toxin with potent cytotoxic and necrotizing 
activity. 
In addition, C. perfringens are not so rare agents of food poisonings 
(or food toxinfections). These disorders are related with production of 
enterotoxins by clostridia. 
 
 
Laboratory Diagnosis of Gas Gangrene 
 
The specimens for examination comprise the pieces of necrotic 
tissues, tissue fluids and wound discharges, surgical stitch materials, 
dressings, etc.  
As preliminary test, microscopical examination of wound discharge 
for C. perfringens or other clostridia is made on the ground of their typical 
morphological characteristics. Also immunofluorescence microscopy can 
be applied for direct identification of clostridia in clinical samples. 
Culture isolation is elaborated in anaerobic conditions (e.g., in 
anaerobic jars). Identification of microbial species takes into account their 
growth on iron sulfite agar, fermentation of carbohydrates, gelatin 
liquefaction and other biochemical tests, microbial serological properties. 
To confirm the diagnosis, experimental injection of mice with broth 
culture filtrates for exotoxin detection as well as antitoxin-toxin 
neutralization reactions are performed. 
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Rapid diagnostic test for detection of clostridial exototoxins in clinical 
samples are based on ELISA test or indirect hemagglutination assay with 
erythrocyte antitoxic diagnosticum. 
Genetic typing of clostridia species is performed by PCR. 
 
 
Treatment and Prophylaxis of Gas Gangrene 
 
Treatment of gas gangrene comprises the intensive surgical 
management of wounds and injuries with removal of affected tissues up to 
limb amputations, massive antibiotic chemotherapy against anaerobic 
infection (e.g., with β-lactams, aminoglycosides, and metronidazole), 
infusion and detoxification therapy, administration of polyvalent purified 
and concentrated antitoxin against C. perfringens and other clostridia. 
Hyperbaric oxygen therapy, blood transfusions and administration of 
inhibitors of proteolytic enzymes are the additional supportive measures 
for gas gangrene treatment. 
Prophylaxis of gas gangrene is non-specific. It primarily includes the 
protection of wounds and injuries from contamination and their adequate 
surgical treatment. 
 
 
CLOSTRIDIUM TETANI – CAUSATIVE AGENT OF TETANUS 
 
The History of Discovery 
 
A causative agent of tetanus was described first by A. Nicolaier in 
1884, and isolated the pure culture by S. Kitasato in 1889. 
 
Classification 
 
Tetanus causative agent pertains to the family Clostridiaceae, genus 
Clostridium, species C. tetani. 
 
Structure and Properties of C. tetani 
 
Morphology 
Clostridium tetani is a thin gram-positive rod about 5 μm in length. It 
is a motile Peritrichous bacterium with round terminal spore. Spore-
containing cells resemble drumsticks. 
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Cultivation 
The temperature range for optimal propagation of C. tetani is 15-45°C. 
Usually it grows on the blood or sugar agar, pH 7.0-8.0 at 37°C being 
cultured in anaerobic conditions within anaerobic jars. At the end of 
cultivation small smooth colonies surrounded by slight zones of hemolysis 
are observed. The view of colonies resembles dew drops. 
When cultured within the deep agar stabs, fragile cloud-like colonies 
appear. Cultivation in Kitt-Tarozzi medium results in homogenous 
turbidity with gas production. 
 
Biochemical properties 
As any other clostridia, C. tetani is obligate anaerobe. It demonstrates 
generally poor biochemical activity. Tetanus causative agent doesn’t 
ferment carbohydrates. Nevertheless, these bacteria liquefy gelatin, 
coagulate milk, and reduce nitrates to nitrites. 
 
Antigenic structure 
Clostridium tetani is divided into 10 serotypes accroding to variations 
of flagellar H-antigen. Somatic O-antigen is group-specific. Microbial 
exotoxin has common antigenic properties in all C. tetani. 
 
Virulence factors 
C. tetani expresses highly poisonous exotoxin composed of two 
fractions: tetanospasmin that causes the contraction of skeletal muscles, 
and tetanolysin, which produces hemolysis. 
The lethal activity of tetanus exotoxin succumbs only to the action of 
the most potent botulotoxin – one mouse lethal dose of dry tetanus toxin is 
about 5 ng. The mortal dose for humans is near 2-2.5 ng per 1 kg of body 
weight. 
Tetanospasmin is Zn-containing metal protease that destroys synaptic 
vesicle-associated protein and synaptobrevin in the synapses of inhibitory 
neurons of central nervous system resulting in generalized muscular 
spasms. 
Tetanolysin is the membrane-damaging fraction of exotoxin with 
hemolytic and cardiotoxic properties. Also it affects medullar nuclei and 
the neurons of autonomic nervous system. 
 
Resistance 
Heating at 60-70°С inactivates vegetative forms of clostridia within 30 
minutes. The bacteria are sensitive to conventional disinfectants. 
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The spores are extremely resistant and keep viability in soil and dust 
for many years. They can withstand boiling for more than 1 hour. Standard 
disinfectants, such us 5% phenol or 1% formaldehyde inactivate clostridia 
spores only after 5-10 h of exposure. 
 
 
Pathogenesis and Clinical Findings in Tetanus 
 
C. tetani is the normal inhabitant of human and animal gut. Animals 
and humans are the major sources of infection. Spores of clostridia appear 
in the soil with feces and may stay there for years. 
Microorganisms enter the body through the injured skin or mucous 
membranes via soil-contaminated wounds or skin lesions (contact route of 
the disease transmission). More often the disease affects children or 
agriculture workers. 
C. tetani multiply in the site of primary contact and release exotoxin. 
Toxin undergoes retroaxonal or perineural lymphatics transport and moves 
into the spinal cord. It binds to ganglioside receptors of neurons, penetrates 
into the synapses and blocks the release of inhibitory neuromediators 
(glycin and γ- aminobutyric acid). 
Impairment of inhibitory signalling leads to uncontrolled stimulation 
of neuromuscular synapses of motor neurons that elicits tonic or myoclonic 
striated muscle contractions. 
At the primary site of pathogen penetration persistent tonic muscular 
cramps are observed. The symptoms arise in descending order. At first the 
disease affects jaw muscles with tonic spasms (trismus) and face muscles 
(risus sardonicus). Then the back muscles and limbs are involved. 
Generalized tetanus muscular spasm is known as opisthotonus. 
The disease prognosis is very serious. In case of delay of treatment the 
developed tetanus results in lethal outcome in 40-50% of cases. 
Anti-toxic natural immunity is very weak and can’t prevent next 
tetanus infection. 
 
 
Laboratory Diagnosis of Tetanus 
 
In most of cases the clinical findings of tetanus are enough evident to 
make correct diagnosis. 
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For laboratory confirmation of the diagnosis of tetanus the specimens 
of wound discharge, biopsy tissue samples, or stitch material can be 
examined. 
Investigation of tetanus toxin in clinical samples is performed by 
ELISA test, or by indirect hemagglutination test with erythrocyte anti-
tetanus diagnosticum, or by neutralization reaction in mice. 
For culture isolation the specimens should be previously heated at 
80°С for 20 min to inactivate non-sporeforming bacteria. Then they are 
inoculated into Kitt-Tarozzi medium or upon blood agar that is placed into 
anaerobic jar. After several days of incubation the grown colonies undergo 
microscopy. Toxin accumulation is evaluated by experimental mice 
infection. The diagnosis is confirmed by neutralization reaction with anti-
tetanus antibodies. 
 
 
 
Treatment and Prophylaxis of Tetanus 
 
Urgent prophylaxis of the disease depends on the level of initial 
antitoxic immunity of affected person. Prophylaxis covers all patients with 
traumas, burns, animal bites, etc. 
Previously vaccinated individuals are immunized with tetanus toxoid. 
Non-immune patients obtain tetanus toxoid and human antitoxic anti-
tetanus immunoglobulin. 
For treatment of developed tetanus the high doses of human antitoxic 
tetanus immunoglobulin or horse antitoxic serum are used. In addition, 
anticonvulsive drug therapy is administered (diplacine, aminazine, 
diazepam, etc.) 
Organized active prophylaxis is performed by vaccination with 
tetanus toxoid. The toxoid is an essential constituent of complex ADPT 
polyvaccine (adsorbed diphtheria, pertussis, tetanus vaccine with 
aluminum hydroxide as adjuvant) or of combined toxoid preparation ADT. 
Tetanus is the completely preventable disease. 
The vaccination starts and repeated thrice at the first year of life. 
Subsequent booster is injected in 9-12 months and then reproduced every 
10 years. 
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CLOSTRIDIUM DIFFICILE –  
CAUSATIVE AGENT OF PSEUDOMEMBRANOUS COLITIS  
 
 
The History of Discovery 
 
Initial description of Clоstridium difficile was given by I.C. Hall and 
E. O’Tool in 1935. Nonetheless, etiological role of C. difficile in the 
development of pseudomembranous colitis and antibiotic-associated 
diarrheas was established by J.G. Bartlett only in 1977. 
 
 
Structure and Properties of C. difficile 
 
Morphology 
Clоstridium difficile is a motile gram-positive rod with round 
subterminal spore. Some strains may carry thin capsule. 
 
Cultivation 
Similar to other clostridia, they grow on the blood agar in anaerobic 
jars resulting in round-shaped middle-size colonies without hemolysis. 
A selective and differential medium for C. difficile culture is 
cycloserine-cefoxitin fructose agar. Antibiotics cycloserine and cefoxitin 
suppress the growth of concomitant microflora. After overnight incubation 
in anaerobic conditions the growth of yellow fructose-positive colonies is 
observed. 
 
Biochemical properties 
These clostridia are chemically active and ferment various 
carbohydrate substrates (e.g., glucose, fructose, mannitol and others). They 
are able to liquefy gelatin. Combined mannitol fermentation and gelatin 
liquefaction distinguishes C. difficile from other clostridia. 
 
Antigenic structure 
C. difficile possess somatic polysaccharide and protein flagellar 
antigens as well as produce exotoxins with marked antigenicity. All 
members of C. difficile species express species-specific antigen – enzyme 
glutamate dehydrogenase. 
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Virulence factors 
The main virulence factors of C. difficile are exotoxins A and B with 
enzymatic glycosyltransferase activity. When entered into enterocytes, 
they perform glycosylation of regulatory G-proteins (also known as “small 
GTPases”) thereby blocking their normal activities. This leads to 
disorganization of cellular metabolism, impairment of polymerization of 
actin cytoskeleton, resulting in cell rounding and final apoptosis. In 
addition, C. difficile exotoxins damage tight junctions between enterocytes. 
Exotoxin A (or enterotoxin) activates the apoptosis of enterocytes and 
stimulates the synthesis of proinflammatory cytokines within intestinal 
wall followed by its neutrophil infiltration. This increases the permeability 
of the intestine resulting in diarrhea and bowel inflammation.  
Similarly, exotoxin B (or cytotoxin) elicits apoptosis of enteric 
epithelial cells and impairs tight junctions between enterocytes that leads to 
progression of inflammatory diarrhea. 
Hospital strains of C. difficile often display multidrug resistance to 
antibiotics. 
 
 
Pathogenesis and Clinical Findings of Diseases 
 
C. difficile spores are widely present in natural environment. They 
maintain viability for a long time in the soil, water, or upon various 
fomites. 
Up to 3% of adult population are the carriers of C. difficile. However, 
most of these community-acquired clostridia are nontoxigenic. By contrast, 
about 20% of patients receiving antibiotic treatment at hospitals become 
the carriers of hospital-aquired toxigenic C. difficile. 
Hospital strains of C. difficile demonstrate enhanced virulence and 
multi-resistance to antimicrobial agents.  
In patients that stay at hospitals and receive antibiotic therapy 
C. difficile is found as etiological agent of 15-30% of all antibiotic-
associated diarrheas, and about 50-75% of all cases of antibiotic-
associated colitis with its severest clinical form pseudomembranous 
colitis. 
In majority of cases the source of C. difficile-associated infections is 
medical personnel of hospitals. That’s why the clinical disorders caused 
by C. difficile are generally ascertained as hospital-acquired infections. 
The spread of infection occurs via fecal-oral route. The predisposing 
factors to the contraction of C. difficile infection is the treatment of patients 
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with broad-spectrum antibiotics (β-lactam drugs – amoxycillin, 
cephalosporins, lincosamides – clindamycin, and to less extent – 
fluoroquinolones). 
Above indicated antimicrobial agents suppress normal microflora of 
gut and grossly deteriorate colonization resistance of intestinal epithelium. 
These conditions foster the intestinal adherence and propagation of 
hospital-acquired toxigenic C. difficile.  
The severety of colitis varies strongly, depending on toxin activities. 
The released microbial toxins exert direct cytotoxic effects on 
intestinal epithelial cells resulting in their apoptosis and stimulate the 
production of proinflammatory cytokines. This leads to inflammatory 
damage of intestinal wall with neutrophil infiltration, microhemorrhages 
and formation of pseudomembranes composed of fibrin, inflammatory and 
necrotic cells (pseudomembranous colitis). 
Bowel inflammation associated with death of intestinal epithelium and 
impairment of microcirculation breaks down the normal reabsorption of 
water and electrolites resulting in diarrhea and intestinal hemorrhages. 
The disease is also manifested by fever and intoxication; in most 
severe cases pseudomembranous colitis leads to the perforation of 
intestinal wall with subsequent peritonitis that strongly worsens clinical 
outcome. 
The immunity against C. difficile is weak and not stable; the recurrent 
infections are observed. 
 
 
Laboratory Diagnosis of Infections, Caused by C. difficile 
 
Antibiotic-associated colitis caused by C. difficile requires laboratory 
confurmation with isolation of infectious agent and assessment of its 
toxigenicity. 
Patient’s stool is examined as primary clinical specimen. 
Rapid method for indication of C. difficile in stool detects species-
specific microbial antigen – enzyme glutamate dehydrogenase – by 
ELISA test. 
Rapid tests that discover exotoxins of C. difficile in clinical samples 
are based on serological testing (ELISA tests and latex agglutination) and 
methods of molecular genetic analysis for toxin-encoding genes (e.g., 
PCR tests). 
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The presence of exotoxins in stool filtrates can be determined also by 
neutralization of toxin cytopathic effect with specific antitoxic antibodies 
in laboratory cell cultures.  
Isolation of C. difficile is performed on selective media (e.g., 
cycloserine-cefoxitin fructose agar, where the growth of yellow fructose-
positive colonies is observed). The bacteria are further identified by their 
specific biochemical and antigenic properties as well as antibiotic 
resistance.  
Toxigenicity of isolated culture is confirmed by serological (ELISA) 
and molecular genetic tests (PCR). 
 
 
Treatment and Prophylaxis of Pseudomembranous Colitis 
 
The treatment of pseudomembranous colitis presumes the immediate 
cessation of current antibiotic therapy and administration of antimicrobial 
agents efficient against C. difficile. The drug of the first line of treatment is 
metronidazole. Vancomycin can be administered as well.  
In order to ameliorate the curative effects of antibiotics and to prevent 
C. difficile infection flare-ups the probiotic-containing biological products 
are administered (the cultures of Lactobacillus acidophilus, 
Saccharomyces boulardii or other bacteria of certain clinical value). They 
entail antagonistic activity against C. difficile hospital strains and restore 
colonization resistance of intestinal epithelium. 
 
 
 
PATHOGENIC GRAM-NEGATIVE NON-SPOREFORMING 
ANAEROBIC BACTERIA  
 
 
Non-sporeforming anaerobic bacteria cause a great variety of bacterial 
infections. Usually they affect human tissues together with facultative 
anaerobic and aerobic microflora. Anaerobic bacteria dominate in several 
body compartments, primarily in the oral cavity and gastrointestinal tract 
but even the infections of respiratory tract are proven to be of 
polymicrobial origin, where anaerobes occur in more than 50% of cases. 
Since most of non-sporeforming anaerobes are the normal 
representatives of human flora, they can induce infectious inflammation 
only in high concentrations, or within normally sterile body cavities and 
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compartments, in immunocompromised patients, etc. Nosocomial strains 
of these bacteria demonstrate enhanced virulence and multidrug antibiotic 
resistance. 
 
 
Classification of Pathogenic Gram-negative Non-sporeforming 
Anaerobes 
 
Most of human anaerobic non-sporeforming pathogens pertain to 
related microbial families (see Table 2): 
Bacteroidaceae,  
Porphyromonadaceae,  
Prevotellaceae,  
Fusobacteriaceae,  
Desulphovibrionaceae  
with their major genera and species: 
Bacteroides (major species are B. fragilis, В. ovatus, В. vulgatus, 
В. thetaiotaomicron); 
Porphyromonas (species P. gingivalis, P. endodontalis), 
Prevotella (species P. intermedia, P. melaninogenica, P. heparinolytica); 
Tannerella (major species is T. forsythia); 
Fusobacteria (species F. nucleatum, F. necroforum);  
Bilophila (species B. wadsworthia). 
 
 
Table 2   
Major medically relevant representatives of  
non-sporeforming gram-negative anaerobic bacteria  
 
 
Taxonomic ranks 
 
Normal body habitation and  
the role in pathology 
 
Family Bacteroidaceae 
Genus Bacteroides 
Species: 
B. fragilis, B. vulgatus, B. galacturonicus, 
B. coagulans, B. ovatus, B. pectinophilus, 
B. pyogenes, B. splanchnicus, B. thetaiotaomicron, 
B. uniformis, B. urealyticus and many others 
 
These bacteria represent a substantial 
part of microbiota of large intestine, oral 
cavity, and genital tract. 
They are isolated in wound infections, 
tissue abscesses, intra-abdominal and 
pelvic infections, osteomyelitis, sepsis 
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Family Fusobacteriaceae 
Genus Fusobacterium  
Species F. necroforum, F. nucleatum and others 
 
Fusobactria inhabit oral cavity, large 
intestine, and genital tract. 
They can be isolated from tissue 
abscesses, in cases of wound infections, 
endocarditis, sepsis, acute necrotizing 
ulcerative gingivitis 
  
 
Family Porphyromonadaceae 
Genus Porphyromonas 
Species: 
P. gingivalis, P. endodontalis, P. asaccharolytica,  
P. circumdentaria and many others 
 
Normal inhabitants of oral cavity, large 
intestine, vagina; commonly isolated in 
odontogenic infections and mixed 
infections after animal bites  
 
Family Porphyromonadaceae 
Genus Tannerella 
Species: 
T. forsythia 
 
Present in oral cavity; commonly 
isolated from dental pockets in cases of 
gingivitis and periodontitis 
 
Family Prevotellaceae 
Genus Prevotella 
Species: 
P. intermedia, P. melaninogenica, P. bivia, 
P. buccae, P. buccalis, P. corporis, P. dentalis, 
P. denticola, P. distens, P. heparinolytica, 
P. nigrescens, P. oralis, P. oris and many others. 
 
 
These bacteria inhabit oral cavity, large 
intestine, and genital tract; they can be 
isolated in various odontogenic 
infections (e.g., periodonititis), pelvic 
infections, tissue abscesses, and sepsis. 
 
Family Desulfovibrionaceae 
Genus Bilophila 
Species: 
B. wadsworthia and others 
 
These bacteria exist in large intestine, 
oral cavity, and genital tract and can be 
isolated in cases of appendicitis, 
cholecystitis, peritonitis, pericarditis, 
osteomyelitis, and sepsis 
 
 
 
Structure and Properties  
 
Morphology 
Bacteroides and related bacteria are gram-negative rods, albeit 
coccobacteria may occur. Certain microbial species can possess capsule 
and/or flagella. Fusobacteria render characteristic rod-like shapes with 
tapered ends. 
 
Cultivation 
All of these agents are anaerobic bacteria, but they develop different 
levels of oxygen tolerance. Some strains of bacteroids can survive at 1-2% 
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concentration of oxygen. Low oxidation-reduction potential promotes 
bacteroidal growth. 
Usually they are cultivated on blood agar with yeast extract and other 
growth factors (e.g., Schaedler anaerobe agar) within anaerobic jars better 
in atmosphere of 5-10% СО2. They grow slowly within 4-5 days. Some 
species (e.g. P. melaninogenica) produce black pigment. 
The representatives of genus Bacteroides are resistant to bile salts and 
penicillin that distinguishes them from other similar bacteria. 
 
Biochemical properties 
Strict anaerobes have no cytochrome systems and possess neither 
catalase, no superoxide dismutase enzymes. Nevertheless, bacteroides 
members express small amounts of catalase and superoxide dismutase that 
partially preserve bacteria from reactive oxygen radicals. 
Anaerobic bacteria gain energy from fermentation of different 
substrates. Bacteroids utilize vast number of carbohydrates producing the 
broad spectrum of acid end products. Also they metabolize pepton. 
 
Antigenic structure 
Antigenic structure is variable, depending on cell wall composition, 
capsule and flagella presence. 
 
Virulence factors 
Bacteroides produce destructive enzymes (hyaluronidase, collagenase, 
plasmin, heparinase, etc.) that cause tissue damage. 
B. fragilis produces exotoxin fragilysin. This toxin exhibits potent 
proteolytic activity destroying intercellular junctions between enterocytes. 
Cell wall lipopolysaccharides can activate leukocyte chemotaxis, but 
they are almost lack of endotoxin activity. Capsule layer of bacteroides 
preserves them from phagocytosis. 
Enzymes destroying antibacterial drugs (e.g., beta-lactamases) confer 
microbial resistance to antibiotics. Also bacteroides are resistant to 
aminoglycosides and demonstrate growing resistance to tetracyclines. 
 
Resistance 
Non-sporeforming anaerobic bacteria demonstrate generally low 
resistance to external influences. They are killed by heating at 65
oС in 
15 min, and in 1 min by boiling; when exposed to the opened air, they are 
irreversibly inactivated in 24-48 h. However, in feces they may stay viable 
up to 1 month. 
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Pathogenesis of Infections caused by Non-sporeforming  
Anaerobic Bacteria 
 
Bacteroides species are the major part of normal microflora of large 
intestine. Bowel injury and/or the increase of permeability of intestinal 
wall induce microbial spread towards peritoneal cavity that results in 
abdominal purulent inflammation followed by peritonitis or intestinal 
abscessing. 
B. fragilis demonstrates markedly enhanced virulence in comparison 
with other bacteroidal species. This pathogen represents only 0.5% of all 
microorganisms of large intestine, but it can be isolated in 30-60% of cases 
of anaerobic infections, especially in their intra-abdominal and wound 
localizations. 
This bacterium possesses the number of potent virulence factors. 
Among them are agressive enzymes hyaluronidase, proteases, and 
hemolysin. Together with enterotoxin fragilysin that destroys intercellular 
contacts of enterocytes they promote microbial leakage across the 
intestinal wall thus stimulating microbial invasiveness and spread from 
their primary sites. 
Capsular polysaccharide of B. fragilis triggers local pathological 
inflammatory response that leads to formation of tissue abscesses. 
As the result, B. fragilis takes an active part in peritonitis, intestinal 
and liver abscesses, appendicitis, abscesses of subcutaneous adipose tissue, 
endometritis, vulvar abscesses, trophic ulcers in diabetes patients, lung 
abscesses, anaerobic infections of central nervous system (brain abscesses 
and subdural empyema),  
Similar pathology can be caused by other bacteroidal species 
(B ovatus, B vulgatus, B. thetaiotaomicron, etc.) 
Severe anaerobic infections are also caused by the members of 
Bilophila and Fusobacterium genera. For instance, Bilophila wadsworthia 
is isolated in 50% of cases of appendicitis.  
Fusobacterium necroforum is relatively common in wound anaerobic 
infections. The rate of its isolation increases in systemic bacterial 
infections such as endocarditis, bacteremia and sepsis.  
Overall, usually five and more of bacterial species can be isolated 
from inflammatory site, including facultatively anaerobic and anaerobic 
bacteria. 
Oral cavity harbors large amounts of porphyromonads (P. gingivalis, 
P. endodontalis and others), prevotellas (P. intermedia, 
P. melaninogenica) and tannerellas (T. forsythia). In various combinations 
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with other microbial pathogens they actively contribute to progression of 
periodontites 
Porphyromonads can be isolated also in suppurative bacterial 
infections of various localizations. 
Likewise, members of prevotella species can affect female genital 
tract, causing pelvic inflammatory disease and tubo-ovarian abscesses. 
 
 
 
Laboratory Diagnosis of Anaerobic Infections 
 
The material is obtained in anaerobic conditions, e.g. by abscess 
puncture with syringe that contains appropriate medium for anaerobes 
(e.g., thioglycolic medium). The specimen should be transferred 
immediately into the sealed bottle with transport anaerobic medium and 
delivered to the laboratory within 1-1.5 h. 
Specimens, obtained from closed purulent foci, blood and 
cerebrospinal fluid are examined. 
Since various anaerobic species produce different spectra of short-
chain fatty acids they can be identified by gas-liquid chromatography. 
This method may be used for rapid diagnosis of anaerobic infection. 
Also rapid identification of non-sporeforming anaerobic bacteria in 
clinical specimens is performed by serological (ELISA) and molecular 
genetic tests (PCR). 
Anaerobes are cultivated upon blood agar, trypticase soy agar, brain-
heart infusion agar and other enriched media in anaerobic jars. The jars are 
usually supplied with disposable packets that produce hydrogen, and a 
catalyst that combines the hydrogen with any free oxygen to form water. 
Cultures are incubated at 35-37°C with addition of CO2. 
The microbial isolates are further identified by their morphology, 
cultural properties and biochemical activities. 
 
 
Treatment and Prophylaxis of Anaerobic Infections 
 
Prophylaxis of anaerobic infections is non-specific and includes 
adequate surgical treatment followed by drainage that ensures sufficient 
oxygen access to affected site. 
The most active antibiotics for treatment of anaerobic infections are 
metronidazole and clindamycin. Most of non-sporeforming anaerobic 
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bacterial strains are shown to develop no resistance to clindamycin and 
metronidazole. In severe cases of anaerobic infections carbapenems are 
successfully used. Sensitive strains are treated with other β-lactam 
antibiotics (e.g., penicillins and cephalosporins). 
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Chapter 3 
CAUSATIVE AGENTS OF ENTERIC BACTERIAL INFECTIONS: 
ESCHERICHIA COLI AND SHIGELLAE 
 
 
PATHOGENIC ESCHERICHIAE 
 
 
General Characteristics and the History of Discovery 
 
The typical member of Enterobacteriaceae family Escherichia coli is 
a widespread normal inhabitant of human intestinal tract. Escherichiae are 
permanently discharged into the environment from the gut of mammals, 
birds, amphibians and many other organisms. These bacteria can be 
isolated from water, soil and different foodstuffs, including dairy products. 
Escherichia coli and other coliform bacteria are defined as sanitary 
indicator microorganisms for these objects. 
German scientist T. Escherich discovered E. coli in 1885. 
 
 
Classification 
 
The family Enterobacteriaceae comprises about 50 genera. Among 
them Escherichia, Shigella, Salmonella, Yersinia, Klebsiella, Proteus, 
Morganella, Providencia are regarded as the most important in clinical 
practice. 
Escherichia genus encompasses at least 6 closely related species. 
Besides E. coli, Escherichia vulneris can be uncommonly found in wound 
infections and E. hermannii is rarely isolated from wounds, blood or 
cerebrospinal fluid (CSF). 
Escherichia coli species consists of several biotypes and great number 
of serotypes, which are discerned by their biochemical and antigenic 
properties. 
 
Structure and Properties of Escherichia coli 
 
Morphology 
Escherichia coli are small or middle-size gram-negative rod-shaped 
bacteria 1-3 m in length. During microscopy they are usually observed as 
single cells. 
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E. coli carry peritrichous flagella; nevertheless, non-motile microbial 
forms can be found. They possess numerous pili that promote microbial 
adherence, nutrition and gene exchange. Escherichiae as well as other 
enterobacteria have no spores, but can produce capsule. 
 
Cultivation 
All escherichiae can grow easily on basic nutrient media within 
standard temperature range 10-45°C at pH of 7.2-7.6. 
The growth on meat peptone agar (MPA) renders round convex 
smooth semi-transparent colonies. Meat peptone broth (MPB) cultivation 
results in diffuse turbidity followed by cell precipitation. 
As E. coli in most of cases utilize lactose, they form lactose-positive 
colonies, which are red on McConkey agar, Endo agar, and dark-blue on 
eosin-methylene blue (EMB) agar (i.e., Levine medium). 
Some E. coli strains produce hemolysin. 
 
Biochemical properties 
E. coli are facultative anaerobes with mixed type of metabolism. They 
ferment great number of carbohydrates (glucose, lactose, maltose, 
mannitol, galactose, and very rarely sucrose) with acid and gas end 
products. They metabolize proteins with indole formation, express lysine 
decarboxylase and reduce nitrates to nitrites. 
As all other members of the family Enterobacteriaceae, E. coli are 
oxidase-negative, but catalase-positive microorganisms. 
 
Antigenic structure 
E. coli carries a large variety of antigenic determinants of different 
origin. 
Somatic lipopolysaccharide cell wall antigen, or O-antigen, is heat-
resistant and withstand heating up to 80-100
oС. It demonstrates endotoxin 
activity due to lipid A moiety, while antigenic epitopes contain 
predominantly various carbohydrate residues and aminosugars.  
O-antigen is regarded as group specific. 
Flagellar H-antigen of E. coli contains protein flagellin, which is 
heat-sensitive and can be destroyed at a temperature above 56
oС.  
Capsular, or K-antigen is composed of complex polysaccharides. It 
covers cell wall O-antigen and preserves it against the actions of 
phagocytes and antibodies. 
K-antigen of capsular E. coli strains displays evident structural 
variations: heat-stable A-fraction and heat-labile L- and B-fractions. 
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The complete antigenic structure of E. coli is very individual. 
Different O-, H-and K-antigens appear in various combinations in 
particular bacterial strains. 
More than 170 serogroups based on O-antigen, about 100 types of K-
antigen and more than 50 types of H-antigen are known to date. Complete 
antigenic formula includes the certain O-, H-and K-antigens of the 
questioned strain (e.g., O26: K60(B6): H2). Antigenic structure of E. coli 
can be modified by genetic recombinations and mutations that affect the 
bacteria. 
 
Virulence factors 
Most of escherichia strains are non-pathogenic, being the 
representatives of normal human intestinal flora. Some pathogenic isolates 
(virotypes) possess virulence factors, encoded predominantly by plasmids 
or temperate bacteriophages. The bacteria produce the number of 
enterotoxins, hemolysins and cytotoxins (e.g., verotoxins or Shiga-like 
toxins SLT I and SLT II). Certain virotypes express the structures of 
type III secretion system (T3SS) or injectisome responsible for microbial 
invasiveness, spread and intracellular persistence. All microbial cells have 
the vast number of adhesion molecules. 
Cell wall LPS exhibits endotoxin activity. Many of E. coli strains 
produce bacteriocins (colicins), thereby affecting neighboring microflora. 
 
Resistance 
E. coli stays viable for several months in different environmental 
conditions. These bacteria are inactivated at temperature of 60°С within 15 
minutes and rapidly destroyed by boiling. They are susceptible to most of 
hospital disinfectants and antiseptics taken in standard concentrations. 
 
 
Pathogenesis and Clinical Findings of Infections Caused by E. coli 
 
The diseases, caused by various escherichia isolates, are generally 
termed “escherichioses”. 
Non-pathogenic and facultatively pathogenic E. coli ensure normal 
intestine functions, taking part in nutrition, cellulose digestion, vitamin 
synthesis, peristaltic regulation, etc. Nevertheless, they can provoke 
pathology after colonization of unusual biotopes, such as urogenital or 
biliary tract, peritoneal cavity or central nervous system. In case of 
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patient’s immunodeficiency the generalization of infectious process is 
possible, resulting in septicemia. 
Non-specific or opportunistic E. coli infections affect predominantly 
urinary tract. E. coli is the main causative agent of urinary infections, 
especially in young women. These bacteria are shown to produce 
hemolysins.  
E. coli, expressing pili of certain type (P pili), become associated 
with pyelonephritis, since P pili promote microbial adhesion to epithelium 
of urinary tract. Bacterial adherence to uroepithelium is followed by 
microbial degradation with the release of LPS endotoxin. It leads to 
neutrophil infiltration, cytokine overproduction and progression of 
inflammatory response. 
E. coli strains are often isolated in patients with cholecystitis, 
cholangitis, appendicitis, peritonitis and other abdominal diseases.  
Also E. coli is an important cause of infant meningitis. It mainly 
affects premature newborns and infants under the age of 1 month. Most of 
causative agents pertain to the specific serovar O18:K1 as K1 capsular 
antigen is resistant to complement action. In addition, these bacteria have 
special S-fimbriae with elevated tropism to endothelial cells of CNS blood 
vessels. The disease is extremely severe; the mortality rate may exceed 
50%. 
Specific E. coli infections comprise a large number of diarrheal 
diseases. They are caused by pathogenic escherichia strains.  
These disorders have the specific mechanisms of the development 
resulting from the action of various E. coli toxins.  
Infection are transmitted by fecal-oral route (foodborne, waterborne 
or through contaminated fomites).  
The main sources of infection are sick persons or carriers. In 
situations with enterohemorrhagic diarrheas there can be carrier animals 
(e.g., cattle).  
Enteropathogenic E. coli (EPEC) affect infants worldwide.  
EPEC coli-enteritis is caused by numerous serotypes of E. coli. EPEC 
reveal a distinct capacity of adherence to intestinal cells.  
Intestinal colonization by EPEC is promoted by interaction of 
microbial adhesin intimin with its specific receptor Tir. This process is 
mediated by bacterial type III secretion system (injectisome) that initially 
translocates an intimin receptor Tir into the host cell (see below).  
As the result, membrane cup-like filamentous pedestals enwrapping 
each bacterium are formed that is followed by destruction of local 
microvilli. This is known as an attaching and effacing (A/E) phenomenon. 
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All of the genes essential for induction of A/E lesions in EPEC are 
confined within specific “pathogenicity island” termed as the locus for 
enterocyte effacement. 
Devastation of epithelial villi results in profound watery diarrhea. 
Enterotoxigenic E. coli (ETEC) is the common causative agent of 
diarrhea in developing countries. Also it causes so-called "traveller's 
diarrhea". The infectious dose here is relatively high – about 106-109 
microbial cells. 
ETEC infection results from the action of heat labile exotoxin 
(enterotoxin) with molecular weight of 80,000 that is very similar with 
cholerogen of Vibrio cholerae.  
B-subunit of enterotoxin is absorbed to the intestinal cells via cell 
membrane ganglioside receptor. Subunit A enters into the cell across the 
membrane promoting ADP-ribosylation of cellular G-proteins. This event 
activates guanylate cyclase and adenylate cyclase resulting in abnormal 
increase of cAMP concentration inside the cells. The latter event 
stimulates secretion of chlorides into the small intestine with impairment of 
sodium and water absorption. As the result, massive non-inflammatory 
diarrhea evolves. 
Certain isolates express several heat stable enterotoxins. Co-
expression of both toxin types results in more profound diarrhea. 
Enterotoxins, as well as colonization factors of ETEC, are encoded 
predominantly by plasmid genes. 
Heat labile exotoxin elicits the synthesis of antitoxic antibodies, which 
possess neutralizing activity. 
Enteroinvasive E. coli (EIEC) reveal the striking ability to invade 
intestinal epitheliocytes with intracellular propagation that is followed by 
microbial lateral spread towards adjacent neighboring cells. The 
enteroinvasive disorders are very similar to shigellosis caused by Shigella 
flexneri, S. boydii and S. sonnei. EIEC are almost identical to shigella (non-
motile bacteria, which are lack of lactose fermentation) but deprived of 
ability to produce Shiga STX toxins. 
Enteroaggregative E. coli (EAEC) promote diarrhea due to their 
strong adhesive capacity to intestinal cells with tendency of self-
aggregation. The mode of their adhesion is not similar with adherence 
pattern of EPEC.  
EAEC binding was primarily determined as diffuse adherence, but 
further two main patterns were observed: aggregative adherence and 
diffuse adherence. Bacteria express two types of specific fimbriae: 
aggregative adherence fimbriae I and II (AAF/I and AAF/II, respectively). 
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Usually EAEC don’t produce toxins. Nevertheless, they damage intestinal 
cells and hamper the normal exchange of water and electrolytes within the 
bowel, thus causing a chronic or persistent form of diarrhea with duration 
of more than 14 days. 
Enterohemorrhagic E. coli (EHEC) are the most dangerous 
representatives of coliform bacteria. They cause severe hemorrhagic 
colitis with diarrhea and intestinal cell destruction. The infection outcome 
becomes much more serious with the development of life-threatening 
hemolytic uremic syndrome (HUS) that is often followed by acute renal 
failure. 
The incubation period of the disease endures about 5-7 days.  
The infectious dose of bacteria is extremely low (1-100 cells). 
For a long time E. coli of O157:H7 serotype was considered to be the 
major pathogenic variant of EHEC. Now it is obvious that STEC strains 
causing human disease, pertain to a very broad range of O:H serotypes 
(more than 30 O-serogroups with multiple antigenic variants are known to 
date, and this list is being increased permanently). 
High virulence of EHEC depends on production of adherence factors 
and potent cytotoxins. 
The ability of EHEC as well as EPEC to attach to and efface 
enterocytes results mainly from the activity of E. coli outer membrane 
protein ”intimin” and its translocated receptor Tir. Both proteins are 
encoded by genes located in the same “locus of enterocyte effacement” 
within pathogenicity island of bacterial chromosome.  
Before tight bacterial attachment, Tir receptor protein is injected into 
intestinal cells via type III bacterial secretion system (needle complex, or 
injectisome). Once expressed on enterocyte membranes, Tir interacts with 
microbial intimin that ensures the strong binding of E. coli to intestinal 
cells. 
EHEC secrete two main types of Shiga-like toxins (SLT I and SLT II 
or verotoxins), which are very similar with Shigella dysentheria exotoxin 
Stx (SLT I toxin is almost identical). Toxin production in EHEC is 
encoded by temperate bacteriophages. 
SLT toxin of EHEC is composed of A and B subunits. Protein A-
subunit of 32 kDa is noncovalently bound to five 7-kDa B-subunits. B-
subunit promotes attachment to eukaryotic cell receptor glycolipid Gb3 (or 
globotriosyl ceramide). The cells, bearing Gb3 receptor, are susceptible to 
SLT toxin action. When Shiga-like toxins appear in the bloodstream, they 
induce the damage of glomerular endothelial cells of kidneys, which 
express large amounts of the Gb3 receptor. 
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After receptor binding, toxin molecules are internalized by receptor-
mediated endocytosis. Subunit A is further cleaved into two fragments, 
where A1 portion of toxin renders RNA N-glycosidase activity. A1 
fragment breaks down N-glycosidic bond in the 28S rRNA, thus 
preventing aminoacyl-tRNA binding to the 60S subunit of ribosome. These 
molecular events terminate elongation of protein sequence and eventually 
cause cell death. 
Additional virulence factors encompass several enterohemolysins and 
extracellular serine protease, which cleaves human coagulation factor V, 
thereby maintaining hemorrhagic colitis. 
Multiple devastating activities of EHEC virulence factors promote 
destructive hemocolitis with severe diarrhea. 
The disease tends to be self-limited, though hemolytic uremic 
syndrome, followed by hemolytic anemia and thrombocytopenia, can 
develop in 10-30% of cases and even more. It is one of the leading causes 
of renal failure in children. The mortality rate in HUS is near 5%. 
Immunity reactions after escherichia infections are usually group 
specific and low grade. Natural passive immunity conferred by maternal 
milk sIgA can protect newborns and infants against coli-enteritis for 
several months after birth. Similarly, trans-placental IgG-mediated 
immunity defends infants against infections, caused by some 
enteroinvasive escherichia strains. 
Normal microflora of gastrointestinal tract (e.g. bifidobacteria and 
lactobacilli) promotes powerful non-specific host defense due to their 
substantial antagonistic activity against pathogenic enterobacteria. 
 
 
Laboratory Diagnosis of Coli-Enteritis and Other E. coli 
Infections 
 
Specimens for diagnosis of non-specific escherichioses are obtained 
from the site of infection: urine, bile, blood, pus, or wound discharge are 
examined. 
For laboratory diagnosis of escherichia-associated diarrhea feces, 
vomiting masses, food remnants, water, washing samples, etc. should be 
examined. 
For rapid identification of pathogenic E. coli in clinical specimens 
molecular genetic tests are applied (e.g., PCR test). 
Microscopical tests are useless owing to the evident morphological 
similarities of all enterobacteria. 
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To confirm the diagnosis of coli-enteritis, isolation of microbial 
culture is elaborated. 
To aim this, the specimens are plated upon the differential or selective 
nutrient media (McConkey agar, EMB or Endo medium). The growth of 
colored lactose-positive colonies is evaluated.  
To determine the nature of grown E. coli isolates, the tentative slide 
agglutination test with polyspecific OK-serum against the most widespread 
enteropathogenic E. coli is performed. At least 10 lactose-positive colonies 
should be investigated. In case of positive results the rest of the colony is 
planted on slant MPA to obtain pure culture. It is identified by slide 
agglutination tests with different serovar-specific OK-sera. 
Positive result of slide agglutination with type-specific OK-serum is 
confirmed by extended tube agglutination test. To establish the 
concordance of isolated culture to serum specifity and titer, the reaction is 
performed separately for O- and K-antigens (with boiled and native 
culture, respectively). 
Evaluation of biochemical properties, phagotyping and antibiotic 
susceptibility tests accomplish culture examination. 
To reveal enterohemorrhagic E. coli, the specimens are planted on 
modified McConkey agar that contains sorbitol instead of lactose. EHEC 
0157:H7 are sorbitol-negative, whereas other escherichia are usually 
sorbitol-positive on MacConkey agar. 
Shiga-like toxins as well as escherichia enterotoxins are determined by 
ELISA, cell culture tests or molecular genetic methods in reference 
laboratories. 
 
 
Treatment and Prophylaxis of E. coli Infections 
 
Various groups of antibiotics (amoxycillin, third-generation 
cephalosporins, aminoglycosides, or fluoroquinolones) are used for 
treatment of opportunistic infections, caused by escherichiae. 
In patients with E. coli-associated diarrheas an adequate antibiotic 
therapy shortens the diarrheal period, but the microbial resistance rapidly 
increases under antibiotic pressure. 
Antibacterial treatment should be administered with great precautions 
in patients with hemorrhagic colitis and HUS. The drugs affecting 
metabolism of microbial nucleic acids (e.g., fluoroquinolones and co-
trimoxazole) are not recommended here as they may stimulate the spread 
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of virulence genes among the enterobacteria. In these clinical situations 
carbapenems are regarded as the most suitable antimicrobial agents. 
The disease therapy with probiotics (e.g., lactobacterin, bificol, 
bifidumbacterin) is also beneficial. 
Specific prophylaxis is not available for E. coli infections. The tight 
control of sanitary conditions, prevention of water and foodstuff 
contamination, maintaining of hygiene standards is of great importance. 
 
 
 
SHIGELLAE 
 
 
The History of Discovery 
 
The agents of bacterial dysentery were first discovered by 
Chantemesse in 1888. In 1898 they were thoroughly studied by K. Shiga. 
A novel causative agent of dysentery was described later by S. Flexner and 
co-workers in 1900. 
At the borderline of 1900s some other agents of bacterial dysentery 
were isolated. К. Duval in 1904, as well as V. Kruse and co-workers in 
1907, and К. Sonne in 1915 revealed the species, able to ferment lactose 
unlike the previously described isolates. 
Finally all these microbial representatives were placed into separate 
genus called Shigella in honor of K. Shiga. 
Shigellae cause bacterial dysentery or shigellosis. This infection 
circulates predominantly among the population of developing countries, 
affecting near to 150 million people annually with more than 1 million 
death cases. About 70% of patients are 1-5-year-old children. 
 
 
Classification 
 
Shigella genus pertains to the family Enterobacteriaceae. The genus 
contains 4 species: S. dysenteriaе of group A, S. flexneri (group B), 
S. boydii (group C), and S. sonnei (group D). 
Different shigella species comprise numerous biotypes and serovars. 
Genetic analysis revealed that all shigellae share more than 90% of 
genomic DNA sequence with escherichiae. Therefore, they can be 
accounted as single genomospecies. However, the evident phenotypic 
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dissimilarities of these bacteria, largely dependent on acquisition of various 
mobile genetic elements, result in striking differences in their virulence for 
humans. Hence, they remain to exist as separate genera and species. 
 
 
Structure and Properties of Shigellae 
 
Morphology 
All shigella closely resemble other Enterobacteriaceae members: 
small gram-negative non-motile rods without spores, possessing multiple 
pili. Certain strains can form thin capsule. 
 
Cultivation 
These bacteria readily grow on basic nutrient media with optimal 
temperature about 37°C, pH 7.2. 
The growth reveals round small convex transparent colonies. In meat 
peptone broth shigellae produce homogenous turbidity. 
After cultivation in lactose-containing media (McConkey agar, or 
Ploskirev’s medium) most of shigellae form lactose-negative transparent 
colonies. S. sonnei can slowly ferment lactose. 
 
 
Biochemical properties  
Shigellae are facultatively anaerobic bacteria. They utilize various 
carbohydrates with acid formation. Individual biovars (Newcastle subsp.) 
can produce small amounts of gas. All shigellae ferment glucose. Most of 
bacteria, except S. dysenteriaе, ferment mannitol. S. sonnei can metabolize 
lactose and sucrose within several days. 
The bacteria can’t produce hydrogen sulfide, but certain strains 
display proteolytic activity with indole formation. 
 
 
Antigenic structure 
Shigellae are classified into 4 groups according to their antigenic 
properties. These groups comprise more than 40 serotypes. 
All of these bacteria contain group-specific O-antigen, some isolates 
produce capsular K antigen. 
Somatic lipopolysaccharide O-antigen possesses endotoxin activity. 
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Virulence factors 
Pathogenic shigellae produce large number of virulence factors, 
responsible for microbial adherence, invasiveness, intercellular spread, 
apoptosis of host immune cells, and intestinal epithelium death that results 
in severe inflammation of large intestine with hemocolitis. 
Bacterial invasion is controlled by special structures of type III 
secretion system (so-called secreton III), which includes bacterial 
injectisome, or needle complex. Once attached to the host cells via needle 
complex, bacteria inject the number of invasion proteins into target cell. 
These effector proteins re-build cytoskeleton of affected cell, thus 
promoting intercellular microbial spread and further invasion. 
All virulent Shigellae contain a large 220-kb plasmid harboring 
pathogenicity island that determines the “invasive phenotype” of bacteria. 
Invasive proteins are encoded predominantly by ipa/spa (invasive plasmid 
antigen) genetic locus. 
Deep damage of bowel epithelium is promoted by cytotoxic action of 
bacterial Shiga toxin (STX toxin), which is encoded by chromosomal stx 
gene. Maximal toxin production is essential for S. dysenteriaе type 1.Toxin 
action pattern is very similar with enterohemorrhagic E. coli verotoxins. 
As in EHEC, STX toxin is composed of A and B subunits. Several 
receptor B-subunits bind to cellular receptor glycolipid Gb3. Exotoxin 
internalization is followed by subunit A cleavage. Toxic A1 fragment 
possesses RNA N-glycosidase activity and thereby cleaves N-glycosidic 
bond within 28S ribosomal RNA. Termination of protein synthesis causes 
the death of host cells. 
LPS-containing endotoxin of shigellae activates phagocytes and other 
immune cells that is followed by exuberant cytokine release and tissue 
inflammation. 
 
Resistance 
Shigellae are not the highly resistant bacteria, but they can survive in 
the environment within 5-10 days. The most resistant is S. sonnei that 
keeps viability for months in water and different foodstuffs, e.g. dairy 
products. 
Bacteria are killed by heating at 56°C within 10-15 minutes and 
inactivated readily by standard medical disinfectants (chloramine, 
hypochlorite, phenol, etc.) 
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Pathogenesis and Clinical Findings in Shigellosis 
 
Different clinical forms of bacterial dysentery or shigellosis are 
caused by enteroinvasive shigellae.  
The disease is transmitted by fecal-oral route and direct contact. It is 
"food, fingers, feces, and flies"-transmitted disorder. 
Water outbreaks of shigellosis are related with S. flexneri, while 
foodborne disease cases ensue from S. sonnei infection. The disease caused 
by S. dysenteriae is particularly severe. 
The main sources of infection are the patients with dysentery and 
bacterial carriers. The disease affects only humans. 
Incubation period lasts from 1 to several days. 
Infectious dose of 10-100 microbial cells is enough to cause the 
disease in adults (e.g., for S. dysenteriae infection).  
Some shigellae are killed, passing through the stomach. The rest of 
bacteria comes to the bowel and invade the colon mucosa. Bacteria are 
specific to the rectal and large intestine mucous membranes. 
The main intestinal entry site for shigellae is the follicle-associated 
epithelium that covers the mucosa-associated lymph nodes. Special 
epithelial M cells (microfold cells) are the primary targets for microbial 
invasion. After cell contact with bacterial needle complex, IpaB and IpaC 
proteins create a pore in eukaryotic cell membrane, and invasive proteins 
are injected inside the target cells. They trigger intracellular actin 
polymerization that results in membrane pocket formation. This way M-
cells engulf and translocate shigellae into the cytoplasm. Bacterial VirG 
protein activates cell actin attachment to the pole of microbial cell with 
formation of actin comet. Comet bacterial cell is able to move within the 
infected cells and can readily achieve the neighboring enterocytes (“lateral 
spread” of shigellae) thus promoting further microbial invasion. 
Intestinal macrophages become invaded in similar manner. Invasive 
IpaB protein induces macrophage release of most potent proinflammatory 
cytokines IL-1 and IL-18 and at the same time triggers phagocyte death via 
caspase 1-mediated apoptosis, thereby preventing shigellae from the death 
within macrophages. 
Inflammatory cytokines cause the injury of intestinal wall. But at the 
same time they activate immune inflammation, attracting neutrophils to the 
invaded bacteria. Efficient leukocyte reaction restricts the infection up to 
its termination. 
Massive cytolysis of intestinal epithelium is promoted also by Shiga 
cytotoxin action. 
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All these events lead to severe colon destruction resulting in 
hemorrhagic colitis. General intoxication is followed by abdominal pain, 
fever, and hemorrhagic diarrhea with water loss. Intermittent painful rectal 
spasm (or tenesmus) is characteristic for developed shigellosis. 
The disease can be self-restricted within several days, but profound 
dehydration and acidosis require urgent therapy and even can cause lethal 
outcome especially in children. 
The immunity acquired after the dysentery is group- and type-specific 
but relatively weak and of a short duration. For this reason the disease may 
recur many times and in some cases may become chronic.  
Shiga toxin as a potent antigen elicits the synthesis of neutralizing 
antibodies. 
 
 
Laboratory Diagnosis of Shigellosis 
 
Reliable results of laboratory examination depend on correct sampling 
of stool specimen and its immediate inoculation onto a selective and 
differential medium at the patient's bedside. The inoculated material should 
be rapidly delivered to the laboratory. 
As an example, the clinical specimen (feces) should be best collected 
directly from patient’s rectum by rectal swab and planted immediately after 
the collection onto McConkey agar, EMB or Ploskirev’s medium.  
Ploskirev’s medium contains meat-peptone agar, lactose, indicator 
neutral red, and bile salts with brilliant green dye to suppress concomitant 
microflora. The similar composition is of McConkey agar. 
The plates are incubated at 37°C for 24 hours. When growing, 
shigellae produce lactose-negative transparent colonies. 
The culture is further isolated in butt-slant double sugar agar (Russel’s 
medium). It contains meat-peptone agar, 1% lactose, 0.1% glucose, and 
indicator dye. Inoculation of bacteria is performed both in aerobic and by 
stab in anaerobic conditions. As the result, the color change will appear 
only in the butt of medium due to glucose fermentation in anaerobic 
conditions. The slant part of agar would be intact because the most of 
shigellae are lactose-negative. 
The pure culture obtained is further identified according to its 
biochemical and serological properties. In latter case the culture is tested 
by agglutination reaction with specific sera. 
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For rapid identification of DNA of shigellae species in clinical 
specimens sensitive and reliable molecular genetic tests are applied (e.g., 
PCR). 
Serological examination has no value in diagnosis of shigellosis. 
 
 
Treatment and Prophylaxis of Shigellosis 
 
Taking into account the increased resistance of shigellae to the long 
list of antimicrobial agents (e.g., ampicillin, trimethoprim-
sulfamethoxazole, doxycycline, or chloramphenicol) fluoroquinolones 
(norfloxacin) and third generation cephalosporins (e.g., cefotaxime or 
ceftazidime) are most commonly used now for treatment of shigellosis. 
Important measures of supportive symptomatic treatment include 
urgent infusion therapy to compensate water and electrolyte loss. The 
treatment of shigellosis with probiotics restores the normal composition of 
intestinal microflora. 
Efficient vaccines for prevention of shigellosis are not available yet. 
Non-specific prophylaxis of the disease comprises thorough control of 
water and food microbial contamination, isolation and adequate treatment 
of patients with laboratory confirmation of the recovery, the detection and 
treatment of carriers, adequate disinfection measures, the maintenance of 
sanitary and hygienic regimens according to the actual regulation acts, etc. 
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Chapter 4 
CAUSATIVE AGENTS OF ENTERIC BACTERIAL INFECTIONS: 
SALMONELLAE AND YERSINIAE 
 
 
 
SALMONELLAE 
 
 
The History of Discovery 
 
In 1880 German scientist K. Eberth first described the bacterium – 
causative agent of enteric typhoid fever. Later in 1884 it was isolated and 
thoroughly investigated by G. Gaffky. 
Causative agent of similar disease, paratyphoid fever, was initially 
isolated by C. Archard and R. Bensaude and studied in details by 
H. Schottmuller in 1900. It was named later Salmonella paratyphi B or 
S. schottmuelleri. Another paratyphoid bacterium, or S. paratyphi A was 
investigated by A. Brion and H. Kayser in Germany. 
All these salmonellae were found to cause the diseases in humans. 
Also many salmonella species were isolated in animal diseases. D. Salmon 
in 1885 revealed the causative agent of pig’s plague, S. choleraesuis. Then 
various salmonellae of animal origin were demonstrated to cause food 
poisoning, or toxinfections in humans. In particular, in 1888 A. Gartner 
isolated S. enteritidis both from cow’s meat and patient, died from 
toxinfection. In 1896-1898 К. Kensche and E. Nobel discovered another 
significant agent of food poisoning, S. typhimurium. Finally, it was proven 
that great number of salmonella species, isolated from animals, can cause 
human food poisoning and in some cases septicemia. 
 
 
Classification 
 
Salmonellae pertain to the family Enterobacteriaceae. In past more 
than two thousand species were described within Salmonella genus. Recent 
genetic studies revealed only two species of salmonellae – S. enterica and 
S. bongori with vast number of antigenic salmonella variations. 
S. enterica species is further divided into several distinct subspecies.  
S. enterica subsp. enterica comprises more than 99% of salmonella 
that cause diseases in humans. 
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The complete name of distinct salmonella isolates includes species 
name and the name of serovar (former species designation). Antigenic 
variant (serovar) is designated with starting upper-case letter and non-
italicized straight font. For instance, causative agent of enteric typhoid 
fever is classified as S. enterica serovar Typhi or S. Typhi for short. 
Limited number of salmonella serovars affects humans only. Most 
serious disease is enteric typhoid fever, caused by S. Typhi. 
S. Paratyphi A, S. Paratyphi B and S. Paratyphi C are the agents of 
paratyphoid enteric fevers. The latter diseases are generally regarded as 
anthroponoses, but these bacteria may be also isolated from animals. 
Numerous salmonella serovars are the causative agents of 
salmonelloses. Usually salmonelloses are contracted from animal sources 
and appear in two major clinical forms – food poisoning (food 
toxinfection) and septicemia. Septicemia as more rare but severe clinical 
condition predominantly affects children. S. Typhimurium and 
S. Enteritidis are the most virulent and frequently isolated agents, causing 
these infections. Many other variants (e.g., S. Choleraesuis, S. Derby, or 
S. Heidelberg) can also cause salmonelloses. 
 
 
Structure and Properties of Salmonellae 
 
Morphology 
All salmonellae are very similar. Their morphology is typical for 
Enterobacteriaceae family members (gram-negative small or medium-size 
rods without spores). 
Salmonellae possess peritrichous flagella and multiple pili. Virulent 
strains carry needle complex, or injectisome – type III secretion system 
structures. 
The strains, isolated from carriers, frequently produce capsule-like 
polysaccharide substance. 
 
Cultivation 
Salmonellae easily grow on basic nutrient media within temperature 
range from 15 to 40°C with optimum of 37°C at pH 7.0. 
The growth in meat peptone agar results in round semitransparent 
middle-size colonies. S. Paratyphi B colonies produce edge mucous 
swelling. 
Salmonellae are resistant to bile salts and number of antiseptics, e.g. 
brilliant green, sodium selenite or sodium tetrathionate. Thus, they are 
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cultivated on various selective and enrichment media that inhibit E. coli 
growth. Among them are meat-peptone broth with bile salts, selenite 
broth, tetrathionate broth, Wilson-Blair agar (i.e., bismuth sulfite agar), 
composed of MPA, glucose, bismuth sulfite, ferrous sulfate and brilliant 
green.  
Growing on bismuth sulfite agar, salmonella produce black colonies 
due to the formation of iron sulfide, except serovar S. Paratyphi A. 
As salmonellae are lack of lactose fermentation, they form lactose-
negative colonies on McConkey agar, EMB (Levine) agar, etc. 
 
Biochemical properties 
Salmonella are facultative anaerobes. 
S. Typhi ferments various carbohydrates (glucose, maltose, mannitol, 
dextrin, glycerol and others) with acid production. Other salmonellae, e.g. 
S. Paratyphi A and B, S. Typhimurium, S. Enteritidis, etc., utilize 
carbohydrates with acid and gas end products. All salmonella are lactose-
negative bacteria. 
Pathogenic salmonellae, except S. paratyphi A, reveal proteolytic 
activity with hydrogen sulfide formation. They reduce nitrates to nitrites. 
As all the members of Enterobacteriaceae family, salmonellae are 
oxidase-negative, but catalase-positive bacteria. 
 
Antigenic structure 
Salmonellae possess somatic O- and flagellar H-antigens. S. Typhi 
strains, predominantly isolated from microbial carriers, synthesize outer 
capsule-like Vi-antigen. Temperate phage transduction can influence the 
expression of salmonella antigens. 
Lipopolysaccharide heat-stable O-antigen displays endotoxin activity. 
Flagellar H-antigen is heat-labile. Polysaccharide complex Vi-antigen is 
also a heat-labile substance. It is readily destroyed by boiling for 10 
minutes.  
Vi-antigen partially covers O-antigen, and thereby hampers microbial 
agglutination by anti-O antibodies. It is almost solely found in S. Typhi 
strains and in rare cases in S. Paratyphi C and S. Dublin. 
Polysaccharides of Vi-antigen bind to the vast number of specific 
bacteriophages. As the result, about 100 of distinct phagotypes are 
determined in Vi-Ag-expressing S. Typhi. 
F. Kauffmann and P. White elaborated the classification of 
salmonellae according to their O- and H-antigen variations (see Table 3). 
O-antigen is shown to be the group specific. It is heterogeneous and 
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contains specific and several non-specific antigenic determinants. About 
70 serogroups were distinguished by specific fraction of salmonellae O-
antigen.  
H-antigen is found to be in two phases, encoded by different genes. 
Only first phase of H-antigen appears to be “species”- or variant-
specific. Phase 2 antigens are agglutinated by group-specific sera. More 
than 2500 serovars of salmonellae are identified by specific phase H-
antigen. 
Thus, serological typing of certain salmonella strains, in spite of their 
tremendous diversity, is reduced to simple two-step procedure: once the 
serogroup was determined by specific O-antigen agglutination, serovar 
identification is accomplished by agglutination with specific anti-H serum. 
 
 
Table 3 
Serological classification of salmonellae (by F. Kauffmann and Р. White) 
 
 
Serovar 
 
Serogroup  
Antigens 
 
О 
Н 
Phase 1 Phase 2 
S. Paratyphi A 2 (А) 1, 2, 12 a 1, 5 
S. Paratyphi B  
 
4 (В) 
1, 4, 5, 12 b 1, 2 
S. Typhimurium 1, 4, 5, 12 i 1, 2 
S. Derby 1, 4, 5, 12 f, g 1, 2 
S. Heidelberg 1, 4, 5, 12 r 1, 2 
S. Paratyphi C  
7 (С1) 
6, 7 (Vi) c 1, 5 
S. Choleraesuis 6, 7 c 1, 5 
S. Isangii 6, 7, 14 d 1, 5 
S. Infantis 6, 7, 14 r 1, 5 
S. Newport 8 (С2-С3) 6, 8, 20 e, h z, 2 
S. Typhi  
 
9 (D1) 
9, 12 (Vi) d – 
S. Enteritidis 1, 9, 12 g, m – 
S. Dublin 1, 9, 12 (Vi) g, p – 
S. Moscow 9, 12 g, q – 
S. Panama 1, 9, 12 e, v 1, 5 
S. Gallinarum 1, 9, 12 – – 
S. London  
3, 10 (Е1) 
3, 10 [15] l, v 1, 6 
S. Anatum 3, 10 [15, 34] c, h 1, 6 
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Virulence factors 
Salmonellae produce various virulence factors that actively participate 
in disease pathogenesis. Since bacteria can persist intracellularly, they 
express multiple adhesins and invasive proteins, which promote microbial 
invasion, intercellular spread, and final impairment of host cellular 
immune response. 
At least 10 genetic salmonella pathogenicity islands (SPI) are 
detected that encode microbial virulence factors. They are found both in 
bacterial nucleoid and plasmids. Many of them were delivered to bacterial 
cell with temperate bacteriophages upon transduction. Besides, S. Typhi 
harbors additional genetic element known as major pathogenicity island.  
Genes located in chromosomal pathogenicity islands SPI-1 and SPI-2 
as well as in major pathogenicity island of S. Typhi play a crucial role in 
pathogenesis of salmonella-associated infections. 
Genes of SPI-1 and SPI-2 code for the structures of type III secretion 
system with bacterial needle complex or injectisome. By means of 
injectisome, salmonellae deliver invasive effector proteins into intestinal 
cells and phagocytes. 
Genes of major pathogenicity island encode the capability of S. Typhi 
to produce capsular Vi-Ag that promotes microbial survival in worsen 
surroundings (e.g., within phagocytes or in gallbladder of carriers). 
One of the most potent virulence factors of salmonellae is 
thermostable LPS endotoxin. It activates macrophages and T cells that is 
followed by proinflammatory cytokine release and subsequent tissue 
damage. Endotoxin action provokes deep disorders of patient’s 
gastrointestinal tract, cardiovascular system and CNS. Bacteria of typho-
paratyphoidal group can produce large amounts of endotoxin. 
Certain salmonella serovars, e.g S. enteritidis, are able to produce 
potent enterotoxin. It activates enterocyte adenylate cyclase elevating 
intracellular cAMP concentration that results in diarrhea with massive 
secretion of water and chlorides into intestinal lumen. 
Several genetic regions within nucleoid and plasmids of salmonellae 
contain genes of multidrug resistance to antibiotics. 
 
Resistance 
Salmonellae reveal marked stability in the environment. They can 
survive for several weeks and even months in soil, contaminated by 
bacteria, as well as in various foodstuffs, where they can propagate (dairy 
products, meat, bread, etc.) The bacteria stay viable upon contaminated 
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fruits and vegetables up to 1-2 weeks. In water they maintain viability for 
3-4 months. Salmonellae readily withstand drying and long-time freezing. 
S. Typhi and S. Paratyphi A are inactivated at 56°С within an hour, 
while other bacteria are relatively resistant to heating at 60-70°С. Boiling 
rapidly inactivates bacteria. Nonetheless, microbial endotoxin is heat-
stable and can cause food poisoning even in absence of live salmonellae. 
S. Typhi is sensitive to conventional disinfectants (e.g., chlorine-
containing chemicals or phenol.) 
 
 
Pathogenesis and Clinical Findings in Typho-Paratyphoid Diseases 
 
Enteric typhoid fever is the anthroponotic disease caused by S. Typhi 
and transmitted by fecal-oral route. In developed countries it occurs as 
sporadic infection. Nevertheless, from 15 to 30 million disease cases 
appear annually worldwide. The disease spreads predominantly in 
developing countries. It results in 250,000-500,000 lethal outcomes being 
the serious public health problem. 
Salmonella carriers and the patients with subclinical forms of illness 
are the main sources of infection.  
Infectious dose of S. Typhi is 10
3
-10
5
 microbial cells, i.e. it is rather 
low. 
Incubation period lasts for about 10-14 days.  
Salmonellae, entering gastrointestinal tract, are partially killed in the 
stomach. The rest of bacteria appears in the intestine and adheres to 
mucosal cells. Microbial intracellular invasion is promoted by salmonella 
needle complex.  
When injected into enterocytes, SPI-1 effector proteins stimulate 
cytoskeleton remodelling and next membrane folding. It leads to 
engulfment of attached bacteria and their entry into epithelial cells by 
macropinocytosis. Other SPI-1 proteins activate membrane channels of 
epithelial cells resulting in chloride excretion and diarrhea. 
In parallel with infection of intestinal epithelium, salmonellae spread 
into the lymphatic follicles and Peyer's patches. Microbial cells have 
multiple mechanisms of survival within phagocytes.  
Certain SPI-1 proteins activate caspase-1 that stimulates production 
of proinflammatory cytokines and eventually triggers phagocyte 
apoptosis. Inflammatory cytokines damage the intestinal tissues. 
Effector proteins, associated with SPI-2, play even more powerful role 
in microbial protection against phagocytosis. Once captured by phagocyte, 
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salmonellae long time survive within phagolysosome. It is related with 
SPI-2 effector proteins that block the enzymes of respiratory burst thereby 
inhibiting microbial digestion.  
Infected phagocytes spread salmonellae throughout the body resulting 
in systemic character of infection. Thus, the presence of genes of SPI-2 
strongly predisposes to the generalized salmonellosis. 
Bacterial transition across the intestinal wall leads to their appearance 
in the bloodstream with subsequent microbial dissemination. Salmonellae 
affect lymph nodes, spleen, liver, bone marrow, etc. Microbial death 
results in massive LPS endotoxin release. It provokes systemic 
inflammatory response and vascular damage that causes cardiovascular 
and CNS disorders. 
At the end of the first week of disease high fever, headache (“status 
typhosus”), myalgia and roseolar skin rashes arise. These symptoms are 
followed by hepatosplenomegalia. To the third week salmonellae 
accumulate within bile ducts and gallbladder and then re-enter the 
intestine. Multiple inflammatory reactions induced by microbial cells cause 
intestinal lesions and necrosis of lymphoid tissue. At this time bacteria are 
intensively released from patient’s intestine with feces. Also they are 
excreted with urine. 
As the disease confers both cellular and humoral immunity, the 
immune reactions ultimately eliminate bacteria promoting patient’s 
recovery. The immunity is rather stable, but sometimes reinfections occur. 
Nevertheless, appropriate conditions for salmonella survival especially 
within gallbladder maintain microbial persistence and often cause the 
development of carrier state. Expression of capsular Vi-Ag increases 
bacterial resistance to bile salts. 
Long-term (sometimes – lifelong) salmonella carriers are proven to be 
the most frequent sources of S. Typhi infection.  
Paratyphoid infections caused by S. Paratyphi A, S. Paratyphi B or 
S. Paratyphi C are characterized by similar but modest clinical course with 
favorable prognosis. 
Salmonelloses pertain to large widespread group of diseases, caused 
by non-typhoidal salmonellae. They are transmitted by fecal-oral and 
contact roots.  
The infected and sick animals are regarded as the main sources of 
infection. 
Incubation period is short – from 2-6 hours to 2-3 days. 
The infectious dose is definitely higher than of enteric fever agents – 
about 10
6
-10
8
 microbial cells. 
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The disease usually evolves after ingestion of contaminated foodstuffs 
(poultry – about 50% of disease cases, also eggs, meet, dairy products, 
etc.) Various serovars of salmonellae (e.g., S. Enteritidis, S. Choleraesuis, 
S. Anatum, S. Derby, and many others) can cause these diseases. The 
symptoms of severe food poisoning (enterocolitis, fever, vomiting, 
diarrhea, collapses, etc.) can appear even in few hours after infection onset 
due to the large microbial load.  
Endotoxin is released from destroyed bacterial cells. Toxin triggers 
inflammatory reactions and affects gastrointestinal tract and 
cardiovascular system. Some bacterial serovars (e.g. S. Enteritidis) express 
enterotoxin, which causes profuse diarrhea. 
Mild forms of diseases are assumed to be self-limited, but severe 
intoxications lead to generalization of infection with septicemia. 
Another type of salmonellosis resulting in systemic disease 
(septicemia) can develop in newborns or in immunocompromised patients. 
The disease is transmitted from human carriers or sick persons. It 
usually occurs as hospital-acquired infection. Very often it is caused by 
multiple antibiotic-resistant strains of S. Typhimurium or S. Enteritidis 
and finally results in endotoxemia and septicemia.  
Systemic character of infection is largely related with bacterial 
pathogenicity island SPI-2 encoding effector proteins that inhibit 
phagocytosis. 
Salmonellosis with septicemia has serious prognosis and may be fatal 
especially in infants. 
Post-salmonellosis immunity is weak, short-term and low specific. 
 
 
Laboratory Diagnosis of Enteric Typhoid Fever and Salmonelloses 
 
Specimen collection for diagnosis of enteric typhoid fever depends on 
pathogenesis stage.  
Hemoculture examination is repeated from the first week of the 
disease. Stool specimens are examined on the second week from enteric 
fever onset. Slightly later the urine can be taken for the investigation. Bone 
marrow culture is examined much more rarely. 
For isolation of salmonellae from patient’s blood hemoculture 
investigation is performed. About 10-15 ml of blood are inoculated into 
100-150 ml of liquid selective medium, e.g. into bile broth.  
After overnight incubation the material is planted onto a differential 
medium (McConkey agar, EMB agar). Salmonellae grow as lactose-
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negative colorless colonies. To isolate the pure culture of salmonellae the 
material from lactose-negative colonies is re-inoculated into slant agar with 
appropriate differential media. For instance, the growth in double sugar 
agar or Russel’s medium (contains meat-peptone agar, 1% lactose, 0.1% 
glucose, and indicator) reveals the color change only within the butt of 
medium that ensues from glucose fermentation. 
Isolated culture is identified by two-step slide agglutination test 
according to Kauffmann-White scheme. The serogroup is defined by 
specific O-antigen agglutination and microbial serovar is determined 
further by agglutination with specific anti-H serum. 
The examination is accomplished by culture biochemical tests and 
phagotyping. The latter test is elaborated with large number of specific 
phages. Vi-I bacteriophage is regarded as universal and reacts with all 
cultures of S. Typhi bearing Vi-Ag. 
In case of stool specimen examination the material is inoculated into 
bile broth, selenite broth, tetrathionate broth or another selective media to 
inhibit concomitant flora. Also it may be planted on bismuth sulfite 
medium (Wilson-Blair agar) resulting in black salmonella colonies. Further 
investigation is similar with hemoculture isolation. 
For serological diagnosis specific antibodies against microbial 
antigens are tested. Antibody titer arises at the end of the second week of 
the disease. Growth of specific antibodies is usually detected by indirect 
hemagglutination test or by tube dilution agglutination (Widal’s 
reaction) with typhoid and paratyphoid A and В antigenic diagnosticums. 
Patient’s serum is regarded as positive in titer of 1:200 and higher.  
Typhoid patients with manifested disease demonstrate high titers of 
antibodies both to O- and H- microbial antigens. Convalescent or 
previously vaccinated individuals maintain the elevated level of H-
antibodies for a long time. 
For carrier state determination the indirect hemagglutination test with 
Vi-antigen erythrocyte diagnosticum is used. Serum of salmonella carriers 
contains anti-Vi antibodies in titers 1:40 and more. 
For laboratory diagnosis of salmonelloses stool specimens, vomit, 
food remnants, animal organs, patient’s blood, urine, etc. should be tested 
repeatedly. 
The material is inoculated into bile broth, selenite or tetrathionate 
selective medium or onto bismuth sulfite agar. Laboratory investigation is 
similar with typho-paratyphoidal culture isolation and identification. 
Genetic typing of salmonellae is performed by PCR. 
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Treatment and Prophylaxis of Enteric Fever and Salmonelloses 
 
Various antibiotics, affecting gram-negative bacteria (primarily, third 
generation cephalosporins or fluoroquinolones) are administered to the 
patients with typho-parathyphoidal diseases and salmonella-caused 
septicemia. Most cases of food poisoning and enterocolitis in adults don’t 
require antibiotic treatment but need adequate infusion therapy. 
Salmonellae reveal marked multidrug antibiotic resistance, which is 
conferred by number of R plasmids. The resistance is easily transmitted 
throughout microbial population, thus susceptibility testing and resistance 
monitoring are the valuable measures in disease control. 
Specific prophylaxis of enteric typhoid fever requires further 
advances. Previously used killed vaccines are regarded today as 
inappropriate due to their short-term activity and side effects. Two 
vaccines are implicated now for practical use. Chemical polysaccharide 
vaccine is derived from capsular Vi antigen of S. Typhi. Another live 
attenuated vaccine of S. Typhi (Ty21a) strain is the result of chemical 
mutagenesis. Nevertheless, they create only relatively short-term 
protection that lasts several years. Genetically engineered and DNA 
vaccines, based on various recombinant S. Typhi strains are intensively 
designed now. 
Non-specific prophylaxis includes the prevention of water and 
foodstuffs from microbial contamination with proper control of their 
sanitary state, maintenance of hygienic regimens and sanitary regulations 
especially in food handling. All foodstuffs prone to possible microbial 
contamination must be thoroughly cooked or sterilized. The patients and 
salmonella carriers should be timely identified and treated. The infection 
sites require intensive disinfection. 
 
 
 
ENTEROPATHOGENIC YERSINIAE 
 
 
Classification 
 
Yersinia genus belongs to the family Enterobacteriaceae and contains 
more than 10 species. Yersinia pestis, a causative agent of plague is the 
most virulent among them. Yersinia pseudotuberculosis and Yersinia 
enterocolitica usually cause self-limiting diarrheal diseases and food 
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poisonings in humans generally termed as yersinioses. However, 
enteropathogenic yersiniae, especially Yersinia pseudotuberculosis, 
sometimes produce persistent chronic infections that can disable patients 
for a long time. 
Causative agents of yersinioses have multiple biotypes and serovars. 
 
 
Structure and Properties of Y. pseudotuberculosis and 
Y. enterocolitica 
 
Morphology 
All yersiniae are similar to some extent with other enterobacteria: 
small polymorphic gram-negative rods that exhibit bipolar stain. They look 
like short chains or diplobacteria under microscopy. Enteric yersiniae carry 
peritrichous flagella with numerous pili. 
 
Cultivation 
Yersiniae readily grow on ordinary nutrient media. The best growth 
temperature for yersiniae is about 25°C. At these conditions bacteria render 
motility; temperature rise to 37°C leads to motility loss. 
Microbial growth exhibits small convex semi-transparent polymorphic 
colonies with slight brownish pigmentation. 
Various lactose-containing media (McConkey, or EMB agar) and 
several special media are used for yersiniae cultivation. During cultivation 
the bacteria produce lactose-negative translucent colonies. Colonies of 
yersiniae can dissociate into S- or R forms. 
 
Biochemical properties 
Yersiniae are facultatively anaerobic bacteria. They display marked 
biochemical diversity. These bacteria are not lactose-fermenting, but they 
can utilize many other carbohydrates (glucose, maltose, mannitol, dextrin, 
glycerin, etc.) with acid formation. Y. enterocolitica ferments sucrose, 
while Y. pseudotuberculosis not. According to carbohydrate fermentation, 
Y. enterocolitica is divided into 5 biotypes. 
Yersiniae have weak proteolytic activity. As other enterobacteria, they 
are oxidase-negative, but catalase positive. Yersiniae produce urease and 
can reduce nitrates into nitrites. 
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Antigenic structure 
Yersiniae possess flagellar H-antigen and several somatic cell wall 
antigens. Y. pseudotuberculosis contains S- and R-somatic antigens, 
Y. enterocolitica has somatic lipopolysaccharide O-antigen. 
More than 50 serovars are described within Y. enterocolitica species; 
serovars 03, 08, and 09 most frequently cause the disease in humans. 
Y. pseudotuberculosis has at least 6 distinct serovars; but serovar 01 is a 
predominant human pathogen. 
 
Virulence factors 
Yersiniae express different virulence factors. After microbial cell lysis 
lipopolysaccharide endotoxin is released, which exhibits pyrogenic, 
hemolytic and proinflammatory activity. Certain serovars of 
Y. pseudotuberculosis can produce enterotoxin. 
Bacterial adhesin invasin is encoded by genes of nucleoid. 
Large number of virulence factors is encoded by mobile genetic 
elements. 
A 72-kb virulence plasmid (pYV – plasmid of yersinia virulence) is 
responsible for microbial adherence, invasiveness, intercellular spread, and 
ability to survive and propagate within host lymphoid tissues. This plasmid 
contains yersinia pathogenicity island or Yop virulon. 
Yop virulon encodes yersinia invasive effector proteins (Yop proteins 
or yersinia outer proteins). Also it codes for structures of type III bacterial 
secretion system (injectisome, or needle complex), composed of 
translocator proteins (so-called Ysc proteins). Needle complex promotes 
microbial adherence to host epithelial or immune cells and delivers 
invasive Yop proteins into them. When injected, Yop molecules impair the 
dynamics of the cytoskeleton, allow microbial penetration and intracellular 
spread, thereby promoting further bacterial invasion. Yop proteins sharply 
diminish the production of proinflammatory cytokines by macrophages and 
other immune cells that maintain bacterial survival within lymphoid 
tissues. 
 
Resistance 
Yersiniae are rather stable in the environment. They can readily 
withstand cooling up to -25
0С. Bacteria survive for several months in water 
and some foodstuffs, contaminated by bacteria (e.g., in butter for 150 days 
and in water for 200 days). They stay viable and even propagate in milk, 
fruits and vegetables. 
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Yersiniae are sensitive to heating, desiccation and also susceptible to 
disinfectant actions. 
 
Pathogenesis and Clinical Findings in Yersinioses 
 
Yersiniae inhabit the intestinal tract of many animals (rodents, hares, 
foxes, cattles, etc.), in which they occasionally cause diseases. Rodents as 
common sources of infection discharge the bacteria into environment with 
feces and urine. 
The disease is transmitted from animals by fecal-oral route 
predominantly through contaminated foodstuffs, especially raw vegetables, 
salads, etc. 
Infectious dose of bacteria is rather high (up to 10
7
-10
9
 microbial 
cells). More often the disease affects infants and young children. 
Incubation period lasts about 5-10 days. 
Yersiniae enter the gastrointestinal tract and bind to enterocytes and 
intestinal M cells by means of needle complex and number of microbial 
adhesins (e.g., by invasin). Yersinia virulon complex ensures microbial 
invasion and intracellular persistence. The bacteria propagate within 
intestinal mucosa, affecting ileum and other parts of gut.  
Then yersiniae spread into intestinal lymphoid tissues (lymph nodes 
and lymphatic follicles) and suppress cytokine synthesis by immune cells, 
thereby inhibiting phagocytosis and maintaining microbial survival. 
Bacterial propagation results in inflammation and ulceration of the 
intestine. 
Inflammatory tissue damage and enterotoxin production elicit watery 
or bloody diarrhea. 
Yersiniosis, caused by Y. enterocolitica is characterized mainly by 
modest diarrheal syndrome and usually self-limited. 
Y. pseudotuberculosis can produce more severe disease with a 
tendency to microbial spread and persistency. Further invasion of bacteria 
results in their appearance in mesenteric lymph nodes and next in 
bloodstream with microbial dissemination and endotoxemia. 
Slow elimination of bacteria may cause chronic disease, which is 
manifested by infectious allergy and autoimmune reactions with arthritis, 
skin lesions (erythema nodosum), and inner organ dysfunction. 
The acquired immunity is low specific and weak, thereby recurrent 
diseases occur. 
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Laboratory Diagnosis of Yersinioses 
 
For laboratory diagnosis of yersinioses stool specimens, vomit, blood, 
food remnants can be examined. 
As the number of yersiniae in stool is often small, the sensitivity of 
cultural method can be enhanced by “cold enrichment”. In that case the 
stool specimen is placed into phosphate buffered saline, pH 7.6, and 
incubated at 4°C for 2-4 weeks. The majority of intestinal flora dies but 
yersiniae can grow. Similar result may be obtained by primary yersinia 
infection on mice. 
Sub-culture is produced on Endo or MacConkey agar. Microbial 
isolate is further identified by its biochemical and antigenic properties. 
For serological diagnosis the specific antibodies against microbial 
antigens are determined at the second week of disease by indirect 
hemagglutination test or ELISA. The assays are considered to be positive 
in titers 1:100-1:200. 
 
 
Treatment and Prophylaxis of Yersinioses  
 
Yersinioses are usually treated with antibiotics that affect gram-
negative bacteria (third generation cephalosporins, fluoroquinolones, 
tetracyclines, or trimethoprim-sulfamethoxazole). Bacteria are resistant to 
ampicillin and first-generation cephalosporins. 
Vaccines are currently not available for disease prophylaxis, thus all 
measures of sanitary control with prevention of food and water resources 
from microbial contamination should be maintained to limit disease spread. 
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Chapter 5 
PATHOGENIC VIBRIOS – CAUSATIVE AGENTS OF CHOLERA. 
CAUSATIVE AGENT OF BOTULISM. HELICOBACTER PYLORI 
 
 
 
CHOLERA VIBRIOS 
 
 
The Discovery of Cholerae Causative Agent and the History of 
Cholera Pandemics  
 
Cholera-like diseases were known from the times of antiquity. 
Nevertheless, the first registered epidemic outbreak of cholera emerged in 
India in 1817. It spread throughout the Indian sub-continent and finally 
was established as the first cholera pandemic in Asia. 
In 1883 Robert Koch discovered the causative agent of cholera, later 
termed as classical Vibrio cholerae biotype (biovar). Later in 1906 another 
biovar, El Tor vibrio was isolated by E. Gotschlich on the Sinai Peninsula 
from the body of dead pilgrim. 
The end of XIX and the beginning of XX century were hallmarked 
with six cholera pandemics. In 1923 the 6
th
 pandemic of cholera affected 
the continents of southern hemisphere, North America and Europe. 
In 1961 the seventh pandemic started from Indonesia, then spread to 
India and the Middle East, appeared in Africa in the 1970s and finally 
achieved South America at 1990s. 
The 5
th
 and 6
th
 pandemics of cholera were caused by V. cholerae 
serogroup O1 of the biotype “classical”. Nevertheless, the 7th pandemic 
was produced by serogroup O1 V. cholerae of biotype El Tor. 
Serogroup conversion of V. cholerae gave rise to novel V. cholerae 
serogroup O139 in 1992. It provoked the emergence of a new large 
epidemic in Bangladesh and India. Multiple cholera cases caused by O139 
strains are being registered now in Southeast Asia. Sometimes this is 
regarded as the start of putative eighth cholera pandemic. However, O1 
El Tor isolates are also detected on these territories as well as in other parts 
of the world. For instance, the great epidemic of cholera in 2010 in Haiti 
was caused by El Tor biovar. 
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Classification 
 
Cholera vibrios belong to the order Vibrionales, family Vibrionaceae, 
genus Vibrio and species V. cholerae. More than 200 serogroups of Vibrio 
cholerae were described but only the members of O1 and recently 
discovered O139 serogroup were proven to cause the epidemic disease. 
Classical Vibrio cholerae biotype and El Tor vibrio biotype pertain to O1 
serogroup. 
Representatives of Vibrio cholerae beyond the serogroups O1 or O139 
are the accidental agents of moderate human diarrheal disorders being of 
lesser clinical relevance. 
Another member of Vibrio genus V. рarahaemolyticus may cause 
diarrhea in humans; in addition, V. vulnificus engenders some individual 
cases of human wound infections or septicemia. 
 
 
Structure and Properties of Cholera Vibrios 
 
Morphology 
Cholera vibrios are comma-shaped gram-negative curved rods 2-4 μm 
long. In old cultures or on artificial media these bacteria occur in grains, 
straight rods, threads or spiral forms. 
Vibrios are non-sporeforming bacteria. Both biotypes from 
O1 serogroup are lack of capsule. However, they synthesize 
exopolysaccharide that provides microbial biofilm formation. It confers 
also the resistance of vibrios to chlorines and bacteriophages. V. cholerae 
of O139 group as well as other vibrios can produce capsule. 
Cholera vibrios are monotrichous motile microorganisms that usually 
carry one polar flagellum. Bacteria possess numerous pili responsible for 
microbial colonization. Among them are mannose-sensitive 
hemagglutinin that ensures vibrio adherence to the chitin of marine 
zooplankton, and toxin-coregulated pili (TCP), which promote microbial 
intestinal attachment as well as reception of enterotoxin-encoding 
bacteriophage СТХφ. 
 
Cultivation 
Cholera vibrios are aerobic or facultatively anaerobic bacteria. They 
actively grow on basic nutrient media with increased salt concentration of 
2-3% NaCl (halotolerant bacteria). The temperature range for culture is 
from 14 to 42°C with optimum at 37°C.  
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Vibrios can withstand alkaline pH, thereby they readily propagate at 
pH 8.0-9.5. Also they are resistant to bile salts. 
In case of nutrient deprivation bacteria are capable of transforming 
into viable, but non-culturable organisms. 
On solid nutrient media V. cholerae produce opaque, granular, 
smooth, round and convex dome-shaped colonies with a light-blue shine. 
In alkaline peptone broth vibrio cultures form a pellicle that contains 
agglomerated cholera vibrios. 
Gelatin cultivation results in transparent granular colonies that 
resemble broken glass on a microscopy. The growth is followed by gelatin 
liquefaction. 
Various enrichment and selective media (e.g. alkaline MPA or 
alkaline nutrient broth) are applied for V. cholerae cultivation. On 
thiosulfate-citrate-bile-sucrose (TCBS) agar with indicator bromine 
thymol blue the bacteria produce yellow colonies. 
 
Biochemical properties 
Cholera vibrios have a broad spectrum of biochemical activity. All 
vibrios are oxidase-positive that discerns them from Enterobacteriaceae 
representatives. They ferment various substrates with acid end products 
(glucose, maltose, sucrose, mannose, mannitol, galactose, starch, glycerol 
and others). 
B. Heiberg divided vibrios into 8 groups according to their 
biochemical activity. Both classical Vibrio cholerae biotype and 
El Tor vibrio pertain to 1  Heiberg’s group and ferment sucrose and 
mannose whereas arabinose and lactose not. 
Bacteria produce ammonia, indole, and reduce nitrates to nitrites. Also 
they coagulate serum and milk, and liquefy gelatin. 
Cholera vibrios render variable hemolytic and hemagglutinating 
properties. 
 
Antigenic structure 
Different vibrios share a common flagellar heat-labile H antigen. 
Somatic lipopolysaccharide (LPS) heat-stable O-antigen is 
responsible for microbial antigenic specificity. More than 200 serogroups 
of vibrios were distinguished by O-antigen variations. It was mentioned 
above that classical Vibrio cholerae biotype and Vibrio cholerae biotype 
El Tor pertain to O1 serogroup. O1 antigen contains A, B and C antigenic 
variations. Thus, three main serotypes within O1 serogroup were 
established: Ogawa (AB), Inaba (AC), and Hikojima (ABC). 
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Vibrio cholerae O139 was proven to originate from El Tor vibrio. It 
was happened after acquisition of gene cluster encoding the synthesis of 
novel O139 LPS antigen, which thereby substituted initial O1 antigen of 
El Tor. 
 
Virulence factors 
Numerous adherence factors of cholera vibrios play substantial role in 
disease pathogenesis. Most important are toxin-coregulated pili (TCP). 
These pili are encoded by Vibrio pathogenicity island VPI. Temperate 
bacteriophage VPIφ is assumed to deliver VPI genes into cholera vibrios.  
TCP pili are responsible for microbial intestinal colonization. 
Moreover, TCP, expressed by cholera vibrio, act as specific receptors to 
bacteriophage СТХφ (cholera toxin encoding phage). СТХφ code for the 
production of cholerogen-enterotoxin by initially non-toxigenic bacteria. 
LPS of the cell wall of O1 serogroup bacteria and the capsule of O139 
group strains accelerate microbial intestinal colonization. Also bacterial 
LPS renders endotoxin activity.  
Exopolysaccharide of V. cholerae actively participate in biofilm 
formation. Capsule of O139 strains protects them from phagocytosis. 
Potent enterotoxin-cholerogen is the major virulence factor of 
cholera vibrios. Cholera toxin is a heterodimer, composed of one A subunit 
in combination with five В subunits with total molecular mass of 84 kDa.  
B-subunits of toxin bind to the intestinal cells via cell membrane 
ganglioside receptor. Subunit A is translocated through cytoplasmic 
membrane into intestinal epithelial cells, undergoes thiol-dependent 
activation and promotes ADP-ribosylation of cell G-proteins. This 
stimulates cellular adenylate cyclase resulting in great increase of cAMP 
concentration. The rise of intracellular cAMP concentration blocks active 
sodium chloride absorption and increases chloride and bicarbonate 
secretion. The latter results in passive water loss with development of 
massive diarrhea. This is followed by marked decrease of intravascular 
volume, life-threatening hypoperfusion of critical organs and hypotension. 
The cholera vibrios produce a number of invasive enzymes, e.g. 
hyaluronidase, collagenase, fibrinolysin, lecithinase, neuraminidase, and 
various proteinases. 
 
Resistance 
Vibrios are the natural components of aquatic ecosystems. 
Colonization of zooplankton, plants, filamentous green algae, crustaceans 
and other marine inhabitants protect bacteria from unfavorable 
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environmental conditions. The El Tor vibrio biotype is characterized by 
relatively high resistance. It stays viable for more than 1 month in sea and 
river waters, up to 10 days in various foodstuffs, etc. 
Cholera vibrios can live in feces for about a month; also they readily 
survive at low temperature. 
Vibrios are sensitive to heating, UV light and desiccation (e.g, heating 
at 100°С immediately kills bacteria). Likewise, they are very susceptible to 
disinfectant treatment and acid exposure. Low concentrations of 
hydrochloric acid inactivate bacteria within one minute. 
 
 
Pathogenesis and Clinical Findings in Cholera 
 
Cholera vibrios inhabit the water of rivers, seas and oceans. Most 
environmental O1 strains are lack of cholerogen expression, but only 
toxigenic V. cholerae can cause the disease. It is considered that natural 
strains acquire the number of virulence genes from pathogenic microbial 
variants, and these events can occur both in external and gastrointestinal 
environment. 
The emergence of virulent V. cholerae strain results from the cascade 
of horizontal gene transfers that eventually convert non-pathogenic 
aquatic bacterium into life-threatening human pathogen. Now it is 
generally assumed that non-toxigenic bacteria become virulent only after 
transduction with several temperate bacteriophages. First transduction 
event confers microbial cell to express toxin-coregulated pili (TCP) – 
receptors for cholera toxin-encoding phage СТХφ. Next cell transduction 
with СТХφ allows affected bacteria to produce cholera enterotoxin. 
Moreover, phage transduction is supposed to be responsible for 
bacterial LPS structure changes. LPS change results in creation of new 
serologic variants of bacteria (e.g., vibrios of O139 serogroup), which 
escape from established human population immunity and provoke new 
large outbreaks of the infection. 
Cholera is anthroponotic disease.  
It is transmitted from sick persons and carriers by fecal-oral route 
with infected foods or water. The causative agent is also carried by flies, or 
can be transmitted by contact route through contaminated hands.  
Short incubation period of disease lasts from several hours to 5-6 
days. 
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After oral ingestion of contaminated water or food most of V. cholerae 
are killed by acidity of gastric juice. Thus, the infectious dose for cholera 
vibrios is rather high (in the range from 10
6
 to 10
11
 microbial cells).  
The rest of bacteria colonize the intestinal epithelial cells of small 
intestine, attach to the microvilli, and ultimately start to produce 
enterotoxin-cholerogen. Toxin expression is activated by gradual decrease 
of bile concentration along the small intestine. 
Action of cholera enterotoxin leads to the development of disease 
symptoms. Patient’s stools resemble "rice water," and contain many 
epithelial cells, mucus, and large number of vibrios. In severe cases 
profuse watery diarrhea and continuous vomit results in lowering of body’s 
temperature, hypovolemic and hypotensive shock with lethal outcome 
within first 12 h of disease. The total fluid loss can achieve 20-30 l per day 
in adults. Without adequate compensatory infusion therapy the mortality 
rate exceeds 20%. 
Abortive and mild disease forms are observed in majority of cases of 
El Tor vibrio cholera. Patient’s carrier state rarely exceeds 1 month. 
Post-infectious immunity is high-grade but of short duration. The 
immunity is both antibacterial and antitoxic; antitoxic antibodies confer 
most efficient protection against the disease. 
 
 
Laboratory Diagnosis of Cholera 
 
The specimens are collected from stool, vomit, autopsy material, 
water, foodstuffs, etc. 
Microscopy is used as a preliminary test. The agglomerated gram-
negative cholera vibrios resembling fish shoals appear in slide smears from 
stool. 
Rapid diagnosis procedures include dark field microscopy of the stool 
specimens that reveal comma-like motile bacterial cells, and 
immunofluorescence assay. 
Identification of cholera causative agent is performed in several steps. 
The specimens are inoculated into alkaline peptone water and alkaline 
agar. After short 6-hour incubation at 37°C thin biofilm of aggregated 
bacteria is formed. The biofilm material is gram-stained, tested for oxidase, 
and examined in slide agglutination test both with O1 and O139 antisera 
taken in titer 1/100. 
If first alkaline broth cultivation result in scarce microbial growth, the 
material is inoculated again into alkaline peptone broth. 
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After primary examination alkaline broth culture is planted onto 
alkaline agar, or TCBS medium. TCBS growth reveals yellow vibrio 
colonies due to sucrose fermentation. 
The vibrio culture is examined by repeat slide agglutination test and 
oxidase test. The latter should be positive for all vibrios. To obtain the pure 
culture the isolate is further planted on slant alkaline agar. Final 
identification of culture is made by agglutination reaction with O1 and 
O139 sera, biochemical tests (mannose, sucrose and arabinose 
fermentation), positive indole test, and by susceptibility to the number of 
specific phages. 
Molecular genetic methods of vibrio typing are used in specialized 
reference centers for epidemiological studies. 
Classical V. cholerae and El Tor vibrios can be distinguished by the 
number of tests: both biotypes are sensitive to specific bacteriophages; 
El Tor biotype is resistant to polymyxin B, it expresses hemolysin and 
produces acetoin with positive Voges-Proskauer test. Classical V. cholerae 
has opposite traits. 
 
Treatment and Prophylaxis of Cholera 
 
The urgent treatment of cholera is based mainly on infusion 
replacement therapy that compensates the loss of water and electrolytes. 
In case of adequate infusion the patient recovers from the disease. 
Different antibiotics, affecting gram-negative flora, can be used to 
facilitate convalescence. Usually oral tetracyclines are administered. 
Antimicrobial chemoprophylaxis and vaccine prophylaxis may be 
used for disease prevention in family contact persons. 
For specific prophylaxis phenol-killed vaccine and cholerogen toxoid 
are occasionally used now. Nevertheless, they confer only the short-term 
protection for 6-12 months in 50-80% of vaccinated individuals. 
Elaboration of modern cholera vaccines is based on live microbial 
strains, but this work should account the possibility of attenuated vaccine 
bacteria to acquire virulence genes from environmental strains. 
Non-specific prophylaxis of cholera includes the improvement of 
sanitation, prevention of water and foodstuffs pollution, protection of 
sources of water supply; proper hygienic and sanitary control measures and 
cholera surveillance. First cases of disease should be verified and carefully 
registered with subsequent isolation and hospitalization of all patients, 
observation and laboratory testing of all contact individuals, current and 
final disinfection in departments for cholera patients. 
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CLOSTRIDIUM BOTULINUM –  
CAUSATIVE AGENT OF BOTULISM 
 
 
The History of Discovery 
 
A causative agent of botulism (L. botulus – sausage, botulism – 
poisoning by sausage toxin) was firstly discovered and studied by 
E. van Ermengem in 1896. He isolated microbial pathogen both from 
intestine and spleen of patients, died from intoxication, and at the same 
time from food they had ingested (ham remnants). 
 
 
Classification 
 
Botulism causative agent belongs to the order Clostridiales, family 
Clostridiaceae, genus Clostridium, and species C. botulinum. 
 
 
Structure and Properties of C. botulinum 
 
Morphology 
Clostridium botulinum is a large gram-positive rod up to 8 μm in 
length. It is a motile peritrichous bacterium with oval terminal or 
subterminal spore. Sporeforming cell looks like tennis racket. 
 
Cultivation 
The optimal temperature for microbial growth is within the range 30-
40°C. These clostridia are readily cultivated in anaerobic conditions at pH 
7.3-7.6. Culturing on sugar-blood agar in anaerobic jar reveals filamentous 
irregular hemolytic colonies. The growing anaerobic culture has the smell 
of rancid butter. 
Cultivation in Kitt-Tarozzi medium results in homogenous turbidity 
followed by microbial precipitation. 
 
Biochemical properties  
Causative agents of botulism are obligate anaerobes. 
They ferment carbohydrates (glucose, maltose, glycerol and some 
others) with acid and gas end products. Mixed type of fermentation results 
in acetic, butyric, and lactic acid. 
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Botulism clostridia express marked proteolytic activity. They produce 
hydrogen sulfide, ammonia, and volatile amines. Also they are able to 
reduce nitrates to nitrites, liquefy gelatin and coagulate milk. 
 
Antigenic structure 
C. botulinum is divided into 8 serovars (A, B, C1α, C2β, D, E, F and G) 
according to antigenic variations of microbial exotoxin. A, B, E, and F 
variants are found to be extremely toxic for humans. 
Also bacteria possess flagellar H-antigen and somatic O-antigen 
similar in all botulism clostridia. 
 
Virulence factors 
C. botulinum produces the most poisonous neurotoxin known to date. 
One human lethal dose of dry botulinum toxin is about 0.1 ng/1 kg of body 
weight. 
In anaerobic conditions clostridia start to secrete exotoxin especially 
after propagation in various foodstuffs (meat, fish, canned mushrooms and 
vegetables, etc.) Toxin production is inhibited in presence of 6-8% NaCl 
and in acidic conditions. Its activity is also neutralized by specific 
antibodies. 
C. botulinum exotoxin is composed of A and B subunits. Subunit A is 
responsible for toxic activity, while B portion preserves the molecule from 
acid inactivation in stomach. Also it is resistant to digestive enzymes of 
gastrointestinal tract. 
Once ingested, the toxin is absorbed in gut. It reaches the nervous 
system and inhibits the release of acetylcholine at cholinergic synapses, 
resulting in muscular paralysis.  
Botulinum neurotoxin is a Zn-containing metal protease that destroys 
synaptic proteins (e.g., vesicle-associated protein, synaptobrevin, 
cellubrevin and others) in cholinergic synapses of motor neurons. 
 
Resistance 
Heating at 90°С for 40 minutes or boiling for about 10 minutes 
irreversibly inactivates botulinum toxin. Heating at 80°С kills vegetative 
forms of clostridia within 30 minutes. The spores have strong resistance 
and remain viable in soil and dust for years. They can withstand boiling for 
up to 6 hours and even keep their viability in large pieces of meat after 
autoclaving for 15 minutes at 120°C. 
Standard disinfectants, such us 5% phenol, inactivate the spores of 
botulism clostridia after exposure for 18-24 h. 
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Pathogenesis and Clinical Findings in Botulism 
 
Spores of C. botulinum can be found in the intestine of animals, birds 
and fishes. They permanently discharge spores into surrounding 
environment with feces. The spores retain viability in the soil for a long 
time and can appear on the surface of vegetables and fruits with the soil 
dust. 
Infected animals and fishes are regarded as the major sources of 
infection. 
Botulism is transmitted predominantly by fecal-oral route after 
ingestion of contaminated meat products, canned mushrooms, poultry, 
sausages, or vegetables, smoked and canned fish and many other products. 
These foodstuffs may contain germinated spores and various amounts of 
exotoxin, produced by viable microbial cells. Also botulinum toxin may 
enter the body through the wound surface. 
Incubation period of the disease varies from several hours to 10 days 
and even more that depends mostly on amount of absorbed exotoxin. 
After ingestion and intestinal absorption of exotoxin it appears in 
blood and invades central nervous system, muscular and other tissues. 
Toxin affects the neuronal nuclei of spinal cord and brain, neuromuscular 
junctions, cardiovascular system. Toxin binding is irreversible. 
Anticholinergic action of toxin cause deep CNS disorders that result 
in dysphagia, vomiting, dry mouth, swallowing troubles, aphonia, 
dizziness, headache, diplopia, and eventual muscular weakness and 
paralysis. Diaphragm paralysis can cause the lethal outcome. Mortality 
rate is very high (about 20-40%). 
Rare but severe clinical condition is infant botulism, where the 
ingested spores germinate directly in baby’s colon because of its poor 
colonization resistance, and the nascent clostridia begin to produce 
exotoxin. 
Natural anti-toxic immunity is almost not created being of very low 
grade. 
Recovery from botulism is followed by gradual restoration of activity 
of cholinergic synapses. 
 
 
Laboratory Diagnosis of Botulism 
 
In most cases the clinical findings of the disease are enough evident to 
make right diagnosis. 
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For laboratory diagnosis of botulism the samples of food remnants, 
vomit, blood and patient’s stool are examined. Stomach contents and 
various corpse tissues (small and large intestine, brain, spinal cord) are 
used for post-mortem examination. 
The presence of botulinum toxin in the specimens is confirmed by 
neutralization reaction in mice or guinea pigs, by ELISA, or by indirect 
hemagglutination test with erythrocyte antitoxin diagnosticum. 
For culture isolation the samples should be previously heated at 80°С 
for 20 min to inactivate non-sporeforming bacteria. They are next 
inoculated into Kitt-Tarozzi broth or other equivalent media and incubated 
in anaerobic conditions. The isolated culture is further tested for 
biochemical and toxigenic properties. Culture toxin secretion is revealed 
by experimental mice infection. Toxin serotype identification is performed 
by neutralization reaction with antitoxin type-specific antibodies. 
Toxigenicity of culture can be also confirmed by molecular genetic 
tests (e.g., PCR). 
 
 
 
Treatment and Prophylaxis of Botulism 
 
Non-specific measures of patient detoxication (stomach lavage, 
adsorbent treatment, infusion therapy) can decrease the amount of 
absorbed toxin. 
Urgent passive immunotherapy includes the repeat injections of high 
doses of horse-derived polyvalent botulinum antitoxic sera against A, B, 
C, and E serovars. Botulism toxoid is sometimes used to elicit specific 
antitoxic immunity in affected patients. The persons, suspected to use 
foodstuffs with botulinum toxin, are treated with polyvalent antitoxic sera 
in lower doses to prevent severe intoxication. 
Non-specific prophylaxis includes the prevention of food 
contamination and the maintenance of established industrial sanitary 
conditions of meat, fish, caviar, or vegetable canning, and their proper 
storage. Home preservation, canning and storage of similar products can’t 
provide their complete decontamination, thus it should be excluded from 
practical use. 
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HELICOBACTER PYLORI – THE AGENT OF  
CHRONIC GASTRITIS, GASTRIC OR DUODENAL ULCER 
 
 
 
The History of Discovery 
 
Single reports about the presence of spiral microorganisms in gastric 
mucosa were repeated several times still from the turn of XIX and XX 
century. 
Nonetheless, only in 1982 Australian scientists physician 
Barry Marshall and pathologist Robin Warren isolated spiral bacteria from 
gastric tissue biopsy of patient with chronic gastritis. By the experiment of 
self-infection B. Marshall and colleague have proved for the first time the 
association between these bacteria and the development of chronic 
gastritis. Multiple next studies completely confirmed this association, as 
well as established new links of these microbial agents with gastric and 
duodenal ulcer, gastric cancer and certain cases of lymphatic tumors. 
In 1989 the novel pathogen has acquired its final taxonomic name 
“Helicobacter pylori”. And in 2005 B. Marshall and R. Warren were 
awarded Nobel Prize in Physiology or Medicine for their outstanding 
discovery. 
 
 
 
Classification 
 
The genus Helicobacter of the family Helicobacteriacea currently 
comprises more than 35 microbial species (Helicobacter pylori, 
Helicobacter heilmannii, Helicobacter mustelae, Helicobacter felis and 
many others). The main agent of human diseases is H. pylori. Some 
relations with human pathology are reported for species H. heilmannii.  
It is generally ascertained that H. pylori plays the substantial role in 
pathogenesis of acute and chronic gastritis, gastric and duodenal ulcer. 
Furthermore, helicobacter infection predisposes to the development of 
stomach cancer and gastric lymphoid tumor MALT lymphoma. 
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Structure and Properties of H. pylori 
 
Morphology 
Helicobacter pylori is a short or medium-size gram-negative 
bacterium of S-like spiral shapes. Microbial cells carry 2-6 flagella 
attached to one pole of bacterial body (lophotrichate bacteria). They have 
no spore or capsule. 
 
Cultivation 
Helicobacters are highly fastidious agents propagating only in 
microaerophilic (5-7% О2) and capnophilic (near 10% of СО2) gaseous 
conditions; in standard aerobic or anaerobic surroundings the bacteria can’t 
grow.  
Also they have narrow temperature optimum for growth near 37°C, 
being completely inactivated at 25-28°C or above 410С.  
H. pylori requires special and selective nutrient media with multiple 
growth factors. It can be cultured in blood or serum agar supplemented 
with broad spectrum antimicrobials (e.g., vancomycin, trimethoprim and 
amphotericin B) that inhibit the propagation of concomitant bacteria. 
Primary growth is evaluated in 5-7 days of culture. 
 
Biochemical properties  
Helicobacters are microaerophilic bacteria. They are oxidase and 
catalase positive; express multiple enzymes – phosphatase, phospholipase, 
hyaluronidase, proteases; produce H2S, demonstrate remarkable urease 
activity.  
These bacteria utilize amino acids as nutrients; from available 
carbohydrates they metabolize only glucose. 
 
Antigenic structure 
The bacteria possess somatic LPS-containing O-antigen, flagellar H-
antigen and superficial outer membrane proteins (OMP), which are type-
specific.  
 
Virulence factors 
H. pylori produces the number of adhesins, aggressive enzymes and 
toxins. 
The major role in pathogenesis of helicobacter infection belongs to 
microbial exotoxins – cytotoxin CagA (cytotoxin-associated gene A) and 
vacuolating cytotoxin A (VacA). 
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Cytotoxin CagA is present in most of the virulent strains of H. pylori. 
It is encoded by the same name pathogenicity island cag. Besides CagA 
cytotoxin, this island codes for type IV secretion system (T4SS) of 
Helicobacter pylori.  
Translocator proteins of T4SS deliver CagA toxin into gastric 
epithelial cells. The main pathogenic functions of CagA include the 
impairment of cellular metabolism and activation of cell-mediated 
inflammatory reactions. 
Vacuolating cytotoxin A or VacA binds to membranes of gastric 
epithelial cells. It demonstrates pleiotropic pathological effects against 
gastric mucosal membrane. 
For instance, VacA elicits the secretion of proinflammatory cytokines 
by leukocytes. Moreover, the molecules of VacA toxin create membrane 
pores allowing their own entry into epithelial cells. When entered into the 
cells, the molecules of VacA toxin trigger cell apoptosis or at least they 
cause profound degenerative changes in gastric mucosa (cell 
vacuolization and disruption of cellular tight junctions). 
Helicobacter peptidoglycan also stimulates inflammatory reactions 
within stomach wall.  
In addition, H. pylori intensively produces the number of aggression 
and invasion enzymes. 
High level of expression is essential for microbial urease that 
catalyzes urea decay. This leads to the production of exuberant amounts of 
ammonia that not only damage the mucosal tissues but also neutralize the 
acidity of gastric juice thus fostering microbial survival. 
Hyaluronidase and microbial flagella stimulate bacterial invasion into 
submucous gastric layer. 
Microbial phospholipases destroy the membranes of epithelial cells. 
Siderophore proteins provide the bacteria with iron. 
H. pylori demonstrates primary genetic resistance to sulfonamides, 
glycopeptides, polymyxins and amphotericin. 
 
Resistance 
Generally helicobacters are low-resistant bacteria taking into account 
the narrow temperature range (34-40
oС) of their growth and toxic action of 
atmospheric oxygen. 
Nevertheless, there are some individual reports about helicobacter 
survival in dental plaque, saliva, vomits and gastric juice. 
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Pathogenesis and Clinical Findings of Diseases, Associated with 
Helicobacter pylori Infection 
 
Helicobacter infection is regarded as one of the most common in 
human population. About 50% of humans are infected with H. pylori (25-
40% in developed countries, where the people above the age of 50 prevail, 
and up to 80% of population in developing states with substantial part of 
young individuals). 
Nevertheless, only 10-20% of H. pylori carriers finally develop gastric 
or duodenal ulcer; likewise, lifetime risk of stomach cancer among infected 
persons is about 1-2%.  
Hence, the progression towards complicated helicobacter infection 
strongly depends on pathogen virulence, individual health state and 
lifestyle, nutritional habits, the safe use of certain groups of medicines like 
nonsteroidal anti-inflammatory drugs (NSAID), etc.  
It has been established that H. pylori species is hallmarked with high 
genetic variability that originates from active lateral gene transfer. Up to 
30% of bacterial genes are involved into infectious process. Thus, 
individual alterations of microbial virulence predispose to various 
manifestations of H. pylori infection. 
The source of H. pylori infection – infected humans. 
The routs of transmission are not completely elucidated yet. In most 
of cases the infection is transmitted orally by fecal-oral mechanism or by 
direct contact. Iatrogenic spread of infection via contaminated endoscopic 
equipment also can’t be excluded.  
When entered the stomach, most of bacteria settle in gastric antrum 
where the local pH of mucosal tissue is higher. Next they move towards 
duodenum. Active locomotion of microbial cells promotes their invasion 
into submucous gastric layer. Here they attach to membrane glycolipid 
receptors.  
Urease of H. pylori metabolizes urea with ammonia release that 
neutralizes the acidity of gastric juice, supports long-time microbial 
survival and directly damages gastric mucosa. 
The most virulent are helicobacter strains with parallel production of 
both bacterial cytotoxins - CagA и VacA.  
The protein apparatus of T4SS injects toxin CagA and the fragments 
of peptidoglycan into gastric epithelial cells. 
CagA interferes in normal life cycle of epithelial cells; peptidoglycan 
fragments stimulate inflammatory response via activation of transcription 
factor NF-kB. Together with VacA toxin they promote the development of 
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acute gastritis and/or duodenitis. This is followed by local 
hyperproduction of proinflammatory cytokines (IL-8 and others) that 
stimulates neutrophil and lymphocyte infiltration of stomach wall. 
Incubation period of acute gastritis doesn’t exceed several days. 
Without proper management acute helicobacter gastritis has evident 
chances for transformation into chronic disease especially under the action 
of other predisposing factors (smoking, alcohol consumption, treatment 
with NSAIDs, etc.) 
The next course of infection largely depends on predominant 
localization of inflammatory process. 
If chronic gastritis affects mainly the pyloric part of the stomach, it 
leads to permanent hyperproduction of gastrin and HCl that finally results 
in development of ulcer of duodenal or antral localization. 
If chronic helicobacter gastritis progresses into chronic pangastritis 
with damage of cardia, fundus and body of stomach, it causes the gradual 
but irreversible destruction of gastric epithelial cells. The production of 
hydrochloric acid declines resulting finally in chronic atrophic gastritis 
with achlorhydria. 
Chronic atrophic gastritis is the significant risk factor of stomach 
cancer. That’s why helicobacter infection is regarded as biological 
carcinogen. 
The influence of helicobacter virulence factors on proliferation of 
immune cells may cause the emergence of rare cancer disease MALT 
lymphoma – the tumor originated from gastric lymphoid follicules. 
Despite intensive activation of local cell-mediated immunity, 
inflammatory response is unable to eliminate the infection resulting in 
lifelong helicobacter carriage. 
Only efficient complex antimicrobial therapy results in eradication 
(complete removal) of helicobacter infection.  
 
 
Laboratory Diagnosis of Helicobacter pylori Infection 
 
As helicobacter infection is common among the individuals, specific 
laboratory examination is usually required for the cohort of patients with 
gastric and duodenal pathology. 
Two groups of laboratory methods are used for detection of H. pylori 
– non-invasive and invasive tests; the latter need gastric biopsy specimens. 
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Rapid non-invasive carbon urea breath test discovers urease activity 
of H. pylori. The test is convenient for mass screening of people attending 
medical offices and clinics.  
When tested, the examined person drinks urea solution radioactively 
labeled with [
14С] or [13C]. Under the action of microbial urease labeled 
CO2 is released that is registered in expired air. 
Other non-invasive tests include determination of Ags of H. pylori in 
feces by ELISA test and detection of microbial DNA by PCR. 
Invasive tests presume the examination of gastric biopsy specimens 
taken during endoscopy. 
For instance, rapid urease test detects helicobacter urease in gastric 
biopsy by placement of the specimen into urea solution. The decay of urea 
is followed by ammonia accumulation that elevates pH of the medium and 
changes the color of indicator dye. 
The most reliable test for direct detection of H. pylori in biopsy 
specimen is microscopy with histological hematoxylin-eosin staining or 
Warthin-Starry's silver stain that is more sensitive. Also luminescent stain 
can be used, e.g. with acridine orange dye. Typical morphology of bacteria 
is observed. 
For isolation of microbial culture, the tissue specimen is inoculated 
into special media supplemented with antibiotics and multiple growth 
factors. Incubation is performed in microaerophilic conditions (5-7% О2) 
with increased concentration of CO2 (5-10%). Primary growth should be 
assessed in 5-7 days. 
The isolated culture is further examined by microscopy, biochemical 
testing (e.g., for oxidase and urease), serological and molecular genetic 
tests. 
Serological diagnosis uses ELISA test for evaluation of specific 
antibodies (Abs) in patient serum directed against H. pylori Ags. 
 
 
Treatment and Prophylaxis of H. pylori Infection 
 
To prevent unfavorable consequences of H. pylori infection, complete 
eradication of this pathogen is required. 
Recommended first-line antimicrobial treatment (so-called “triple 
therapy”) includes proton pump inhibitor (e.g., omeprazole) and two 
antibiotics amoxicillin and clarithromycin. The efficacy of this regimen is 
more than 85%.  
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Microbiological confirmation of eradication is performed after the end 
of treatment course.  
In case of first-line treatment failure, quadruple therapy is used 
expanded with colloidal bismuth salts. 
In the light of growing antimicrobial resistance of H. pylori, 
antibiotics of other groups can be administered – metronidazole, 
tetracycline, and fluoroquinolones. 
Despite the high frequency of successful eradication, the cases of 
reinfection with H. pylori are common mainly due to the broad spread of 
this agent among human population.  
Prophylaxis of H. pylori infection remains non-specific. It is based on 
general measures for efficient sterilization of medical instruments, 
antisepsis and disinfection. 
Various kinds of candidate vaccines against H. pylori are under 
clinical trials now. 
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Chapter 6 
CAUSATIVE AGENTS OF BACTERIAL RESPIRATORY 
INFECTIONS:  
MENINGOCOCCI, HAEMOPHILUS INFLUENZAE, 
BORDETELLAE, LEGIONELLAE, AND MYCOPLASMAS 
 
 
 
MENINGOCOCCI 
 
 
The History of Discovery 
 
The meningococcus (Neisseria meningitidis) was primary isolated 
from the cerebrospinal fluid of patients with meningitis and studied in 
details in 1887 by A. Weichselbaum. 
 
 
 
Classification of Meningococci 
 
Meningococci pertain to the family Neisseriaceae, genus Neisseria, 
and species Neisseria meningitidis. They are further subdivided according 
to their antigenic features into serogroups and serotypes. 
 
 
 
Structure and Properties of Meningococci 
 
Morphology  
Meningococci are gram-negative, bean-shaped pathogenic diplococci 
that similar to other gram-negative bacteria are surrounded by an outer 
membrane composed of lipids, outer membrane proteins (OMPs), and 
lipopolysaccharides. Pathogenic meningococci are enveloped by a 
polysaccharide capsule attached to this outer membrane. 
Menigococci are non-sporeforming non-motile organisms. They 
possess multiple pili and fimbriae. 
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Cultivation 
Meningococci are fastidious bacteria and can’t grow on basic nutrient 
media. 
They should be cultured on media with blood, serum or ascitic fluid 
(ascitic agar), better in atmosphere, supplemented with 5-10% CO2 
(capnophilic bacteria). 
Optimum temperature for growth is 36-37°С. Bacteria can’t grow at 
22°C. After 48 h of cultivation on solid media they produce transparent, 
convex, glistening, and elevated small colonies without hemolysis. In 
serum broth turbidity and a precipitate at the bottom of the test tube 
appears. 
 
Biochemical properties 
Meningococci are aerobic or facultatively anaerobic bacteria. They 
produce oxidase and catalase. 
Generally meningococci show poor biochemical activity – the bacteria 
utilize only glucose and maltose with acid formation being lack of 
proteolytic activity. 
 
Antigenic structure 
Meningococci carry multiple antigenic polysaccharides and proteins in 
their cell wall and capsule. 
They demonstrate more genetic diversity than most of other 
pathogenic human bacteria. This is explained by horizontal intraspecies 
recombination and gene incorporation from closely related Neisseria 
species. 
Because of this striking variability 13 serogroups by capsule antigens 
(A, B, C, D, Y, W-135, etc.) and 20 serotypes identifying outer membrane 
proteins (OMP) were defined. 
On the ground of antigenic properties of lipopolysaccharide, termed 
lipooligosaccharide (LOS) because of its relatively short sugar chain, 
another 13 immunotypes were described. Further additional typing is 
possible according to the antigenic properties of immunoglobulin Al (IgAl) 
proteases and pili. 
 
Virulence factors 
Pili and outer membrane proteins are the major adhesins that 
contribute to meningococcal attachment to mucosal cells. 
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The most essential bacterial virulence factor for survival in the 
bloodstream is its polysaccharide capsule, which protects bacteria against 
complement-mediated bacteriolysis and phagocytosis by neutrophils. 
IgA proteases of meningococci break down human IgAs, thus 
impairing mucosal immunity. 
Hyaluronidase and neuraminidase promote microbial invasion. 
Disintegration of meningococci leads to the release of a highly toxic 
LOS-based endotoxin. Its liberation produces large amounts of 
proinflammatory cytokines such as tumor necrosis factor-alpha ( -TNF), 
IL-1, IL-6, IL-8, γ-interferon, and various colony-stimulating factors.  
Unlike other endotoxins, meningococcal LOS can be actively secreted 
by bacteria within membrane microvesicles, and microbial cells retain their 
viability after LOS shedding.  
 
Resistance 
Meningococcus is the microbial agent of low stability – it is destroyed 
by drying in a few hours. By heating to a temperature of 60°С the 
bacterium is killed in 10 minutes and to 80°C in 2 minutes. When treated 
with 1% phenol, the culture becomes inactivated in 1 minute. 
Meningococci are very sensitive to low temperatures. 
 
 
Pathogenesis and Clinical Findings in Meningococcal Infections 
 
Meningococcal infections affect only humans (anthroponotic 
disease).  
Meningococcal disease occurs worldwide. The bacteria from 
serogroups В and С cause the majority of infections in industrialized 
countries. Strains of serogroups A and, to a lesser extent, С dominate in 
third-world countries. 
Meningococcal carriers are the predominant source of infection. The 
causative agent is localized primarily in their nasopharynx. About 10% of 
adult population may become the carriers of meningococci through the 
lifetime.  
Infants and children remain to be the most susceptible group for the 
disease. 
The infection is transmitted by the air droplet route.  
Several forms of meningococcal infection exist: meningococcal 
carriage, meningococcal nasopharyngitis, meningitis, and 
meningococcemia (including fulminant meningococcal sepsis). 
 101 
Meningococcal carriage and meningococcal nasopharyngitis are the 
predominant forms of infection, being most spread in population. 
Nevertheless, some patients develop severe acute meningococcal 
disease: meningitis and meningococcemia. Meningococcal meningitis is 
regarded now as a form of systemic meningococcal disease, which is 
always followed by microbial dissemination. 
Systemic meningococcal infection is the invasive disease. It is 
occurred after exposure to a pathogenic strain and colonization of the naso-
oropharyngeal mucosa, followed by microbial passage through mucosal 
tissues, and survival of meningococci in the bloodstream.  
Damage of the nasopharyngeal ciliated epithelium may be the first 
step that provokes colonization. After primary adherence to CD46, further 
microbial attachment is promoted by interaction of outer membrane 
proteins (OMP) to CD66 receptors.  
Microbial binding to CD66 on phagocytic and endothelial cells 
activates phagocytosis and cytokine production and stimulates the 
engulfment of meningococci by epithelial cells resulting in their 
transcellular passage. 
Microbial entry into the bloodstream leads to bacterial dissemination 
and endotoxin release. It triggers massive proinflammatory cytokine 
liberation that may cause toxic shock. High cytokine concentrations reflect 
the depth of shock. Extensive disseminated intravascular coagulation 
(DIC) and tissue damage are the most severe complications of 
meningococcal endotoxemia. 
Incubation period lasts from several hours to several days, i.e., acute 
meningococcal disease is one of the most swift-progressing infections. 
In some patients with low degrees of bacteremia, meningococci can be 
eliminated spontaneously. 
Other patients demonstrate sudden attack of the disease with high 
fever 39-40
оС, vomiting, rigidity of the occipital muscles, severe headache, 
and hemorrhagic skin rashes. Involvement of the cranial nerves results 
from the increase of the intracranial pressure. A large number of 
neutrophils are found in the cerebrospinal fluid. 
In case of meningitis the inflammatory response is localized 
predominantly in an extravascular compartment.  
If meningococcal sepsis (meningococcemia) has abnormally high 
fatality rate (20-50% and even more), meningococcal meningitis develops 
lower rate of lethality (about 1-5%) and post-infectious neurological 
sequelae (in 10-20% of patients). 
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Immunity to meningococcal infection is associated with the presence 
of specific bactericidal complement-dependent antibodies in patient’s 
serum. These antibodies arise in the course of infection. They can be type-
specific and/or group-specific. Antimicrobial antibodies prevent the 
development of invasive disease. Recurring infections are not common. 
Infants are generally protected from the infection for 3-5 months by 
passive immunity via IgG antibodies transferred from the mother. 
 
 
Laboratory Diagnosis of Meningococcal Infections 
 
Nasopharyngeal swabs and blood samples are taken for culture. 
Specimens of cerebrospinal fluid (CSF) and skin petechiac biopsy are 
taken for microscopy, culture, and microbial antigen detection. 
Meningococcal antigens can be rapidly determined in CSF by 
precipitation or ELISA test.  
Microbial DNA in CSF is detected by molecular genetic tests (PCR). 
Microscopy of gram-stained slides with the samples of centrifuged 
cerebrospinal fluid detects typical gram-negative bean-shaped diplococci 
within polymorphonuclear leukocytes (incomplete phagocytosis) or 
extracellularly. 
Cultivation of clinical specimens is performed in serum, ascitic or 
blood agar, supplemented with antibiotics, suppressing gram-positive 
microflora (vancomycin, amphotericin or ristomycin). After incubation for 
48 h in aerobic atmosphere with 5-10% CO2 pure cultures of meningococci 
can be recovered from CSF or blood.  
The bacteria are further identified by carbohydrate fermentation and 
agglutination with group and type-specific sera. 
Antibodies to meningococcal polysaccharides (serological diagnosis) 
can be measured by latex agglutination or ELISA. Test for antibodies is 
elaborated mainly in cases of unclear meningococcal infection.  
 
 
Treatment and Prophylaxis of Meningococcal Infections 
 
Taking into account the fulminant character of disseminated 
meningococcal infection, it is generally accepted that the therapy should 
never be delayed by diagnostic procedures, and antibiotics are the 
cornerstone of treatment. 
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Beta-lactam antibiotics (penicillin G or third-generation 
cephalosporins) are the drugs of choice for treatment of meningococcal 
disease. Azalides or chloramphenicol can be used in allergic persons. 
Treatment of shock includes fluid resuscitation, administration of 
glucocorticoids, transfusion of fresh-frozen plasma, mechanical lung 
ventilation if required. 
For specific prophylaxis various polysaccharide chemical vaccines 
based on group A and С capsular antigens were developed.  
Currently, a quadrivalent vaccine containing the antigens of 
serogroups A, C, W, and Y is available. Vaccination is highly effecient in 
the control of outbreaks and epidemics of meningococcal infection 
conferring the protective immunity at least for 2-3 years. However, 
vaccination doesn’t affect carriers. 
The major drawback of these vaccines is the absence of activity 
against group В meningococci. It has been found, that group В 
polysaccharide mimics the human neuronal cell adhesion molecules; 
therefore, the use of group В capsular antigen for immunization elevates 
the risk of autoimmune response. 
Now experimental group В vaccines based on meningococcal outer 
membrane proteins are under the clinical trials. 
 
 
 
HAEMOPHILUS INFLUENZAE AND OTHER  
RELATED BACTERIA 
 
 
 
The History of Discovery 
 
Hemophilic bacteria were primarily discovered in the early 1880s by 
R. Koch, who detected them in conjunctival exudate of patient with 
purulent conjunctivitis. 
Some time later, M. Afanassiev in 1891 and R. Pfeiffer in 1892 
isolated similar bacteria from patients in the course of influenza epidemic. 
As the result, for a long time these pathogens were regarded as the 
causative agents of influenza and therefore, acquired their own species 
name Haemophilus influenzae. 
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Classification 
 
Hemophilic bacteria pertain to the family Pasteurellaceae and genus 
Haemophilus. This genus comprises more than 10 species of bacteria; 
some of them are seriously pathogenic for humans. 
Haemophilus influenzae species is the dominant human pathogen. The 
members of this species commonly cause respiratory infections, but in 
certain cases they may trigger severe invasive disorders, such as meningitis 
or septicemia. 
Similar pathogenic activity is sporadically demonstrated by 
H. parainfluenzae, H. haemolyticus and H. parahaemolyticus species.  
H. ducreyi causes chancroid or soft chancre – one of the bacterial 
sexually transmitted diseases (STD). 
Genera Aggregatibacter and Pasteurella that pertain to the same 
microbial family also harbor human pathogenic representatives. For 
instance, Аggregatibacter aprophilus can be isolated in patients with 
bacterial endocarditis; one more agent Аggregatibacter 
actinomycetemcomitans is an agressive oral pathogen that participates in 
progression of periodontitis. 
 
 
Structure and Properties of Haemophilus influenzae 
 
Morphology 
These organisms are small 0.3-1.0 μm gram-negative polymorphic 
coccobacteria. They are non-sporeforming, but produce capsule.  
 
Cultivation 
Hemophilic bacteria are rather difficult for culture. As fastidious 
microorganisms, they need the number of auxiliary factors for efficient 
growth.  
For instance, they require factor V (nicotinamide adenine dinucleotide 
or NAD) and factor X (hemin), which are commonly present in red blood 
cells. Thus, the optimal medium for them is chocolate agar, where 
erythrocytes are lysed by heating. The bacteria grow better in presence of 
elevated concentrations of CO2.  
Also H. influenzae can be cultured on blood agar, but only nearby 
paper disc impregnated with V and X factors. Likewise, H. influenzae may 
grow together with satellite hemolytic bacteria (e.g., S. aureus) that liberate 
factors V and X from red blood cells.  
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The colonies of bacteria are small, convex, and glistening. Pathogenic 
H. influenzae render S- or M (mucous) forms of colonies. Non-pathogenic 
strains usually produce R-forms. 
 
Biochemical properties 
The bacteria are facultative anaerobes with mixed type of metabolism. 
They produce catalase and oxidase. 
H. influenzae ferment glucose. Some strains produce indole and 
metabolize urea. The latter reactions are used for biotyping of 
H. influenzae.  
Biochemical differentiation of hemophils and related bacteria is based 
on the number of tests, presented in table 4. 
Table 4  
Differential tests for various Haemophilus species  
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СО2 
H. influenzae X, V + + + – – + – – – 
H. haemolyticus X, V – + + + + + – – – 
H. parainfluenzae V – + + + – + + – + 
H. ducreyi X – – – – – – – – – 
А. aphrophilus X + – – + – + + + + 
 
 
Antigenic structure 
The bacteria possess thermostable somatic O-antigen made of 
lipooligosaccharide (or LOS) and superficial capsular polysaccharide K-
antigen. Six basic serovars or types (a, b, c, d, e, and f) are recognized by 
capsular K-Ag. Non-capsulated strains are referred to as nontypable. 
Protein M-antigen is present in non-pathogenic strains, 
 
Virulence factors 
The major factor of bacterial virulence is capsule. It shows adhesive 
properties and prevents bacteria from phagocytosis and complement 
activity. 
Most of severe invasive infections are caused by capsular strains of 
Н. influenzae type b (or Hib). 
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Unlike other types, Hibs are covered with the capsule that contains 
polyribosil ribitol phosphate (PRP). All other capsulated Н. influenzae 
have a hexose instead of pentose (ribose) in the structure of PRP.  
PRP is a strong T-independent antigen. 
The lipooligosaccharide (LOS) shows endotoxin activity.  
Multiple pili play a role of the adhesins. They promote microbial 
attachment to epithelial cells. 
IgA proteases of hemophilic bacteria destroy human IgAs thereby 
downgrading mucosal immunity. 
Synthesis of beta-lactamases confers microbial resistance to certain β-
lactam antibiotics.  
 
Resistance 
Н. influenzae is enough sensitive to environmental factors being 
rapidly inactivated outside the body. However, in sputum and mucus it 
stays viable up to 18 h, on plastic surfaces – for 12 h.  
Microbial cells are readily inactivated by all standard disinfectants 
(e.g., sodium hypochlorite, phenol, or formaldehyde). 
 
 
Pathogenesis and Clinical Findings of Infections, Caused by 
Haemophilus influenzae 
 
Н. influenzae is solely human pathogen engendering various kinds of 
anthroponotic infections. Nevertheless, hemophilic bacteria especially 
their nontypable strains are the normal inhabitants of human respiratory 
tract. 
The decline of mucosal immunity of respiratory tract as well as airway 
damages predispose to active propagation of Н. influenzae. They replicate 
extra- and intracellularly and may enter the bloodstream. 
Sick persons and carriers of Н. influenzae are the major sources of 
infection.  
The diseases are transmitted by air droplet route and, to lesser extent, 
by contact route. 
Children under the age of 4-5 years are the most susceptible to 
Н. influenzae. 
The infections caused by Н. influenzae are divided into two main 
groups – non-invasive and invasive. 
Non-invasive diseases affect the epithelium of respiratory tract. 
Among them are acute sinusitis, acute otitis media and exacerbations of 
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chronic bronchitis. They result from the colonization of bronchial mucosa 
by Н. influenzae after the impairment of mucociliary clearance. In most of 
cases they occur as the complications of primary respiratory infections, 
e.g., caused by viruses. 
Invasive diseases are predominantly associated with Н. influenzae of 
Hib type. They comprise the severe disorders with hematogenous spread – 
meningitis, epiglottitis (acute inflammation of epiglottis), pneumonia, and 
septicemia (sepsis). 
The leading clinical forms of infections, caused by various types of 
Н. influenzae are presented in Table 5. 
 
 
 
Table 5 
Infections caused by H. influenzae 
 
 
Infections 
 
Groups of patients 
 
Types of H. influenzae  
 
Non-invasive 
 
Acute sinusitis, acute otitis media, 
bronchitis, conjunctivitis 
 
All age groups 
 
Nontypable serovars: >90% 
 
Invasive 
 
 
Epiglottitis, meningitis, 
pneumonia, osteomyelitis,  
septic arthritits, cellulitis 
 
Children under the age 
of 4 years – 90%;  
other children  
and adults – 10% 
 
 
 
Hib – about 90%;  
Nontypable serovars – 10%; 
e and f serovars – 1% 
 
Bacteremia and sepsis 
 
 
Newborns,  
postpartum women 
 
 
Nontypable serovars: >90% 
 
The association of the most severe infections with Н. influenzae type b 
(Hib) seems to be related with the expression of PRP capsule by these 
bacteria. It protects Hib from phagocytosis, opsonization, and complement 
lysis, ensuring microbial survival in the bloodstream. 
Hib-associated meningitis has the mortality rate of 3-6% in affected 
children. The bacteria cause acute pyogenic damage of brain tissues 
resulted from the inflammatory action of microbial endotoxin. 
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About 10-20% of children recovered from meningitis retain long-term 
and stable neurological complications, e.g., hearing loss. 
Local invasive disease caused by Н. influenzae is acute epiglottitis 
that may result in purulent necrosis of epiglottis with asphyxia of infant. 
Newborns and postpartum women are under the risk of development 
of Н. influenzae septicemia, largely mediated by nontypable bacterial 
serovars. 
In adults Н. influenzae may cause pneumonia or bronchitis mainly as a 
complication of primary viral or bacterial respiratory infection. 
Post-infectious immunity is stable. It is maintained predominantly by 
antibacterial antibodies. Babies and infants are passively protected with 
maternal antibodies for 2-3 months after birth.  
 
 
Laboratory Diagnosis of Haemophilus influenzae Infections 
 
Specimen collection for laboratory examination depends on the 
clinical form of the diasease. Initially sterile media are of the most clinical 
value – cerebrospinal fluid (CSF), blood, pleural exudate, pericardial or 
synovial fluids. 
Microscopy with Gram stain of the sediments of centrifuged CSF 
reveals small gram-negative non-sporeforming coccobacteria.  
Rapid detection of antigens of Н. influenzae type b (Hib) in 
cerebrospinal fluid, blood or pleural exudate is achieved by latex 
agglutination or ELISA test.  
Molecular typing of DNA of Н. influenzae in clinical samples is 
performed by genetic tests (PCR). 
For culture of CSF or other biological fluids the clinical materials 
should be managed immediately, or stored maximum 30 minutes at room 
temperature before culturing to prevent microbial autolysis.  
CSF is primarily centrifuged before inoculation. Microbial antigens 
are detemined in supernatants by ELISA.  
Sediments of CSF are cultured on chocolate agar, or blood agar with 
factors V and X in aerobic atmosphere with 5-10% CO2. 
The test of satellite cultures on blood agar can be applied as well. 
Here Н. influenzae is inoculated along the streaks of satellite hemolytic 
bacteria (e.g., S. aureus) that release factors V and X from red blood cells. 
The growth of Н. influenzae is possible only in close proximity to 
hemolytic satellite culture. 
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After assessment of microbial growth, the bacteria are further 
identified by the number of biochemical and serological tests. 
Identification of specific antigens allows to determine antigenic type of 
Н. influenzae.  
 
 
Treatment and Prophylaxis of Infections, Caused by 
Haemophilus influenzae  
 
Invasive infections, associated with Н. influenzae (meningitis, acute 
epiglottitis, or septicemia) require urgent antibiotic treatment.  
Taking into account possible resistance of Н. influenzae to penicillins, 
mediated by production of beta-lactamases, third-generation 
cephalosporins (cefotaxime or ceftriaxone) are the drugs of choice for 
treatment of these diseases. Fluoroqunolones and macrolides 
(clarithromycin) can be administered as well. 
For specific prophylaxis highly efficient polysaccharide chemical 
vaccines based on capsular antigen of Н. influenzae type b (Hib) were 
developed. They are commonly used in combination with DPT vaccine 
(diphtheria, pertussis, tetanus vaccine) and vaccine against hepatitis B. 
Infants are vaccinated four times in 3, 4, 5 and 18 months after birth. 
Non-specific prophylaxis includes isolation and successful treatment 
of patients, prevention of carriage, improvement of sanitary conditions, 
proper disinfection. 
 
 
 
 
PATHOGENIC BORDETELLAE: CAUSATIVE AGENTS OF 
WHOOPING COUGH 
 
 
 
The History of Discovery  
 
The causative agent of whooping cough Bordetella pertussis was 
discovered and isolated from patients in pure culture by J. Bordet and 
O. Gengou in 1906. 
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Classification 
 
Bordetellae pertain to the family Alcaligenaceae and genus Bordetella. 
Main pathogen is Bordetella pertussis, causative agent of whooping 
cough. Bordetella parapertussis cause similar milder disease. Bordetella 
bronchiseptica rarely produce human respiratory diseases (opportunistic 
pathogen). 
 
 
Structure and Properties of Bordetellae 
 
Morphology 
The bacteria are small 0.5-1.0 μm gram-negative oval-shaped non-
motile rods, except Bordetella bronchiseptica, which possesses polar 
flagella. They are non-sporeforming, Bordetella pertussis produce capsule. 
Bacteria stain poorly with aniline dyes, the ends of bacterial body stain 
more intensively. 
 
Cultivation 
В. parapertussis and B. bronchiseptica can grow on basic nutrient 
media.  
Isolation of В. pertussis requires enriched media. As additional growth 
factors amino acids cystein and methionin are applied. 
Bordet-Gengou medium (potato-blood-glycerol agar) with penicillin 
or caseine-charcoal agar can be used. The plates are incubated at 35-37 °C 
for 3-7 days in a moist environment. 
The colonies are small, convex, and glistening, resembling globules of 
mercury. They can dissociate into S- or R-forms. B. bronchiseptica 
synthesizes brownish pigment. 
 
Biochemical properties 
Bordetellae are obligate aerobes.  
В. pertussis shows minimal biochemical activity. The bacteria 
metabolize glucose with acid production. They are lack of proteolytic 
activity and urease, but produce catalase. 
В. parapertussis and B. bronchiseptica are more active, producing 
urease, nitrate reductase, etc. 
Some strains express hemolytic activity 
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Antigenic structure 
The causative agents of whooping cough share a common 
thermostable somatic O-antigen and superficial capsular antigens.  
At least 14 somatic antigenic variations have been identified in various 
Bordetella strains. Factor 7 is generic and common to all Bordetella 
bacteria; factor 1 is essential for B. pertussis, factor 14 – for 
B. parapertussis, and factor 12 for B. bronchiseptica. 
 
Virulence factors 
В. pertussis produces various toxic and aggressive substances.  
Pili play a role in adherence of the bacteria to the ciliated epithelial 
cells of the upper respiratory tract. 
Capsule of В. pertussis protects against phagocytosis and takes part in 
adhesion. 
Most of virulence factors are governed by genetic bvg regulon 
(bordetella virulence gene).  
Filamentous hemagglutinin mediates adhesion to ciliated epithelial 
cells. 
Pertussis toxin (exotoxin) is the main virulence substance. It has 
typical A and B subunit structure and renders ADP-ribosylating activity, 
influencing cellular metabolism. 
Also it stimulates lymphocytosis, sensitization to histamine, and 
enhances insulin secretion. 
Adenylate cyclase toxin, dermonecrotic toxin and hemolysin are also 
regulated by bvg genes. 
The tracheal cytotoxin inhibits DNA synthesis in ciliated cells.  
The lipopolysaccharide of the cell wall may cause the damage of 
epithelial cells of upper respiratory tract. 
 
Resistance 
B. pertussis is sensitive to environmental factors. Nevertheless, it can 
withstand exposure to sunlight for about one hour. The bacterium is 
inactivated by heating at temperature of 56°С for 10-15 minutes. It is 
rapidly destroyed in solutions of conventional disinfectants (e.g., phenols 
or chlorines). 
 
Pathogenesis and Clinical Findings in Whooping Cough  
 
Whooping cough, caused by В. pertussis, is a severe infectious 
disease of childhood.  
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This ailment affects only humans (anthroponosis), being transmitted 
by air droplet route.  
The possible sources of infection are patients in the early catarrhal 
stage of disease and carriers. Communicability is high, ranging from 30% 
to 90%. 
Bacteria attach to and propagate on the epithelial surface of the trachea 
and bronchi. The blood is not invaded. The bacteria liberate the toxins and 
substances that irritate epithelial cells, causing intensive coughing.  
After an incubation period of about 2 weeks, the “catarrhal stage” 
develops, with mild coughing and sneezing.  
During the “paroxysmal” stage, the cough becomes explosive. The 
stage lasts for another 4 or 6 weeks. Necrosis of parts of the epithelium and 
polymorphonuclear infiltration produces peribronchial inflammation and 
interstitial pneumonia.  
Blood cell count reveals marked lymphocytosis. 
Secondary infection by staphylococci or H. influenzae may easily 
cause bacterial pneumonia. Obstruction of the smaller bronchioles and 
diminished oxygenation of the blood can cause convulsions in infants with 
whooping cough. 
The disease course is protracted and may last for 2-3 months in total; 
convalescence develops slowly.  
Whooping cough confers stable long-term immunity, but rare 
recurrent diseases in adults may be severe. 
Bordetella parapertussis produce a disease similar to whooping 
cough. The infection is often subclinical. These bacteria usually have a 
silent copy of the pertussis toxin gene. 
Bordetella bronchiseptica may cause so-called “kennel cough” in 
dogs. In rare cases it may be responsible for human respiratory infections 
especially in immunocompromised persons. 
 
 
 
Laboratory Diagnosis of Whooping Cough 
 
A saline nasal wash is the most preferable specimen. Cough droplets 
obtained with “cough plate” method during patient’s paroxysm or 
nasopharyngeal swabs are of lesser clinical relevance. 
For rapid diagnosis of bacteria in the specimen immunofluorescent 
test is used. 
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For culture isolation the specimens are inoculated into Bordet-
Gengou medium or casein-charcoal medium supplemented with 
antibiotics, inhibiting concomitant microflora. 
After incubation on Bordet-Gengou medium the pure culture of 
bacteria is further identified by its morphological, cultural, biochemical 
tests. Antigenic properties are determined by slide agglutination test with 
specific antibodies. 
Serological diagnosis is employed at the end of the second week of 
the disease. Antibodies against filamentous hemagglutinin and pertussis 
toxin are determined by ELISA. 
PCR is the most sensitive method of pertussis diagnosis. Primers for 
both В. pertussis and В. parapertussis should be included.  
If available, PCR test should replace both cultural method and 
serological testing. 
 
Treatment and Prophylaxis of Whooping Cough 
 
Treatment with antibiotics from macrolide or azalide groups during 
the catarrhal stage of the disease fosters the elimination of pathogens and 
may have prophylactic effect.  
Treatment in paroxysmal stage demonstrates only low impact on the 
clinical course of the disease. 
For specific prophylaxis effective inactivated pertussis vaccine is 
used. Administration of acellular vaccines based on pertussis toxoid or 
filamentous hemagglutinin is preferable in comparison with the whole cell 
vaccines because of greatly decreased side effects. Infants should obtain 
three doses of pertussis vaccine during the first year of life followed by 
repeat boosters for a total of five. 
Pertussis vaccine is usually administered in combination with toxoids 
of diphtheria and tetanus (DPT vaccine). 
 
 
LEGIONELLA PNEUMOPHILA – CAUSATIVE AGENT OF 
LEGIONNAIRES’ DISEASE 
 
The History of Discovery  
 
First mass outbreak of legionellosis designated later as “Legionnaires’ 
disease” was registered in Philadelphia in 1976 among the participants of 
convention of American Legion (US veterans’ organization). This disease 
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manifested as severe pneumonia. The outbreak demonstrated high case-
fatality ratio above 15% – from 4400 delegates attending the meeting 182 
have become ill and 29 died. 
The causative agent of this disease was discovered in 1977 by 
J.E. McDade and C.C. Shepard after its isolation from the lung tissue of 
patients died from pneumonia. 
 
 
Classification 
 
The bacteria pertain to the order Legionellales and family 
Legionellaceae. This family includes the single genus Legionella. 
Near 60 legionella species are known to date. Despite more than 20 
species are encountered as human pathogens in certain clinical conditions, 
Legionella pneumophila is responsible for more than 90% of cases of 
legionella-associated infections including the most severe clinical forms 
like Legionnaires’ disease. 
 
 
Structure and Properties of Legionella pneumophila 
 
Morphology 
The bacteria are small polymorphic gram-negative rods with tapered 
ends; coccobacteria and filamentous forms can be observed.  
Microbial cells have no capsule or spore, albeit possess 1-3 polar 
flagella. 
These bacteria are facultative intracellular parasites. In natural 
conditions they replicate inside water protozoa, e.g. amoebae cells. 
Life cycle of Legionella pneumophila includes two basic phases – 
replicative and transmissive; each represents distinct morphological forms 
of bacteria. 
In replicative phase under nutrient-rich conditions the bacteria actively 
propagate intracellularly within Legionella-containing vacuole (or LCV). 
Microbial cells look like non-flagellated long rods, which are low-
cytotoxic and low-virulent.  
When the conditions become worsened, Legionella pneumophila 
transforms into short thick motile rods, which are stress-resistant, cytotoxic 
and demonstrate enhanced virulence. These bacteria leave the host cell 
being capable of infecting new cells (transmissive phase). 
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If replicated inside free-living amoeba cells, transmissive phase results 
in almost dormant spore-like but motile and virulent mature infectious 
forms (MIFs). In case of prolonged stay in water they turn into viable but 
non-culturable (VBNC) morphological forms. 
 
Cultivation 
Legionella pneumophila grows in aerobic conditions in atmosphere, 
supplemented with 5% CO2.  
The bacterium needs special media for culture like buffered charcoal 
yeast extract (BCYE) agar with cystein, iron salts (ferric pyrophosphate) 
and antibiotics, or blood agar with various supplements. The optimum 
temperature for growth is 35-37
oС. In 3-5 days “opal-like” gray-white 
colonies appear. Sometimes they may produce brownish pigment. 
Blood agar culture may show hemolysis. Some strains produce 
autofluorescence. 
As facultative intracellular parasites, legionellae grow well in cell 
culture lines and yolk sac of chicken embryos.  
 
Biochemical properties  
Legionella pneumophila is aerobic bacterium that produces oxidase 
and catalase.  
As primary source of carbon and energy the bacteria largely use amino 
acids (e.g., serine). To lesser extent the bacteria metabolize glucose. 
L. pneumophila has no urease, but possesses the number of proteases. 
Microbial cells liquefy gelatin and slowly hydrolyze starch. 
 
Antigenic structure 
L. pneumophila are divided into at least 16 serogroups by their 
thermostable somatic polysaccharide O-antigen.  
Nevertheless, about 85% of all cases of Legionnaires’ disease are 
related with bacteria of serogroup 1. 
Bacterial H-Ag is lack of diagnostic value. 
 
Virulence factors 
L. pneumophila has powerful systems of protein secretion that ensure 
the translocation of virulent effector proteins into the host cells. 
The structures of type IV secretion system (T4SS) generally termed as 
translocon deliver almost 300 microbial effector proteins into eukaryotic 
cell. They govern all the process of bacterial habitation inside the host cells 
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– from microbial entry and its replication in legionella-containing vacuole 
up to bacterial egress and infection of new host cells.  
These proteins account for microbial long-term survival within 
phagocytes inhibiting phagosome-lysosome fusion. 
Many bacterial effector proteins share evident similarity with proteins 
of eukaryotic host cells thus emphasizing the unique capacity of 
L. pneumophila to interkingdom gene exchange. 
Additional type II secretion system of legionellae (LSP – Legionella 
secretion pathway) stimulates the secretion of virulent microbial enzymes. 
Among them are numerous phospholipases A and C that destroy the 
membranes of cells. Also the bacteria produce metalloproteases, 
phosphatases and other enzymes. 
Bacterial exotoxins legiolysin and cytolysin contribute to the 
membrane pore formation, lysis of host cells and hemolytic activity of 
legionellae. 
Outer membrane proteins participate in adhesion. The flagella foster 
microbial entry into the cells. 
When living outside the natural hosts, L. pneumophila indispensably 
creates tough biofilm, firmly attached to the underlying surface. Within 
biofilm the bacteria remain highly protected against natural and artificial 
biocides. 
 
Resistance 
As the bacteria normally live in freshwater reservoirs, they are 
markedly resistant in watery environment. They stay viable for years in tap 
water, artificial systems of water supply, cooling towers, fountains, spa 
baths, etc. 
Protozoans, harboring the bacteria, protect them from the action of 
biocides. Nevertheless, microbial cells are generally sensitive to 
conventional disinfectants (e.g., chlorine-containing substances, phenol, 
aldehydes, ethanol, etc.) For water disinfection chloramine and calcium 
hypochlorite are commonly used. 
 
 
 
Pathogenesis and Clinical Findings in Legionelloses  
 
Legionellae are broadly distributed in nature. They are normal 
habitants of freshwater sources, where they predominantly live inside the 
ciliated protozoa (like amoebae Acanthamoeba or Naegleria) or in slime 
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moulds. Dwelling in protozoan cells is beneficial for bacterial survival 
protecting them from harsh environmental influences and providing with 
nutrients. 
Generally present in low amounts in natural freshwater habitats, 
L. pneumophila intensively colonizes human-made acquatic systems that 
operate in temperature range 25-55
o
C and produce large amounts of water 
aerosol. They are found in hot-water supplies, air-conditioning cooling 
towers, baths, shower-rooms, whirlpool and thermal spas, etc. The bacteria 
form poorly permeable biofilm on plastics and other artificial surfaces. 
As the environmental conditions play a decisive role in microbial 
propagation and spread, the infections caused by L. pneumophila are 
regarded as typical sapronoses. 
Humans are occasionally infected with L. pneumophila being exposed 
to infected water aerosol. Overall, humans are the “dead ends” for 
legionellae replication. 
There are two main forms of human L. pneumophila infections – 
Legionnaires’ disease and Pontiac fever. The individuals with healthy 
immune status usually demonstrate self-limiting illness or remain 
asymptomatic. 
Pontiac fever is relatively benign infection of upper respiratory tract 
with favorable prognosis. 
By contrast, Legionnaires’ disease is severe lung disorder manifesting 
like atypical pneumonia with serious prognosis and high fatality rate 
especially in cases of epidemic outbreaks. 
It is opportunistic infection predominantly affecting males with 
chronic lung diseases, smokers, immunocompromised or elderly persons, 
cancer patients, etc.  
The disease may arise as hospital outbreaks. 
Transmission route for the infection – airborne via infected aerosol. 
Human-to-human transmission is not observed. 
Incubation period varies from 2 to 14 days. 
When appeared in the airways, L. pneumophila is captured by alveolar 
macrophages and epithelial cells. The bacteria enter the macrophages by 
macropinocytosis or coiling phagocytosis, thereby making Legionella-
containing vacuole (LCV) isolated from cytoplasm by membrane.  
All this process is controlled by effector proteins of type IV secretion 
system. These proteins also inhibit phagosome-lysosome fusion, thus 
preventing microbial digestion and vacuole acidification. 
Inside LCV the bacteria come into replicative phase and propagate. 
When the nutrients are exhausted, they undergo transformation into motile 
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transmissive virulent forms. By the action of cytotoxins and enzymes 
legionellae penetrate vacuole, move into cytoplasm and finally leave the 
cell through the pores, created in cytoplasmic membrane. This leads to the 
destruction of respiratory epithelium and macrophages and stimulates 
inflammatory response.  
Newly generated bacteria commence to infect neighbouring host cells 
leading to microbial dissemination. 
Legionnaires’ disease affects lower respiratory tract – terminal 
bronchioli and alveoli – resulting in severe lobar pneumonia.  
The disease has sharp onset with fever, chills and headache. This is 
followed by cough, tachypnea, and chest pain.  
Necrosis of lung tissue may stimulate further microbial spread. It 
results in systemic infection and septic shock with lung hemorrhages, 
damage of gastrointestinal tract, kidneys and CNS. 
Lethality in Legionnaires’ disease strongly depends on initial patient’s 
state, comorbidity and quality of treatment. Usually it falls into the range 
8-25% but in case of hospital outbreaks it may exceed 50% in persons with 
immunosuppression. 
Humoral and cellular post-infectious immunity is type-specific, 
protective and relatively stable. 
 
 
 
Laboratory Diagnosis of Legionellosis 
 
The specimens are taken from sputum, pleural exudate, blood, urine, 
samples of lung tissue on autopsy. 
Rapid detection of bacteria is elaborated by immunofluorescence test; 
microbial antigens are determined by ELISA.  
DNA of L. pneumophila in clinical samples is detected by genetic tests 
(PCR). 
Microbial culture isolation is performed in blood agar and buffered 
charcoal yeast extract (BCYE) agar with cystein, iron salts and antibiotics. 
After incubation for 3-5 days characteristic “opal-like” gray-white 
colonies are determined. The growth on blood agar is followed by 
hemolysis.  
Microscopy of culture reveals small polymorphic gram-negative rods. 
Identification of microbial serogroup is made by agglutination test – 
most of virulent L. pneumophila pertain to serogroup 1. 
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Additional biochemical tests for utilization of amino acids, proteins 
and carbohydrates are elaborated. 
Besides agar plating, L. pneumophila can be cultured in various cell 
lines (macrophage or epithelial cultures) and in laboratory animals (e.g., 
guinea pigs). 
Serological testing is performed by indirect immunofluorescence and 
ELISA. The diagnostic titer of patients’ antibodies in single 
immunofluorescence test is 1:128 and higher.  
Serological testing can be also carried out with paired sera tests, 
where fourfold rise in antibody titer should be observed,  
 
 
Treatment and Prophylaxis of Legionellosis 
 
Favorable prognosis of Legionnaires’ disease strongly depends on 
timely administrated adequate antibiotic treatment. 
Macrolides and azalides (e.g. azithromycin and clarithromycin) as 
well as respiratory fluoroquinolones are the drugs of choice for 
legionellosis treatment. 
Additional cure includes fluid resuscitation, administration of 
glucocorticoids, mechanical lung ventilation if required. 
Prophylaxis of infection is non-specific. Sanitary control measures 
should prevent microbial contamination of public and private water 
systems as well as exclude the possibility of hospital outbreaks of 
Legionnaires’ disease. 
A proper strategy of prevention of disease spread in health care 
settings comprises efficient disinfection of systems of water supply, air 
conditioning, and patient management; laboratory testing of patients with 
hospital-acquired pneumonia for legionellosis; epidemiological 
investigations of disease outbreaks with clarification of transmission 
routes. 
High-efficacy measure resulting in eradication of L. pneumophila from 
artificial water systems is the increase of temperature of circulating water 
above 60
o
C. 
From commonly available disinfectants chloramine demonstrates 
elevated biocidal activity against legionellae. 
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PATHOGENIC MYCOPLASMAS:  
M. PNEUMONIAE – CAUSATIVE AGENT OF PNEUMONIA 
 
 
The History of Discovery 
 
First mycoplasma representatives – the causative agents of 
pleuropneumonia – were isolated by E. Nocard and E. Roux from the lungs 
of cattle. 
In 1944 M. Eaton isolated a filterable agent from patient’s sputum, 
which caused pneumonia in animals (cotton rats). Further investigations 
carried out by R. Chanok, L. Haifflik, and M. Borrel confirmed that the 
Eaton’s agent belongs to the mycoplasmas. 
 
Classification 
 
Mycoplasmas pertain to the separate phylum Tenericutes, class 
Mollicutes, order Mycoplasmatales, family Mycoplasmataceae, which 
includes two genera with pathogenic representatives: Mycoplasma and 
Ureaplasma. More than 200 mycoplasmal species are known to date.  
In humans several species of mycoplasma have evident clinical 
relevance. The most virulent agent Mycoplasma pneumoniae causes 
pneumonia; also this bacterium is associated with joint and some other 
infections. 
Ureaplasma urealyticum, Ureaplasma parvum, Mycoplasma hominis, 
and in certain cases Mycoplasma genitalium can cause human 
nongonococcal urethritis, especially in association with other bacteria. 
 
Structure and Properties of Mycoplasmas 
 
Morphology 
Mycoplasmas are the smallest bacteria known being 125-250 nm in 
size. They pass through the filters with 0.45 μm pore size; hence, they are 
comparable to large viruses. Mycoplasmas are highly pleomorphic gram-
negative bacteria (appear in rings, bacillary and spiral bodies, filaments, 
granules, etc.) because they have no cell wall.  
The cells of mycoplasmas are surrounded by thick triple-layered 
membrane containing large amounts of sterols (as the result, mycoplasmas 
require sterols for growth). 
They are lack of capsule; ureaplasmas can carry flagella. 
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Cultivation 
The optimum growth temperature for mycoplasmas is 36-37°C. 
Despite mycoplasmas are membrane parasites, they can grow on cell-free 
media that contain lipoproteins and sterols. 
For instance, many strains of mycoplasmas can be cultured in heart 
infusion peptone broth with 2% agar (pH 7.8) supplemented with human 
ascitic fluid or animal serum (horse, rabbit), as well as on blood, serum or 
ascitic agar. Mycoplasmas are resistant to thallium acetate that is used for 
inhibition of concomitant bacteria. 
After cultivation for 5-10 days or even more the round colonies of 
minimal sizes appear that have a granular surface and a dark center 
resembling “fried eggs”. 
Some strains can produce hemolysis. 
In cell cultures as well as in vivo mycoplasmas grow predominantly at 
the cell surfaces being attached to cytoplasmic membranes of the cells. 
Mycoplasmas readily multiply in the chorioallantoic membrane of chicken 
embryos. 
 
Biochemical properties 
Mycoplasmas are facultative anaerobes or microaerophils. Overall, 
they have limited number of enzymes with reduced metabolism. 
Many mycoplasmas ferment glucose as the source of energy with acid 
end products; some strains utilize arginine, ureaplasmas require urea.  
Certain species are able to produce peroxides. 
Mycoplasmas acquire sterols for their growth directly from cellular 
membranes (membrane parasitism).  
 
Antigenic structure 
Basic antigens of mycoplasmas are glycolipids and proteins with 
variable structure. Microbial enzymes also demonstrate antigenic 
properties. 
 
Virulence factors 
The whole number of mycoplasmal virulence factors is not well 
elucidated yet. Mycoplasmas carry various adherence structures: 
interactive proteins, adhesins, and adherence-accessory proteins, 
responsible for microbial attachment.  
Adhesin P1 is the major virulence factor of M. pneumoniae that 
impairs the function of ciliated epithelium. 
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Some strains were shown to produce toxin-like substances and 
hemolysins. 
Bacteria can generate cytotoxic hydrogen peroxide and superoxide 
radicals. 
Membrane compounds of mycoplasma play the role of superantigens. 
 
Resistance 
Mycoplasmas are very sensitive to the environmental influences. They 
are easily inactivated by heating, drying, sunlight, UV irradiation, and pH 
fluctuations. The bacteria are destroyed under the action of conventional 
disinfectants. 
 
 
Pathogenesis and Clinical Findings in Mycoplasmal Pneumonia 
 
The mycoplasmas appear to be rather host-specific, being contagious 
and virulent only for the specific host.  
Thus, the source of micoplasmal pneumonia is the sick person and 
mycoplasma carrier.  
The disease is transmitted by airborne route. 
Minimum infectious dose of bacteria to cause pneumonia is very low 
– about 100 microbial cells. 
M. pneumoniae attachs to the membranes of ciliated and nonciliated 
epithelium of respiratory tract (membrane parasitism). During infection, 
the bacteria remain extracellularly. 
Cytotoxic substances, free radicals and peroxides, microbial 
superantigens as well as immune complex-mediated cytolysis and cellular 
inflammation intensify the injury of respiratory epithelium mainly resulting 
in interstitial pneumonia. 
The incubation period of the disease varies from 1 to 3 weeks. 
Usually mycoplasmal pneumonia has moderate manifestations with torpid 
course of infection.  
The clinical spectrum of mycoplasmal pneumonia varies from 
asymptomatic infection to serious pneumonitis.  
The onset of the disease is usually faint with fatigue, dry cough, 
subfebrile temperature or fever, and sore throat.  
Initially the patient demonstrates only moderate illness. The physical 
signs of pulmonary inflammation are poorly determined but X-ray 
examination shows intensive lung involvement.  
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Resolution of pneumonitis and clinical improvement are observed in 
2-4 weeks. 
The presence of antibodies to M. pneumoniae is associated with 
resistance to infection. Cell-mediated immune reactions occur as well. The 
pneumonic process may be attributed in part to an immunologic response 
rather than only to infection by mycoplasmas. 
After manifested form of the disease the specific humoral and cellular 
immunity lasts for 5-10 years. Mild and subclinical cases of micoplasmal 
infections confer only short-term and low-grade immune response. 
 
 
Laboratory Diagnosis of Mycoplasmal Pneumonia 
 
The diagnosis of pneumonia caused by M. pneumoniae can be largely 
made on the ground of clinical findings and X-rays.  
Laboratory testing has to confirm the clinical diagnosis. 
The basic clinical specimen is sputum. 
Rapid detection of bacteria is performed with immunofluorescence; 
microbial antigens are determined by ELISA.  
The most sensitive test for the detection of microbial DNA is PCR. It 
remains the method of choice for laboratory diagnosis of mycoplasmal 
infections. 
Culture isolation is the long-term and cumbersome technique; thereby 
it is performed mainly in reference laboratories. 
Serological diagnosis for mycoplasmal pneumonia is confirmed by 
ELISA in paired sera test. The fourfold increase of the titer of specific 
antibodies indicates ongoing infection. 
 
 
Treatment and Prophylaxis of Mycoplasmal Pneumonia 
 
As micoplasmas are totally lack of the cell wall, they are endowed 
with the intrinsic resistance to all β-lactams. Also they are resistant to 
sulfonamides because of inabilty to produce folic acid. 
Azalides, macrolides, and tetracyclines are the drugs of choice for 
treatment of mycoplasma-associated infections. 
None of specific vaccines are available now for clinical use. 
 124 
Chapter 7 
CAUSATIVE AGENTS  
OF BACTERIAL RESPIRATORY INFECTIONS:  
PATHOGENIC MYCOBACTERIA AND CORYNEBACTERIA 
 
 
 
MYCOBACTERIUM TUBERCULOSIS –  
CAUSATIVE AGENT OF TUBERCULOSIS 
 
 
The History of Discovery 
 
Causative agent of tuberculosis (Mycobacterium tuberculosis) was 
first discovered and thoroughly investigated in 1882 by R. Koch.  
R. Koch and coworkers created the experimental animal models of the 
disease that made possible to study pathogenesis and immunity in 
tuberculosis. In 1890 R. Koch obtained complex antigenic substance 
(tuberculin) from tubercle bacilli and tried to use it for tuberculosis 
treatment. This attempt appeared to be unsuccessful, but later tuberculin 
was applied for tuberculosis immunodiagnostics. 
In 1919 A. Calmette and Ch. Guerin created live attenuated vaccine 
against tuberculosis. The strain BCG (or bacillus Calmette-Guerin) was 
introduced into medical practice, and it is used now for specific 
prophylaxis of the disease. 
At the middle of XX century first efficient drugs for tuberculosis 
treatment were worked out (streptomycin in 1944, para-aminosalicylic acid 
in 1946, and isoniazid in 1952), thereby making possible the control of this 
severe disorder. 
 
 
Classification of Pathogenic Mycobacteria 
 
Mycobacteria pertain to the order Actinomycetales, family 
Mycobacteriaceae, and genus Mycobacteria. To date more than 130 
mycobacterial species are known. 
Mycobacterium tuberculosis is the predominant causative agent of 
tuberculosis in humans. 
Mycobacterium bovis causes tuberculosis in cattle and much more 
seldom in humans (about 2-5% of cases).  
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Several other mycobacteria, e.g. M. africanum can rarely produce 
human tuberculosis infection. 
Causative agents of mycobacterioses comprise more than 60 species. 
These bacteria exert severe opportunistic infections. The predominant 
pathogens here are Mycobacterium avium-intracellulare, M. kansasii 
M. ulcerans and others. They usually affect immunocompromised 
individuals, e.g. AIDS patients. 
Mycobacterium leprae is the causative agent of leprosy. 
Many of mycobacteria are acid-resistant saprophytes, e.g. 
M. smegmatis. 
 
 
 
Structure and Properties of Mycobacteria 
 
Morphology 
Most of mycobacteria are thin straight rods without capsule, spores 
and flagella.  
Being highly pleomorphic, the bacteria can appear in granular, 
coccoid, thread-like, branching and filtering forms. The latter can pass 
through bacterial filters similar with mycoplasmas and viruses. Various 
microbial forms can be found intracellularly. 
Mycobacteria are considered to be gram-positive, albeit they are 
poorly stained by aniline dyes.  
Microorganisms reveal striking acid and alkaline resistance (so-called 
“acid-fastness”). These abilities ensue from particular chemical 
composition of mycobacteria. They contain the great number of chemically 
inert lipids, phosphatides and waxes, usually termed as mycolic acids 
(various high molecular weight hydroxy fatty acids) in a complex with cell 
wall mucopeptides. Besides lipid fractions, bacteria include various 
proteins and polysaccharides. 
Acid-fast mycobacteria stain red by basic phenol fuchsin in Ziehl-
Neelsen stain, whereas other bacteria are sensitive to sulfuric acid 
treatment and counterstain with methylene blue. 
Also mycobacteria are successfully stained by fluorescent dyes, e.g. 
auramine. 
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Cultivation 
Mycobacteria grow very slowly in aerobic conditions. It depends on 
long period of microbial replication (about 15 h for doubling). Growth is 
possible within temperature range from 24
o
C to 42
o
C with optimum at 
37
o
C. 
Various selective and special media are used for their cultivation. 
Lowenstein-Jensen medium contains agar, egg yolk, glycerol, potato 
extract, asparagine, milk, salts and malachite green to inhibit concomitant 
microflora. Composition of Finn medium is almost the same, but 
asparagine is substituted by additional number of salts. 
Middlebrook semisynthetic agar is composed of oleic acid, albumin, 
vitamins and cofactors, various salts, catalase, glycerol, glucose, and 
malachite green.  
Primary growth on solid media is observed in 3-6 weeks. 
Mycobacterium tuberculosis usually grows in warty dry colonies (R forms) 
with cream-colored “ivory” pigment. 
Saprophytic mycobacteria proliferate more rapidly and appear in few 
days. They are able to produce orange or yellow pigment. 
Different broth media support the cultivation of small amounts of 
mycobacteria. Liquid media growth reveals thin, brittle, wrinkled film 
resulted from microbial hydrophobic substances. 
Pryce's microculture method on narrow glass slides is available for 
rapid cultivation of mycobacteria in citrate blood. 
Rapid advanced cultural methods (e.g., BACTEC radiometric broth 
system) allow swift identification of M. tuberculosis in minimal amounts. 
Modern BACTEC radiometric system is composed of liquid medium 
supplemented with [
14С]-labeled palmitic acid. The medium also contains a 
number of antibiotics with broad spectrum of action to inhibit concomitant 
bacteria. During cultivation M. tuberculosis metabolizes palmitic acid with 
formation of radiolabeled carbon dioxide, which is further registered by 
radioactivity counter. By this method the infection is detected in 7-8 days 
of culturing. 
 
Biochemical properties 
Mycobacteria are aerobic microorganisms. M. tuberculosis produces a 
number of oxidation-reduction enzymes, including thermolabile catalase-
peroxidase and superoxide dismutase. Also the bacteria express lecithinase, 
phosphatase, and urease. 
M. tuberculosis can utilize various carbohydrates and proteins.  
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Antigenic structure 
Lipids and phosphatides, encased in mycobacteria, are generally 
regarded as moderate antigens or haptens.  
Nevertheless, in complex with mycobacterial proteins they elicit both 
cellular and humoral immune responses. M. tuberculosis infection induces 
cell-mediated reactions of delayed type hypersensitivity with chronic 
inflammation. Also mycobacterial antigens activate production of specific 
antibodies usually in low or moderate titers. 
Tuberculin is a peculiar antigenic complex composed of various 
tuberculoproteins and wax fractions. It causes hypersensitivity reactions 
evaluated by tuberculin skin test (TST). 
 
Virulence factors 
Toxic substances of mycobacteria are closely associated with 
microbial body and mainly release after microbial decomposition. 
For instance, mycolic acids render toxic effects against host cells and 
tissues.  
Cell wall structures of glycolipid nature (mycosides, mannosides, etc.) 
participate in microbial adhesion and inhibit phagocytosis. 
In addition, M. tuberculosis possesses highly specific type VII 
secretion system (T7SS) that promotes active secretion of micobacterial 
proteins across lipid-containing cell wall of mycobacteria. 
T7SS is characteristic for virulent strains of M. tuberculosis and 
M. bovis being absent in vaccine BCG strain.  
With the aid of T7SS M. tuberculosis expels some virulence effector 
proteins into the cytoplasm of infected cells (e.g., macrophages). Among 
them are CFP-10 and ESAT-6, which inhibit respiratory burst and 
secretion of proinflammatory cytokines by macrophages. Other proteins 
prevent the recognition of mycobacteria by Toll-like receptors of immune 
cells. 
Microbial enzymes catalase and superoxide dismutase contribute to 
the inhibition of respiratory burst by macrophages. 
Also M. tuberculosis carries so-called “cord factor” – potent toxic 
glycolipid fraction (trehalose dimycolate), which inhibits biological 
oxidation in the host cells and induces chronic immune inflammatory 
response with granuloma formation.  
The production of cord factor is determined in Pryce's microculture 
method, where virulent mycobacterial cells are grouped in tightly braced 
chains (or «serpentine cords») visible under the microscopy with Ziehl-
Neelsen stain. 
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Tuberculin is toxic for guinea pigs in course of experimental infection 
and elicits hypersensitivity in human infections, followed by tissue 
inflammation. 
Mutations in genes, encoding bacterial enzymes catalase and RNA-
polymerase confer the resistance of mycobacteria to basic tuberculosis 
drugs of the first line – isoniazid and rifampicin. 
 
Resistance 
Mycobacteria show high resistance in the environment. They remain 
viable in water for 1 year, in soil for 6 months, in the home dust and dried 
sputum for several months. Due to high lipid contents the bacteria can 
withstand the action of generally used disinfectants, thus ordinary 
disinfection regimens should be prolonged to inactivate mycobacteria. The 
most efficient are chlorine-containing chemical agents.  
Mycobacteria are resistant to majority of antimicrobial drugs. 
Nevertheless, heating at a temperature of 100°C readily kills all 
mycobacteria. Pasteurization inactivates M. bovis in dairy products, 
thereby preventing alimentary transmission of the disease. 
Also mycobacteria are susceptible to sunlight and UV irradiation. 
 
 
Epidemiology, Pathogenesis and Clinical Findings in Tuberculosis 
 
Tuberculosis is one of the most important threats for human health at 
the beginning of XXI century. According to WHO data, annual total 
number of disease cases is about 9.6 million.  
It is generally assumed that about one quarter of affected persons dies 
from tuberculosis and its consequences, and most of patients are young 
adults. Moreover, mortality rate in untreated or untreatable disease exceeds 
50%. Thus, tuberculosis remains the leading infectious cause of human 
death resulting in approximately 1.4 million lethal cases every year. 
Moreover, tuberculosis is the major AIDS-indicator disease in HIV-
infected persons. It develops at least in 30-40% of HIV-infected 
individuals being the major cause of death of AIDS patients (25-40% of 
total AIDS lethality). 
Finally, the uprising threat that faces public health nowadays is the 
rapid spread of multidrug resistant (MDR) and extensively drug-resistant 
(or XDR) tuberculosis. Now about 3.5% of tuberculosis cases worldwide 
are produced by MDR mycobacteria, and in certain world regions (African 
countries, several Chinese and Russia provinces, Baltic states, etc.) their 
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incidence greatly exceeds 10-20%. Therefore, the global spread of MDR 
tuberculosis is a problem of great medical and social importance. 
Overall, tuberculosis is a ubiquitous disease that affects various living 
beings including animals, birds, and humans. It is generally ascertained 
that one-third of the world’s human population (about 2 billion people) is 
infected with M. tuberculosis.  
However, humans demonstrate high natural resistance to tubercle 
bacilli; therefore, tuberculosis remains the social disease that strongly 
correlates with poverty, adverse living and working conditions and general 
economic decline. 
The main sources of infection are persons with active tuberculosis. 
Sick animals (cattle) can also spread the disease. 
The infection is transmitted predominantly by the airborne 
(air droplet) route and more seldom by contact route. Ingestion of 
contaminated foodstuffs, usually milk, is also possible especially for 
M. bovis infection. Very seldom the disease can be transmitted by direct 
inoculation that may occur among health care workers. 
Overcrowding, malnutrition and starvation, inaccessibility of medical 
care and other hard socioeconomic conditions, as well as suppression of 
patient’s immune system (e.g., by HIV infection), are in the direct 
relationships with tuberculosis susceptibility and pathogen dissemination. 
After primary penetration mycobacterial infection usually remains 
latent. Without prophylaxis about 5-10% of infected persons produce 
tuberculosis disease. 
Inhaled mycobacteria are ingested by lung macrophages and 
transported to regional bronchial lymph nodes. M. tuberculosis survives 
within phagocytes, blocking phagolysosome fusion. Cord-factor inhibits 
cell migration within the inflammatory focus. 
Primary lung tuberculosis is characterized by acute exudative lesion 
affecting lung acinary tissue with subsequent rapid involvement of 
lymphatic vessels and regional bronchial lymph nodes (primary tubercular 
complex). Cell-mediated inflammation leads to formation of tubercular 
granulomas (tubercles) with caseous necrosis in their centers. 
Multinucleated giant cells, epithelioid cells, lymphocytes, macrophages 
and fibroblasts surround inflammation focus with mycobacteria. 
Typical symptoms of progressive pulmonary disease include 
intoxication, fever, productive cough with hemoptysis, enlargement of 
lymph nodes, and abnormal results of chest X-ray examination. 
Cellular immune reactions restrict inflammation area and terminate the 
propagation of M. tuberculosis. Primary specific process is resolved with 
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connective tissue progression, fibrosis, and calcification. Remaining live 
mycobacteria come into dormant state and usually persist intracellularly 
within macrophages or epithelial cells lifelong. 
In case of decreased immune resistance especially combined with 
large microbial load further spread of pathogen is possible via bronchi, 
lymphatic and blood vessels. Disseminated disease affects lungs (miliary 
tuberculosis) or leads to extrapulmonary tuberculosis (tuberculosis of 
eyes, intestine, kidneys, tubercular meningitis, etc). These forms are much 
more severe and may cause patient’s death. 
Reactivation of viable mycobacteria is possible due to many 
unfavorable external or internal stimuli, and easily affects 
immunocompromised persons (e.g., HIV patients). 
Secondary tuberculosis is characterized by chronic tissue lesions 
(tubercles, cavities with caseous necrosis, etc.), followed by disseminated 
fibrosis. Secondary lesions are very difficult in treatment showing no 
tendency to self-recovery. 
Immunity in tuberculosis is predominantly cell-mediated and non-
sterile, maintained by viable mycobacteria. Macrophages, dendritic cells 
and Th1 cell subsets produce the vast number of proinflammatory 
cytokines (e.g., γ-interferon), thereby inhibiting microbial propagation. 
Antibodies are not proven to possess substantial antimicrobial activity.  
As it was mentioned above, human population has high natural 
resistance to M. tuberculosis. 
 
 
 
Laboratory Diagnosis of Tuberculosis 
 
Patient’s sputum, lymph nodes puncture contents, urine, pleural or 
cerebrospinal fluid, etc. are used for bacteriological examination. 
Conventional methods comprise the acid-fast stain, culture, and 
biochemical tests for detecting and identifying M. tuberculosis. 
However, rising spread of tuberculosis with high incidence of MDR 
mycobacteria has required new rapid laboratory tests for M. tuberculosis 
identification. 
Microscopy of acid-fast bacilli is a valuable primary test for 
laboratory diagnosis of the disease. Tubercle bacilli stain red by fuchsin in 
Ziehl-Neelsen method due to the remarkable acid resistance of bacteria. 
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Fluorescent microscopy is more sensitive method than Ziehl-Neelsen 
technique. Mycobacteria easily stain with luminescent dyes (auramine or 
rhodamine). 
In case of small amounts of pathogen the clinical sample is treated 
to enrich microbial content. The material is digested with a mucolytic 
agent (e.g., N-acetyl-L-cysteine) and treated with sodium hydroxide that 
kills acid-sensitive microorganisms. After centrifugation the smears from 
the sediment are prepared and stained. 
Nevertheless, microscopy can reveal only 10
4
-10
5
 microbial cells. 
For culture isolation both solid and liquid media may be used. 
After sulfuric acid treatment specimens are usually inoculated into 
egg-based media (e.g., Lowenstein-Jensen agar, Finn medium, etc.) After 
long-term cultivation bacteria are identified by cultural, biochemical and 
virulent properties. 
M. tuberculosis growth appears in 15-60 days resulting in typical dry 
colonies with “ivory”-colored pigment (R forms). Bacteria grow only at 
37-38
оС, being unable to propagate in ordinary media or when treated with 
salicylates. M. tuberculosis carries thermolabile catalase, produces urease, 
and reduces nitrates into nitrites. Guinea pigs are very sensitive to 
M. tuberculosis. 
Cord factor production is essential for M. tuberculosis. It is estimated 
by Pryce's microculture method using several narrow glass slides placed 
into citrate blood. After 4-5 days of cultivation slides are stained by Ziehl-
Neelsen acid-fast stain. Cord factor elicits “serpentine cord”-like 
aggregations of microbial cells visible on microscopy. 
Mycobacterium bovis grows within about 40 days. Bacterial growth 
renders smooth round colonies, or S forms. Microbial cells produce 
thermolabile catalase, urease, but can’t reduce nitrates into nitrites. 
M. bovis is highly virulent for rabbits. 
Atypical mycobacteria (e.g. Mycobacterium avium-intracellulare 
complex, M. kansasii, M. microti, M. ulcerans, etc.) are virulent in S form, 
can grow at 22-45
oС and in salicylate presence, produce orange pigment, 
carry thermostable catalase, being lack of cord factor and urease. 
Acid-fast saprophytic mycobacteria (e.g., M. smegmatis) are non-
virulent, microbial growth evolves within 3-4 days; bacteria propagate in 
ordinary media resulting in S-form colonies with orange pigment. 
Rapid advanced cultural methods like BACTEC radiometric broth 
system greatly accelerate identification of M. tuberculosis taken in minimal 
amounts. 
By this method the infection is detected in 7-8 days of culturing. 
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For rapid mycobacteria identification in clinical specimens 
polymerase chain reaction (PCR) with specific primers is used. This 
method is the most promising technique for express-detection of virulent 
mycobacteria. 
Experimental animal infection has only a little worth for diagnosis. 
Similar, determination of specific antibodies against M. tuberculosis is also 
of limited value due to low specifity of serological reactions in 
tuberculosis. 
Tuberculin skin test (TST) or Mantoux reaction evaluates delayed 
hypersensitivity in M. tuberculosis infection. Tuberculin is a multi-
component antigenic complex of M. tuberculosis, composed of various 
tuberculoproteins and wax fractions. R. Koch obtained it as glycerol-based 
filtrated suspension of killed tubercle bacilli. He applied it for tuberculosis 
treatment but without evident success. Nevertheless, tuberculin was proven 
to be worthy for diagnostics of tuberculosis. It was further purified to 
derive protein fractions (tuberculin PPD or purified protein derivative). 
After intracutaneous injection of a definite amount (usually 2 
tuberculin units) of tuberculin PPD to the patient previously exposed to 
M. tuberculosis, the papule (induration and redness) appear, being maximal 
in 24-72 hours.  
A positive TST indicates that the person has been infected with 
M. tuberculosis. Test explanation may be difficult, because previous BCG 
vaccination, specific chemotherapy, or host immune status can influence 
the reaction. However, test conversion from negative to positive implies 
recent infection and possible current activity of tuberculosis. A positive 
skin test assists in diagnosis, and it is also helpful for evaluation of 
tuberculosis treatment. 
More advanced version of allergic skin test in tuberculosis is recently 
devised Diaskintest (DST). It uses recombinant proteins of M. tuberculosis 
CFP-10 and ESAT-6 as infectious mycobacterial allergens for 
intracutaneous injection. This test has serious advantages against TST as it 
is not influenced by primary BCG vaccination (BCG bacilli are lack of 
CFP-10 and ESAT-6 virulence proteins). 
Blood lymphocyte culture tests like interferon-gamma release assay 
(IGRA test) are also of rising value in immunological diagnosis of 
tuberculosis. They determine patient’s lymphocyte sensitization to 
M. tuberculosis. The test is based on detection of γ-interferon release after 
the challenge of lymphocyte culture with specific micobacterial antigens. 
Finally, adequate patient management in tuberculosis is impossible 
without rapid antibiotic susceptibility testing of isolated M. tuberculosis 
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culture. For these purpose both cultural and genetic methods are used. In 
latter case PCR (like in GeneXpert system) and hybridization techniques 
are employed to detect bacterial genes, conferring the resistance to 
antimicrobial drugs. 
 
 
Specific Treatment and Prophylaxis of Tuberculosis 
 
Treatment course of tuberculosis patient lasts from 6 to 12 months. 
Long duration of treatment period ensues from slow metabolism of 
tubercle bacilli as they tend to intracellular persistency and permanent 
evasion from host immune system. 
Very short list of antimicrobial drugs was proven to be effective in 
tuberculosis treatment. 
They pertain to the first line drugs. Among them are isoniazid, 
rifampicin, pyrazinamide, ethambutol, and streptomycin. Pyrazinamide is 
a sole antimycobacterial drug that can affect intracellular forms of 
M. tuberculosis. 
Combined use of first line drugs for 6 months of so-called “short 
chemotherapy course”, recommended by WHO, yields cure rates rather 
than 80-90% and prevents the emergence of drug resistance. 
Second line preparations (e.g., fluoroquinolones, ethionamide, 
cycloserine, etc.) demonstrate lower efficacy, but often increased toxicity, 
being of more seldom use. 
The treatment of MDR and XDR tuberculosis poses serious 
difficulties.  
MDR bacteria are resistant to isoniazid and rifampicin, whereas XDR 
microbial cells are additionally resistant to fluoroquinolones and one more 
drug of the second line. 
In these clinical cases the treatment course may last for 1.5-2 years. 
The worsened situation with the highly limited list of efficient drugs 
against tuberculosis stimulated the design of novel antimycobacterial 
agents. Some of them are already introduced into clinical practice (e.g., 
bedaquiline and delamanid). They are predominantly administered in 
MDR and XDR tuberculosis. 
Non-specific prophylaxis of the disease is achieved by isolation and 
adequate treatment of tuberculosis patients. Hospital disinfection is made 
by 5% carbolic acid or chlorine-containing disinfectants. 
Vaccination with live attenuated BCG vaccine is used for specific 
prophylaxis of tuberculosis. Vaccine contains avirulent strain of M. bovis, 
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obtained by A. Calmette and Ch. Guerin after 13-year continuous bacterial 
passage through bile-containing media. 
Newborn infants undergo primary vaccination at 3-5 day of life. 
Human immunization with BCG vaccine reduces the risk of tuberculosis in 
vaccinated persons by about 50%. 
 
 
 
MYCOBACTERIUM LEPRAE 
 
 
The history of discovery 
 
Mycobacterium leprae, causative agent of leprosy, was discovered in 
1874 by Norwegian scientist G. Hansen. 
 
 
Structure and Properties of Mycobacterium leprae 
 
Morphology 
M. leprae is similar with M. tuberculosis in many respects. 
They are acid-fast gram-positive pleomorphic bacteria that mostly 
appear as long straight or curved rods 1-8 μm in length. Granular, 
branching and other forms also occur. These microorganisms don’t 
produce spores or flagella. The pathogens are enwrapped into capsule-like 
layer made of glycolipids and mannosides. 
M. leprae stain red by Ziehl-Neelsen method. They are determined 
intracellularly in tight bundles, resembling packets of cigars. 
 
Cultivation 
The bacteria are not adapted to grow in artificial nutrient media. They 
are obligate intracellular parasites. 
M. leprae can propagate after inoculation into mouse footpad within 
25-30 days. The most suitable model for bacterial culture in vivo is the 
experimental infection of armadillos, which produce high bacillary 
lepromatous leprosy. 
 
Biochemical properties 
Biochemical properties of M. leprae are not fully investigated because 
of bacterial slow metabolism and absence of feasible methods for 
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culturing. The bacteria pertain to microaerophils. They have the reduced 
number of enzymes in comparison with M. tuberculosis. 
M. leprae produces enzyme superoxide dismutase that protects it 
against phagocytosis. 
 
Antigenic structure and virulence factors 
Bacterial antigenic structure as well as virulence factor production is 
also not completely elucidated. M. leprae contains antigenic 
polysaccharides and numerous lipids, including leprosinic oxy fatty acid, 
wax leprozine, and various phosphatides. 
Antigenic specificity of bacteria is related with phenolic glycolipid 
fraction PGL-1 of microbial cell wall. 
Toxic substances of bacteria are associated with microbial body and 
release upon its destruction. 
Glycolipid capsule-like layer protect M. leprae against phagocytosis. 
The enzyme superoxide dismutase inhibits respiratory burst in phagocytes. 
Phenolic glycolipid fraction PGL-1 suppresses the activity of dendritic 
cells and T lymphocytes and takes part in M. leprae binding to Schwann 
cells of myelinated nerve fibers. 
During infection bacteria cause the allergic sensitization of host with 
remarkable cellular immune suppression and demyelination of nerve 
tissue. 
 
Resistance 
M. leprae shows similar resistance with M. tuberculosis and stays 
viable in tissues of human corpse for more than a year. Nevertheless, free 
bacterial cells rapidly lose viability in the environment. 
 
 
Pathogenesis and Clinical Findings in Leprosy 
 
Leprosy is an anthroponotic torpid chronic disease.  
Due to the active strategy of treatment, total number of patients with 
leprosy seriously decreased – from 805,000 persons in 1995 to about 
175,000 affected individuals at the end of 2014 predominantly in Asia and 
Africa. 
People usually develop the disease after extremely long incubation 
period lasting from 3-5 years to several decades. 
Illness acquisition is possible only after close prolonged contact of a 
person with leprosy patient.  
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It is generally considered that disease progression is strongly related 
with individual genetic predisposition. Natural resistance to leprosy is 
common and may cover about 95% of human population. Genetic 
mechanisms of the resistance are not well-elucidated. Probably, they are 
associated with genes controlling cellular immune response (antigen 
recognition, processing and presentation, cytokine production, microbial 
cell killing, etc.) 
The disease is transmitted via airborne or contact route through the 
nasopharynx epithelium or injured skin. Various fomites play a role of 
auxiliary vehicles in the disease transmission. 
M. leprae can persist only within living cells. The disease may be 
latent all over the life. Bacteria slowly disseminate throughout the body 
and affect skin, nasopharynx, larynx, eyes, peripheral nerves and other 
tissues. Microbial active propagation is possible in conditions of 
suppression of cellular immunity with inefficacy of phagocytosis. 
It is considered that M. leprae persist predominantly within 
demyelinated nervous tissue, where the bacteria are able to maintain 
favorable conditions for their survival. 
Within epineurium the bacteria target myelinating Schwann cells and 
macrophages and propagate. As the result, chronic granulomatous 
inflammation arises resulting in direct injury of peripheral nerves with 
their demyelination.  
Erythematous painless lesions with nodular infiltration appear in the 
skin. The damage of nerves is followed by paresthesia and polyneuritis. 
Trophic disorders lead to deep tissue lesions resulting in bone resorption. 
Sometimes it might be followed by phalanx self-amputations. 
Three main clinical forms of leprosy are observed: lepromatous, 
tuberculoid, and undifferentiated.  
WHO distinguishes multibacillary leprosy and paucibacillary 
leprosy. 
Lepromatous type of disease is characterized by malignant course of 
infection with active microbial propagation within myelinated nerve fibers 
that results in severe tissue lesions and neurologic disorders. 
The disease progression rests on the activation of suppressor immune 
cells and T helper 2 subsets. Together with deleterious effects of M. leprae 
itself (e.g., by the action of phenolic glycolipid PGL-1) it strongly inhibits 
cell-mediated immune response. This abrogates limitations for microbial 
growth.  
M. leprae in large amounts are determined in the sites of infection. 
Therefore, this clinical condition corresponds to multibacillary leprosy. 
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The allergic skin test with lepromin (boiled extract of lepromatous 
node) is negative in this situation due to deep immune suppression. 
Tuberculoid type of the disease develops benign course with favorable 
prognosis. Skin lesions and peripheral nerves are involved in the process 
but only few or lack of bacteria can be found there (paucibacillary 
leprosy).  
Cell-mediated immunity is capable of controlling tuberculoid disease 
as T helper 1 cells remain active. They stimulate macrophages and 
dendritic cells that is followed by sufficient production of proinflammatory 
cytokines (IL-1, IL-12, IL-18, α-TNF, γ-interferon). The ongoing reactions 
of delayed hypersensitivity tackle the infection.  
Lepromin test is positive in this clinical condition. 
Undifferentiated type is usually related with the intermediate stage of 
the disease that may result in leprosy progression. 
 
 
Laboratory Diagnosis of Leprosy 
 
Specimens from scrapings of nasal mucosa, skin lesions, lepromatous 
nodes and lymph node biopsies, patient’s sputum and ulcer discharges are 
used for examination. 
Microscopy is the basic method for laboratory diagnosis of leprosy. 
The slides are stained with Ziehl-Neelsen method. Intracellular bundles of 
acid-fast bacilli are observed. 
The detection of M. leprae is also performed by immunofluorescence. 
The advanced molecular tests for laboratory diagnosis of leprosy are 
based on PCR that detects microbial DNA. 
Allergic skin test with lepromin (Mitsuda reaction) is useful to 
distinguish lepromatous or tuberculoid type of the disease. 
Serological testing is of limited value due to the moderate titers of 
specific antibodies. Antibodies against PGL-1 are determined by ELISA.  
 
 
Specific Treatment and Prophylaxis of Leprosy 
 
Recently WHO announced Global Leprosy Strategy 2016–2020 under 
the common motto “Accelerating towards a leprosy-free world”. It has 
been stated that evident successes in leprosy management are essentially 
related with the availability of efficient disease treatment. 
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Now MDT (or multidrug therapy) regimen is commonly used. It 
presumes the administration of sulfone drug dapson, antimycobacterial 
agent rifampicin and clofazimine. The course of therapy for multibacillary 
leprosy lasts for 12 months to provide complete elimination of pathogens. 
Prophylaxis is only non-specific, though numerous attempts of BCG 
vaccination were performed with contradictory results. Leprosy patients, 
who are active producers of mycobacteria, should be isolated and treated 
until complete clinical recovery. The healthy children need to be separated 
from sick parents and, if necessary, treated with antimicrobial drugs for 
disease chemoprophylaxis. 
 
 
 
 
CORYNEBACTERIUM DIPHTHERIA 
 
 
The History of Discovery 
 
Causative agent of diphtheria, Corynebacterium diphtheria, was 
discovered by E. Klebs in 1883. F. Loeffler isolated it in pure culture in 
1884. E. Roux and A. Yersin first derived the main virulence factor of 
Corynebacterium diphtheria, diphtheria exotoxin, in 1888. Corresponding 
antitoxin antibodies were obtained by E. Behring and S. Kitasato in 1890. 
Finally, G. Ramon created first biological product for specific prophylaxis 
of diphtheria, diphtheria toxoid, in 1923. 
 
 
Classification 
 
Corynebacterium diphtheria pertains to family Corynebacteriaceae, 
genus Corynebacterium. It accounts for extremely dangerous toxinemic 
infection – diphtheria. Closely related species Corynebacterium ulcerans 
and Corynebacterium pseudotuberculosis can carry tox gene that encodes 
diphtheria toxin production, thereby they can also exert the disease in rare 
conditions. 
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Structure and Properties of Corynebacterium diphtheria 
 
Morphology 
Corynebacterium diphtheriae (Lat. coryna – club) is a straight or 
slightly curved polymorphic rod 1-8 μm in length. Under microscopy the 
groups of bacteria resemble letters X or V. Branched and thread-like forms 
as well as short coccobacterial forms may occur. 
The rods of C. diphtheriae frequently display terminal club-shaped 
bulges with volutin granules, stained blue by Neisser stain. Volutin is the 
store of polyphosphates for microbial cells.  
Granules of volutin are detected also by luminescent microscopy (e.g., 
they stain orange-red with coriphosphine dye). 
Microbial cells are gram-positive. They are lack of spores or flagella, 
but may possess capsule. 
 
 
Cultivation 
The optimal temperature for microbial growth is about 37°С, and the 
bacteria can’t propagate at temperatures below 15°С and above 45°С. 
Optimal medium pH is 7.2-7.6.  
These organisms grow in media enriched with proteins (coagulated 
serum, blood agar, and serum agar) or in sugar broth. On Roux (coagulated 
horse serum) or Loeffler medium (three parts of bovine serum and one part 
of sugar broth) visible growth appear in 16-18 hours. 
Now blood tellurite agar, containing blood and potassium tellurite 
(Clauberg II medium) and cystine-tellurite agar or Tinsdale medium are 
most often used for C. diphtheriae culture. 
According to cultural and biological properties, various biovars of 
C. diphtheriae were defined: gravis, mitis, and intermedius, which differ 
in a number of properties. Recently a new C. diphtheriae biovar belfanti 
was described. 
Corynebacteria of the gravis biovar produce large rough (R forms) 
rosette-like black or grey colonies on tellurite agar. The bacteria ferment 
starch with acid end products and produce a pellicle in meat broth. They 
are usually highly toxic with marked invasive properties. 
The colonies produced by corynebacteria of mitis biovar on tellurite 
agar are dark, smooth (S forms), and glistening. Starch is not fermented. 
Bacteria cause hemolysis of animal erythrocytes and produce diffuse 
turbidity in meat broth. Cultures of this biovar are usually less toxic and 
invasive than those of gravis biovar. 
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The bacteria of intermedius biovar are transitional. They produce 
small (R-S forms) black colonies on tellurite agar. Starch is not fermented. 
Growth in meat broth results in turbidity. 
Newly discovered biovar belfanti is similar to other bacteria, but can’t 
reduce nitrates into nitrites. 
It was proven that gravis biovar is isolated in epidemic outbreaks of 
diphtheria, while mitis biovar appears in sporadic cases of the disease. 
 
Biochemical properties 
The causative agent of diphtheria is facultatively anaerobic bacterium. 
C. diphtheriae ferments glucose with acid formation, whereas galactose, 
maltose, starch, and glycerol fermentation is variable. Bacteria have no 
urease, produce no indole, and slowly produce hydrogen sulfide. They 
reduce nitrates to nitrites except biovar belfanti. 
C. diphtheriae has the enzyme cystinase that is determined in Pizu test 
(serum agar media with cystine and lead acetate is blackened due to lead 
sulfide production). Conversely, diphtheria agents have no 
pyrazinamidase enzyme. 
Production of cystinase and lack of pyrazinamidase distinguishes 
C. diphtheriae from other corynebacteria. 
C. diphtheriae expresses the number of virulence enzymes – catalase, 
hyaluronidase, neuraminidase, and DNAse. 
 
Antigenic structure 
There are two major antigenic fractions in corynebacteria. Superficial 
heat-labile type-specific K-antigen is of protein nature.  
Somatic group-specific lipopolysaccharide O-Ag is heat stable. 
To date 57 serotypes of C. diphtheriae have been determined by 
agglutination reaction. 
 
Virulence factors 
All toxigenic С. diphtheriae express extremely poisonous exotoxin. 
Bacterial toxigenicity is under the control of phage genes. When some 
nontoxigenic diphtheria strains are infected with bacteriophage transduced 
from toxigenic diphtheria agent, the offsprings of the exposed bacteria 
become lysogenic and toxigenic. Thus, acquisition of phage leads to 
toxigenicity (lysogenic conversion). The actual production of toxin usually 
occurs only after activation of the prophage within lysogenic 
С. diphtheriae. 
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In addition, toxin synthesis is governed by transcriptional regulator 
diphtheria toxin repressor (DtxR) encoded by nucleoid dtxR gene.  
DtxR is iron-dependent transcriptional regulator. When the 
concentration of iron is sufficient, it blocks the expression of diphtheria 
toxin. And vice versa, low iron concentrations render DtxR repressor 
inactive, allowing the synthesis of exotoxin. 
Diphtheria toxin is a heat-labile polypeptide with molecular weight 
62,000. After inner thiol reduction the molecule is splitted into two 
fragments. Portion В is required for the transport of fragment A into the 
cell. Fragment A inhibits peptide chain elongation factor EF-2 by its 
ADP-ribosylation.  
Block of protein synthesis disrupts normal cellular functions. Abrupt 
termination of protein synthesis is responsible for the necrotizing and 
neurotoxic effects of diphtheria toxin. Pure diphtheria toxin may be lethal 
in extremely low dose of 40 ng. 
Other virulence factors include adhesive pili and fimbria, invasive 
enzymes, hemolysins, and cord-factor.  
Cord-factor of С. diphtheriae (trehalose dimycolate) damages 
mitochondria, affecting the processes of respiration and phosphorylation. 
 
Resistance 
C. diphtheriae are relatively resistant to various environmental factors. 
For instance, they survive for two months at room temperature. 
Corynebacteria remain viable in the membranes of diphtheria patients at 
least for 2 weeks, in water and milk – for 20 days. The bacteria are killed 
by a temperature of 60°С and by 1% phenol solution in 10 minutes 
 
 
Pathogenesis and Clinical Findings in Diphtheria 
 
Patients suffering from the disease and carriers are the main sources 
of infection in diphtheria.  
The disease is communicated by airborne (air droplet or air-dust) 
route. Transmission by various objects or fomites (toys, books, towels, 
utensils, etc.) and foodstuffs (e.g., milk) contaminated with C. diphtheriae 
is also possible. 
Exotoxin plays the principal role in the pathogenesis of diphtheria, 
blocking protein synthesis.  
It crosses the mucous membranes and causes the destruction of 
epithelium. The necrotic epithelium forms grayish “pseudomembranes” 
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over the tonsils, pharynx, or larynx. They are tightly bound to the affected 
tissues. Any attempt to remove the pseudomembrane results in bleeding. 
Pseudomembrane respiratory obstruction (diphtheritic croup) can cause 
patient suffocation. The regional lymph nodes in the neck enlarge, and 
there may be total neck edema. The diphtheria agents continue to produce 
toxin within the membranes.  
Toxin absorption results in distant toxic action with tissue damage, 
particularly degeneration and necrosis in myocardium, liver, kidneys, and 
adrenals, sometimes accompanied by hemorrhages. The toxin also exerts 
nerve damage, resulting often in paralysis of the soft palate, eye muscles, 
or limbs. 
The incidence of diphtheria of other organs (eyes, ears, skin or genital 
tract) is much seldom. 
Post-infectious active immunity depends mainly on the antitoxin 
contents in the blood. However, a definite role of the antibacterial 
immunity, associated with phagocytosis, T cells, opsonization and 
complement-dependent microbial lysis is also significant. Therefore, the 
immune response produced by diphtheria infection is both antitoxic and 
antibacterial. 
In general, diphtheria confers not very stable immunity, thus 
reinfection may occur up to 10% of cases. 
 
 
Laboratory Diagnosis of Diphtheria 
 
Swabs from the throat, nose, or other lesions as well as diphtheria 
pseudomembranes are tested as clinical specimens. 
Neisser-stained smears are examined and reveal typical corynebacteria 
with volutin granules. As rapid sensitive test, luminescent microscopy is 
used with coriphosphine staining that determines the presence of orange-
stained volutin granules within microbial cells. 
Nonetheless, diphtheria diagnosis is confirmed only in case of 
exotoxin detection in the clinical specimen or in isolated culture. 
Rapid determination of diphtheria exotoxin in clinical samples is 
elaborated by ELISA; identification of microbial tox-genes is performed 
by PCR.  
Overall, PCR is regarded as the most sensitive, rapid and specific test 
for the confirmation of toxigenicity of С. diphtheriae. 
When cultured, the specimens are planted onto special media, e.g. 
Loeffler coagulated serum, Clauberg II medium, Tinsdale agar, etc. 
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Primary growth is assessed on the Loeffler slant in 12-18 hours. In 36-
48 hours the typical colonies on tellurite-containing media are observed. 
The isolated culture is further identified by biochemical and antigenic 
tests and by phagotyping. 
For the determination of toxigenicity of isolated cultures various 
neutralization tests are applied. 
In case of animal experimental infection, the material can be injected 
into 2 groups of animals (guinea pigs or mice), where one of them was 
passively protected with diphtheria antitoxin. The unprotected animals die 
in 2-3 days, whereas the immunized ones survive. 
Plate immunoprecipitation or Elek’s test is made as follows: a strip of 
filter paper saturated with antitoxin is placed onto serum agar plate. The 
cultures to be tested for toxigenicity are streaked across the plate at right 
angles to the filter paper. After 16-24 hour incubation the antitoxin 
diffusing from the paper strip yields the precipitation of toxin diffusing 
from toxigenic cultures. As the result, precipitation lines are determined 
between the strip and bacterial growth. 
The toxigenicity of С. diphtheriae can be also shown by inoculation of 
bacteria into cell culture monolayers (e.g., Vero cell cultures). It is 
followed by evidenr cytopathic effect of the toxin with the destruction of 
cell monolayer. 
 
 
Specific Treatment and Prophylaxis of Diphtheria 
 
The specific treatment of diphtheria rests largely on the early 
administration of specific antitoxic antibodies that neutralize highly 
poisonous exotoxin of С. diphtheriae. Treatment with antibiotics that 
causes rapid suppression of toxin-producing bacteria is also helpful in the 
disease management. 
Diphtheria antitoxin (DAT) is horse serum-derived biological 
product. It is obtained by the repeated immunizations of horses with 
purified and concentrated toxoid with subsequent purification.  
Treatment with antitoxin is mandatory for patient’s recovery. From 
20,000 to 100,000 units are injected depending on disease severety.  
Skin test should be made before antitoxin treatment to detect possible 
hypersensitivity to animal serum proteins. 
Antimicrobial drugs (e.g., penicillin G, clarithromycin or azithromycin) 
inhibit the growth of diphtheria agents. As the result, they greatly diminish 
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toxin production. Antibiotics also help to eliminate coexistent pathogenic 
bacteria (e.g., streptococci) from the respiratory tracts of affected patients. 
Specific prophylaxis is achieved by active immunization. Usually 
DPT vaccine or combined tetanus-diphtheria toxoid are used.  
It should be emphasized that diphtheria is regarded as the disease fully 
preventable by vaccination. 
Population (or “herd”) immunity above 95% is regarded as sufficient 
to cease the disease contraction among the individuals. 
All the children must receive the course of diphtheria toxoid 
immunization. It is afforded thrice at the first year of life starting from the 
age of 3 month. Subsequent boosters are injected in 9-12 months and then 
reproduced every 10 years. 
 145 
Chapter 8 
CAUSATIVE AGENTS OF SEXUALLY TRANSMITTED 
DISEASES 
 
 
 
TREPONEMA PALLIDUM –  
CAUSATIVE AGENT OF SYPHILIS 
 
 
The History of Discovery 
 
Syphilis, the most notorious venereal or sexually transmitted disease 
(STD) is known for many ages. Until quite recently two main theories of 
syphilis origin existed: pre-Columbian, which supposed syphilis to emerge 
in ancient times in Central Africa with farther spread towards Europe and 
Asia, and Columbian one, relied upon syphilis epidemic rise in Europe 
after Columbus voyage.  
According to multiple investigations of fossils the first theory was 
preferentially supported for a long time. 
Nonetheless, in 2008-2011 the thorough phylogenetic analysis of 
evolution of various groups of treponemas elaborated by K. Harper and 
colleagues has proven the agent of syphilis to be phylogenetically youngest 
from all other treponemas. The most probably it has been developed from 
some non-venereal treponema subspecies and later caused epidemics of 
syphilis in Europe after the voyage of Columbus. 
It is generally believed that syphilis was named by G. Fracastoro in 
1530 after a mythical shepherd, Syphilus, described in his poem "Syphilis 
or the French Disease". 
Only in 1905 F. Schaudinn and E. Hoffmann discovered Treponema 
pallidum to be the causative agent of syphilis. They revealed spirochetes in 
Giemsa-stained fluid smears from secondary syphilitic lesions. Year later 
A. Wassermann proposed complement fixation test for serological 
diagnosis of syphilis. 
First chemical drugs for syphilis treatment were introduced into 
clinical practice still by P. Erlich (organic arsenical compound salvarsan). 
In 1943 J. Mahoney demonstrated the effectiveness of penicillin for 
syphilis therapy, and it remains to be the most preferable drug for disease 
treatment. 
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Classification of Pathogenic Treponemas 
 
T. pallidum belongs to the order Spirochaetales, family 
Spirochaetaceae, and genus Treponema. 
Pathogenic species T. pallidum has 3 subspecies and 1 closely related 
species: 
T. pallidum subsp. pallidum, which causes venereal syphilis; 
T. pallidum subsp. endemicum that causes endemic syphilis or bejel; 
T. pallidum subsp. pertenue that produces yaws;  
T. carateum, the agent of pinta. 
These microbial pathogens are very similar; their DNA homology 
exceeds 95%. 
 
 
Structure and Properties of T. pallidum 
 
Morphology 
T. pallidum are gram-negative thin corkscrew-shaped bacteria about 
0.2 μm in diameter and 5 to 20 μm in length with 6-20 regular small coils 
with tapered ends. The cytoplasmic membrane lends treponemas a spiral 
shape. 
Microbial body consists of an axial filament and cytoplasm wound 
spirally around the filament. Cytoplasmic membrane is covered by three-
layer outer membrane. It covers basal bodies with attached 3-4 bacterial 
endoflagella or fibrils localized in periplasmic space. Endoflagella provide 
active variable motility of bacteria. 
Treponemas are lack of producing spores or capsules. Old treponema 
cultures form cyst-like structures. 
The bacteria stain pale-pink with Romanowsky-Giemsa method as 
they poorly stained with aniline dyes due to the large lipid contents. 
Treponemas can be detected by silver impregnation method, dark field and 
phase contrast microscopy. 
 
Cultivation 
T. pallidum are extremely fastidious microaerophilic bacteria that 
maintain viability in presence of 1-4% oxygen. They can’t propagate in 
ordinary media. When cultivated at 37°C on rich artificial media with 
ascitic fluid and brain tissue under anaerobic conditions they gradually lose 
their virulence (cultural treponemas). 
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Nevertheless, T. pallidum grows well and maintain virulence by 
animal inoculation, e.g., in rabbit testicular tissue (tissue treponemas). 
However, rabbit infectivity test is long lasting and requires from 3 to 6 
months for cultivation. 
Cultural and tissue treponemas demonstrate various antigenic 
properties. 
 
Biochemical properties 
The bacteria have slow metabolism, which is not ascertained in 
details. Genome sequence revealed treponemas to be unable to synthesize 
necessary growth factors (enzyme cofactors, fatty acids, nucleotides, and 
others). On the contrary, treponemas carry multiple transport proteins, 
specific to various substrates, to compensate the lack of nutrients. 
Carbohydrates serve as energy source in microbial metabolism owing to 
the presence of all glycolytic pathway enzymes in bacterial cell. 
T. pallidum doesn’t produce superoxide dismutase, catalase, or 
peroxidase. 
 
Antigenic structure 
Antigenic characteristics of T. pallidum are also not completely 
elucidated. Bacteria are considered to have many lipid and protein 
antigenic substances mostly with haptenic activity. 
More than 100 protein antigens have been found in treponemas. 
Among them three core proteins of endoflagella are similar with other 
bacterial flagellin proteins. 
Lipid antigens include phospholipid cardiolipin that shows mimicry 
with bovine heart lipid antigens. It is important for syphilis serological 
diagnosis. 
Multiple lipid and protein antigens of T. pallidum cause 
hypersensitivity reactions of host immune system. 
 
Virulence factors 
T. pallidum bears membrane proteins that may function as porins and 
adhesins. These microorganisms are not shown to produce LPS endotoxins 
or clear exotoxins, but can develop cytotoxic activity against various cell 
cultures. Bacteria render hemolytic activity encoded by genes of five 
hemolytic proteins, and may produce hyaluronidase, which promotes 
microbial invasiveness. 
Pathogenesis of syphilis is closely associated with host autoimmune 
reactions triggered by microbial antigens. 
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Resistance 
Spirochetes are very sensitive to drying, heating, and action of 
chemical disinfectants. For instance, heating at 55°C kills them in 15 
minutes. Nevertheless, they stay viable for a meaningful time in tissues 
especially at low temperatures. For example, bacteria survive for one day 
and even more in blood or plasma, stored at 4°C. 
 
 
Pathogenesis and Clinical Findings in Syphilis 
 
Syphilis is an anthroponotic disease with cyclic chronic course. It is 
an actual example of social disease, where economic and social conditions, 
the state of healthcare service as well as personal lifestyle and mode of 
behaviour play decisive role in disease spread. 
Syphilis is transmitted predominantly by sexual intercourse; 
transmission by direct contact or via medical manipulations seems 
negligible. 
T. pallidum penetrates through small lesions in the skin or mucosals. 
Infectious dose for disease is minimal: as little as 1-5 microbial cells can 
cause the disease. 
Incubation period depends on inoculated dose. A large inoculum, e.g., 
about 10
7
 bacterial cells, results in disease appearance in 5-7 days. 
There are several consequent stages in syphilis course. 
After 7-90 days of incubation with average of about 3 weeks a hard 
chancre, essential tissue lesion of primary syphilis, appears. It is followed 
by regional lymphadenopathy. 
Chancre evolves at the primary site of microbial entry. In men it 
usually affects penis. Anorectal chancres emerge in homosexual men. In 
women it predominantly occurs on vulva. Hard chancre is a painless ulcer 
about 0.5-3 cm with sharp margins, clean base, induration, and sometimes 
with purulent discharge. 
In most cases chancre heals spontaneously within about 6 weeks. 
Nevertheless, in several weeks the disease comes into stage of “secondary 
syphilis”, which results from lymphogenous and hematogenous microbial 
dissemination. 
Secondary syphilis is characterized by skin rashes, headache, fever, 
malaise, lymphadenopathy, mucosal lesions, and CNS disorders. It lasts 
from 2-3 months to more than 1 year. 
Primary and secondary syphilitic lesions contain great amount of 
spirochetes, being highly infectious. 
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In secondary stage specific immune reactions against spirochetes arise 
(seropositive syphilis). Primary syphilis is regarded as seronegative, but 
the end of primary syphilis might be seropositive as well. 
Meanwhile, hypersensitivity response doesn’t provide complete 
microbial elimination without antimicrobial treatment; and after latent 
period of various duration (about 1 year and more) tertiary syphilis 
develops. 
Tertiary syphilis affects various body’s organs and tissues, especially 
cardiovascular system and CNS. Syphilitic aortitis damages the ascending 
aorta. It may happen between 10 and 30 years after primary infection. 
Specific slow indurative injuries (gummas) emerge in central nervous 
system and parenchimatous organs. They are followed by necrosis and 
connective tissue proliferation. 
The latest period of disease is characterized by profound CNS 
disorders (neurosyphilis). This period is usually regarded as seronegative 
because spirochetes are absent in bloodstream and antibody titers are low. 
The disease results in meningovascular syphilis, pareses, and tabes 
dorsalis. Tabes dorsalis ensues from the severe injury of dorsal roots and 
columns of spinal cord. 
Congenital syphilis results from vertical disease transmission from 
mother to fetus with a rate of 70 to 100% for primary syphilis. Congenital 
syphilis influences pregnancy outcome, thus it is often followed by 
spontaneous abortion, or perinatal death. 
The infected infants may be asymptomatic or show various early and 
late manifestations, such as lymphadenopathy, hepatomegaly; skeleton and 
teeth lesions, CNS disorders like deafness (Hutchinson's triad), 
asymptomatic neurosyphilis, etc. 
The immunity in syphilis is not sterile. It always causes patient’s 
hypersensitivity. Immune response usually doesn’t prevent disease 
progression, but autoimmune reactions accelerate tissue damage 
aggravating the disease course. 
 
 
Laboratory Diagnosis of Syphilis 
 
Laboratory diagnosis rests on microscopical examination of lesion 
specimens for treponemas, and/or serological tests for specific antibodies. 
Microscopy is the main diagnostic method for primary syphilis 
diagnosis. It also may be used in secondary syphilis. 
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Specimens are collected from chancre discharge, rash elements, lymph 
node aspirates, etc. 
Romanowsky-Giemsa stain, silver impregnation, dark field microscopy 
and direct fluorescent-antibody testing for T. pallidum (DFA-TP) are used. 
Serological testing is the cornerstone for laboratory diagnosis for 
latent, secondary, and tertiary syphilis. 
The methods of analysis include nontreponemal and treponemal 
reactions. 
Nontreponemal reactions are employed for mass screening, whereas 
treponemal tests are confirmatory. 
Widespread nontreponemal tests comprise two similar reactions – 
Venereal Disease Research Laboratory test (VDRL test) and Rapid 
Plasma Reagin test (RPR test). Both tests are based on flocculation 
reaction. In these methods a complex antigen containing lecithin, 
cholesterol, and purified cardiolipin is used to reveal host antibodies 
against cardiolipin that arise in syphilis. 
The method is cheap and rapid but of limited sensitivity; and it can 
give false-positive data in autoimmune diseases, patients with 
malignancies, tuberculosis, leprosy, viral and parasitic infections, 
pregnancy, etc. 
Wasserman reaction devised from complement fixation test can use 
both nontreponemal cardiolipin antigen and specific treponemal antigens 
for detection of anti-treponemal antibodies. 
Treponemal tests comprise serum fluorescent treponemal antibody 
absorption test, as well as T. pallidum immobilization test, 
microhemagglutination test and ELISA for detection of antibodies against 
T. pallidum.  
These tests use pathogenic killed or live T. pallidum cultures or the 
filtrate of virulent tissue treponemas as an antigenic source.  
ELISA test is regarded as the most convenient and universal for 
routine laboratory diagnosis of syphilis.  
PCR for T. pallidum DNA is swift, sensitive and reproducible method; 
it becomes available now in wide clinical practice. 
Clinical diagnosis of primary syphilis is confirmed by positive results 
of microscopy and/or positive results of one nontreponemal and one 
treponemal test. 
Secondary syphilis is diagnosed by positive data from one 
nontreponemal and one treponemal test. 
Tertiary syphilis should be confirmed by two or more treponemal 
tests. 
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Congenital syphilis is diagnosed by clinical, serological, and direct 
microscopic methods. Detection of immunoglobulin M antibodies by 
fluorescent treponemal antibody absorption test or ELISA confirms the 
diagnosis. 
 
 
Treatment and prophylaxis of syphilis 
 
As T. pallidum has no genetic resistance to beta-lactam drugs, 
benzylpenicillin and its long-acting derivatives (e.g., benzathine penicillin) 
remain the drugs of choice for syphilis treatment. Tetracyclines and 
macrolides can be used in case of patient’s allergy to beta-lactam 
antibiotics. 
Prophylaxis of syphilis is non-specific. It requires public education, 
screening for syphilis, timely recognition of syphilitic cases, their adequate 
treatment, and improvement of socioeconomic conditions. 
 
 
 
 
 
NEISSERIA GONORRHOEAE 
 
 
The History of Discovery 
 
Gonococci, the causative agents of gonorrhoea, were described first by 
A. Neisser in 1879. Later in 1885 E. Baum obtained the pure culture of 
these bacteria. 
 
 
 
Classification 
 
Gonococci belong to the family Neisseriaceae, genus Neisseria, and 
species Neisseria gonorrhoeae. 
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Structure and Properties of Neisseria gonorrhoeae 
 
Morphology 
Gonococci are similar with meningococci (about 70% of genetic 
similarity). Bacteria are visualized as gram-negative, bean-shaped 
diplococci.  
Gonococci are non-sporeforming non-motile microorganisms. Unlike 
meningococci, Neisseria gonorrhoeae is lack of capsule. 
The bacteria express multiple pili and fimbriae. They carry a large 
number of plasmids. Some of them confer resistance of gonococci to 
antimicrobial drugs resulting from beta-lactamase expression.  
 
Cultivation 
N. gonorrhoeae are even more fastidious than meningococci and can’t 
multiply on basic nutrient media. 
They are cultivated on media, containing blood, serum or ascitic fluid 
(blood, serum or ascitic agar) better in atmosphere with 5-10% CO2 at pH 
7.2-7.6. Optimal growth temperature is 37°C; the bacteria lose viability out 
of range 25-42°C. 
Gonococci produce very small convex colonies, opaque or transparent, 
depending on Opa protein expression. 
 
Biochemical properties 
Gonococci are mostly aerobic or facultatively anaerobic bacteria. The 
bacteria yield minimal biochemical activity. They ferment solely glucose 
with acid end products being lack of proteolytic activity. 
Similar to other members of the genus, gonococci produce oxidase and 
catalase. 
 
Antigenic structure 
N. gonorrhoeae harbors various antigenic determinants of 
polysaccharide and protein nature. The pathogens are able to alter surface 
antigen expression to evade host immune response. Bacterial pili contain 
protein pilin, which significantly varies among gonococcal strains (about 
100 serovars). Gonococci express a number of porins, namely PorA and 
PorB proteins. Multiple serovars are determined according to Por antigen 
variations. 
Adhesive Opa (opacity) proteins also render antigenic activity. 
Polysaccharide epitopes of gonococci are confined within bacterial 
cell wall lipooligosaccharide (LOS). 
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N. gonorrhoeae can switch the synthesis of various antigenic 
molecules, e.g pilins, Opa proteins or LOS residues triggering alternate 
gene expression. Overall, gonococci are regarded as the bacteria with 
highest genetic variability and genetic exchange with other bacterial 
species. 
 
Virulence factors 
Bacterial adhesins, including pili and Opa proteins promote microbial 
attachment to the host cells. Opa proteins principally bind to the cells 
bearing CD66 carcinoembryonic antigen.  
Opa and Por proteins stimulate intracellular invasion of gonococci and 
inhibit phagocytosis, preventing phagosome-lysosome fusion. 
Microbial lipooligosaccharide displays evident endotoxin activity. 
LOS antigenic mimicry with human glycosphingolipids support gonococci 
to escape host defensive reactions. 
Gonococci produce IgA1 protease that cleaves human mucosal IgA1. 
Many bacterial strains express plasmid-encoded beta-lactamases. 
 
Resistance 
Gonococci demonstrate a low viability, being very sensitive to 
external influences. They can’t resist cooling, drying, or UV irradiation. 
Gonococci best survive in the moist conditions in various human 
discharges. 
Bacteria are killed at temperature of 56°C within 5 minutes. They are 
readily inactivated by treatment with ordinary disinfectants. 
 
 
Pathogenesis and Clinical Findings in Gonorrhoea 
 
Gonococcus is the strictly human pathogen. 
Gonorrhoea is a typical sexually transmitted disease that affects 
predominantly urogenital tract. Unprotected sexual intercourse results in 
50% likelihood of disease contraction in women and 30-50% in men. 
Also gonococci produce gonorrhoeal conjunctivitis in adults and 
ophthalmia neonatorum (or blennorrhoea) in newborn infants transmitted 
by contact route. 
Infectious dose of bacteria is generally low – about 103 cells of 
virulent strains 
Only piliated opaque gonococcal cultures, containing multiple 
adhesins (e.g., Opa proteins), are able to adhere and invade host tissues. 
 154 
Gonococci attach to mucosa of urogenital tract, rectum, or eye, and 
induce acute inflammation. They stay viable within phagocytes impairing 
their bactericidal activity (incomplete phagocytosis).  
In males they cause specific urethritis with suppurative discharge 
followed by dysuria with frequent painful urination. The process often 
involves epididymis. When untreated, the disease produces chronic 
inflammation with extensive tissue fibrosis and seminal duct obliteration 
that may cause male infertility.  
In females the primary penetration of bacteria occurs in the 
endocervical epithelium. The infection extends to the urethra and vagina, 
and affects uterine tubes thus provoking salpingitis. Fibrosis and obturation 
of uterine tubes result in female infertility. Female gonorrhoea may be 
asymptomatic. 
If not treated the disease easily becomes chronic. 
In some rare cases the infection breaks tissue barriers, and the bacteria 
enter the bloodstream. This leads to hematogenous microbial spread with 
hemorrhagic skin rashes. Gonococcal dissemination may produce specific 
arthritis or endocarditis. 
Blennorrhoea or ophthalmia neonatorum evolves as the result of 
neonate infection, when newborns pass through infected maternal canal. 
Specific gonococcal eye injury can cause infant blindness. 
The immunity doesn’t confer the resistance against gonococci albeit 
specific antibodies and immune cells can appear in human secretions. 
 
 
Laboratory Diagnosis of Gonorrhoea 
 
Specimens are collected from the discharge of urethra, vagina, vulva, 
cervix, rectum or conjunctiva in case of ophthalmia neonatorum. 
Gram-stained smears of secretions show typical gram-negative bean-
shaped cocci within polymorphonuclear leukocytes (incomplete 
phagocytosis) or extracellularly. 
More sensitive and specific is immunofluorescent test. 
Gonococcal antigens in clinical specimens are determined by ELISA. 
To obtain microbial culture the collected specimens are inoculated 
immediately into serum or ascitic agar. The media are supplemented with 
antibiotics, suppressing concomitant bacteria and fungi (vancomycin, 
amphotericin or ristomycin). For men the culture is not necessary in case 
of positive microscopic examination, but cultures for women are 
indispensable. 
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After incubation for 48 h in chamber with 5% CO2 the specimens can 
yield pure cultures. They are further confirmed by microscopy with Gram 
stain, fermentation tests and microbial antigens determination. 
Serological reactions are of limited use in gonorrhoea. 
As confirmatory tests for detection of microbial nucleic acids, PCR 
and other nucleic acid amplification tests (NAATs) are used. 
 
 
Treatment and Prophylaxis of Gonorrhoea 
 
Because of rapidly growing resistance of gonococci to antimicrobial 
agents, third generation cephalosporins (e.g., ceftriaxone) and 
macrolides/azalides (azithromycin) are currently recommended for 
treatment of gonorrhoea..  
However, in 2011 first ceftriaxone-resistant isolates of gonococci were 
registered. Later in 2013 a new drug combination of azithromycin and 
gentamycin was introduced into clinical practice that is efficient against 
multiresistant gonococcal strains. 
For treatment of chronic gonorrhoea the injections of gonococcal 
killed vaccine can be administered to stimulate host immunity. 
For protection of newborns against ophthalmia neonatorum, urgent 
eye instillations of sulfacetamide (sulfacyl-sodium) solution as well as 
applications of tetracycline or azithromycin ophthalmic ointments are 
administered immediately after birth. 
 
 
 
PATHOGENIC UROGENITAL CHLAMYDIAE 
 
 
The History of Discovery 
 
Primary discovery of chlamydial inclusion bodies in conjunctival 
exudate of patient with trachoma was made in 1907 by S. Prowazek and 
L. Halberstдdter. They found microbial microcolonies later termed as 
Halberstдdter-Prowazek bodies enwrapped within common coat in the 
cytoplasm of infected cells. Hence, these and other similar bacteria were 
termed “Chlamydia” (from Gr. chlamyda that means “cloak”). 
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Classification of Chlamydiae 
 
The order Chlamydiales includes the family Chlamydiaceae; 
pathogenic represenatives pertain to genera Chlamydia and 
Chlamydophila. 
Human pathogen Chlamydia trachomatis causes trachoma, 
lymphogranuloma venereum or Nicolas-Favre disease, inclusion 
conjunctivitis, and numerous nongonococcal urogenital infections like 
urethritis and salpingitis. 
The genus Chlamydophila comprises two species pathogenic for 
humans – C. pneumoniae and C. psittaci. 
C. pneumoniae causes human pneumonia, bronchitis and sinusitis, 
whereas C. psittaci is the causative agent of avian disease ornithosis (or 
psittacosis) that in some cases may occur as severe respiratory infection in 
humans. 
 
 
Structure and Properties of Chlamydiae 
 
Morphology and life cycle 
Chlamidiae are the obligate intracellular parasites. They are non-
motile and non-sporeforming. 
Bacteria are of very small sizes and have two stages in life cycle – 
elementary bodies and reticulate bodies.  
Elementary bodies measuring 0.2-0.3 μm possess infectious properties 
being capable of invading the host cells.  
In the infected cells elementary bodies transform into vegetative 
reticulate inclusions 0.8-1.5 μm in size. They might be covered with 
capsule. After several reproductions reticulate bodies convert again into 
elementary invasive forms. 
The whole developmental cycle takes about 48-72 hours. 
According to their structure, chlamydiae are gram-negative bacteria 
with atypical peptidoglycan without acetylmuramic acid but with multiple 
cystein-containing peptide cross-bridges. 
Chlamydiae are primarily visualized by Romanowsky-Giemsa stain 
(reticulate bodies produce blue inclusions attached to cell nuclear 
membrane, while elementary bodies stain purple). Intracellular detection of 
bacteria is also performed by immunofluorescence technique. 
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Cultivation 
As the obligate intracellular parasites, chlamydiae grow in cultures of 
a variety of eukaryotic cell lines. 
McCoy cells are commonly used to isolate these pathogens. All types 
of chlamydiae proliferate in embryonated eggs, particularly in the yolk sac. 
Various animal models are used also for cultivation, e.g. mice. 
 
Biochemical properties 
In general, chlamidiae render weak biochemical activity. Bacteria are 
unable to synthesize ATP and need the host cell for energy and nutrient 
donations. 
Some chlamydiae demonstrate endogenous metabolism like other 
bacterial representatives. They can liberate CO2 from glucose, pyruvate, 
and glutamate; they also contain dehydrogenases. 
 
Antigenic structure 
Chlamydiae possess group-specific antigens. These are heat-stable 
lipopolysaccharides.  
Serovar-specific antigens are mainly outer membrane proteins 
(OMP). Major outer membrane protein (MOMP) covers about 60% of 
total amount of proteins in chlamydial cells. Other protein antigens of 
microbial outer membrane are variable (Pmp, OmcA, OmcB and others). 
Antigenic proteins are also found in the coat encasing bacterial 
intracellular inclusions (Inc proteins). 
Specific antigens are shared by only a limited number of chlamydiae. 
Fifteen serovars of С. trachomatis have been identified (e.g., A, B, Ва, C; 
D-K; L1-L3). 
 
Virulence factors 
Virulence factors of chlamydiae are not completely elucidated. 
Microbial LPS displays proinflammatory properties as endotoxin. 
The proteins of outer membrane such as MOMP are the bacterial 
adhesins. Together with cystein-containing chlamydial proteins they 
suppress phagocytosis inhibiting phagosome-lysosome fusion. 
Heat shock proteins hsp60 and others stimulate cellular inflammation. 
Chlamydiae possess type III secretion system (T3SS) with activity of 
injectisome. The structures of T3SS are responsible for microbial 
invasiveness and intracellular persistence. 
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For instance, effector protein TARP after injection into the cell 
stimulates cytoskeleton remodelling and next membrane folding. It leads to 
engulfment of attached bacteria and their entry into the epithelial cells. 
Another effector protein CPAF with proteolytic activity destroys 
intracellular regulatory proteins, thus preventing the apoptosis of infected 
cells and presentation of chlamydial antigens. 
 
Resistance 
In general, chlamydiae demonstrate a low environmental resistance. 
More stable are elementary bodies, which stay viable for 5-10 min within 
droplet aerosol phase. The temperatures above 40
o
C and pH fluctuations 
rapidly inactivate bacteria. Nevertheless, their survival might be longer at 
low temperatures and in clinical samples with high protein contents.  
Chlamydiae are sensitive to all conventional antiseptics and 
disinfectants. 
 
 
Pathogenesis and Clinical Findings in Chlamydial Urogenital 
infections 
 
Humans are the natural hosts for С. trachomatis. The bacterium 
causes various human infections depending on the microbial serovar. 
Serovars А, Ва, В and С are the agents of trachoma; serovars from D 
to K are responsible for urogenital infections, and L-1, L-2, L-3 serovars 
cause lymphogranuloma venereum. 
Trachoma is an ancient eye disease. It is a chronic 
keratoconjunctivitis that begins with acute inflammatory changes in the 
conjunctiva and cornea and progresses to scarring and blindness. 
Also С. trachomatis cause numerous urogenital infections. Bacteria 
of serovars D-K cause sexually transmitted diseases and may also produce 
the specific infection of the eyes (inclusion conjunctivitis). 
The bacteria bind to epithelial cells by multiple adhesins, enter the 
infected cell by the action of type III secretion system and impair normal 
cellullar metabolism. Chlamydia persistence stimulates chronic 
inflammatory reactions within urogenital tract that may lead to sclerosis. 
Propagation of chlamydiae followed by the egress of elementary bodies by 
lysis or membrane body extrusion results in degradation of urogenital 
epithelium.  
In males С. trachomatis provokes nongonococcal urethritis and 
epididymitis. In females С. trachomatis causes urethritis, cervicitis, and 
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pelvic inflammatory disease, which can lead to sterility and predisposes to 
ectopic pregnancy.  
Up to 50% of nongonococcal urethritis in men or the urethral dysuria 
in women is associated with chlamydiae. Overall, С. trachomatis annually 
causes more than 140 mln cases of sexually transmitted infections 
worldwide. 
The infection may stay long asymptomatic but transmissible to other 
persons. 
The newborns acquire the chlamydial infection, when passing through 
the infected maternal birth canal. From 20 to 50% of newborns may 
acquire the infection, 15-20% of them display eye symptoms and 10-20% 
demonstrate the involvement of respiratory tract. 
Inclusion conjunctivitis of the newborns commences as suppurative 
conjunctivitis arisen in 1-2 weeks after the delivery. It is manifested like 
chronic chlamydial infection similar to childhood trachoma. 
 
 
Laboratory Diagnosis of Chlamydial Urogenital Infections 
 
A cytology brush or swab is used to detach epithelial cells 1-2 cm 
deep from the endocervix. A similar method is applied to collect 
specimens from the vagina, urethra, or conjunctiva. Biopsy specimens of 
the uterine tube or epididymis can also be examined. 
The presence of chlamydia inclusions in smears is determined by 
microscopy with Romanowsky-Giemsa stain and immunofluorescence 
microscopy. 
The swab specimens should be placed into chlamydia transportation 
medium and kept at refrigerator temperature before transportation to the 
laboratory. 
McCoy cells grown in monolayers are inoculated for culture. The 
inoculum from the swab specimen is incubated at 37°C for 48-72 hours. 
The monolayers are examined by direct immunofluorescence to visualize 
the cytoplasmic inclusions. This method of chlamydial cultures 
demonstrates about 80% sensitivity and near 100% specificity. 
Nevertheless, cultural tests remain laborious and cumbersome. 
Therefore, the laboratory diagnosis of chlamydial infections in clinical 
practice is mainly based on PCR as the highly sensitive, specific and 
reproducible molecular genetic test. It is more sensitive than culture and 
other nonamplification tests. The specificity of PCR appears to be close to 
100%. 
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Direct fluorescent antibody assay and enzyme-linked immunoassay 
(ELISA) are used to detect C. trachomatis by their antigens.  
Serological diagnosis of chlamydial infections (e.g., by ELISA) 
indicates the growth of serum antibodies against the pathogen. The rise of 
levels of specific antibodies occurs during and after the acute chlamydial 
infection. 
 
 
Treatment of Urogenital Chlamydioses 
 
Macrolides and azalides (e.g., azithromycin) are commonly used for 
treatment of urogenital chlamydial infections. Erythromycin is given to 
pregnant women. Tetracyclines (e.g., doxycycline) can be administered as 
well. 
Aminoglycosides and β-lactams are clinically inefficient due to the 
poor availability of chlamydiae inside the cells. Topical tetracyclines or 
macrolides are administered in case for inclusion conjunctivitis, sometimes 
in combination with a systemic drug. 
Efficient vaccines for prevention of chlamydial infections are not yet 
elaborated. 
 
 
 
PATHOGENIC UROGENITAL MYCOPLASMAS 
 
 
Classification of Uropathogenic Mycoplasmas  
 
As it was mentioned above in Chapter 6, mycoplasmas pertain to the 
separate class Mollicutes, order Mycoplasmatales, and family 
Mycoplasmataceae, which includes two genera with pathogenic 
representatives: Mycoplasma and Ureaplasma. 
In certain clinical conditions Ureaplasma urealyticum, 
Ureaplasma parvum, Mycoplasma hominis, and Mycoplasma genitalium 
can cause human nongonococcal urethritis and some other urogenital 
disorders. These ailments are usually not found as monoinfection but 
predominantly as the tight association of various urogenital pathogens. 
The role of other mycoplasmal species in pathology of urogenital tract 
remains elusive.  
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Pathogenic Mycoplasmas – Basic Characteristics 
 
The structure and common properties of mycoplasmas were already 
described earlier (see Chapter 6 for details). 
Briefly, mycoplasmas are the smallest pleomorphic bacteria, which are 
lack of the cell wall. Their cells are covered with thick lipid-containing 
membrane. They are facultative anaerobes or microaerophils with reduced 
metabolism. 
Mycoplasmas are membrane parasites, but they can grow on special 
nutrient media supplemented with serum, ascitic fluid, lipoproteins and 
sterols. After growth the bacteria yield round colonies of minimal sizes 
looking like “fried eggs”. 
When cultured within the cell lines and chicken embryos, 
mycoplasmas become closely attached to the membranes of affected cells.  
Basic antigens of mycoplasmas are glycolipids and proteins of 
variable structure.  
The virulence factors of mycoplasmas are not well-defined. The 
bacteria can generate cytotoxic hydrogen peroxide and superoxide 
radicals. Some strains may express hemolysins. Membrane fractions of 
mycoplasma play the role of superantigens. All mycoplasmas possess 
multiple adhesins. 
The bacteria are very sensitive to external influences. They are easily 
inactivated under the action of conventional antiseptics and disinfectants. 
 
 
Pathogenesis and Clinical Findings in Mycoplasmal Urogenital 
Infections 
 
Various mycoplasmas have non-equal association with urogenital 
disorders. Moreover, such a relationship is hard to establish due to 
relatively low virulence of these bacteria. Isolated mycoplasmal culture 
may occur as nonpathogenic concomitant bacteria, which only follow 
infection process. In addition, these microbials frequently play a role in 
urogenital disorders only in closest associations with other urogenital 
pathogens (trichomonads, gardnerellas, chlamydiae and many others). 
Thus it remains difficult to evaluate real contribution of mycoplasmal 
infection into urogenital pathology. 
Mycoplasma hominis was demonstrated in some patients with 
pyelonephritis, urethritis, prostatitis, salpingitis and tubo-ovarian 
abscesses. Systemic mycoplasmal infection may provoke postabortal or 
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postpartum fever in females. Mycoplasma genitalium can be revealed in 
patients with nongonococcal urethritis. Ureaplasma urealyticum can be 
often found in female urogenital tract, but its role in women genital 
disorders remains unclear. Ureaplasmas may be isolated also in some cases 
of nongonococcal urethritis in men. 
 
 
Laboratory Diagnosis of Mycoplasmal Urogenital Infections 
 
Urethral and vaginal scrapes or swabs, genital secretions are largely 
used for specimen collection. 
PCR has become the most valuable, rapid and sensitive test for 
mycoplasma detection. The only drawback of the method depends on 
reaction inability to discriminate viable and degraded microbial cells by 
their nucleic acids. The latter condition may rarely cause false-positive test 
results. 
For culture the specimens are inoculated into special solid or liquid 
media and incubated for 1-2 weeks. After incubation the growth of minute 
characteristic “fried egg”-like colonies is observed. Further subculture is 
useful to identify bacteria by immunofluorescence test. Mycoplasma 
culturing is usually available in specialized reference laboratories. 
Serological tests are of limited significance in local mycoplasmal 
infections.  
 
 
Prophylaxis and Treatment 
 
The bacteria are resistant to antibiotics that inhibit cell wall synthesis 
(e.g., beta-lactams and vancomycin). Macrolides, azalides and tetracyclines 
(doxycycline) are preferable in treatment of urogenital mycoplasmal 
infections. Some strains develop increased resistance to tetracyclines and 
macrolides. 
Specific prophylaxis of infection is not available. Non-specific 
measures are used to prevent disease transmission. 
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Chapter 9 
CAUSATIVE AGENTS OF BACTERIAL ZOONOZES: 
PLAGUE, ANTHRAX, BRUCELLOSIS, AND TULAREMIA 
 
 
YERSINIA PESTIS – CAUSATIVE AGENT OF PLAGUE 
 
 
The History of Discovery 
 
 
Plague is a highly devastating epidemic disease still known from the 
times of antiquity. It followed human civilization from the deep past. 
Three global pandemics of plague were registered in the written 
history – the Justinian Plague of 541 AD that affected the all ancient world, 
lasted for two centuries and caused about 25 mln deaths; the Great Plague 
or “Black Death” of Middle Ages that killed 60% of European population, 
and the last plague pandemic started in China in the 1860s and continued 
for several decades with about 10 mln victims. 
In XX century the total number of plague cases gradually declined. 
Nowadays between 1,000 and 2,000 plague reports are delivered annually 
to WHO, but this statistics is regarded as seriously underestimated. 
The causative agent of plague, Yersinia pestis, was discovered by the 
French microbiologist A. Yersin in Hong Kong in 1894 during the last 
global pandemic of the disease. 
 
 
Classification of Yersinia pestis 
 
Yersinia genus belongs to the family Enterobacteriaceae. 
Yersinia pestis, a causative agent of plague is the most virulent 
yersinia representative. 
 
 
Structure and Properties of Yersinia pestis 
 
Morphology 
All yersiniae are similar with other enterobacteria – small polymorphic 
gram-negative rods that have characteristic bipolar stain. Stained microbial 
cells look like “closed safety pins” on microscopy.  
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Y. pestis are nonmotile enterobacteria, in contrast to other yersiniae, 
which express flagella. 
In smears from tissues and cultures Y. pestis is found to have a delicate 
capsule. 
 
 
Cultivation 
Yersiniae can grow on ordinary nutrient media. The optimal 
temperature for cultivation is 25-30°C. 
The growth on blood agar after 48 h of incubation at 35°C yields gray-
white opaque colonies 1-2 mm in diameter usually without hemolysis. The 
colonies resemble “fried-egg” or “crumpled lace handkerchief” at 
appearance. 
Various lactose-containing media (McConkey, or EMB agar) and 
several special media are used for yersiniae cultivation. Small lactose-
negative colonies arise after 24 h of incubation at 35°C. 
In meat broth the cultures form a pellicle on the surface with 
threadlike growth resembling stalactites. 
Y. pestis is virulent in R form. 
 
 
Biochemical properties 
Yersiniae are facultatively anaerobic bacteria. As all enterobacteria, 
they are catalase positive and oxidase negative. 
Y. pestis has rather weak and variable biochemical activity. The 
bacterium ferments glucose, maltose, galactose, mannitol and some other 
carbohydrates with acid end products, but can’t metabolize sucrose, and in 
most cases lactose. It reduces nitrates to nitrites. 
Y. pestis neither liquefy gelatin, nor produce indole. They are urease 
negative. 
 
 
Antigenic structure 
Y. pestis express many antigens and toxins that act as virulence 
factors. O-antigen contains lipopolysaccharides that have endotoxic 
activity, when released. Capsular K- (or F1) antigen of glycoprotein nature 
is shown to protect bacteria against phagocytosis. 
Protein V-Ag and lipoprotein W-Ag can also develop anti-phagocytic 
activity. 
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Virulence factors 
All virulence factors of Y. pestis are under the tight genetic control. 
A 72-kb virulence plasmid (pYV – plasmid of Yersinia virulence) is 
responsible for microbial adherence, invasiveness, intercellular spread, and 
ability to survive and propagate within host lymphoid tissues. It is essential 
for mirobial virulence; avirulent strains lack this plasmid. The plasmid 
contains yersinia pathogenicity island or Yop virulon. 
Yop virulon encodes invasive yersinia outer proteins (Yop proteins) 
and structures of type III bacterial secretion system (injectisome, or needle 
complex), composed of about 30 protein units (so-called Ysc proteins). 
Needle complex promotes microbial adherence to epithelial or immune 
cells and delivers invasive Yop proteins into cytoplasm of the host cells. 
Injected Yops impair the dynamics of the cytoskeleton, allow microbial 
penetration and intracellular spread, thereby promoting further bacterial 
invasion.  
Yop proteins sharply diminish the production of proinflammatory 
cytokines by macrophages and other immune cells, thus maintaining 
bacterial survival within immune cells and tissues. Also they stimulate 
macrophage apoptosis. 
Among secreted exotoxins, one is lethal for mice in amounts of 1 ng. 
This deleterious protein substance is extremely cardiotoxic for 
experimental animals. Its role in human infection is not clearly elucidated. 
K- (or F1), V- and W-antigens protect bacteria against phagocytosis. 
Y. pestis expresses plasminogen activator – a potent agressive enzyme 
complex. At 28°C (the normal temperature of the flea body) it shows 
coagulase activity supporting bacterial dwelling within insect vector, 
whereas at 35-37°C (human body temperature) it affords fibrinolysin 
activity, thereby breaking down the tissue matrix and promoting microbial 
invasion. The latter is additionally stimulated by microbial hyaluronidase. 
Also the bacteria produce bacteriocins (or pesticins) that antagonize 
normal microbiota. 
Bacterial lipopolysaccharide has potent endotoxic activity. In human 
body conditions at 37
o
C the structure of lipid part of endotoxin alters, and 
modified LPS loses its capacity to stimulate macrophages thus maintaining 
microbial survival.  
 
Resistance 
The plague agents can withstand low temperatures. At 0°С they live 
for 6 months. Y. pestis survives in water for 30 days; in milk for 90 days; in 
bubonic pus for 20-30 days; in sputum for 10 days. 
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Y. pestis is very sensitive to drying and high temperatures. Boiling 
kills the microbials within 1 minute, when heated to 60°C they are 
inactivated in 1 hour. Standard disinfectants in ordinary concentrations 
(e.g., 5% phenol) readily destroy them in 5-10 minutes. 
 
 
Epidemiology, Pathogenesis and Clinical Findings in Plague  
 
Plague is a zoonotic disease of rodents and other animals that is 
usually transmitted to humans via fleabites. 
Rodents, among them black rats, grey rats, mice, gophers, marmots 
(tarbagans) and many others are susceptible to plague. More than 300 
rodent species as primary sources of infection may spontaneously contract 
the disease.  
When an insect vector (flea) feeds on a rodent infected with Y. pestis, 
the ingested bacteria multiply in the gut of the flea. Microbial cells block 
vector’s digestive tract owing to coagulase action. Then the flea attacks 
and bites the mammal host, and flea gut contents contaminated with 
Y. pestis become expelled into the bite wound. 
At the temperature of the flea body 28°C Y. pestis neither secrete 
virulence proteins, nor alter the structure of LPS and express capsular F1-
Ag. 
In human body at 37°C the inversion of microbial metabolism occurs. 
By activation of injectisome Y. pestis delivers virulence effector proteins 
into macrophages and other immune cells. They paralyze the activity of 
innate immune response with profound inhibition of cytokine secretion. 
Alteration of LPS structure and expression of bacterial F1-, V- and W-Ags 
protects the bacteria against fagocytosis. 
Fibrinolysin activity of bacterial plasminogen activator and 
hyaluronidase facilitate microbial dissemination. 
Thus, the powerful mechanisms of suppression of innate immunity 
essential for Y. pestis create the conditions for generalized systemic 
devastating infection. 
Depending on the location of the pathogen, virulence of the microbe, 
and host immunity human plague is manifested in three major forms: 
bubonic, pneumonic, and septicemic. More seldom are cutaneous and 
intestinal forms. 
Fleabite results in the bubonic form of plague, characterized by the 
sudden rise of fever and an extremely painful lymphadenitis known as 
bubo. It usually appears in the groin or axillae. 
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Skin dark-purple lesions may develop during the systemic stage of the 
infection. They rapidly become necrotic and likely account for the plague 
name “black death”.  
The term septicemic plague describes fulminant disseminative 
infection without bubonic lymphadenitis. 
Pneumonic plague arises after hematogenous spread of yersiniae from 
a bubo to the lungs (secondary pneumonic) or via the direct inhalation of 
pathogens.  
Direct inhalation of Y. pestis sharply accelerates the disease 
transmission between humans (primary pneumonic plague).  
The pneumonic disease is highly contagious and easily spread among 
individuals via airborne route. 
As the result of systemic infection, hemorrhagic and necrotic lesions 
emerge in all organs and tissues. They lead to meningitis, pneumonia and 
other inflammatory disorders followed by kidney, liver and cardiovascular 
failure. Disseminated intravascular coagulation (DIC) entails hypotension 
and collapse. 
Administration of antimicrobial agents (e.g., gentamycin or 
tetracycline) early in the course of the disease can reduce mortality from 
approximately 50% in untreated plague cases to about 5-10%. 
After patient’s recovery a stable immunity of long duration is 
acquired. 
Due to its prominent virulence, rapid air-droplet spread of pneumonic 
disease and high fatality of infection if not treated Y. pestis is ascertained 
as the potential agent of bioterrorism and biological warfare.  
According to United States regulations, the list of “Biological Select 
Agents or Toxins” comprises microorganisms and their toxins that possess 
“...the potential to pose a severe threat to public health and safety”. 
Y. pestis stays in Tier 1 of US Select Agents list (the highest rank of 
public threat). Criteria for Tier 1 are summarized as follows: “(1) ability to 
produce a mass casualty event or devastating effects to the economy; 
(2) communicability; (3) low infectious dose; (4) history of or current 
interest in weaponization based on threat reporting”. 
 
Laboratory Diagnosis of Plague 
 
For isolation of Y. pestis the specimens from blood, sputum, or lymph 
node aspirates are taken. The bacteria are also recovered from autopsy 
material (organs, blood, lungs, lymph node samples), rodent corpses, fleas, 
foodstuffs, water, etc. 
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At the first stage of examination Y. pestis are often detected by 
microscopy in smears stained by Gram method or methylene blue.  
Immunofluorescence test is used for rapid detection of bacteria in 
clinical samples. 
Microbial nucleic acids are detected by PCR. 
Cultures of Y. pestis should be operated in special biosafety facilities 
(BSL-2 – biosafety level 2) with minimization of procedures that may 
create aerosols.  
Microbial isolation is performed in ordinary media supplemented with 
antiseptics, e.g., gentian violet that inhibits concomitant microflora. 
Growth on media incubated at 35-37°C is slower than growth at 28°C or 
room temperature. 
Any suspected Y. pestis isolate should be delivered to the state 
reference laboratory for identification. 
For biological tests (animal experimental infection) isolated pure 
cultures or specimens are inoculated into guinea pigs. If plague agents are 
present, the animals die in 5-7 days. 
Y. pestis is further identified according to their biochemical and 
antigenic properties and by phagotyping. It should be differentiated from 
other yersiniae, e.g. the causative agent of pseudotuberculosis. 
Serological testing of patients detects arisen antibody levels to 
Y. pestis by agglutination or ELISA test. 
 
 
 
Treatment and Prophylaxis of Plague 
 
Aminoglycoside antibiotics (streptomycin or gentamycin) are used for 
the treatment of the plague. The drugs are effective even in pneumonic 
plague. Good results were obtained from a combination of streptomycin 
with tetracyclines and passive treatment with anti-plague immune globulin. 
Specific prophylaxis is afforded with live EV vaccine. The persons 
from the groups of risk working in the areas of infection are vaccinated 
(e.g., medical personnel, veterinary workers, hunters, herdsmen, etc.) 
Immunity lasts for about 1 year. Booster injections are possible in 6-12 
months. The efficacy of vaccination is generally moderate.  
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В. ANTHRACIS – CAUSATIVE AGENT OF ANTHRAX 
 
 
The History of Discovery 
 
The bacterial origin of anthrax was primarily noted by A. Pollander 
(Germany) in 1849, by K. Davaine (France) in 1850, and by F. Brauell 
(Russia) in 1854.  
First isolation of anthrax agent was fulfilled by R. Koch in 1876. 
In Russia the disease was named as Siberian sore owing to the large 
epidemic of 1786-1788 in the Urals, described by S. Andreyevsky.  
In Germany the infection is known as spleen fever. 
 
Classification of Bacillae 
 
Bacillus genus pertains to the same name family Bacillaceae. 
Most members of the genus are saprophytic organisms prevalent in 
soil, water, air, and on vegetations, such as Bacillus cereus and Bacillus 
subtilis. These bacteria may occasionally produce disease in 
immunocompromised persons (e.g., meningitis, endocarditis, acute 
gastroenteritis, etc.)  
В. anthracis, which causes anthrax, is the principal pathogen of the 
genus. 
 
Structure and properties of B. anthracis 
 
Morphology 
B. anthracis are viewed as the large gram-positive rods (1-1.5 μm in 
breadth and 4-10 μm in length). The microbials are nonmotile, 
encapsulated, and arranged in chains (streptobacilli).  
In stained smears the ends of the bacilli appear to be sharply cut 
across, resembling bamboo canes. Peptide capsule is usually evident in 
samples from infected tissues.  
The bacilli produce oval subterminal spores that not exceed the width 
of bacterial cell. Spores are formed only in the presence of oxygen. 
 
Cultivation 
B. anthracis grows well in ordinary media and sheep blood agar at 
37°C, usually forming nonhemolytic rough colonies (R forms) after 
overnight incubation.  
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The round colonies are usually flat or slightly convex with irregular 
edges, sometimes curly tailing edges are observed. It was historically 
indicated that they resemble the “head of a medusa” or “lion mane.” 
The smooth S forms display low virulence or are completely avirulent. 
When grown on penicillin-containing meat-peptone agar, the bacilli 
are transformed into globules that become arranged as a necklace (“pearl 
necklace”). 
Broth cultures of the anthrax bacilli produce flocculent growth as 
“cotton wool” near the bottom of the tube. 
Growth of B. anthracis in gelatin stabs with substrate liquefaction 
resembles an inverted “fir tree”. 
 
 
Biochemical properties 
The anthrax bacilli are aerobic and facultatively anaerobic. They have 
potent and versatile biochemical activity.  
B. anthracis expresses various enzymes – peroxidase, catalase, lipase, 
amylase. Bacteria utilize proteins producing ammonia and hydrogen 
sulfide. In addition, anthrax bacilli liquefy gelatin and cause late 
liquefaction of coagulated serum. They slowly reduce nitrates to nitrites 
and coagulate milk.  
B. anthracis ferments glucose, maltose, sucrose, dextrin, etc. with acid 
production. 
 
 
Antigenic structure 
The anthrax bacilli carry capsular protein and thermoresistant 
polysaccharide cell wall antigen.  
The polysaccharide antigen remains stable for the long period of time 
in tissues obtained from animal carcasses. The presence of this antigen in 
raw materials is determined by Ascoli’s thermoprecipitin test – a boiled 
B. anthracis extract containing thermoresistant Ag yields a precipitin 
reaction with the specific serum. 
The capsular antigen is composed of poly-D-glutamic acid 
B. anthracis produces also a special antigenic fraction, referred to as 
protective antigen. This antigen is a thermolabile protein with marked 
immunogenic activity. It takes an active part in metabolism of microbial 
toxins. 
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Virulence factors 
The virulence factors of B. anthracis include two exotoxins and 
antiphagocytic polypeptide capsule. The loss of the capsule abolishes the 
virulence of bacteria. 
The genes encoding virulence factors of B. anthracis are located in 
two separate plasmids. 
The anthrax toxins are composed of three proteins: PA (protective 
antigen), and EF (edema factor) or LF (lethal factor).  
Protective antigen plays a role of receptor and transport subunit for 
both microbial toxins. The PA molecule attachs to specific receptors on the 
host cell membrane. PA is further cleaved by a cellular protease, producing 
a PA fragment that functions as a specific receptor for edema factor (EF) 
and lethal factor (LF).  
Edema factor is an adenylate cyclase; after binding to PA it forms a 
toxin known as edema toxin. It suppresses the activity of macrophages and 
increases vascular permeability resulting in tissue edema. 
Lethal factor coupled with PA creates cytotoxic lethal toxin, which is 
the major virulence factor of B. anthracis. 
LF itself is zinc-containing metalloprotease that with high specificity 
destroys key intracellular regulatory enzyme, namely kinase of mitogen-
activated protein kinase (MAPK kinase).  
Inactivation of MAPK kinase by lethal toxin profoundly disorganizes 
intracellular metabolism eventually resulting in cell death. 
Both lethal and edema toxins are delivered into the host cell via 
receptor-mediated endocytosis. Initially confined within endosome, LF and 
EF cross endosomal membrane and enter the cytoplasm of affected cell 
through the channel made by protective antigen subunit.  
 
 
 
Resistance 
The intrinsic toughness of B. anthracis spores is outstanding: they may 
survive in soil for decades (at least more than 50 years). They are grossly 
more resistant to disinfectants than the vegetative cells. The vegetative 
bacteria are killed in 15 minutes at 60°C and in 1-2 minutes at 100°C. The 
spores are thermostable, and withstand boiling for 15-20 minutes or 
autoclaving at 110°С for 5-10 minutes. They are gradually destroyed by 
1% formaldehyde and 10% sodium hydroxide within 2 hours.  
 
 
 172 
Epidemiology, Pathogenesis and Clinical Findings in Anthrax 
 
Anthrax is a typical zoonosis. It is enzootic in many parts of the 
world. The potential source of infection is the vast number of wild and 
domestic animals (e.g., cattle). 
Herbivores become infected with anthrax by grazing in pastures that 
are contaminated with spores. The animal infection results in bacterial 
propagation that leads to environmental contamination with vegetative 
microbial cells. They subsequently sporulate and persist in the soil for 50 
years and even more. Animal carcasses are highly infectious. Biting flies 
can become vectors for the spread of anthrax.  
As the environmental conditions play a substantial role in preservation 
and spread of anthrax germs, the infection caused by B. anthracis is 
referred to as sapronosis.  
Contact with animals (butchering, skinning, or exposure to hides or 
wool), and consumption of contaminated meat are the risk factors for 
infection transmission to humans. The incidence of inhalation anthrax is 
considerably reduced by decontamination procedures for wool and hair. 
Depending on the primary portal of entry, anthrax cases demonstrate 
highly variable clinical manifestations. 
In cutaneous anthrax, spores are introduced into the skin by direct 
contact. Germination occurs within hours, and vegetative cells produce 
anthrax toxin. The disease usually develops within 1-7 days after entry. 
Primary papular-vesicular skin lesion is next changed by ulceration 
with formation of blackened necrotic eschar or anthrax carbuncle 
(malignant pustule). This lesion is usually painless. A regional 
lymphadenitis is commonly observed in these patients. Eventually eschar 
dries, loosens, and separates; spontaneous healing occurs in 80 to 90% of 
untreated cases. Bacterial dissemination may lead to systemic infection 
with high fever and possible lethal outcome. 
In case of inhalation anthrax (wool-sorter’s disease), the spores are 
aerosolized and enter the alveoli of the lungs. The incubation period in 
inhalation anthrax may last up to 6 weeks. 
The spores are ingested by alveolar macrophages and begin to 
germinate moving to mediastinal lymph nodes. It results in hemorrhagic 
mediastinitis and massive B. anthracis bacteremia, accompanied by 
secondary pneumonia. Meningitis may also occur. 
The disease manifests by fever, tachypnea, and hypoxia accompanied 
by hypotension. Severe respiratory distress syndrome leads to lethal 
outcome within 24 h of the primary phase of infection.  
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There is no individual human-to-human transmission of inhalation 
anthrax; nevertheless, this form of disease might be contracted as the 
result of potential bioterrorist attack due to the high stability of microbial 
spores. 
Accidental gastrointestinal anthrax arises under the ingestion of 
contaminated meat that was not thoroughly cooked. The course of the 
disease is severe, fatality is high. 
B. anthracis bacteremia occurs in all three forms of human anthrax 
and it is observed in literally all death cases. Cutaneous anthrax is the most 
frequent form of disease (95%), next is inhalation anthrax (5%). 
Gastrointestinal anthrax is extremely rare and may be seen in less than 1% 
of all clinical cases. 
Due to its evident threat to personal and public health, B. anthracis is 
also placed into Tier 1 of US list of “Biological Select Agents or Toxins” 
comprising the most dangerous microbial pathogens. Bacillus anthracis 
ranks high in the list of potential agents of bioterrorist attacks. 
 
 
Laboratory Diagnosis of Anthrax 
 
Depending on the type of infection, B. anthracis may be isolated from 
various samples: cutaneous lesions, respiratory specimens, stool or other 
gastrointestinal excretions, blood or cerebrospinal fluid. 
The microscopy of Gram-stained smears reveals the presence of 
characteristic capsulated bacilli, arranged in chains that permits a 
preliminary diagnosis. 
Also anthrax bacilli can be identified by immunofluorescence assay. 
Nucleic acids of B. anthracis are determined by PCR. 
For isolation of the pure culture the specimens are inoculated into 
meat-peptone agar, meat-peptone broth and blood agar (the latter yields 
non-hemolytic colonies). The isolated culture is differentiated from other 
bacteria by its morphological, biochemical and antigenic properties. 
Laboratory animals (mice, guinea pigs and rabbits) are inoculated 
directly by pathogenic material or by isolated culture. As an example, 
B. anthracis causes the death of mice in 24-48 hours after inoculation. 
Microscopical examination of smears made from blood and internal organs 
reveals anthrax bacilli, which are surrounded by a capsule. 
Post-mortem sections as well as leather and hair used as raw materials 
are examined by thermoprecipitin reaction (Ascoli's test) to detect anthrax 
antigens.  
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Bacterial phagotyping is a valuable test, as the specific bacteriophage 
causes the lysis of pathogenic culture. 
In serological diagnosis various kinds of ELISA are developed to 
determine antibodies against bacterial toxins, capsular and spore-derived 
antigens. Acute and convalescent sera obtained 3-4 weeks afterwards 
should be tested. A positive result is a fourfold rise of specific antibody 
levels. 
 
 
 
 
Treatment and Prophylaxis of Anthrax 
 
Penicillin is the drug of choice for treatment of anthrax, but it must 
be started early. Macrolides, fluoroquinolones (e.g., ciprofloxacin), and 
vancomycin are also active against these bacteria. Treatment may also 
include passive immunization with anthrax antitoxic immune globulin. 
For specific prophylaxis live (attenuated) vaccine containing spores 
of non-capsulated B. anthracis vaccine strain is used in many countries to 
immunize herbivores and groups of humans with high occupational risk of 
infection. 
The vaccine is harmless, but with some side effects; it produces the 
immunity quite rapidly (in 48 hours) and for a period of over a year. It is 
inoculated in a single dose.  
Another anthrax vaccine is an aluminum hydroxide-precipitated 
protective antigen. 
General measures of anthrax control are carried out in tight 
cooperation with veterinary workers. These measures are aimed for timely 
recognition, isolation, and treatment of sick animals. They also include 
thorough disinfection of premises for livestock, affected territory and all 
the objects, followed by ploughing the pastures. Carcasses of animals died 
of anthrax must be burnt or buried in specially assigned areas. 
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PATHOGENIC BRUCELLAE – CAUSATIVE AGENTS OF 
BRUCELLOSIS 
 
 
 
The History of Discovery 
 
In 1886 on the Island of Malta an English bacteriologist D. Bruce 
demonstrated the presence of the causative agent of Malta fever in the 
spleen of a dead patient. Later in 1887 he isolated these bacteria in pure 
culture. 
In 1896 the Danish scientist B. Bang established the etiology of 
contagious abortion of cattle. In 1914 the American investigator G. Traum 
isolated from pigs the bacteria responsible for contagious abortion of these 
animals. Other brucellae species were discovered in 1953, 1957, and 1966. 
 
 
 
Classification of Brucellae 
 
Brucellae belong to the family Brucellaceae, genus Brucella. For a 
long time they were classified into numerous species, depending on 
primarily affected host. Among them are brucellae of goats and sheep – 
Brucella melitensis; brucellae of cattle – Brucella abortus; brucellae of 
pigs – Brucella suis; brucellae of forest rats – Brucella neotomae; the 
causative agents of abortion in sheep – Brucella ovis; and B. canis of dogs. 
However, DNA-DNA hybridization studies elaborated in 1980s 
suggested that Brucella is a monospecific genus. These data were 
confirmed in further studies, and the latest edition of Bergey's Manual of 
Determinative Bacteriology consolidated all brucellae of medical 
importance within the only species Brucella melitensis. 
Nevertheless, isolates from human infection are still classified into 
groups using the former species names. This correlates with the animal 
species the strains of brucelllae are predominantly isolated from (cattle, 
goats, pigs, and dogs.) These groups are differentiated on the basis of their 
special phenotypical traits. 
Human pathology is predominantly associated with B. melitensis, 
B. abortus, and B. suis. 
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Structure and Properties of Brucellae 
 
Morphology 
Isolates of Brucellae form small gram-negative ovoid-shaped 
coccobacteria. They have no spores or capsules (in some strains of 
Brucella melitensis the capsule is present). 
Brucellae have unusual genome structure composed of two non-
identical circular closed chromosomes without plasmids. 
 
Cultivation 
When recovered from patients, brucellae propagate slowly, being 
cultured for 1-2 weeks. In laboratory subcultures the growth may appear in 
1-2 days. The optimal temperature for culture is 37°C, pH 6.8-7.2. 
Brucellae are cultured on special media, e.g. liver-extract agar and 
liver-extract broth. They produce small, convex, smooth colonies with a 
white or pearly hue. Brucella abortus prefers to grow in atmosphere of 5-
10% of carbon dioxide. Selective media containing certain dyes and 
antibiotics are used for isolating of bacteria. Blood agar culture renders 
nonhemolytic glistening colonies. 
All brucella actively propagate in the yolk sac of chicken embryos. 
 
Biochemical properties 
Brucellae are the aerobic bacteria. They produce catalase and oxidase. 
The bacteria display weak carbohydrate fermentation (sometimes 
metabolize glucose). 
Some strains hydrolyze urea and asparagin, reduce nitrates to nitrites, 
and metabolize proteins, peptones and amino acids with release of 
ammonia and hydrogen sulfide. The bacteria don’t liquefy gelatin. 
Also they produce enzymes lipase, phosphatase, and hyaluronidase. 
 
Antigenic structure 
Brucellae are defined to contain two lipopolysaccharide antigens, A 
and M. Brucella melitensis carries predominantly M fraction, whereas 
Brucella abortus group – A fraction. Superficial L antigen has been 
demonstrated; it resembles the capsular Vi antigen. 
 
Virulence factors 
Despite evident virulence of brucellae strains, their genome doesn’t 
harbor genetic pathogenicity islands. So the virulence factors of brucellae 
remain not well-determined. 
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Brucellae don’t produce soluble toxins.  
An endotoxin is released as a result of disintegration of the bacterial 
cell, but it poorly activates the innate immune response. It can’t be 
excluded that it maintains microbial survival inside phagocytes.  
In addition, low-molecular weight components of microbial body 
block phagosome-lysosome fusion.  
Microbial capsule protects brucellae from phagocytosis. 
Also the bacteria express invasive enzymes, e.g. hyaluronidase and 
lipase. 
Resistance 
Brucellae are characterized by marked resistance and viability. They 
survive for a long time at low temperatures (up to 4 months in ice). 
Bacteria live for about 4 months in urine and animal feces, from 3 to 4 
months in sheep’s wool and sheep’s cheese, for 1 month in dust, about 20 
days in meat, and for 7 days in milk.  
Nevertheless, brucellae are sensitive to high temperatures and 
disinfectants. At 60°C they are destroyed in 30 min, at 80-95° in 5 min, 
boiling kills them almost instantly. 
They are easily inactivated by all conventional disinfectants. 
 
 
Pathogenesis and Clinical Findings in Brucellosis 
 
Brucellosis is a zoonotic infection contracted by humans via direct or 
indirect contact with animals (sources of infection), which were infected 
(usually chronically) with Brucella.  
The disease usually affects veterinary and zootechnical personnel, 
herdsmen, livestock handlers, etc. 
Infection can be established via cutaneous (contact with infected 
tissues of animals), respiratory, or alimentary routes. Cheese made from 
unpasteurized goats’ milk is a particularly common vehicle. 
Symptoms of brucellosis are generally non-specific, and the onset of 
illness may be acute or insidious. As a result of the systemic nature of 
brucellosis, almost any organ of the body might be infected. 
The incubation period lasts about 1-6 weeks. 
The pathogens spread from the portal of entry via lymphatic vessels 
and regional lymph nodes to the bloodstream and then to parenchymatous 
organs. Due to the marked resistance to phagocytosis the bacteria 
disseminate throughout the body. They stay long within phagosomes 
without inactivation. The protracted clinical course of brucellosis 
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maintained by viable bacteria is generally regarded as chronic systemic 
infection (sepsis). 
Granulomatous nodules and abscesses emerge in lymphatic tissue, 
liver, spleen, and bone marrow. The lesions contain viable brucellae, 
located within the infected cells. The invaded pathogen stimulates the 
reactions of delayed (cell-mediated) hypersensitivity. Overproduction of 
cytotoxic molecules enhances tissue damage. 
Specific granulomas consist of mononuclear cells, epithelioid 
histiocytes and giant cells; active tissue inflammation results in focal 
necrosis with subsequent gradual fibrosis. 
Clinical manifestations of brucellosis are highly variable – from faint 
febrile ilness (“fever of unknown origin”) to evident respiratory infection 
and joint involvement. Various complications (e.g., osteomyelitis or 
meningitis) occasionally occur.  
Usually В. abortus causes mild disease without suppurative 
complications; В. suis infection tends to be chronic with suppurative 
lesions. В melitensis infection is more acute and severe. 
A long-lasting immunity both cellular and humoral is acquired 
following brucellosis, and the patient usually becomes resistant to recurrent 
infection. Cell-mediated reactions (T-lymphocyte activation and 
phagocytosis) play the major role in pathogen elimination. 
 
 
Laboratory Diagnosis of Brucellosis 
 
The specimens taken from patient’s blood and urine (for isolation of 
the pathogen), serum (for detection of antibodies), milk and dairy products 
(for detection of brucellae) are examined. Any suspected Brucella isolates 
determined in the clinical laboratory should be handled in a biological 
safety cabinet. 
PCR with primers specific to various brucella species is used for 
detection of pathogens directly in clinical specimens. 
Blood or tissues samples are inoculated for culture into liver-extract 
or ascitic-fluid broth, or trypticase-soy broth. At intervals of several days, 
subcultures are made on solid media of similar composition. All cultures 
are incubated in 10% CO2 and should be observed and subcultured for at 
least 3 weeks prior to negative conclusion.  
The brucellae are aerobic small gram-negative coccobacilli, which are 
nonhemolytic and oxidase-positive; they do not ferment lactose or glucose. 
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Most of strains are urease-positive. Bacteria matching the criteria are 
further tested for agglutination with specific anti-brucella serum. 
Suspected Brucella isolates should be sent to a reference laboratory 
for final identification. 
Brucella cultures may be isolated by the biological method. To aim 
this, guinea pigs or mice are injected with test materials. A month later the 
pure culture is isolated.  
Serological tests are the most practically relevant in laboratory 
diagnosis of brucellosis. They are performed from the 2
nd
 week after the 
disease onset.  
Huddleson reaction or tentative slide agglutination test is usually 
applied for primary examination of specific antibodies in brucellosis. 
Extended tube agglutionation test or Wright reaction validates the 
primary positive result of afflutination and confirms the diagnosis of 
brucellosis. Wright’s reaction is valued positive in a titer of specific 
antibodies 1:200 and more.  
Allergic skin test (or Burne brucellin test) is used to determine 
delayed hypersensitivity in brucellosis. Burne test is conducted with 
specific infectious allergen brucellin derived from brucella cells. The 
analysis becomes positive from the 2
nd
-3
rd
 week of the disease. 
 
 
 
Treatment and Prophylaxis of Brucellosis 
 
Because of their intracellular location, brucellae are not readily 
eradicated by antimicrobial agents. For best results, the treatment must be 
prolonged. Administration of aminoglycosides (e.g., gentamycin), 
fluoroquinolones, and tetracyclines accelerates the recovery. 
Chronic cases can be additionally treated with killed vaccine that 
activates antimicrobial immunity. 
For specific prophylaxis of brucellosis various live and inactivated 
vaccines were introduced into clinical practice. They can be administered 
to protect the contact persons as well as the personnel with occupational 
risk of brucellosis. However, vaccination is not able to confer the long 
lasting high-grade immunity. 
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CAUSATIVE AGENT OF TULAREMIA 
 
 
The History of Discovery 
 
Tularemia causative agent was first described by G. McCoy and 
Ch. Chapin in Californian town Tulare in 1912. Later it was studied 
thoroughly by E. Francis; thereby the agent was finally named as 
Francisella tularensis. 
 
Classification 
 
Causative agent of tularemia, Francisella tularensis, is placed into the 
separate family Francisellaceae apart from other similar bacteria. 
Other species or biogroups of Francisella genus may cause human 
infection, but F. tularensis appeared to be the most virulent agent within 
the genus. 
 
 
Structure and Properties of Francisella tularensis 
 
Morphology 
Francisella tularensis is viewed as small (0.2-0.7 μm) pleomorphic 
gram-negative coccobacterium. It is a fastidious non-motile, non-spore-
forming microorganism. 
Within infected tissues F. tularensis produces capsule. 
 
Cultivation 
The bacteria don’t grow in ordinary media. They are cultured on 
special media with growth factors – glucose cysteine blood agar, glucose 
blood agar, chocolate agar or charcoal yeast extract agar at 37°C yielding 
small, smooth, gray-white, flat, and shiny colonies after 48 h of incubation. 
Increased concentrations of CO2 stimulate bacterial propagation.  
Biological method is also used for microbial cultivation in laboratory 
animals (mice or guinea pigs). 
 
 
Biochemical properties 
Francisellas are strict aerobes, being catalase-positive, but oxidase-
negative. 
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The bacteria ferment glucose and maltose yielding acid end products. 
They metabolize asparagin and produce hydrogen sulfide after protein 
fermenation.  
There are two major biogroups or subspecies of F. tularensis – type A 
and type B.  
Type A occurs only in North America, is lethal for rabbits, produces 
severe illness in humans, ferments glycerol, and contains citrulline 
ureidase enzyme.  
Type В lacks these biochemical features, is not lethal for rabbits, 
produces milder disease in humans. Bacteria of type B are often isolated 
from rodents or from water in Europe, Asia, and North America. 
Antigenic structure 
F. tularensis contains somatic lipopolysaccharide O-antigen and 
superficial capsule-like Vi antigen. 
 
Virulence factors 
Virulence factors of F. tularensis are not completely studied. 
These bacteria are not found to produce exotoxins.  
An endotoxin is released after the degradation of microbial cells. As 
in brucellae, it poorly stimulates innate immune response. 
Other bacterial virulent factors (e.g., capsule) inhibit phagocytosis and 
prevent phagosome-lysosome fusion. 
Cell wall allergens stimulate the reactions of delayed hypersensitivity. 
Some strains may produce hemolysins. 
Francisellas are the extremely invasive bacteria, and they can infect 
humans even through intact skin. 
 
Resistance 
Francisellas are markedly resistant in the environment. They stay 
viable in water at 4
o
C for about 4 months, at 20
o
C – more than 2 month. 
Nevertheless, francisellas are sensitive to heating at 60-80
o
C, and 
commonly used disinfectants readily inactivate them. 
 
 
Pathogenesis and Clinical Findings in Tularemia 
 
The natural reservoirs and sources of infection of F. tularensis include 
numerous rodent species (rats, muskrats, mice, etc.), hares, rabbits and 
other animals. Humans can become infected after direct animal contact or 
via insect bites (ticks, biting flies, mosquitoes, etc.) 
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F. tularensis is highly invasive: extremely low infectious dose of 50 
microbial cells penetrated through the skin or mucous membranes or even 
about 10 cells by inhalation is enough to result in infection. In most of 
cases the bacteria enter the body through skin lesions. 
Incubation period is short ranging 2-6 days. 
The clinical manifestations of tularemia in human hosts depend on the 
site of entry of the bacteria (cutaneous inoculation, inhalation, or 
ingestion). 
The infection has acute onset with chills and fever. Primary ulcerative 
lesion appears on the skin in the site of entry. The bacteria enter the 
phagocytes and actively propagate. They show remarkable resistance to 
microbicidal activities of phagocytes 
F. tularensis replicate intracellularly causing cell destruction. 
Virulence factors of bacteria stimulate apoptosis of infected cells. 
F. tularensis spread to regional lymph nodes that enlarge and become 
painful and necrotic (primary buboes). Further the bacteria migrate to 
organs and tissues. Degradation of bacterial cells leads to endotoxin 
release. Microbial accumulations in affected tissues stimulate 
granulomatous inflammation followed by cell-mediated reactions of 
delayed hypersensitivity.  
Inhalation of infective aerosol results in severe pneumonitis. 
Clinical forms of tularemia are classified as ulceroglandular 
(primarily affecting skin and lymph nodes), glandular, conjunctival and 
oculoglandular, oropharyngeal, pneumonic, or systemic typhoidal. 
Various mixed clinical variations are observed. 
Severe pneumonic form of tularemia is manifested like atypical 
pneumonia with fever, cough with low sputum, chest pain, and ulcerative 
damage of lymph nodes.  
Pneumonic and systemic diseases demonstrate high lethality of 30-
60%; the fatality of more common local infections is about 3%.  
Due to the high environmental resistance, enhanced invasiveness, 
minimal infectious dose, and severe course of the disease F. tularensis 
bacteria are accounted as the potential agents of bioterrorist attacks. 
They are present in Tier 1 of US Biological Select Agents list with the 
highest rank of public threat. 
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Laboratory Diagnosis of Tularemia 
 
Tularemia may be diagnosed by isolation of the bacteria from various 
specimens: blood, pleural fluid, sputum, lymph nodes, wounds, or gastric 
aspirates that depend on the clinical form of infection. 
In order to avoid laboratory-acquired infection, francisella should be 
cultured only in biological safety cabinet of BSL-2 level maintaining all 
personal safety measures. 
Laboratory procedures that may result in aerosol production require 
BSL-3 safety conditions 
Microbial antigens in specimens are detected by immunofluorescence 
assay and ELISA.  
Nucleic acids of bacteria are determined by PCR. 
For cultivation cysteine blood agar or glucose blood agar are used. 
More effective is biobacteriological method, where primary animal 
infection is followed by further inoculation of animal specimen into 
nutrient media for culture. 
Suspected F. tularensis isolates should be delivered to a reference 
laboratory for confirmatory identification; it is related with the evident 
danger of laboratory-acquired infection. 
In standard laboratory practice the diagnosis of tularemia relies 
largely upon the serological studies of patient’s serum for presence of 
specific antibodies.  
Agglutination reaction is regarded as positive in a titer of 1:100-1:200 
and more. Paired serum samples demonstrate the elevation of Ab titers. 
However, cross-reactions of antibodies with Brucella spp., Yersinia spp., 
etc. have been documented. 
Allergic skin test with infectious allergen tularin is obviously helpful 
in diagnosis of infection. It evaluates specific cell-mediated response to 
F. tularensis based on delayed hypersensitivity. 
 
Treatment and Prophylaxis of Tularemia 
 
Chemotherapy with aminoglycosides (gentamicin or amikacin) or 
fluoroquinolones produces rapid clinical improvement. Tetracyclines 
(doxycycline) are almost equally effective. 
For specific prophylaxis the individuals of high risk (e.g., laboratory 
personnel) are immunized with live attenuated vaccine of F. tularensis 
created by N. Gaisky and B. Elbert. Protection with live vaccine maintains 
the specific immunity for several years. 
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Chapter 10 
CAUSATIVE AGENTS OF LEPTOSPIROSIS AND BORRELIOSES 
 
 
PATHOGENIC LEPTOSPIRAE 
 
 
The History of Discovery 
 
First observations of icteric leptospirosis with renal failure were 
registrated in 1886 by A. Weil in Germany, though the similar disorders 
were described still in ancient ages (e.g., the disease of rice harvesters in 
China or autumn fever in Japan). 
In 1907 A. Simpson discovered the presence of hook-ended 
spirochetes in the kidney specimen of patient, who supposed to die from 
yellow fever. He called them Spirochaeta interrogans, as they resembled 
question mark. 
Only in 1915 these agents were re-discovered by R. Inada and R. Ido 
in Japan, who isolated bacteria from the blood of Japanese miners with 
infectious jaundice, and almost at the same time by two independent 
groups of German researchers (P. Uhlenhuth and W. Fromme; E. Hubener 
and H. Reiter) after examination of German soldiers in northeast France 
that suffered from so-called “French disease” during World War I. 
 
Modern Classification of Leptospirae 
 
Leptospirae pertain to the order Spirochaetales, family 
Leptospiraceae, and genus Leptospira.  
Recently classification of leptospirae has been greatly changed within 
the borders of the same genus. Before early 90
th
 only two leptospira 
species have been distinguished, L. interrogans that contained all 
pathogenic serovars, and L. biflexa, encompassed all environmental 
saprophytic strains. Further division was grounded on microbial serologic 
properties. L. interrogans comprised more than 200 serovars, while 
L. biflexa included about 60 serovars. Bacterial serovars were consolidated 
into various serogroups. 
With the progress of bacterial genetic typing, genotypic classification 
of leptospirae substituted the serological division, and numerous 
genomospecies accumulated the serovars of initial species, L. interrogans 
and L. biflexa.  
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More than 20 genetic species of leptospirae are distinguished now. In 
this classification pathogenic and saprophytic serovars can be placed into 
the same genomospecies. Moreover, former species L. interrogans sensu 
lato and L. biflexa sensu lato don’t coincide with the same name 
genomospecies. Therefore, previous phenotypic classification lacked 
correspondence with modern genetic typing of leptospirae, albeit 
serological division remains convenient for practical use and retains its 
value for seroepidemiological studies. 
Main genomospecies and serogroups of leptospirae are present in 
Table 6. 
 
Table 6 
Various serogroups of leptospirae, associated with certain genomospecies 
 
Serogroups of leptospirae Genomospecies 
Icterohaemorrhagiae, Grippotyphosa, Mini, 
Pomona, Canicola, Australis, Pyrogenes, 
Autumnalis, and others 
L. interrogans 
Semaranga, Andamana L. biflexa 
Icterohaemorrhagiae, Pyrogenes, Javanica, 
Mini, Tarassovi, and others 
L. weilii 
Icterohaemorrhagiae, Lyme, Tarassovi, 
Javanica, Canicola, Panama, and others 
L. inadai 
Pyrogenes, Autumnalis, Australis, Javanica, 
Tarassovi, Mini, Bataviae, and others 
L  borgpetersenii 
Pyrogenes, Australis, Louisiana, Bataviae, 
Tarassovi, Autumnalis, Pomona, Panama, and 
others  
L. noguchii 
Icterohaemorrhagiae, Grippotyphosa, 
Australis, Autumnalis, Pomona, Canicola, and 
others 
L. kirschneri 
Grippotyphosa, Pyrogenes, Tarassovi, 
Bataviae, Mini, Autumnalis, Pomona, 
Javanica, and others 
L. santarosai 
Mini, Javanica, and others L. alexanderi 
Mini, Javanica, Semaranga, and others  L. meyeri 
Codice L. wolbachii 
Hurstbridge L. fainei 
Turneria L. parva  
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Structure and properties of leptospirae 
 
Morphology 
Leptospirae have very thin cell structure, usually 0.1 by 20 μm in size. 
These spiral bacteria make multiple turns around the axial filaments, thus 
forming small primary coils. Being supercoiled, leptospirae produce 
secondary twists with distinctive hooks at their ends, shaping interrogative 
mark, or letters C and S under microscopy. The organisms bear two axial 
filaments (periplasmic flagella) attached at opposite ends to basal bodies 
within periplasmic space. Flagella ensure striking motility of microbial 
cells. 
The bacterial genome was shown to be composed of two parts: large 
4,400 kb chromosome and small 350 kb chromosome. No other plasmids 
were described. 
Leptospirae don’t contain spores and capsules. Microbial body is 
encased within the outer membrane. Bacterial lipopolysaccharide is similar 
with other spirochetes, but shows lower endotoxin activity. 
Leptospirae poorly accept aniline dyes due to their compact structure 
and large lipid contents. These bacteria are gram-negative; also they stain 
pinkish with Romanowsky-Giemsa method. The best technique of bacterial 
visualization is dark field microscopy. Silver impregnation or Burri stain 
with Indian ink background may be applied as well. 
 
Cultivation 
Leptospirae are cumbersome for culture. Optimal growth temperature 
for cultivation is 28-30°C. Bacteria propagate slowly in liquid and 
semisolid media, e.g. Vervoort-Wolff, Fletcher, Noguchi and others. The 
media contain serum or albumin, vitamins, long-chain fatty acids, and 
ammonium salts. Several synthetic protein-free media were elaborated, e.g. 
complex oleic acid-albumin medium is used. Primary growth appears in 
several weeks of cultivation, subcultures grow within 1-2 weeks. 
 
Biochemical properties 
Leptospirae are obligate aerobic bacteria. They produce catalase and 
oxidase. 
As many other spirochetes, leptospirae have slow metabolism, which 
is not completely elucidated. Bacteria use exclusively long-chain fatty 
acids as the only source of carbon. They can’t utilize peptides and 
carbohydrates as energy supplies. Ammonium salts are used as the source 
of nitrogen. 
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Antigenic structure 
Antigenic composition of leptospirae is complex and renders great 
cross-reactivity between various serogroups and serovars. 
The outer membrane of bacteria contains LPS antigen and various 
lipoproteins, i.e. outer membrane proteins (OMPs) that show antigenic 
activity.  
Microbial LPS confers serovar specificity. 
 
Virulence factors 
Leptospirae carry various adhesins promoting microbial attachment to 
host cells and tissues, e.g. renal epithelial cells. 
Bacteria possess low but distinct endotoxic activity of LPS. Microbial 
LPS also stimulates platelet aggregation during infection. 
Leptospirae are capable of producing several hemolysins, some of 
them show sphingomyelinase or phospholypase activity. Particular strains 
elaborate limited number of cytotoxins of protein or glycolipoprotein 
nature. 
Bacteria express some antiphagocytic substances, and fibronectin-
binding protein that hinders microbial opsonization. 
 
Resistance 
Leptospirae show resistance to low temperatures, alkaline pH and stay 
viable in water reservoirs for many months. They are very sensitive to 
drying and acids. Heating at 56°C for 30 minutes inevitably kills bacteria. 
Leptospirae are easily lysed in bile-containing media. They are sensitive to 
standard disinfectants. 
 
 
Pathogenesis and Clinical Findings in Leptospirosis 
 
Leptospirosis is a typical zoonotic disease. It is regarded as one of the 
most widespread zoonosis.  
The disease is transmitted predominantly via direct contact of 
susceptible host with the urine of infected animal. The incidence of disease 
is greatly increased in tropical countries with moist climate with maximal 
incidence in summer or rainy seasons. 
The main sources of infection are rodents (e.g., rats), which may 
contract infection to domestic animals (e.g., cattle), dogs, and other 
mammals. They can appear to be additional infection source for humans.  
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Leptospirosis is an occupational disease. The increased risk of illness 
is reported in farmers, fish workers, sewer workers, veterinarians, miners, 
soldiers and others. 
The causative agent usually enters the body through skin lesions or 
cuts. Also it can penetrate conjunctiva. Long exposure to infected water 
may provide infection through intact skin. Waterborne and foodborne 
transmission is possible via contaminated water and foodstuffs. Likewise, 
inhalation of water aerosol may produce infection. 
Incubation period lasts for about 1-2 weeks. 
Great number of leptospirosis cases is subclinical or mild. 
Nevertheless, about 5-10% of patients develop life-threatening icteric 
leptospirosis with sudden onset, fever, severe headache, transient rashes, 
myalgia, and abdominal pain. The fever may be biphasic with relapse in 3-
4 days. Bacteremia emerges in the first days of illness. 
The disease is characterized by profound injury and dysfunction of 
most inner organs. It ensues from generalized infectious vasculitis caused 
by leptospirae that is followed by endothelial damage and tissue 
inflammation. 
Manifested infection results in infectious hepatitis with jaundice and 
high serum bilirubin level that maintains for a long time. Up to 40% of 
affected persons produce acute renal failure due to kidney tubular damage. 
Necrotizing pancreatitis, lung and cardiac involvement followed by 
pneumonia and myocarditis are also characteristic for disease. Aseptic 
meningitis appears in quarter of patients.  
If not terminated by efficient treatment, the disease comes into second 
immune phase. It is followed by bacterial disappearance from the 
bloodstream with the rise of specific IgM antibodies. Autoimmune 
mechanisms contribute to disease progression. Various autoantibodies, 
including anticardiolipin and antineutrophil cytoplasmic antibodies appear 
in the disease course. Accumulating immune complexes promote 
complement activation and cell-mediated cytolysis that enhances tissue 
damage. 
Disease lethality in case of icteric leptospirosis varies within 5-15%. 
High levels of specific antibodies ultimately cause bacterial 
elimination that lead to patient recovery. Nevertheless, shedding of viable 
bacteria with urine is possible long after clinical convalescence. 
The disease confers long lasting stable immunity, which is largely 
maintained by specific antibodies. In most cases the protection is serovar-
specific. 
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Laboratory Diagnosis of Leptospirosis 
 
Specimens are collected from patient’s blood, urine, tissue aspirates, 
or cerebrospinal fluid, which are used for microscopy and culture. Serum is 
taken for serological tests. 
Dark field microscopy can reveal about 10
4
 leptospirae/ml. Sample 
centrifugation can increase the sensitivity of test. Immunofluorescence 
technique or light microscopy with Giemsa stain are also used to visualize 
leptospirae in blood or urine. Microscopy of blood can be positive only at 
the first few days of the disease in bacteremia stage. 
Serologic determination of leptospiral antigens in clinical specimens 
by ELISA provides higher sensitivity and accuracy comparing with 
microscopic methods.  
Bacterial culture is difficult in routine practice. Patient’s blood should 
be taken only within first days of the disease in bacteremia stage. Urine is 
tested from the second week of the disease onset. 
Samples are inoculated into special nutrient media. Cultures are tested 
weekly by dark field microscopy for up to 13 weeks. Identification of 
bacteria is improved by serological methods or molecular tests (PCR). 
Faster detection of leptospiral growth is possible by radiometric methods. 
To accelerate microbial isolation intraperitoneal inoculation of 
hamsters or guinea pigs with patient’s material is elaborated. Leptospirae 
can be detected in peritoneal cavity of infected animals at the end of the 
first week after inoculation. 
Serological tests prevail in laboratory diagnosis of leptospirosis. 
Various methods are applied to clinical practice.  
In case of microscopic agglutination test (MAT) patient’s serum 
containing specific antibodies is incubated with antigenic mixture of 
various live leptospiral serovars. After incubation the reaction is evaluated 
mainly by dark field microscopy. The titer or end point of the reaction is 
the highest dilution of serum, where 50% agglutination of leptospirae 
occurs. Antibody titers of 1/200-1/400 are regarded as the positive result. 
Acute infection elicits much more high titers of specific antibodies (even 
greater than 1/25,000). 
Complement fixation test, indirect hemagglutination and ELISA are 
also used for serological diagnosis. 
Molecular methods, including DNA and RNA hybridization and PCR 
show highest sensitivity but can’t determine the serovar of isolated 
bacteria. 
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Specific Prophylaxis and Treatment of Leptospirosis 
 
Early vaccines for specific prophylaxis of leptospirosis contained the 
mixture of inactivated leptospirae cultured in serum media. After injection 
they provoked various side effects. Modern vaccines are obtained from 
serum-free media and include a number of the most clinically significant 
serovars (L. icterohaemorrhagiae, L. canicola, L. grippotyphosa, and 
others). These biological products can be used for vaccination of domestic 
animals as well as for protection of humans from groups of risk. 
Antibiotic treatment of the disease should be started as soon as 
possible. Beta-lactams (amoxycillin, cephalosporins) and doxycycline are 
regarded as the most effective drugs for leptospirosis treatment. Patients 
with acute renal failure require urgent hemodialysis. 
 
 
 
PATHOGENIC BORRELIA – CAUSATIVE AGENTS OF 
RELAPSING FEVERS AND LYME DISEASE 
 
 
The History of Discovery 
 
Borrelia recurrentis, a causative agent of human epidemic relapsing 
fever, was discovered by O. Obermeier in 1868. The causative agents of 
similar zoonotic diseases, i.e. endemic relapsing fevers, were discovered 
later (e.g., B. duttoni, B. persica, B. caucasica and others). 
And in 1982 W. Burgdorfer isolated one more serious borrelia 
pathogen that caused systemic tick-borne borreliosis in animals and 
humans. This agent is known now as B. burgdorferi. The disease was first 
described in Lyme town, USA in 1977, and thereby was entitled as Lyme 
disease. 
 
 
Classification of Borrelia 
 
All pathogenic borrelia pertain to the order Spirochaetales, family 
Spirochaetaceae, and genus Borrelia. It was already mentioned that 
Borrelia recurrentis causes epidemic relapsing fever, while B. duttoni, 
B. persica, B. caucasica, B. hispanica and others are the causative agents 
of tick-born endemic relapsing fevers. 
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Another representative of Borrelia genus, B. burgdorferi, was still 
recently regarded as homogenous microbial species. However, molecular 
genotyping of numerous B. burgdorferi isolates revealed that these bacteria 
are enough divergent and pertain to closely related but distinct species. It 
has become evident that former B. burgdorferi microbial cluster, termed 
now as B. burgdorferi sensu lato, is referred to all B. burgdorferi isolates 
that pertain to various novel borrelial species. 
Today more than 15 definite species are distinguished within 
B. burgdorferi sensu lato genogroup. Among them the members of 
3 species, B. burgdorferi sensu stricto, B. garinii, and B. afzelii were 
proven to cause Lyme borrelliosis in humans. 
 
Structure and Common Properties of Borreliae 
 
Morphology 
Borreliae are thin long spiral-shaped gram-negative bacteria with 
pointed ends. Their size varies in the range 0.2-0.4 μm in width and 10-30 
μm in length. Bacterial cell forms large, obtuse-angled, irregular coils of 
total number from 3 to 10. Cytoplasmatic cylinder of microbial body is 
covered by outer membrane similar with other spirochetes. Bacterial 
endoflagella (7-11 for B. burgdorferi) are located within periplasmic space 
being attached to the opposite ends of microbial cell. Armed with 
endoflagella, borreliae exhibit striking motility. 
Sequenced genome of B. burgdorferi is composed of 910 kb linear 
chromosome and various circular and linear plasmids. 
Borreliae easily accept aniline dyes due to high nucleoprotein content 
and stain blue-violet with Romanowsky-Giemsa stain. Also spirochetes 
can be detected by dark field or fluorescent microscopy. 
 
Cultivation 
B. recurrentis grow under anaerobic conditions in liquid media 
enriched with ascitic fluid, blood, serum, or pieces of tissues and organs 
but the bacteria alter their virulence during culturing. They easily 
propagate, when inoculated onto the chorioallantoic membrane of chicken 
embryo. 
B. burgdorferi sensu lato is cultured in commercially available 
complex Barbour-Stoenner-Kelly (or BSK) medium supplemented with 
amino acids, vitamins, yeast extract and rifampicin, phosphomycin, and 
amphotericin В antibiotics to inhibit concomitant flora. The primary 
growth may be obtained at 1-2 week of incubation. 
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Biochemical properties 
Borreliae are fastidious microorganisms that need multiple growth 
factors. They are determined to be non-fermentative bacteria. Their 
metabolism is slow and needs further elucidation. 
 
Antigenic structure 
B. burgdorferi contains various antigens of lipid, lipoprotein, and 
carbohydrate nature. Most important are the outer surface proteins OspA-
OspG, heat shock proteins (Hsp) and flagellin from bacterial endoflagella.  
OspC lipoprotein shows remarkable antigenic variability. 
Antigens of B. recurrentis are similar with above mentioned but they 
are not completely defined yet. These bacteria considerably change their 
antigenic composition under permanent pressure of host immune system 
during infection course. 
 
Virulence factors 
Bacterial lipopolysaccharides and lipoproteins mediate endotoxin 
activity of borreliae. Multiple adhesins promote microbial attachment to 
the host cells. Microbial heat shock proteins activate massive 
proinflammatory cytokine release by host immune cells that is followed by 
tissue damage. 
 
Resistance 
Bacteria demonstrate relatively low resistance, but they can withstand 
deep freezing for 4-5 days. Also they stay viable for several days in liquid 
media at room temperature. Heating at 45°C kills them in 30 minutes. 
Borreliae are easily inactivated by ordinary disinfectants. 
 
 
Pathogenesis and Clinical Findings in Epidemic and Endemic 
Relapsing Fevers 
 
Epidemic relapsing fever is an acute anthroponotic vector-borne 
disease transmitted by louse Pediculus humanus.  
The human is the only source of infection. The louse becomes 
infectious sucking the patient's blood. After 5-12 days of microbial 
propagation within louse body it starts to transfer disease to susceptible 
persons. Lice contain the pathogen during the whole life cycle but they are 
lack of transovarial transmission of borreliae. 
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Humans acquire infection scratching the site of louse bite, thus 
crushing the louse and rubbing the parasite’s hemolymph with borreliae 
into injured skin. 
Incubation period lasts 3 to 10 days. After primary inoculation 
bacteria propagate within phagocytes, endothelial cells and 
parenchymatous organs, e.g. spleen, liver and kidneys. 
Multiplied borreliae come into the bloodstream. This is followed by 
microbial lysis due to complement activation and cytotoxic activity of 
immune cells. Microbial destruction leads to endotoxin release that 
provokes sudden disease onset with high fever, chills, and headache.  
Toxic action of microbial substances damages the cells of blood 
vessels and most of inner organs thereby producing spleen and liver 
necroses, kidney hemorrhagic lesions, platelet aggregation, etc. 
The severity of the illness gradually decreases following borrelia 
elimination from the bloodstream. The remained microbials hide within 
host cells and continue propagation. Subsequent relapse of the disease 
occurs in 5-7 days resulting from the next emergence of borreliae in the 
bloodstream. 
Latest generations of bacteria alter their antigenicity under the 
selective pressure of immune response thereby evading host defense. They 
provoke 3-5 sequential attacks of the disease. Nevertheless, the rise of 
specific antibodies and phagocytic activity eventually cause bacterial 
elimination. Every next relapse of fever is milder, and the interval between 
attacks increases. The absence of fever within 25 days confirms patient’s 
recovery. 
Immunity in epidemic relapsing fever is largely humoral and not very 
stable. 
Endemic relapsing fever is zoonotic disease, caused by numerous 
endemic borrelia species, e.g. B. duttoni, B. persica, B. hispanica, 
B. caucasica and others. It is similar with human relapsing fever but not as 
sharp as the human illness. The disease has seasonal prevalence with the 
highest incidence in spring and summer. 
Rodents are the predominant sources of infection. The main vectors 
for disease transmission are the ticks of genus Ornithodorus. Transovarial 
transmission of borreliae in ticks is common. 
Humans are infected via tick bites or by rubbing of crushed parasite. 
The incubation period of disorder is about 5-10 days. The specific papule 
or primary affect appears at the bite site. 
Pathogenesis and clinical findings in endemic disease resemble 
epidemic relapsing fever. 
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The immunity against tick-borne fever is widespread in endemic 
regions. Thus, the newcomers devoid of specific acquired immunity are the 
most affected persons. 
 
 
Laboratory Diagnosis of Relapsing Fevers 
 
Patient’s blood is collected during the febrile period of disease. 
Microscopy of thick blood smears is used to detect borreliae in the 
drop of patient’s blood. Specimens are stained by Romanowsky-Giemsa or 
examined by dark field microscopy. 
Various serological tests are applied to determine specific anti-
borrelial antibodies especially in the period of apyrexia. Complement 
fixation test or reactions of specific borrelia immobilization by antibodies 
may be employed. 
PCR is elaborated as rapid method for microbial DNA detection. 
To discriminate endemic tick-born relapsing fever from human 
epidemic disease the biological method of experimental animal infection 
is used. Mice, rats or guinea pigs are inoculated with infected blood of sick 
person. In case of endemic fever the animals develop the disease after short 
incubation period, and spirochetes can be readily detected in blood of 
infected animal by microscopy. 
 
Treatment and Prophylaxis of Relapsing Fevers 
 
Antibiotic treatment with drugs of various groups (e.g., penicillins, 
tetracyclines and macrolides) is effective in relapsing fevers. 
The measures of non-specific protection are prevalent in disease 
prophylaxis, specific vaccines are not available. 
 
Pathogenesis and Clinical Findings in Lyme Disease 
 
Lyme disease is a polyorganic and multistage zoonotic infection. The 
disease is transmitted by ticks of definite species from I. ricinus complex. 
I. scapularis and I. pacificus predominantly spread the disease in Northern 
America, while I. ricinus and I. persulcatus are the predominant vectors in 
Europe and Asia. 
The main sources of infection are rodents, birds, wild and domestic 
animals (e.g., deer, cattle, sheep, dogs and many others.) 
Usually humans are infected with В. burgdorferi via tick bites. 
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Clinical picture of Lyme disease develops in several stages, the 
pathogen affects a variety of tissues and organs, including skin, joints, 
heart, and nervous system. 
Early local infection flares up by primary erythema migrans, an 
annular skin rash that begins days to weeks after a tick bite. 
Hematogenous dissemination of spirochetes during the second stage 
(known as early dissiminated infection) over the next days or weeks 
results in multiple skin lesions (secondary erythema migrans), as well as 
meningitis, radiculoneuritis, atrio-ventricular block, myocarditis, and 
oligoarticular arthritis. Borreliae interact with endothelial cells, synovial 
tissue, glial cells of CNS, promoting systemic inflammation. 
Persistent infection at third stage (late Lyme borreliosis) occurs 
months to years after the initial exposure and can be associated with 
acrodermatitis chronica atrophicans, encephalomyelitis with 
encephalopathy, and persistent arthritis. 
Now it is almost proven that various symptoms and complications of 
Lyme disease result from human infection by certain genospecies of 
borrelia. For instance, Lyme arthritis is associated with infection of 
В. burgdorferi sensu stricto; neuroborreliosis depends on B. garinii 
infection whereas acrodermatitis chronica atrophicans is related with 
B. afzelii. 
At the latest stages the disease progression is maintained by multiple 
autoimmune reactions evolved in the pathology course. 
When untreated, the disease can lead to deep disability of patient or 
even cause patient death. 
 
 
Laboratory Diagnosis of Lyme Disease 
 
Lyme borreliosis is largely a clinical diagnosis; laboratory testing is 
used to confirm clinical findings. 
Serological methods are most feasible for laboratory diagnosis of 
Lyme disease detecting specific antibodies against the causative agent. 
They include indirect immunofluorescence assays, enzyme-linked 
immunosorbent assays (ELISA), and immunoblotting assay. 
In USA two-step procedure is recommended for serological diagnosis 
of Lyme disease. The first step employs a sensitive serological test, such as 
ELISA. Specimens found to be negative are not tested further. All the 
specimens with positive or equivocal results are tested by immunoblotting. 
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In Europe and Asia, the elaboration of a uniform approach for the 
immunoserologic evaluation of the disease is complicated by the presence 
of bacteria from three genospecies of B. burgdorferi sensu lato genogroup 
and by significant antigenic variation within each genospecies. 
For culture isolation of B. burgdorferi patient blood, skin biopsy or 
cutaneous lavage from erythema migrans are used. Culturing is produced 
in BSK medium. Spirochetes are detected by dark field microscopy or by 
fluorescent microscopy wiih acridine orange stain. 
Molecular methods primarily imply PCR with specific primers. 
Patient’s blood, synovial or cerebrospinal fluids are tested. 
 
 
Treatment and Prophylaxis of Lyme Disease 
 
For treatment of Lyme borreliosis beta-lactam antibiotics (e.g., 
amoxycillin) as well as doxycycline or azalides (azythromycine) are 
successfully used. Timely administered antimicrobial treatment prevents 
the progression of the disease and ensures recovery. 
Amoxycillin and doxycycline are also recommended for post-
exposure chemoprophylaxis of Lyme borreliosis after accidental bite of 
infected tick. If administered within 3-5 days after the exposure, antibiotics 
completely prevent the disease onset. 
For specific prophylaxis various vaccines, including whole-cell 
vaccine, live attenuated vaccine and recombinant vaccine based on genetic 
engineered OspA and OspC proteins are being worked out. The efficacy of 
OspA vaccine is reported to be about 75-90%. 
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Chapter 11 
CAUSATIVE AGENTS OF RICKKETSIOSES AND Q FEVER 
 
 
 
PATHOGENIC RICKETTSIAE 
 
 
The History of Discovery 
 
First description of pathogenic rickettsiae was made in 1910 by 
American scientists H. Ricketts and R. Wilder, who revealed small oval-
shaped bacteria both in blood of patients with Mexican typhus and in lice, 
inhabiting patient’s body. Later in 1913, Czech microbiologist S. Prowazek 
discovered the similar agents in blood of patients with typhus fever. 
Finally, in 1916 Brazilian pathologist H. da Rocha-Lima, who has 
been working in close collaboration with S. Prowazek, thoroughly 
investigated the newly discovered bacteriae, revised all collected data and 
finally established these organisms as the causative agents of epidemic 
typhus. He termed them Rickettsia provazekii in honor of H. Ricketts and 
S. Prowazek, who both died, investigating this life-threatening disease. 
Further it was found that rickettsioses comprise a numerous group of 
arthropod-borne diseases. Today they are regarded as the emerging 
diseases because of 19 currently known rickettsioses more than 10 were 
discovered in last 20-25 years. 
 
 
Modern Classification of Rickettsiae 
 
Until quite recently the family Rickettsiaceae encompassed a great 
variety of pathogenic bacteria. Later many of them were organized into 
separate taxa, which became the members of new bacterial families and 
even classes. 
According to current classification the order Rickettsiales comprises 
two families with pathogenic bacterial representatives: Rickettsiaceae and 
Anaplasmataceae  
The family Rickettsiaceae encompasses the genus Rickettsia (with 
human and animal pathogenic species R. prowazekii, R. typhi, R. conorii, 
R. sibirica, R. akari and many others) and genus Orientia (species 
O. tsutsugamushi). 
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The family Anaplasmataceae includes the genera Ehrlichia, 
Anaplasma, Neorickettsia, and Wolbachia. 
Only the members of the first family are regarded now as the causative 
agents of rickettsioses. 
Former representatives of Rickettsiales order, namely bartonellae and 
coxiellae, are placed now into the same name new families, Bartonellaceae 
and Coxiellaceae. 
The main rickettsial pathogens and their diseases are listed in Table 7. 
 
Table 7 
Main rickettsioses and their causative agents 
 
Group 
 
Causative agent The disease Vector 
 
 
Typhus group 
 
R. provazekii Epidemic typhus and  
Brill-Zinsser disease 
Human body louse  
(Pediculus humanus) 
 
R. typhi Murine typhus  
or endemic typhus 
 
Several flea species, rarely lice, 
mites and ticks 
 
 
 
 
 
 
 
Spotted fever 
group 
 
(about 20 known 
species) 
 
 
 
 
 
 
 
 
 
 
 
 
 
R. rickettsii Rocky Mountain spotted 
fever (RMSF) 
 
Ticks of genera Dermacentor, 
Haemaphysalis and Ixodes  
R. conorii Mediterranean spotted 
fever (MSF) 
 
Ticks of genera Rhipicephalus 
and Haemaphysalis 
 
R. sibirica Siberian tick typhus Ticks of genera Dermacentor 
and Haemaphysalis 
 
R. africae African tick bite fever Ticks of genus Amblyomma  
 
R. australis Queensland tick typhus Ticks of genus Ixodes 
 
R. akari Rickettsialpox Mite Allodermanyssus 
sanguineus 
 
R. japonica Japanese fever Ticks of genera Dermacentor, 
Haemaphysalis and Ixodes 
 
R. honei Flinders Island spotted 
fever 
Ticks 
R. felis Californian flea 
rickettsioses 
Cat fleas 
Astrakhan fever 
rickettsia 
Astrakhan fever Ticks of genus Rhipicephalus 
Israeli tick typhus 
rickettsia 
Israeli spotted fever  Ticks of genus Rhipicephalus 
Scrub typhus 
group 
Orientia 
tsutsugamishi 
Scrub typhus  Mites of genus Trombicula 
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Structure and Properties of Rickettsiae 
 
Morphology 
Rickettsiae are pleomorphic gram-negative bacteria. Coccoid forms 
are about 0.5 μm in size. Rod-shaped rickettsiae also demonstrate 
substantial polymorphism; short organisms of 1 by 1.5 μm as well as long 
or curved thin rods 3-4 μm in size occur. The thread-like or filamentous 
forms are up to 40 μm in length. 
Rickettsiae are non-motile bacteria; they don’t contain spores and 
capsules. R. provazekii may produce capsule-like substance.  
These bacteria are visualized by Romanowsky-Giemsa stain, Gimenez 
stain (applies fuchsin and malachite green dye for counterstain) and by 
modified Ziehl-Neelsen stain (Zdrodovsky method). 
Rickettsial genome is composed of small single circular chromosome 
1,000-1,600 kb in size. 
 
Cultivation 
All rickettsiae are obilgate intracellular parasites. 
Typhus group (TG) rickettsiae are localized exclusively in the 
cytoplasm of affected cells, while spotted fever group (SFG) rickettsiae 
can invade the cell nuclei, as they possess intracellular motility due to 
cellular actin polymerization. 
For primary isolation various cell cultures both of tick and 
mammalian origin are used. Bacterial generation time is about 8-10 hours. 
Less fastidious is the cultivation of rickettsiae in yolk sacs of embryonated 
eggs. For animal inoculation guinea pigs, rats and mice are used. 
 
Biochemical properties 
Rickettsiae metabolism largely depends on cellular biochemical 
pathways, e.g., the bacteria can’t synthesize proteins. For energy gain they 
possess the enzymes ATP translocases that deliver ATP molecules directly 
from the infected cells. Also rickettsiae may acquire ATP by oxidative 
phosphorylation.  
Rickettsiae are capable of producing gram-negative cell wall that is 
composed of peptidoglycan with muramic and diaminopimelic acids. 
 
Antigenic structure 
As an example, R. provazekii contains specific superficial protein 
antigens – outer membrane proteins OmpA and OmpB, and cell wall heat 
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stable polysaccharide antigen, common for R. provazekii, R. typhi and 
certain strains of enterobacterial member, Proteus OХ-19. 
 
Virulence factors 
Rickettsiae contain polysaccharide heat stable endotoxin and heat 
labile protein toxic substance tightly associated with microbial body. The 
latter can be transformed into toxoid by formaldehyde treatment. 
In the course of infection the main deleterious effects of rickettsiae are 
related with their active propagation inside the infected cells, followed by 
cell destruction and severe inflammatory response.  
 
Resistance 
In normal conditions rickettsiae can survive only in the body of 
infected host, vector or microbial reservoir. They rapidly lose viability in 
the natural environment. Dried bacteria usually stay viable for about 5-6 
days. 
Treatment with ordinary disinfectants and as well as heating at 80
oС 
destroys rickettsiae within several minutes, heating at 100
oС cause 
immediate microbial death. 
 
 
Pathogenesis and Clinical Findings in Rickettsioses 
 
Rickettsial diseases of the same clinical group show certain similarity 
in pathogenesis and clinical features. All rickettsioses are characterized by 
high fever, skin rashes, and generalized vasculitis. 
Most severe disorder, epidemic typhus, is caused by R. provazekii and 
transmitted by body louse. 
Epidemic typhus is the anthroponotic disease, which follows social 
disasters (wars, starvation, socioeconomic disorganization with substantial 
lack of hygienic conditions, etc.) It is believed that epidemic typhus has 
caused even more deaths than all the wars in human history. 
Humans are the main sources of infection. The patients are contagious 
at fever period and within the week after. The persons, recovered from 
typhus, retain some viable bacteria for the whole life, thus maintaining the 
persistent infection. 
Feeding louse becomes infected and within 4-5 days can spread the 
disease. Nevertheless, lice are lack of transovarial transmission of 
rickettsiae. 
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Incubation period of epidemic typhus is about 2 weeks (6 to 24 days) 
after primary inoculation.  
Humans acquire infection rubbing louse excrements containing 
rickettsiae into injured skin after louse bite. 
Rickettsiae multiply primarily in the site of penetration. Then they 
reach regional lymph nodes and enter the bloodstream, where the bacteria 
invade endothelial cells. Rickettsiae propagate within cytoplasm of 
endotheliocytes thereby causing their damage and lysis. The progressing 
endovasculitis is manifested by high fever, generalized roseolous-petechial 
skin rashes, myalgias, pneumonias and severe disorders of central nervous 
system with headaches, brain sinus thromboses and mental abnormalities 
(status typhosus). Disseminated intravascular coagulation (DIC) may 
occur. 
When untreated, the disease fatality is about 10-30% at the peak of the 
infection. 
During convalescence the growing specific antibodies eliminate 
bacteria. The disease confers long-lasting immunity.  
However, rickettsiae can stay viable within phagocytes for many 
years, thus provoking the relapse of epidemic typhus (or Brill-Zinsser 
disease) in elderly persons. 
Endemic or murine typhus is similar but much milder zoonotic 
rickettsial disease, caused by R. typhi. Ubiquitous rats and mice are the 
main reservoirs and sources of this infection in nature. The disease is 
transmitted by various arthropod vectors (several flea species, lice, mites, 
and ticks). In fleas transovarial transmission is possible. 
Occasional disease acquisition by humans occurs via contamination of 
the injured skin, conjunctivae or respiratory tract by aerosols with 
infectious material, e.g. infected flea feces. Patients can develop fever, 
headaches, and rash. 
The infection confers a relatively stable immunity, cross-reactive with 
epidemic typhus agent. 
Scrub typhus is caused by Orientia tsutsugamishi, and transmitted by 
mites of genus Trombicula. It is found in Asia, including India and Japan, 
and in northern Australia. 
The disease is generally similar with epidemic typhus, but the patients 
reveal the eschar in the primary site of mite bite followed by progressing 
lymphadenopathy and lymphocytosis. 
Rickettsioses from the spotted fever group comprise a large number of 
fever diseases. Among them are Rocky Mountain spotted fever (RMSF), 
caused by R. rickettsii, Mediterranean spotted fever (MSF), produced by 
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R. conorii, Siberian tick typhus (by R. sibirica), rickettsialpox (by 
R. akari) and several newly described diseases such as Japanese fever (by 
R. japonica), Astrakhan fever (Astrakhan fever rickettsia), African tick 
bite fever (R. africae), Israeli spotted fever (Israeli tick typhus rickettsia) 
and some others. 
Spotted fevers are largely endemic diseases, transmitted by numerous 
arthropod species (ticks, mites, fleas, etc).  
Rodents are the main sources of infection. 
These disorders are generally characterized by fever, headache, rash, 
and eschar; the latter appears in the most of the diseases. 
The particular diseases (e.g., RMSF) can cause large local outbreaks 
with high lethality (>30-40%). 
 
 
Laboratory Diagnosis of Epidemic Typhus and Other Rickettsioses 
 
Specimens are collected from patient’s blood, tissue biopsies and 
autopsy material. Serum is taken for serological tests. 
Serological tests are most available for laboratory diagnosis of 
epidemic typhus and other rickettsioses. Immune fluorescent technique, 
complement fixation test and ELISA are commonly used. Diagnostic titer 
of antibodies in epidemic typhus determined by complement fixation test is 
1/160 and higher. 
By means of serological methods the differential diagnosis between 
primary epidemic typhus and relapsing Brill-Zinsser disease is possible. 
The reaction is made with two samples of titrated patient serum, where one 
sample was previously treated with potent reductive agent, e.g. cystein. 
Primary epidemic typhus is characterized by high levels of specific serum 
IgM that are noticeably susceptible to chemical reduction because of large 
cystin content. Fall of serum antibody titer verifies the presence of specific 
IgM and confirms the diagnosis of primary epidemic typhus whereas the 
lack of changes in antibody titers reveals the presence of IgG class 
antibodies testifying the diagnosis of epidemic typhus relapse, or Brill-
Zinsser disease. 
Direct detection of rickettsiae in biopsy specimens and arthropod 
material is possible by immunofluorescence or molecular tests, e.g. PCR. 
For culture the specimens are inoculated into yolk sacs of 
embryonated eggs, various cell lines of tick or mammalian origin, or into 
susceptible animals, e.g. guinea pigs, mice, etc. Isolation is made only in 
reference laboratories with appropriate biosafety level. 
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Inoculation of male guinea pigs with patient’s blood makes possible to 
discriminate endemic typhus from epidemic disease. Once infected with 
R. typhi, animals display specific periorchitis (the scrotal swelling) due to 
rickettsial propagation in the coats of guinea pig testis. 
 
 
Specific Prophylaxis and Treatment of Epidemic Typhus and 
Other Rickettsioses 
 
Single dose of 200 mg of doxycycline is effective for prevention of 
epidemic fever, thus any suspected case should be treated immediately. 
Fluoroquinolones are administered in spotted fevers. Treatment with 
chloramphenicol and macrolides is also possible. 
Nevertheless, rickettsiae have intrinsic resistance to β-lactams and 
aminoglycosides and low sensitivity to sulfonamides. 
Various live, formaldehyde-treated, and chemical vaccines are used 
for specific prophylaxis of epidemic typhus and other rickettsioses in the 
centres of disease outbreak or epidemic. 
 
 
 
COXIELLA BURNETII – CAUSATIVE AGENT OF Q FEVER 
 
 
The History of Discovery 
 
For a long time Q fever disease was regarded as rickettsiosis. First 
description of febrile disorder regularly occurred among abattoirs was 
made in 1937 by E.H. Derrick in Queensland, Australia. Derrick termed it 
Q fever (short for “query fever”). He was not successful in isolation of its 
putative causative agent and supposed it to be the unknown virus. Then 
M. Burnet and M. Freeman reproduced the disease in animals and detected 
the infectious agent in the vacuoles of infected cells. 
Similar work was produced by G. Davis and H.R. Cox in USA, who 
isolated rickettsia-like causative agent from patients with unusual fever or 
Nine Mile disease. 
Further collaborative studies proved these newly discovered diseases 
to be identical. The agent was finally termed as Coxiella burnetii – a novel 
genus within Rickettsiacea family. 
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Only latest phylogenetic investigations relied upon 16S rRNA typing 
demonstrated considerable divergence between coxiellae and rickettsiae. 
Today C. burnetii is placed into new separate family in the borders of 
another microbial class lying apart from rickettsiae. 
 
 
Classification of Q Fever Agent 
 
Q fever agent pertains to the order Legionellales, family Coxiellaciae, 
genus Coxiella, and species C. burnetii. 
 
 
Structure and Properties of Coxiellae 
 
Morphology 
Coxiellae, similar to rickettsiae, are 0.3 by 0.5-1 μm small size gram-
negative bacteria with obligate intracellular parasitism. They are poorly 
stained with Gram method but can be readily detected by Gimenez stain as 
well as by Zdrodovsky method. 
Two main morphological types of bacteria arise in the course of 
C. burnetii infection. 
“Small-cell” variant is an extracellular resistant bacterial form with 
slow metabolism that is capable of invading mammalian phagocytes.  
Further it turns into active intracellular “large-cell” form within host 
phagolysosomes. Both types can multiply by binary fission. In unfavorable 
conditions (e.g., within phagolysosome) large-cell variants can undergo 
further transformation into spore-like microbial bodies. The latter are the 
special bacterial forms resistant to external impacts. Finally, spore-like 
bodies transform back into small-cell microbials, which spread outside via 
exocytosis or after lysis of the infected cell. 
Bacterial genome carries nucleoid and a number of plasmids. 
 
Cultivation 
Coxiellae can’t grow in artificial nutrient media. They may be cultured 
in various cell lines (e.g., human embryo fibroblasts), embryonated eggs 
and in susceptible animals (guinea pigs, mice, etc). In cell lines the bacteria 
are detected in 5-7 days after primary inoculation. 
During persistent infection bacteria show slow propagation with 
doubling time of about 20 h. 
 
 205 
Biochemical properties 
Coxiellae are more biochemically active than rickettsiae; bacteria use 
their own methabolic pathways for ATP and protein synthesis. 
 
Antigenic structure 
Antigenic composition of coxiellae depends on phase variation of 
cellular lipopolysaccharide structure that results from the cascade of 
mutational events.  
Bacteria with LPS of phase I are isolated from infected animals or 
humans and regarded as highly infectious bacterial form. They are similar 
with S forms of other microorganisms. Phase II bacteria appear after 
multiple passages of coxiellae in cell cultures or embrionated eggs. They 
are related with rough LPS with altered structure. 
 
Virulence factors 
Toxic and immunosuppressive factors of C. burnetii are not well 
defined yet. The bacteria produce catalase and superoxide dismutase that 
inhibit respiratory burst in phagocytes. 
After degradation microbial cells release endotoxin. 
 
Resistance 
Coxiellae show high resistance in natural environment. The organisms 
stay viable about 1 year at 4
o
C. Heating at 70-90
o
C only partially 
inactivates bacteria, while 100
o
C heating kills them within 10 minutes. 
They resist desiccation, as well as low and high pH conditions.  
Disinfectants work slowly against coxiellae; the bacteria can withstand 
the action of formaldehyde and carbolic acid but show sensitivity to 
alcohols and ether. 
 
 
Pathogenesis and Clinical Findings in Q fever 
 
Q fever is a zoonotic ubiquitous disease that affects various mammals, 
birds and arthropods (ticks). Ticks maintain transovarial transmission of 
coxiellae. 
The main sources of infection for humans are domestic animals and 
pets (cattle, goats, sheep, cats, dogs, etc.) The infected animals excrete 
bacteria with urine and feces. The disease is regarded now as occupational 
hazard in staff working with domestic animals. 
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The disease is transmitted predominantly by airborne (aerosol) route 
after inhalation of dust from contaminated fomites. Fecal-oral transmission 
is seldom; it occurs mostly after drinking raw milk. Other variants of 
disease contraction are extremely rare. 
Incubation period of illness lasts for about 2-3 weeks.  
Coxiellae can persist only within phagocytes of the host.  
Phase I bacteria enter human phagocytes via membrane integrins. 
After internalization they appear within phagolysosomes that results in 
large vacuole formation. Bacteria are extremely resistant to acidic pH 4.7-
5.2 of phagolysosomes thereby maintaining their capability to multiply 
within phagocytes (incomplete phagocytosis).  
Coxiellae can modulate host immune response. They block reactive 
oxygen species of phagocytes producing catalase and superoxide 
dismutase. Bacteria depress T cell response and cause T helper 
lymphopenia partially via induction of suppressive cytokine synthesis by 
host immune cells. On the other hand, they provoke body inflammation 
stimulating the synthesis of TNF-α and γ-interferon. The cell-mediated 
reactions of delayed hypersensitivity are common. 
About 60% of disease cases are asymptomatic or may develop mild 
symptoms. Nevertheless, the rest of cases are severe, especially in 
immunocompromised patients. 
Acute Q fever is characterized by sudden onset with high fever, chills 
and headaches. Two main clinical syndromes (severe atypical pneumonia 
and granulomatous hepatitis) are usually common depending 
predominantly on aerosol or foodborne microbial transmission. 
Myocarditis and meningoencephalitis may rarely occur. 
Chronic Q fever is developed in 6 month after primary infection. It is 
a potentially fatal disease that is manifested by life-threatening 
endocarditis and inflammatory syndrome. The endocarditis appears to be 
highly resistant to antimicrobial therapy. 
Post-infectious immunity is rather stable, cellular reactions play 
predominant role in body protection. 
 
 
Laboratory Diagnosis of Q fever 
 
Specimens are collected from patient’s blood and tissue biopsies. 
Serum is used for serological examination. 
To determine bacteria in tissue specimens indirect 
immunofluorescence technique is applied. 
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Serological testing dominates in routine laboratory practice to confirm 
Q fever diagnosis.  
Indirect immunofluorescence and complement fixation test are most 
widely used. Antibodies against the microbial antigens of both I and II 
phase are determined. The rise of antibody IgG titer against phase II 
antigens is characteristic for acute Q fever, while antibodies against the 
antigens of phase I prevail in chronic disease. 
Microagglutination test, dot immunoblotting and ELISA are also 
available. 
Cultivation of coxiellae as well as animal experimental infection is 
possible only in specialized laboratories of biosafety level 3 due to high 
infectivity of Q fever causative agent. The material is inoculated into 
various cell lines, embryonated eggs and susceptible animals (guinea pigs 
or mice). 
Molecular methods, including PCR, are progressively introduced now 
into laboratory practice to diagnose Q fever. 
 
 
Prophylaxis and Treatment of Q fever 
 
C. burnetii is primarily resistant to beta-lactam and aminoglycoside 
antibiotics. Therefore, macrolides, doxycycline and fluoroquinolones are 
the drugs of choice for treatment of acute Q fever. 
It is much more difficult to cure chronic Q fever endocarditis. 
Treatment schemes that include combined therapy with doxycycline and 
fluoroquinolones at least for 1-3 years are introduced into clinical practice. 
For specific prophylaxis of Q fever various live, formaldehyde-
treated, and chemical vaccines were proposed. They are used to protect the 
persons with occupation of risk. Nevertheless, these vaccines develop 
various adverse effects and usually confer the immunity of short duration. 
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Chapter 12 
INFECTION-ASSOCIATED DISEASES OF ORAL CAVITY  
(For students of Dentistry faculty) 
 
 
Brief Outline of Teeth and Mouth Pathology of Infectious Origin 
 
Now it is generally ascertained that caries, pulpitis, or periodontal 
diseases are the ailments essentially related with infection. They are caused 
by microbial pathogens has been found in dental plaque. 
There are two alternative albeit complementary assumptions 
concerning the role of dental plaque microflora in pathogenesis of oral 
disorders.  
One of these hypotheses (the hypothesis of “specific dental plaque”) 
presumes the active participation of only limited (or “specific”) number of 
bacterial species in the emergence of teeth and mouse pathology.  
And on the contrary, certain considerations are made in favor of “non-
specific plaque hypothesis”, where most of oral diseases are generated by 
common non-specific deteriorating activities of total dental microbial mass 
despite their species origin.  
To date the first hypothesis has got more confirmations indicating the 
prevalence of definite bacterial representatives in carious or periodontal 
lesions. Nonetheless, violation of oral hygienic measures results in rapid 
growth of bulk microbial biomass thereby elevating the risk of emergence 
of dental pathology. All this emphasizes the deleterious role of any shift in 
balance of normal oral microbiota. 
But further progression of oral diseases inevitably leads to selection of 
the limited number of dental and periodontal pathogenic species 
responsible for basic disease course.  
All infections of oral cavity are divided according to affected 
anatomical region.  
Among them are dental (caries and pulpitis), periodontal (all forms of 
periodontitis) and gum diseases (gingivitis); infections of oral mucosa 
(stomatitis) and salivary glands; suppurative infections of neck and 
orofacial area (facial bones periostitis and osteomyelitis, sinusitis, 
lymphadenitis, soft tissue infections of neck and face). These primary 
infections may spread from initial sites resulting in odontogenic life-
threatening regional or systemic disorders and complications 
(retropharyngeal, mediastinal or intracranial abscesses or phlegmons; and 
in exceptional cases, sepsis and septic shock). 
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Besides mentioned above, in some cases various non-odontogenic 
diseases of neck and facial area can arise. They comprise a number of 
purulent infections – folliculitis, furuncles (boils) and carbuncles, 
lymphadenitis, erysipelas, secondary hematogenous osteomyelitis and 
others.  
And finally, orofacial area is commonly affected in patients suffering 
from the variety of specific infectious diseases (actinomycosis, 
tuberculosis, syphilis, diphtheria and many others). 
 
 
 
Pathogenesis of Oral Infections: Common Steps 
 
Infection-associated pathology of oral cavity commences from 
microbial adherence to dental and/or mucosal tissues resulting in dental 
plaque formation (microbial biofilm). Tight attachment of bacteria to host 
cells ensues from selective binding of multiple microbial adhesins to 
membrane cellular receptors of variable specificity. 
Numerous groups of bacterial adhesins comprise cell wall 
polysaccharides, teichoic acids, certain bacterial enzymes, e.g., 
glycosyltransferases, polysaccharide-binding proteins or lectins and many 
others. Their counterparts – receptors of cell membranes – belong to 
exuberant groups of surface molecules such as mucins, lectins, integrins, 
members of immunoglobulin superfamily receptors, prolin-containing 
proteins, various glycoproteins, antibodies together with the considerable 
amounts of membrane-absorbed bacterial components 
(glycosyltransferases, glucans, etc.) In substantial number of cases this 
firm binding demonstrates moderate or low specificity. For instance, 
bacterial lipoteichoic acids bind to all negatively charged membranes by 
means of calcium ions.  
Nevertheless, selective colonization of bacteria upon oral epithelium 
is promoted by specific interactions of microbial pathogens with host cells. 
In fact, Actinomyces naeslundii binds to superficial cell antigens by I
st
 type 
fimbria; S. mutans reacts with host prolin-enriched proteins, S. gordonii – 
with oral amylase, S. sanguis interacts with sialyl-containing 
oligosaccharides of MG2 mucins.  
Moreover, the bacteria dramatically enhance primary oral colonization 
making tight cross-linkages between attached microbial cells.  
The process of bacterial cells cross-binding is termed as 
coaggregation. The most common is intergeneric coaggregation that 
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involves bacterial species from various genera. Intrageneric coaggregation 
occurs more seldom albeit it is typical for oral viridance streptococci. In 
latter case coaggregation is mediated by lectin binding. 
Bacterial coaggregation entails the formation of microbial biofilm and 
dental plaque. 
Synthesis of exopolysaccharides (glucans) from sucrose- or glucose-
containing nutrients by Streptococcus mutans plays pivotal role in 
coaggregation of dental pathogens. Streptococcal glycosyltransferases 
produce polymeric glucans attached to microbial envelope. This elicits 
tight binding of streptococci to dental surface as well as to other bacterial 
cells via numerous microbial lectins. 
Furthermore, the oral pathogens can directly impair host immune 
response making havoc of host defense factors. For instance, a great 
number of pathogenic bacterial species (e.g., S. sanguis, S. oralis, S. mitis, 
Porphyromonas gingivalis, Prevotella intermedia, Capnocytophaga spp. 
and others) are capable of producing high-rate IgA-proteases that actively 
destroy salivary sIgAs. This substantially lowers the grade of oral cavity 
protection. 
Overall, under poor situation with oral hygiene, malnutrition or 
starvation conditions, or host endocrine and immune disorders bacterial 
colonization of oral cavity progresses rapidly. It biases the established 
equilibrium among normal oral microbiota towards the prevalence of 
pathogenic bacterial species. This in turn leads to preponderance of 
aggressive influences over protective ones within oral cavity. Finally the 
defense barriers can be broken down, and deleterious activities of 
microbial and non-microbial origin simulate the progression of certain oral 
disorders – e.g., dental caries, pulpitis or periodontitis.  
 
Dental Caries 
 
Caries is dental disease of bacterial origin affecting all of dental hard 
tissues (enamel, dentin and cementum) that is followed by 
demineralization and progressive decay of tooth structure resulting in 
cavity formation. 
For about 2.5 billion people (approximately one third of global 
population) demonstrate dental caries of permanent teeth. 
Usually caries emerges as local bacterial process. It starts from dental 
plaque expansion. Common tooth sites affected by caries are coronal 
surfaces, especially their fissures and pits. The disease can arise also on 
bare parts of dental roots in case of gingival recession. 
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General scheme of pathogenesis of dental caries looks as follows: 
demineralization (primarily, decalcification) of tooth hard tissues is caused 
by accumulation of organic acids in the offing of dental surface. 
The rise of concentration of organic acids in oral cavity ensues from 
fermentation of food-derived carbohydrates (e.g., sucrose) by certain 
acidogenic species of indigenous oral microflora. The shift of pH towards 
acidity creates the conditions for selective propagation of so-called 
aciduric bacteria or capable of tolerating acids. These bacteria intensify 
acid production.  
Organic acids (lactate and others) dissolve dental tissues resulting in 
tooth decalcification. A crucial pH level for start of tooth demineralization 
should be equal or less than 5.0-5.5.  
A vast number of experiments and clinical observations confirmed the 
major role of viridance streptococci (and first of all – of species S. mutans 
and S. sobrinus) in caries emergence and progression. Acidification of 
microenvironment spurs the next growth of lactobacilli in primary lesions. 
These two bacterial groups can rapidly metabolize carbohydrates 
predominantly with lactic acid byproducts. First steps of the disease are 
related with S. mutans and S. sobrinus activity. Lactobacilli grow more 
slowly being concurrent with clinical signs of caries. Thus streptococci are 
cariogenic bacteria that initiate caries of dental tissues whereas lactobacilli 
are more responsible for disease progression.  
Pathogenicity of S. mutans is maintained by its high adhesive capacity 
to dental enamel that stimulates dental plaque growth. S. mutans produces 
the enzymes glycosyltransferase and fructosyltransferase. They polymerize 
food-derived glucose and fructose into insoluble polysaccharides glucan 
and fructan. Glucan is the leading substance promoting adherence and 
coaggregation of S. mutans and other bacteria with reinforcement of dental 
plaque structure. For example, actinomycetes reside in dental biofilm via 
binding with their fimbria to biofilm glucans. 
At neutral pH dental plaque harbors relatively low amounts of 
S. mutans and lactobacilli. By contrast, abundant consumption of sugar-
containing nutrients results in their active microbial fermentation yielding 
lactic acid as the main byproduct that lowers dental plaque pH. This in turn 
dampens the growth of many resident bacterial species, such as S. mitis, 
S. oralis, S. sanguis, but accelerates propagation of S. mutans and 
lactobacilli. It biases local tooth metabolism to progressive 
demineralization. If oral defense factors (mainly, salivary flow and 
bicarbonate buffer) are unable to neutralize detrimental activity of 
pathogenic microflora the dental caries ultimately appears.  
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Meanwhile, the list of cariogenic microbial pathogens is not limited 
with the above mentioned bacterial species. In parallel with streptococci 
and lactobacilli the carious lesion confines broad spectrum of indigenous 
dental microflora. It was established quiet recently by methods of 
molecular genetic analysis (polymerase chain reaction or PCR, ribotyping, 
DNA and RNA microarray hybridization analysis) that many other 
bacterial species tamper with dental caries 
Among them are Actinomyces gerencseriae, Bifidobacterium spp., 
S. salivarius, S. constellatus, S. parasanguinis and others. In particular, 
Actinomyces gerencseriae is supposed to play a role in caries initiation, 
whereas the activity of bifidobacteria accounts for profound caries. On the 
contrary, domination of S. sanguis in dental plaque slows down the disease 
progression. Thus, dental caries results from deranging of complex 
multiple interplays normally established within oral microbiota.  
If arisen but not treated, dental caries passes through several 
consecutive steps:  
(1) initial caries;  
(2) superficial caries;  
(3) moderate caries;  
(4) deep caries  
(5) deep complicated caries. 
 
Initial caries appears as primarily white, then yellowish and later 
brownish spot. It is characterized by local tooth demineralization without 
visible structural changes. Initial caries is reversible if active mouth 
hygiene and fluoridation will be done.  
Superficial caries affects enamel demonstrating wedge-shaped 
enamel defects but without dentin involvement.  
Moderate caries corresponds to marked dentin damage.  
Deep caries is followed by deep dentin penetration in closest vicinity 
to the pulp. 
Deep complicated caries results in opening of the pulp cavity with 
pulpitis, periodontitis or abscess formation. 
This division is generally consistent with WHO classification that 
includes four grade scale:  
D1. clinically detectable enamel lesions with intact (non-cavitated) 
surfaces;  
D2. clinically detectable cavities limited to enamel;  
D3. clinically detectable cavities in dentin; 
D4. lesions extending into the pulp. 
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Treatment and Prophylaxis of Caries 
 
The treatment of dental caries depends on its stage. Initial caries and 
non-cavitated lesions don’t need operative treatment. As the initial caries is 
reversible, enhanced oral hygiene favors remineralization. Topical fluoride 
therapy, e.g., fluoride varnish, demonstrates high preventive and treatment 
efficacy. 
Cavitation requires restorative dentistry with operative interventions. 
All of the destroyed tissues should be removed with subsequent cavity 
filling. 
Caries prophylaxis is primarily based on adequate oral hygiene and 
proper dietary recommendations with limited consumption of food sugars 
(e.g., “table sugar”) and sticky foods like candies. A proper dental hygiene 
presumes regular teeth cleaning with toothbrushes and interdental brushes, 
flossing, the use of chewing gums with xylitol, etc.  
Fluoride- and biocide-containing toothpastes evidently foster caries 
prophylaxis: oral antiseptics inhibit the growth of cariogenic microflora; 
fluorides stimulate calcification of dental hard tissues. Usage of dental 
sealants isolate teeth surface from aggressive external influences. 
Specific prophylaxis of caries by vaccination still remains the subject 
of experimental medical design. Based on genetically modified strains of 
S. mutans or lactobacilli several experimental anti-caries vaccines undergo 
clinical trials now but their preventive efficacy requires further unbiased 
confirmation.  
The results of caries prevention by topical applications of soluble 
antigens derived from cariogenic bacteria also remain controversial and 
need further elucidation. 
 
 
Pulpitis 
 
Pulpitis or inflammation of dental pulp arises predominantly as 
complication of deep caries, where profound dentin decay provokes pulp 
exposure to aggressive activity of microbial and other inflammatory 
factors. 
Emergence of pulpitis is stimulated also by dental traumas, chemical 
irritation of pulp with dental restorative materials (e.g., sodium fluoride or 
phosphoric acid), surgical treatment of periodontal diseases or other 
medical interventions. 
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Nonetheless, it is obvious that the major role in etiology of pulpitis 
should be reserved for infectious agents. A multitude of oral pathogens 
may participate in pulpitis. Most common causative agents are numerous 
species of -hemolytic streptococci, representatives of gram-negative 
non-sporeforming anaerobic rods (bacteroids, fusobacteria, 
porphyromonads, prevotellas) and gram-positive anaerobic cocci (or 
GPAC) – peptococci and peptostreptococci; actinomycetes and lactobacilli.  
From carious cavity the bacteria enter the primarily sterile pulp 
through dentinal canaliculi, in some cases – by apical channel of dental 
roots. Also pulpitis might be borne from extradental infectious sites, such 
as infected gingival pockets, or as the result of sinusitis or orofacial 
osteomyelitis. The spread of hematogenous infection into the pulp is 
seldom observed. 
Acute pulpitis is characterized by sudden onset and rapidly 
progressive inflammation with edema and sharp pain. It impairs dental 
blood supply. 
Reactive inflammatory response in pulp is promoted by activity of 
innate immune cells against microbial pathogens. They comprise 
neutrophils, dendritic cells, T cells, natural killer cells, macrophages, 
odontoblasts. All these cells produce exuberant amounts of antimicrobial 
peptides, cytokines, chemokines and enzymes. 
In several hours active purulent exudation may lead to periodontal 
inflammatory infiltrations or abscesses. If not treated, acute pulpitis exerts 
pulp necrosis, sometimes complicated with apical periodontitis; in case of 
modest activity it resolves into chronic process. 
The treatment of reversible pulpitis foremost implies entire and high-
quality treatment of caries. Removal of hard tissue decay and cavity 
restoration dampens inflammation and causes pulp healing. 
Irreversible pulpitis with non-vital pulp requires endodontical 
treatment followed by removal of irreversibly damaged pulp. 
Antimicrobial therapy is applied in cases of infection spread from pulp 
into surrounding tissues resulting in periodontitis, periostitis, regional 
lymphadenitis, or other complications. Beta-lactam antibiotics, 
doxycycline or anti-anaerobic drugs (metronidazole, clindamycin) can be 
administered. 
Prophylaxis of pulpitis is non-specific. It depends on adequate dental 
care.  
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Periodontal Diseases 
 
Periodontal pathology is the group of inflammatory diseases of 
infectious origin affecting any of tooth-supporting tissues (alveolar bone, 
periodontal ligament, cementum and gingiva).  
Periodontal diseases are induced by deleterious activity of infectious 
agents concentrated in dental plaque. Poorly manifested, microbial 
pathogens stimulate local inflammatory responses that eventually lead to 
tissue atrophy with progressive collagen loss from tooth-supporting 
structures. 
Inflammatory periodontal disorders are divided into 2 main categories: 
gingivites and periodontites. 
More than 50% of adult population have gingivitis and above 30% 
suffer from periodontitis. 
 
 
 
Gingivitis 
 
Gingivitis is the inflammatory gum disease. It is characterized by 
superficial inflammation affecting gums only. In these cases dental hard 
tissues and dental ligament still remain intact; and the depth of periodontal 
pockets doesn’t exceed 3 mm. 
Gingivitis begins from dental plaques expansion over gingival margin. 
Normally, progression of dental plaque is strictly limited by adequate 
dental hygiene that removes the most of oral pathogens. As the result, only 
low amounts of facultatively anaerobic gram-positive bacteria remain 
within gingival crevice. But in case of gingival inflammation total number 
of microbial cells increases rapidly up to 10-20 times from initial. It is 
followed by active preponderance of anaerobic gram-negative bacterial 
species amongst crevicular microbiota.  
Non-specific (plaque-induced) gingivitis is the disease of evident 
polymicrobial nature. S. sanguis, S. mitis, Fusobacterium nucleatum, 
Prevotella intermedia, Actinomyces naeslundii genospecies 2 (formerly 
known as A. viscosus), bacterial members from genera Veillonella, 
Wolinella, Capnocytophaga are commonly isolated. 
By contrast, non-plaque-accociated gingival lesions comprise specific 
bacterial, fungal and viral gingivites, caused by certain microbial 
pathogens. These infectious agents are able to exert the direct damage of 
gum and oral mucosa in the course of primary infection. 
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Non-infectious secondary gingivites may follow systemic autoimmune 
or genetic disorders; or traumatic lesions. 
Beyond the vast number of non-specific (or plaque-induced) microbial 
gingivites there is a special form of bacterial disease known as acute 
necrotizing ulcerative gingivitis or ANUG.  
It affects predominantly young persons, demonstrating sharp onset and 
severe pain due to necrosis of interdental papilla (gingival parts between 
the teeth). This acute gingival damage was primarily described by French 
physician H. Vincent and thereafter named as “Vincent's angina” or 
“Vincent's disease”. 
During the years of World War I the disorder was known as “trench 
mouth”, afflicting predominantly military staff. However, it may occur in 
any person in conditions of starvation or malnutrition and under stress.  
H. Vincent ascribed the etiology of the disease to mixed spirochetal 
and fusobacterial infection mainly due to permanent detection of this 
agents within specific oral lesions. The presence of large spirochetes with 
irregular coils carrying more than 20 fibrils was commonly found in 
clinical specimens taken from these patients. 
Now it is generally ascertained that acute necrotizing ulcerative 
gingivitis arises from complex polymicrobial infection, where major role 
belongs to oral spirochetes and the members of gram-negative anaerobic 
Prevotella intermedia species. 
The treatment of microbial gingivitis includes the administration of 
oxidizing agents (hydrogen peroxide or iodine) and the use of 
antimicrobial drugs, affecting anaerobic bacteria, such as metronidazole. 
Rinsing of oral cavity with solutions of oxidants (e.g., hydrogen peroxide) 
prevents the emergence of acute necrotizing ulcerative gingivitis. Overall, 
adequate prophylaxis and treatment ensures favorable prognosis of these 
disorders. 
 
 
 
Periodontitis 
 
Periodontitis is the inflammatory polymicrobial infectious disease 
affecting supportive dental tissues that if not treated, leads to tissue 
attrition with progressive collagen degradation, alveolar bone resorption 
and eventual tooth destabilization or loss. 
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Pathogenesis of Periodontitis 
 
Pathogenesis of periodontal diseases is a complex multifactorial 
process comprising dental plaque overgrowth, exuberant accumulation of 
microbial wastes and virulence factors ultimately resulting in local 
progressive inflammatory response.  
In the course of disease the gingival crevice deepens over 3 mm and 
transfigures into periodontal pocket gradually expanding from 4 to 10-
12 mm and even more. Every pocket may contain 10
7
-10
9
 of microbial 
cells. Detrimental activity of microbial pathogens harbored in the pocket 
accounts for disease progression and tissue destruction. 
The composition of local microbial communities changes grossly 
following the development of periodontitis. 
As early as in 1998 S. Socransky with coworkers proposed to divide 
the members of oral microbiota into separate groups that correspond to 
healthy or pathological conditions found within oral cavity.  
Each group harbors a number of related microbial species that are 
commonly isolated at certain steps of dental plaque growth or, by contrast, 
when pathology arises. However, there are striking dissimilarities observed 
between the groups. Therefore, every group reflect unique colonization 
pattern essential for various microbial communities. 
By S. Socransky, different “colors” were assigned to these microbial 
clusters, named as “complexes”. 
It was pointed out that “purple”, “cyan” “yellow” and “green” 
complexes comprise early first colonizers of the tooth surface especially of 
its subgingival sulcus. Thus, the members of these complexes were 
primarily ascertained as the residents of healthy gums. 
“Purple or magenta complex” is closely associated with healthy 
gingival state and includes species Veillonella parvula and Actinomyces 
odontolyticus. 
“Yellow complex” encompasses a number of streptococci (S. sanguis, 
S. mitis, S. gordonii and S. intermedius), “cyan complex” – numerous 
actinomycetes. 
The bacteria from purple and yellow complexes are regarded as 
protective microbial agents demonstrating antagonistic activities against 
pathogenic microflora. 
“Green complex” was found to contain diverse microbial agents such 
as Eikenella corrodens, Aggregatibacter actinomycetemcomitans 
serotype a, Campylobacter concisus, Capnocytophaga spp. It has been 
shown after close scrutiny that species of green complex can actively 
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participate in progression of serious dental pathology, e.g., periodontites 
with tissue destruction.  
Finally, the bacteria from red and orange complexes demonstrate 
intimate association with oral pathological conditions. 
Three members of red complex – gram-negative obligate anaerobes 
Porphyromonas gingivalis, Tannerella forsythia (former Bacteroides 
forsythus), and Treponema denticola are the pivotal periodontal pathogens 
commonly isolated in chronic periodontitis with deep pockets and gingival 
recession. 
The orange complex embraces the variety of anaerobic pathogens 
Prevotella intermedia and Prevotella nigrescens; Streptococcus 
constellatus, Eubacterium nodatum, Peptostreptococcus micros, several 
species from genera Fusobacterium (F. nucleatum, F. periodonticum), and 
Campylobacter (e.g., C. rectus).  
The bacteria of orange complex are associated with gingivitis and 
gingival bleeding. They are tightly related with red complex members 
demonstrating mutual pathogenesis. 
Three other pathogenic species, namely A. actinomycetemcomitans 
serotype b, Selenomonas noxia and Actinomyces naeslundii genospecies 2 
(formerly A. viscosus) don’t’ pertain to any outlined complex but 
intensively impact on progression of dental pathology as well.  
Division of bacteria into pathogenicity groups or “complexes” 
strongly correlates with clinical situation in periodontal diseases. These 
disorders are proven to be inflammatory injuries of polymicrobial origin. 
Normal microbiota of subgingival plaque commonly harbors 
facultatively anaerobic gram-positive bacteria (mainly, streptococci), 
actinomycetes and anaerobic gram-negative veillonellas (purple and yellow 
complexes), but only 5% of spirochetes or anaerobic motile rods.  
In case of irregular and poor oral hygiene the expansion of dental 
plaque accelerates secretion of crevicular fluid and stimulates local 
inflammatory response. If not recovered, microbial metabolism and 
inflammation turns down crevicular redox potential thereby affording the 
growth of anaerobic bacteria. Most of them release powerful virulence 
factors with proinflammatory (e.g., bacterial LPS), enzymatic (collagenase, 
elastase, hyaluronidase, etc.) and toxic activities. gram-negative anaerobes 
from genera Porphyromonas, Prevotella, Fusobacterium, Tannerella, 
Aggregatibacter, Capnocytophaga, Wolinella, and Treponema 
substantially worsen the local periodontal status.  
Tissue matrix metalloproteinases and bacterial hydrolytic enzymes 
destroy supportive dental surroundings with marked collagen degradation. 
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Persistent inflammation converts into chronic periodontal disease. The 
latter results in dental pocket excavation, gingival recession and final tooth 
destabilization. 
Overall, in course of chronic periodontitis naturally present bacteria of 
“purple” and “yellow” complexes are gradually substituted by periodontal 
pathogens of “red” and “orange” microbial groups. In these conditions 
gram-negative bacteria comprise 75% of total cells, and what’s more, 90% 
pertain to strict anaerobes. 
 
 
Clinical Variations of Periodontitis 
 
There are several kinds of periodontitis that are different in clinical 
course. 
Among them are chronic periodontitis, aggressive periodontitis, 
periodontitis as a manifestation of systemic diseases; periodontites, 
associated with genetic or hematological disorders. All of these forms can 
be localized, generalized or refractory (see Table 8). 
 
Table 8  
Classification of periodontal diseases   
from The American Academy of Periodontology, 1999   
 
 
I. Chronic 
periodontitis 
 
II. Aggressive 
periodontitis 
 
III. Periodontitis as  
a manifestation of systemic disease 
 
 
IV. Necrotizing 
periodontal 
disease 
 
Localized 
Generalized 
Refractory 
 
 
Localized 
Generalized 
Refractory 
 
 
Associated with hematological 
disorders 
Associated with genetic disorders 
 
 
Also periodontites are divided into the disorders affecting individuals 
of 35 years or younger, and periodontites of adults (the disease in persons 
over 35). 
At last, there are special clinical forms of periodontitis, for instance, 
local juvenile periodontitis and necrotizing periodontal disease. 
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Local Juvenile Periodontitis 
 
Local juvenile periodontitis predominantly affects teenagers with 
annual morbidity rate from 1 to 5 in 1,000 of population. 
In absence of treatment, rapid degenerative lesions after the disease 
emergence lead to ultimate dental loss.  
In spite of its severity, the low volume of dental plaque is 
characteristic for this pathology. It damages mainly molar and incisor teeth 
without extensive plaque or calculus formation. 
Unlike other kinds of periodontites, the disease has narrow range of 
microbial species in its etiology. In most of cases microaerophilic bacteria 
Aggregatibacter actinomycetemcomitans are isolated from periodontal 
lesions. They are cultured on malachite green-bacitracin selective medium. 
This periodontal pathogen produces potent virulence factors, such as 
LPS with proinflammatory activity and highly active leukotoxin. 
Leukotoxin suppresses the actions of neutrophils thus ensuring 
microbial penetration into nethermost tissues. In some cases the infection 
may spread further to the bloodstream. Generalization of infectious process 
triggers both local and systemic immune responses. 
Manifested severe forms of the disease are supposed to evolve in 
children, which carry genetic defects in neutrophil chemotaxis. Protracted 
course of local juvenile periodontitis allows other microbial species (e.g., 
anaerobic bacteria) to participate in disease pathogenesis thereby 
worsening its prognosis. Nevertheless, administration of broad spectrum 
antibiotics (doxycycline or metronidazole) successfully interrupts the 
infectious process. 
 
 
Periodontitis of Young Individuals  
(Early-onset Periodontitis, Aggressive Periodontitis) 
 
This form of the disease afflicts the young persons below the age of 
35. It may affect from 0.5 to 2% or even more of children and young 
people. The most of disease cases are followed by dental plaque 
broadening and calculus formation. The infection moves to periodontal 
tissues and actively propagates there. In case of aggressive disease course 
eventual dental loss is possible even before the age of 20. 
It was long-time supposed that a major role in etiology of early-onset 
aggressive periodontitis belongs to periodontal pathogen 
A. actinomycetemcomitans. However, it has been found by now that the 
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disease emergence and progression is not primarily related with 
microaerophilic bacteria but depends on limited number of obligate 
anaerobic bacterial species Treponema denticola, Prevotella intermedia, 
Tannerella forsythia, Porphyromonas gingivalis and some others. 
The prophylaxis and treatment of this ailment is generally similar to 
above-mentioned clinical forms of the disease. 
 
 
Adult Periodontitis (or Chronic Periodontitis) 
 
It is one of the most common infectious diseases affecting adult 
population. Usually it demonstrates slowly progressive course with 
multiple dim exacerbations. It is characterized by low-grade or moderate 
inflammation resulting in degenerative lesions of periodontal tissues and 
tissue atrophy. 
The disease is evidently of polymicrobial origin with high prevalence 
of anaerobic bacteria. The culturability of most of this species is very low; 
that’s why they can be discovered only by methods of molecular genetic 
analysis (polymerase chain reaction or PCR and DNA hybridization). 
By lowering of redox potential in periodontal pocket, a selective 
growth of bacteria from red and orange complexes accompanied by 
numerous microaerophilic pathogens is stimulated. The association 
between microaerophil species A actinomycetemcomitans, Wolinella recta, 
Eikenella corrodens and obligate anaerobes Porphyromonas gingivalis, 
Treponema denticola, Tannerella forsythia, Prevotella intermedia, 
Fusobacterium nucleatum and some others is typically observed. 
Peri-implantitis, the disease resembling periodontitis, but affecting 
dental implant surroundings, demonstrate similar behavior. Failing 
implants and residual teeth can be the subject of bacterial attack. 
Despite the striking variability of microbial communities residing in 
dental pockets, the therapy of chronic periodontites should be oriented on 
prevention or restrain of only limited number of the most active 
periodontal pathogens. As they are predominantly anaerobic, the 
administered drugs must impact mainly this group of bacteria. Most 
effective are metronidazole, clindamycin, doxycycline or beta-lactams. 
They can be used locally by applications of polymeric antibiotic-
containing films into dental pockets or by systemic administration in 
severe cases. 
Drug therapy should be only the constitutive part of complex versatile 
treatment of chronic periodontitis. It comprises also the debridement 
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procedures (scaling and root planning) and, if needs, dental surgery. Taken 
together, these procedures terminate the disease progression and prevent 
tooth loss. 
 
 
 
Periostitis and Osteomyelitis of Mandibular and Maxillofacial Region 
 
Jaw periostitis is the inflammation of periosteum of corresponding 
bone. 
In majority of cases it ensues from complicated acute periodontitis or 
as the result of exacerbation of chronic periodontal disease. More seldom it 
arises from periapical abscess, suppurative radical or follicular cysts, 
wounds after dental extraction, etc.  
Osteomyelitis is the inflammatory process affecting bones and/or bone 
marrow. 
Osteomyelites are divided into suppurative or infectious (the most 
common) and non-suppurative (e.g., after aseptic traumatic injury). They 
are also classified into acute and chronic (with duration more than 1 
month). 
In dentistry osteomyelites of orofacial area can be odontogenic (from 
dental infection) and non-odontogenic (hematogenous, post-traumatic and 
others). 
The most commonly isolated microbial pathogens that cause 
periostitis and osteomyelitis are S. aureus (more than 80% of cases in 
adults), group A streptococci, Enterobacter species; and H. influenzae in 
children. 
Suppurative post-traumatic osteomyelitis can be provoked by 
S. aureus, Enterobacteriaceae members or P. aeruginosa. 
Complex treatment of periostitis and osteomyelitis encompasses 
adequate surgery of infectious sites and antimicrobial treatment with 
antiseptics and antibiotics. Antiseptics (e.g., chlorhexidine) are applied 
locally; antibiotics should be administered according to the results of 
laboratory testing of microbial antibiotic resistance. The most commonly 
used drugs for antimicrobial treatment in these cases are beta-lactams in 
combinations with β-lactamase inhibitors, e.g., amoxicillin-clavulanic acid; 
in case of P. aeruginosa infections carbapenems, piperacillin/tazobactam 
or ceftazidime are used. 
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Odontogenic Maxillary Sinusitis 
 
Acute or chronic sinusitis is relatively rarely caused by tooth 
infection. 
Nevertheless, odontogenic maxillary sinusitis makes up to 20% of 
total cases of maxillary sinusitis. 
The most common agents of odontogenic maxillary sinusitis are 
S. pneumoniae, H. influenzae, or M. сatarrhalis, sometimes S. aureus or 
non-sporeforming anaerobic bacteria. Vaccination against H. influenza 
type B (or Hib) substantially reduced the incidence of sinusitis caused by 
this bacterial pathogen. 
In most cases of acute sinusitis antibiotic treatment is not used. If the 
disease exceeds 10 days of duration, a short 3-7 days course of 
amoxicillin/clavulanate is recommended.  
 
 
Suppurative Infections of Soft Tissues of Facial and Neck Areas 
 
Suppurative odontogenic infection of face and neck soft tissues is rare 
but highly severe complication of primary infections of oral cavity. It 
affects muscles, subcutaneous fat, blood vessels, fibrous connective tissue 
and fascia of orofacial and neck regions. 
These injuries are clearly of polymicrobial nature with active 
participation of streptococci, staphylococci, bacteroids, fusobacteria, 
peptostreptocci, in case of hospital infections – Pseudomonas aeruginosa. 
Once appeared, suppurative infections spread from initial site resulting 
in abscess or phlegmon formation. 
Tissue abscess is the localized cavity filled with the pus, bacteria, 
phagocytes and elements of destroyed tissues (or debris). It is surrounded 
with abscess wall or capsule made of inflammatory granulation tissue. 
Encapsulation acts to hold pus inside and prevents its further spread but the 
same time it restrains the activity of immune cells. 
Phlegmon is the severe purulent inflammation of soft tissues that 
actively spreads from primary site without tendency to self-limitation. It 
affects muscles, fascias and adipose tissue resulting in non-capsulated pus 
accumulation amid muscles and fascial compartments. 
Odontogenic phlegmons or abscesses originate from initial infectious 
sites located in teeth or periodontal lesions, inflamed salivary glands 
(sialadenitis), tonsil crypts, lymph nodes or other structures.  
 224 
Depending on microbial virulence and immune reactivity, the course 
of infections might be drastic and aggressive with high fever and 
intoxication or, by contrast, torpid and faint. Anyway, both situations can’t 
lead to self-recovery. 
This pathology requires active surgical treatment and antibacterial 
therapy. Patients should be treated with antibiotics according to estimated 
microbial drug resistance. Beta-lactams in combination with β-lactamase 
inhibitors, (e.g., amoxicillin-clavulanate) can be used as the drugs of first 
line. 
 
 
Facial and Neck Lymphadenitis 
 
Regional lymphadenitis of neck and facial area usually follows the 
inflammatory infections of oropharyngeal and facial zones. 
Overall, sub-mandibular and neck lymphadenites can arise from 
odontogenic or non-odontogenic infections. 
Sub-mandibular lymphadenitis and lymphadenitis of anterior and 
posterior neck surface in children before 4-5 are related mainly with viral 
infection. 
Most common are so-called “non-specific” lymphadenites that pose 
the background for virtually any suppurative lesion of orofacial region. 
“Specific” lymphadenites may arise after specific microbial antigen 
exposure, e.g., BCG vaccination against tuberculosis. 
Abscesses of lymph nodes are provoked by secondary bacterial 
infection spread throughout regional lymphatic system. They are usually 
caused by typical number of infectious agents, such as streptococci, 
staphylococci, actinomycetes, gram-negative anaerobic microflora. 
Antimicrobial treatment of lymphadenitis is performed as auxiliary 
measure in complex cure for primary oral infection of bacterial origin. 
 
 
Odontogenic Bronchial and Pulmonary Infections 
 
In certain cases dental and periodontal infections can elicit bronchial 
or pulmonary pathology. 
As the oral cavity harbors myriads of microorganisms, some of 
opportunistic pathogens may cause respiratory diseases (bronchitis or 
pneumonia) if they reach bronchial or pulmonary tree. Among them are 
pneumococci, klebsiellas, S. pyogenes, mycoplasmas, chlamydiae, 
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bacteroids, several uncommon bacterial agents such as Moraxella spp., 
Kingella kingee, Acinetobacter baumanii, or viruses (e.g., herpes virus). 
Secondary bacterial pneumonias arise in patients under severe 
conditions affecting respiratory tract. They occur in case of aspiration of 
oral or gastric contents in patients with bedridden status or long-time 
unconscious; in postoperative patients, patients receiving mechanical 
ventilation, patients with debilitating neurologic disorders; 
immunocompromised individuals with primary or secondary immune 
deficiencies, etc. 
Secondary pneumonias usually demonstrate mixed polymicrobial 
infection. They are caused by long list of opportunistic bacterial agents 
(e.g., staphylococci, enterococci, klebsiellas, pseudomonads, 
enterobacterial pathogens, anaerobic bacteria). In many situations this 
microflora can be of odontogenic origin. 
Aspiration pneumonia occurs after inspiration of foreign substances 
that enter respiratory tract from outside (e.g., from oral cavity). Aspirates 
may contain oral secretions, acidic gastric contents, vomiting masses, 
foods, and multiple microorganisms. It starts as chemical and mechanical 
pneumonitis followed by progressive bacterial inflammation. Aspiration 
pneumonia often leads to lung abscess or pleurisy with empyema. 
In most of cases this disease emerges as hospital acquired pneumonia. 
It is caused predominantly by gram-negative anaerobes, S. aureus, 
Klebsiella pneumoniae or Pseudomonas aeruginosa. 
Ventilator-associated pneumonia or VAP is one more type of 
hospital-acquired (or nosocomial) pneumonia. It may develop in patients 
undergoing mechanical ventilation within intensive care units. 
Severe hospital pathogens demonstrating striking resistance to 
antimicrobial therapy are commonly isolated in case of VAP. Among them 
are methicillin resistant Staphylococcus aureus (or MRSA), Acinetobacter 
baumannii, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, 
Klebsiella pneumoniae, and Serratia marcescens.  
Laboratory diagnosis of nosocomial pneumonias includes specimen 
sampling followed by identification of isolated bacterial cultures and their 
antibiotic susceptibility testing. 
Patient’s sputum, airway samplings, endotracheal aspirates, 
bronchoalveolar lavage fluids, pleural fluid cultures are usually examined. 
Direct identification of bacterial strains in clinical specimens is performed 
by polymerase chain reaction (PCR). 
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The treatment of severe pneumonias caused by multi-resistant 
hospital strains requires high-dosage combined antibiotic treatment with 
broad-spectrum antibiotics.  
Antipseudomonal cephalosporins (cefoperazone or ceftazidime), 
carbepenems, combined β-lactam/β-lactamase inhibitor-containing 
antibiotic piperacillin-tazobactam, fluoroquinolones (levofloxacin) or 
aminoglycosides (amikacin or tobramycin) are generally administered.  
Gram-positive multidrug resistant microflora, e.g. methicillin resistant 
Staphylococcus aureus, is treated with linezolid or vancomycin. 
 
 
Odontogenic Sepsis 
 
Sepsis is a systemic bacterial or fungal disease followed by life-
threatening organ dysfunction caused by a dysregulated host response to 
infection. 
The term “sepsis” originates from Greek: “putrefaction” or “rotten 
flesh” indicating deep impairment of the whole body due to the severe 
infection. 
Odontogenic sepsis is induced by infection residing in oral cavity. It 
becomes much more likely if odontogenic infection spreads through the 
fascial spaces to the head and neck.  
Primary focus of infection may localize in mandibular (about 70%) or 
maxillary (for about 30%) zones. If not restricted, the infection can spread 
further to unaffected anatomical regions and tissues along the sites of least 
resistance. 
When arisen, the septic state develops into mortal systemic 
inflammatory disease via several consecutive phases. They reflect the 
levels of disease progression followed by growing incapacity of host 
defense to restore normal body functions. 
The stages of systemic bacterial infection expand as follows: 
(1) bacteremia phase; (2) sepsis; (3) septic shock. 
Bacteremia means the presence of viable bacteria in bloodstream. 
Nevertheless, bacterial dwelling in blood creates only necessary but not yet 
sufficient condition for sepsis development. 
Bacteremia is generally divided into transient, intermittent, or 
continuous depending on duration of bacterial stay in blood. 
Transient bacteremia lasts from a few minutes to few hours. It may 
occur under ordinary medical manipulations (i.e., dental extractions or 
percutaneous injections and catheterizations). 
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Intermittent bacteremia appears in case of presence of localized 
infectious focus such as abscess or osteomyelitis. It is characterized by 
periodical entry of bacteria into bloodstream with subsequent clearance. 
Finally, continuous bacteremia occurs when the infection long-time 
resides directly within blood vessels or cardiac valves, i.e., in cases of 
infective endocarditis or vessel graft infections.  
But the progression of conventional bacteremia into systemic disease 
or sepsis requires extra-conditions that must aggravate primary course of 
infection.  
The bacteria should demonstrate high virulence with powerful 
adhesive, invasive and immunosuppressive capacity; on the other hand, 
host defensive systems exhibit ineffective inflammatory response or, 
conversely, fall into anergy both unable to clean the invaded pathogen. 
Since early 1990s sepsis was regarded as infectious systemic 
inflammatory response syndrome (or SIRS) that leads to severe tissue 
damage and organ dysfunction. Every SIRS case shows characteristic 
clinical manifestations resulting in changes of body temperature (e.g., 
<36°C or >38°C), pulse and respiratory rates, and white blood cell count.  
However, it became evident that the term “SIRS” has more expanded 
meaning than sepsis itself. According to the above criteria, SIRS as 
systemic inflammation can arise from both infectious and non-infectious 
insults. For instance, non-infectious SIRS emerges in course of 
pancreatitis, burn disease, multiple trauma with massive tissue injury, or 
hemorrhagic shock. 
Moreover, intensive systemic immune response against the infection 
resembles clinical conditions of SIRS, but it successfully eliminates the 
invaded microbial pathogen despite the development of active body 
inflammation.  
As the result, in 2016 the concept of sepsis was revised by 
international Task Force that established International Consensus 
Definitions for Sepsis and Septic Shock.  
According to current Definitions, sepsis is defined as “life-threatening 
organ dysfunction caused by a dysregulated host response to infection”. 
The infection might be documented or clinically suspected. 
Pathogenesis of sepsis is based on abnormal hyper- or hypoactivity of 
immune response against systemic infection coupled with enhanced 
virulence of microbial pathogens. 
Immune hyperactivity is followed by massive secretion of 
proinflammatory cytokines (“cytokine storm”) from granulocytes, dendritic 
cells, macrophages and all other cells of innate response. This leads to 
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endothelial damage, deep microcirculation disturbances and intensive 
procoagulant activity that ensure inner organs malfunction. 
And vice versa, highly virulent microbial pathogen causes similar 
body injuries on the background of inefficient immune response. 
If not treated perfectly, sepsis progresses into septic shock with 
multiple organ failure and tissue damage. 
Septic shock is defined as sepsis condition “in which particularly 
profound circulatory, cellular, and metabolic abnormalities are associated 
with a greater risk of mortality”. 
Overall, sepsis mortality rate remains high even in developed 
countries. In Europe it exceeds 40% in cases of septic shock. Nowadays 
the disease is called as “hidden public health disaster”. For instance, there 
are about 750,000 patients with sepsis registered in United States annually 
resulting in more than 200,000 death cases; and the total cost of treatment 
of hospitalized patients is equivalent to $20 billion. 
Laboratory diagnosis of sepsis including its odontogenic forms poses 
serious difficulties.  
The diagnosis must be established as soon as possible (in first few 
hours) while massive early and targeted antibiotic therapy substantially 
favors the prognosis. The presence of initial infectious focus (e.g., 
necrotizing soft tissue infection) should be confirmed or excluded within 
12 hours. 
However, repetitive blood bacterial cultures become positive in less 
than 50% of cases. Primary culturing should be done before initiation of 
antimicrobial treatment. The most commonly isolated microbial species 
(e.g., staphylococci, viridance streptococci, gram-negative anaerobes, 
enterococci, Pseudomonas aeruginosa) are identified and tested for 
antibiotic resistance according to standard protocols. 
Current progress in laboratory diagnosis of sepsis is related with 
methods of molecular genetic analysis. Multiplex real-time PCR tests and 
fluorescence in situ hybridization are used. Ideally they can detect 
individual microbial cells in 1 ml of blood. 
Discovery of rapid reliable biomarkers of emergence of sepsis still 
remains the subject of intensive research. Laboratory monitoring of blood 
levels of biomarkers with relatively high specificity and sensitivity for 
sepsis (lactate, procalcitonin, C-reactive protein, IL-6 and some other 
cytokines) might be helpful in disease diagnosis and in control of treatment 
efficacy.  
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Treatment of odontogenic sepsis must be highly intensive and 
complex. It commences with complete surgical eradication of primary 
septic focus in orofacial or neck area. 
Adequate and urgent antibiotic therapy that starts within 1 hour of 
sepsis diagnosis is the subject of ultimate clinical value. Initial empiric 
antibiotic treatment is performed before the results of antibiotic 
susceptibility testing and it can be changed after collecting of microbial 
resistance data.  
High doses of beta-lactams combined with β-lactamase inhibitors, 
carbapenems, aminoglycosides (amikacin or tobramycin), 
fluoroquinolones or vancomycin for gram-positive microflora can be used. 
In case of fungal sepsis amphotericin B is administered. 
The treatment is followed by intensive maintenance of body vital 
functions – fluid resuscitation, the control and maintenance of blood 
pressure, cardiovascular, respiratory and renal support. 
Prophylaxis of odontogenic sepsis is essentially based on active 
elimination and treatment of primary infection focus located in oral cavity. 
 
 
Bacteriological Testing in Dental Practice 
 
Bacteriological analysis in patients with odontogenic diseases is 
performed in several clinical conditions:  
a) in cases of suppurative infections of orofacial and neck areas; the 
main goal of this study is the isolation of causative agent and its antibiotic 
susceptibility testing;  
b) in clinical cases of “specific” infections, where oral cavity lesions 
arise in primary infectious diseases (e.g., diphtheria, syphilis, scarlet fever, 
tuberculosis and others); it fosters the establishment of correct etiological 
diagnosis of infection; 
c) in cases of long-term oral lesions of unknown origin (unclear 
diagnosis). 
Specimen taking for microbiology examination requires some common 
rules. Sampling should be done without any preliminary mouth treatment 
by antiseptics or other drugs and before tooth brush. Directly before taking 
oral cavity is rinsed with sterile warm saline. In case of oral ulcerative 
lesion its superficial covering film should be removed, and the specimen is 
delivered from lesion’s bottom.  
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Without delay the material should be sent to the laboratory for culture 
examination. If proper nutrient media present, the inoculation can be done 
directly in dental cabinet. 
Most common situations that demand bacteriological testing of 
odontogenic infections are related with cervical lymphadenitis, 
submandibular, retropharyngeal and other deep space infections, 
peritonsillar abscesses. 
Specimen collection is made by aspiration or biopsy of inflammatory 
material from injured tissues and tissue spaces. Samples have to be placed 
into anaerobic transport container to make possible isolation of anaerobic 
bacteria, which are common in these conditions. Besides, facultatively 
anaerobic bacteria remain viable in anaerobic transport. All the specimens 
should be immediately delivered to the laboratory, where the isolation of 
microbial cultures and their antibiotic susceptibility testing are elaborated. 
In odontogenic sepsis (as well as in other septic cases) the repeated 
blood sets taken from patient are examined. At least 2–4 blood culture sets 
are tested per septic episode.  
For successful microbial recovery the most critical is the volume of 
blood that is collected by venipuncture. Not less than 20-30 ml of blood for 
every bottle with nutrient media should be taken. In adults 2-4 bottles for 
single blood culture set are used, at least one aerobic and one anaerobic. 
The amount of nutrient medium in every bottle has to be 200 ml or more to 
remit bactericidal activity of blood. Catheter-drawn blood cultures 
demonstrate a higher risk of external contamination.  
In sepsis two and more blood culture sets must be taken sequentially 
in a short period of time before initiation of antibiotic treatment; after 
blood sampling empiric antibiotic therapy should be started immediately. 
For rapid sepsis diagnosis nucleic acid amplification tests (NAATs) 
are used. Patients’ plasma or serum is examined by multiplex real-time 
PCR or molecular hybridization tests.  
Microbiological testing of saliva and gingival crevicular fluid 
ameliorates the diagnosis of periodontal diseases and helps to assess risks 
in patients with caries. 
Saliva testing can be done both with resting (unstimulated) or 
stimulated salivary specimen. 
Resting saliva is secreted predominantly by submandibular glands. It 
is collected by allowing a patient to expectorate saliva into a collection 
cup. 
Stimulated saliva is derived mainly from the parotid gland; it can be 
taken by masticatory stimulus (e.g., a piece of wax). To get stimulated 
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salivary specimen, the patient chews a piece of wax for a 5 min 
expectorating saliva into a small receptacle at regular time periods.  
Salivary samples are used for rapid chairside caries risk assessment 
tests. Risk assessment tests estimate total amount of the most cariogenic 
bacterial species, namely S. mutans and lactobacilli, by reaction of salivary 
aliquot with highly specific monoclonal antibodies against these 
pathogens. 
Gingival crevicular fluid (GCF) is tested for laboratory diagnosis of 
periodontal diseases. GCF samples are obtained from periodontal lesions 
(e.g., gingival pockets) of the tested teeth. The teeth should be cleaned to 
remove any supragingival plaque, then isolated with cotton roll to prevent 
saliva contamination and dried with air. Standard endodontic paper points 
(e.g., of size 30) or collection paper stripes are inserted into the gingival 
crevice. Standardization is achieved by equal time of sampling.  
Next step the obtained specimen is transferred to appropriate nutrient 
media for growth. Anaerobic culturing is preferable in this condition as the 
most active periodontal pathogens (i.e., Prevotella intermedia, Tannerella 
forsythia or Porphyromonas gingivalis) pertain to obligate anaerobic 
bacteria. 
Swabs of dental plaques are used to evaluate the grades of common 
oral cleanliness. For example, the quantity of microbial ATP can be 
determined in this sample that correlates with total amount of bacteria 
present in dental biofilm. 
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Chapter 13 
GENERAL CHARACTERISTICS OF VIRUSES 
 
 
The History of Virus Discovery 
 
The beginning of the history of viruses has started from the discovery 
of tobacco mosaic disease causative agent, made by Russian scientist 
D.I. Ivanovsky in 1892. He has found this agent as the smallest size 
particle, capable of passing through bacterial filters, invisible in light 
microscope, and devoid of ability to grow in different nutrient media. Thus 
he described several major essential traits of viruses, albeit the term 
“virus” (Lat. virus – poison) appeared later. This name was proposed by 
the Dutch scientist M. Beijerinck in 1898. Finally it was applied to all of 
the similar infectious agents. 
 
General Characteristics of Viruses 
 
All of the viruses demostrate the number of common properties: 
 
– molecular (non-cellular) structure; 
– viral genome represents only the one type of nucleic acid – DNA or 
RNA that indicates DNA or RNA viruses, respectively; viral nucleic acids 
can be organized as double-stranded or single-stranded; 
– viruses are obligate intracellular parasites capable of propagating 
solely in the living cells; 
– viruses are devoid of molecular structures for protein synthesis; the 
infected cell provides energy and ribosomal apparatus for successful viral 
propagation (synthesis of proteins and nucleic acids, viral assembly, etc.) 
– viruses are the minute microorganisms, ranging from about 15-
20 nm to 400 nm in most of cases; viral particles are able to pass through 
the filter membranes, retaining the majority of bacterial cells. 
– viruses demonstrate highly intensive genetic variability; 
phylogenesis of viruses is governed by the laws of evolution; 
– viruses are ubiquitous in nature; they can multiply in bacteria, 
algae, fungi, and protozoa as well as in plants and animals; 
– viruses are not affected by antibiotics; viral infections are treated 
by special class of antiviral drugs. 
The host range for a certain virus may be wide or extremely limited. 
Usually viruses can interact only with the cells of a few related species. 
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Classification of Viruses 
 
Modern classification of viruses is elaborated by International 
Committee on Taxonomy of Viruses (ICTV). ICTV is a committee of 
Virology Division of the International Union of Microbiological Societies. 
In contrast to any other biological objects, as ICTV states, 
“...nomenclature of viruses is independent of other biological 
nomenclature” and further “...virus taxon nomenclature is recognized as 
an exception in the proposed International Code of Bionomenclature”. 
The data concerning actual viral classsification are periodically 
published in ICTV Reports and releases. The last 9
th
 Report was developed 
in 2009-2012; the latest release of virus taxonomy was presented in 2015. 
According to ICTV principles, universal classification of viruses 
operates with taxonomic levels of order, family, subfamily, genus, and 
species. 
Current version of international classification of viruses comprises 7 
viral orders, 111 families that include at least 27 subfamilies and 609 
genera with more than 3700 viral representatives. Nevertheless, hundreds 
of viruses are not classified yet. 
Not all, but many viral families are organized into orders.  
Virus order names are marked with the suffix -virales, whereas the 
titles of viral families contain the suffix -viridae.  
For instance, several families are included into the order 
Mononegavirales; among them Filoviridae, Paramyxoviridae and 
Rhabdoviridae harbor the large number of viruses, pathogenic for 
humans. 
Subfamilies have the suffix -virinae. As an example, the family 
Herpesviridae comprises 3 subfamilies: Alphaherpesvirinae, 
Betaherpesvirinae and Gammaherpesvirinae. 
Viral families and subfamilies encompass numerous genera. Genus 
names are ended with the suffix -virus (e.g. Orthomyxovirus, 
Hepatovirus, Rubivirus and many others.) 
 
Species is the primary lowest taxonomic unit of international viral 
classification. Species name of virus may indicate virus locality, its 
susceptible host or virus-associated disease, e.g. measles virus. 
ICTV designates viral species as “...a monophyletic group of viruses 
whose properties can be distinguished from those of other species by 
multiple criteria”. Among these multiple criteria are: 
– the degree of relatedness of viral genomes or genes;  
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– natural and experimental host range; 
– cell and tissue tropism; 
– viral pathogenicity;  
– vector specificity;  
– antigenicity, etc.  
 
Monophyletic group means the closely related population of viruses 
where all the members originated from the common ancestor.  
This is determined on the base of viral phylogenetic analysis with 
molecular genetic methods, mainly by sequencing of viral nucleic acids 
(DNA or RNA).  
Nucleic acid sequencing and sequence comparison evaluates the 
genetic relatedness and origin of members of viral species.  
In case of absence of full genomic data the sequencing of viral 
proteins is proposed.  
However, the uniform genetic criteria suitable for delineation of any 
viral species are not elaborated. For instance, the plant viruses from the 
family Geminiviridae are established from the same species in case of 
genetic identity from 90%, whereas for ebolaviruses this criterion is equal 
to 70% of their RNA relatedness. 
That’s why above mentioned additional criteria for virus speciation 
are used.  
Taxonomic ranks from genus and above are described by ICTV as the 
group of related taxa of lower level (e.g., for viral genus – the number of 
viral species) that share certain common properties. 
Taking into account the existing difficulties of viral taxonomy 
accompanied with low accessibility of genetic sequencing and other 
advanced molecular tests for most of clinical laboratories parallel viral 
division into 7 distinct groups is commonly used in practice. 
This classification was primarily proposed by Nobel Laureate US 
virologist D. Baltimore still in 1971. 
It grounds on the basic structure of viral genome – type of genomic 
nucleic acid (DNA or RNA), number of nucleic acid strands (double-
stranded or single-stranded), polarity of viral RNA – positive-sense or 
(+) RNA and negative-sense or (–) RNA; mode of replication of viral 
genome.  
There are the next viral groups according to Baltimore classification: 
 
group I   – double-stranded DNA viruses; 
group II  – single-stranded DNA viruses; 
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group III – double-stranded RNA viruses; 
group IV – single-stranded RNA viruses – positive-sense RNA; 
group V  – single-stranded RNA viruses – negative-sense RNA; 
group VI – positive-sense single-stranded RNA viruses that replicate 
       through a DNA intermediate 
group VII – double-stranded DNA viruses that replicate through a 
        single-stranded RNA intermediate 
 
The groups VI and VII comprise the viruses with replication via the 
reverse transcription – synthesis of DNA on viral RNA template by reverse 
transcriptase enzyme. 
Further division of viruses within the groups is possible by viral type 
of symmetry, presence or absence of envelope, etc. 
It is established to date that above 300 viral species that pertain to 
more than 30 families can cause human diseases. The current list of viral 
human pathogens is only expanding all the time. 
The viral families of most medical relevance are presented in Table 9. 
 
Table 9  
Viral families of major clinical significance 
 
Baltimore 
group 
Type of nucleic acid 
 
Type of 
symmetry 
Envelope Viral families 
of medical relevance 
I 
dsDNA linear Icosahedral  Non-
enveloped 
Adenoviridae 
dsDNA linear Icosahedral Enveloped Herpesviridae 
dsDNA linear Complex Enveloped Poxviridae 
dsDNA circular Icosahedral Non-
enveloped 
Polyomaviridae 
Papillomaviridae 
     
II 
ssDNA linear Icosahedral Non-
enveloped 
Parvoviridae 
ssDNA circular Icosahedral Non-
enveloped 
Anelloviridae 
     
III 
dsRNA segmented Icosahedral Non-
enveloped 
Picobirnaviridae 
Reoviridae 
     
IV 
ss (+) RNA  Icosahedral Non-
enveloped 
Picornaviridae 
Astroviridae 
Caliciviridae 
Hepeviridae 
ss (+) RNA  Icosahedral Enveloped Togaviridae 
Flaviviridae 
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 ss (+) RNA  Helical Enveloped Coronaviridae 
     
     
V 
ss (–) RNA Helical Enveloped Paramyxoviridae 
Filoviridae  
Rhabdoviridae 
Bornaviridae 
ss (–) RNA segmented Helical Enveloped Orthomyxoviridae 
ss (–) RNA segmented Helical or 
icosahedral 
Enveloped Bunyaviridae 
ss (–) RNA segmented, 
ambisense 
Not determined Enveloped Arenaviridae 
     
VI 
ss (+) RNA 2 copies, 
reverse transcription 
Cone-like Enveloped Retroviridae 
     
VII 
dsDNA circular; 
reverse transcription 
Icosahedral Enveloped Hepadnaviridae 
     
 
The note: double-stranded nucleic acid is designated as ds, single-stranded – as ss. 
 
 
For individual precise identification of viruses especially isolated from 
the clinical source further infraspecies division of viruses is required. 
Nevertheless, ICTV states that viral division below the rank of species 
is not regarded as a part of official taxonomy of viruses.  
According to ICTV, the classification and naming of serotypes, 
genotypes, strains, variants and isolates of the same virus species “...is the 
responsibility of acknowledged international specialist groups”. 
Particular types and variants of the same virus can be greatly different 
in their virulence against the human host. 
Serotype of virus is determined by reactions with specific antiviral 
antibodies, e.g. by neutralization tests, ELISA, immunofluorescence assay, 
complement fixation test, inhibition of hemagglutination, etc. 
Genotype of virus (its genetic variant) is identified by molecular 
genetic tests, e.g. nucleic acid hybridization, PCR, or nucleic acid 
sequencing. 
Viral isolate is a pure viral culture isolated from the certain patient in 
the course of infection. 
Viral strain is defined as geneticaly homogenous population of 
viruses sharing the number of established common characters that 
distinguish this strain from other viral populations of the same species.  
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After detailed identification the strain is designated with number, date, 
point of isolation, etc. and stored in viral collection. 
It is generally ascertained that viral members of the same strain share 
genetic identity at least more than 90%. 
The variant of the same virus usually displays even higher genetic 
relatedness – about 96-98%.  
Nevertheless, in many cases the viruses demonstrate low genetic 
stability due to the elevated frequency of mutations and recombinations.  
During the course of infection the primary virus that initially affected 
the host undergoes rapid individual evolution. It results from intensive 
viral replication with multiple mutations as well as from the action of host 
immune system and/or administered antiviral treatment. 
This leads to formation of so-called viral “quasispecies”. It is not a 
taxonomic category. 
In general, quasispecies is a total number of closely related genetic 
variants arisen from intensive mutations of primary virus (“mutant cloud”) 
in the course of individual viral infection. 
Generation of quasispecies is typical for fast propagating RNA-
containing viruses with error-prone replication with high mutation rate, 
e.g. hepatitis C virus or HIV. 
The emergence of quasispecies is extremely significant in progression 
of viral infection. The ongoing pressure of host immune system and the 
influence of antiviral drugs promote the selection of resistant viral mutants. 
This creates new genetic lines resistant to antiviral therapy and therefore, 
leads to chronic viral disease. 
 
General Structure of Viruses 
 
Outside the cell the virus stays as inert particle known as virion. It 
can’t propagate in the environment. 
Virion is the extracellular form of virus existence. Virions are 
liberated from the cells after virus maturation.  
The inner (or core) part of virion harbors viral genome – the molecule 
of nucleic acid. 
Viral nucleic acid is enwrapped with protein coat, termed a capsid. 
Capsid is composed of identical protein subunits called capsomeres.  
Viral capsid proteins are bound tightly to genomic nucleic acid. This 
complex is termed nucleocapsid. Great number of viruses contains the 
capsid as the only external coat. These viruses are determined as the naked 
(or simplex) viruses.  
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More composite viruses carry additional outer lipid membrane or 
envelope, which is usually obtained from the cytoplasmic membrane of the 
host cell. These viruses are designated as enveloped viruses.  
Lipid coat usually contains the protein termed the matrix protein. 
Viral glycoprotein receptors form spikes that jut out of the viral envelope. 
They are responsible for the viral attachment to the susceptible cells. 
Viral structure is organized according to different types of symmetry. 
Widespread is icosahedral (or cubic) symmetry, because it is based on the 
icosahedral pattern – polyhedron with 20 faces. This assemblage provides 
the most efficient fit of capsomers into the tightly packed coat. Virions of 
icosahedral symmetry are usually spherical in shape. 
Another type is helical symmetry, where protein subunits with core 
nucleic acid are wound into the common helix with periodic coils. This 
complex is packed within the external lipid envelope.  
And some viruses with composite architectonics possess complex 
structure (or mixed symmetry). For instance, bacteriophages resemble 
spermatozoids in their shapes, where phage head is of icosahedral 
symmetry and the tail is of helical symmetry. Poxvirus resembles brick in 
shape with lateral bodies within the envelope. 
Naked viruses are usually resistant to the ether or other organic 
solvents, whereas enveloped lipid-containing viruses are sensitive. 
Impairment of external lipid shell leads to the loss of viral infectivity. 
There is a very special group of viruses, composed solely of nucleic 
acid, termed viroids.  
Viroids are the smallest viral agents infecting plants. Known viroids 
contain only the small single-stranded circular RNA. They are devoid of 
capsid and viroid RNA doesn’t encode protein molecules. 
 
 
Chemical Structure of Viruses  
 
Virus particles are composed of different kinds of polymeric 
molecules. 
Viral proteins are divided into structural and non-structural. 
Supercapsid and capsid proteins are referred to structural proteins. 
Supercapsid proteins are subdivided into attachment and fusion 
proteins. 
Attachment proteins initiate the recognition of susceptible cell by 
virus and provide specific interaction of virion with cell surface receptors. 
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Attachment glycoproteins are presented in viral spikes that bind to the 
target cells (e.g. hemagglutinin of influenza virus). 
Fusion proteins accelerate viral fusion with the cell membrane. 
Capsid proteins form nucleocapsid protein units (capsomers). 
Non-structural proteins comprise the early precursors of viral 
proteins; viral enzymes (DNA- and RNA-polymerases, proteases, 
neuraminidase, etc.); genomic and regulatory proteins, which control 
transcription and translation. 
Most of non-structural viral proteins are expressed inside the cells in 
the course of viral infection. 
Viral proteins possess antigenic properties, reacting with specific 
antibodies and immune cell receptors. 
Besides its own proteins, during maturation the virus may capture the 
proteins of the host cells. For instance, HIV harbors cellular protein 
cyclophilin up to 30% of its weight; without this protein HIV particles are 
non-infectious.  
Viral lipids are obtained from the infected cells, coming into the 
structure of viral envelope. They provide viral infectivity and stimulate 
hydrophobic interaction of virus particles with cell membranes facilitating 
viral entry. Overall, lipid structures comprise up to 30% of enveloped 
virion mass. 
Carbohydrate residues are usually bound to proteins in glycoprotein 
complexes of spikes and other viral receptors. They cover about 10-15% of 
virion contents. 
 
 
Viral Genomic Organization 
 
As was previously mentioned, viral genome includes a single type of 
nucleic acid. Viral DNA or RNA may be single-stranded (e.g. ortho- and 
paramyxoviruses) or double-stranded (reoviruses), segmented 
(orthomyxoviruses, etc.) or non-segmented (togaviruses, picornaviruses 
and many others), positive or negative, circular or linear. 
Protein-encoding strand of nucleic acid is called positive, or plus-
strand. This strand serves as a direct template for subsequent transcription 
and translation. 
RNA(+)-containing viruses (picornaviruses, togaviruses) use positive-
sense nucleic acid as a messenger RNA for protein synthesis. This RNA is 
considered to possess the infectivity, being able to induce the infectious 
process directly after virus penetration. 
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Negative or minus strand means the nucleic acid chain 
complementary the positive one. In that case viral protein formation is 
impossible without preliminary synthesis of positive chain on the negative 
strand template. For this purpose (–) RNA viruses contain RNA 
polymerase. It catalyzes the complementary RNA(+) synthesis within 
infected cells. The latter serves as mRNA. 
The smallest DNA-containing organisms are hepadnaviruses with 
genome size of 3.2 kbp, the largest poxviruses have the genome of 
375 kbp. 
Retroviruses carry reverse transcriptase, an enzyme that performs 
single strand DNA copy of viral RNA template. Then a second 
complementary strand of DNA is polymerized. This DNA molecule is 
capable of further integration with DNA of the infected animal or human 
cell, and retrovirus comes into provirus state. Integrated DNA serves as a 
template for transcription and translation of retroviral proteins. 
Poxviruses are the most intricately constructed viruses. Virions carry 
different enzymes in their own transcriptional system for nucleic acid and 
protein synthesis. 
Nucleic acid structure of human pathogenic viruses of the main 
importance is presented in the Table 9. 
 
 
Virus replication cycle 
 
Viral life cycle passes through definite consecutive stages: 
– viral attachment; 
– penetration (virus entry); 
– uncoating; 
– biosynthesis of viral components; 
– morphogenesis with assembly of viral particles; 
– virion release (or egress). 
 
The first step of infection is the attachment stage with adsorption of 
virions to the host cells. Viral spikes, containing attachment proteins, 
project out of the surface of the viral shell. Viral receptor molecules as well 
as the opposite cell receptors are usually glycoproteins. In some cases virus 
interacts with cell protein sequences (picornaviruses) and with 
oligosaccharides (orthomyxoviruses or paramyxoviruses). 
Сell receptor density for particular virus is in the range 10,000-
100,000 per infected cell. 
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Viral penetration or virus entry involves different mechanisms, 
depending on virus nature. Naked viruses are captured into the host cell by 
endocytosis (or viropexis) after virus adsorption. Adsorption usually occurs 
in membrane sites enriched with cellular receptor proteins clathrin or 
caveolin.  
Virion-containing vesicle (endosome or vacuole) is opened in 
cytoplasm, disseminating viral particles. 
Enveloped viruses can use the endocytosis mechanism also. The 
fragment of the cell plasma membrane enwraps the attached virion with the 
vesicle formation. Further the virus lipid envelope fuses with the cell 
membrane due to hydrophobic forces with subsequent release of free 
nucleocapsids into the cytoplasm. 
In another case the direct fusion of viral envelope with the plasma 
membrane is performed following the strong specific adsorption of viruses 
to the host cell receptors. Specific fusion proteins stimulate membrane 
fusion (e.g. F-protein of paramyxoviruses, the similar action is controlled 
by influenza virus hemagglutinin). Fusion proteins promote specific type 
of viral cytopathic activity (see below), causing host cell integration with 
symplasts and syncytium appearance. The envelope-devoid nucleocapsids 
are then liberated into the cytoplasm under the inner side of the cell 
membrane. 
Uncoating of virus results in nucleic acid release from the 
surrounding proteins before the genome replication and early protein 
synthesis. Uncoating follows viral entry and continues after penetration. 
Dissolution of virus is facilitated by acidic pH in the endosome. Viral 
genome can be liberated as a naked nucleic acid (property of 
picornaviruses) or as a nucleocapsid (essential for reoviruses). In latter 
case it carries polymerases, necessary for further viral replication. 
Biosynthesis of viral components varies strongly in different viruses. 
It depends on viral nucleic acid structure and polarity.  
DNA viruses are reproduced usually in the nucleus of the infected 
cells. They use cell DNA and RNA polymerases for nucleic acid 
replication. 
The majority of DNA viruses contains double-stranded DNA, which is 
transcribed into sense mRNA (e.g herpesviruses). The latter is used as a 
pattern for protein synthesis. 
The final transcript of mRNA can be achieved in several ways 
including reading frame shift or change of transcription starting point in 
the same reading frame (overlapping genes).  
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Splicing of primary transcript, where the elimination of inserted non-
coding RNA fragments occurs resulting in formation of mature mRNA, is 
essential for adenoviruses. 
Newly formed viral mRNAs are translated on cellular ribosomes 
yielding viral proteins. 
Virus-induced early viral proteins are synthesized before the 
replication of viral genome. They are produced in host cell ribosomes 
usung viral mRNA template. Most of them are viral enzymes and 
regulatory protens serving for the next steps of viral reproduction. 
Late proteins are mostly the structural units of viral capsid; they are 
formed after the replication of viral genomic nucleic acid. 
Replication patterns of RNA viruses are even more entangled.  
For instance, reoviruses use initial double stranded segmented RNA 
for mRNA synthesis by the own viral RNA polymerase.  
Positive single-stranded RNA of many viruses (e.g. picornaviruses or 
flaviviruses) is infectious, and it is used as a template for direct protein 
synthesis. Viral RNA of these viruses is multiplied through double-
stranded plus-minus RNA intermediate. 
Viruses, containing negative genomic RNA (e.g. rhabdoviruses, 
paramyxoviruses, orthomyxoviruses), synthesize positive RNA strand by 
viral RNA polymerase. In case of segmented viral genomes 
(orthomyxoviruses) mRNA is transcribed sequentially from different 
segments. 
Long replication cycle of retroviruses is maintained by viral reverse 
transcriptase. It catalyzes DNA copy formation on the viral RNA 
template. After DNA integration into the host cell genome it is used for 
transcription of mRNA, coding for the viral proteins. 
Viral genomic RNA is usually multiplied in the cytoplasm of infected 
cells with some exceptions (e.g. retroviruses). 
RNA-containing viruses are characterized by the almost simultaneous 
expression of all viral proteins. Some viruses (picornaviruses, retroviruses) 
translate mRNA into common precursor polyprotein, which is cleaved by 
proteases with final formation of protein sequence. 
Overall, viruses demonstrate the disjunctive type of reproduction, 
where viral components (DNA and proteins of the coat) are synthesized in 
separate bacterial cell compartments. 
Viral morphogenesis (or maturation stage) includes the self-assembly 
of virions within the cells. It is the multistep process of viral capsid 
formation and nucleic acid packing. 
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The time interval between the virus penetration and the end of viral 
assembly is known as the eclipse period, where the virus is deprived of 
infectivity, being incapable of causing infectious process. The infectivity is 
restored only after full-value maturation of virus progeny. 
Virion release (or viral egress) is performed in several ways. In case 
of the cell death due to viral infection the virus is liberated by the lysis of 
the host cell. Another mechanism is budding through the cellular 
membrane, which retains the viability of the infected cells. 
For enveloped viruses the maturation step is accomplished during 
budding, where the fragments of plasma membrane cover the nucleocapsid 
making viral envelope with parallel embedding of matrix proteins and 
spikes. 
The whole length of the virus replication cycle varies from 6-8 hours 
for picornaviruses to several days for adenoviruses or measles viruses. 
Sometimes after reproduction cycle the defective viruses are formed, 
which are usually non-infectious. Such virus particles lack some important 
genes due to incorrect nucleic acid excision or impaired viral protein 
translation and assemblage. 
Outcomes of viral infection result in the productive, persistent, 
transforming and latent infection. 
Productive infection leads to active accumulation of viral particles 
with destruction of infected cells e.g., by lysis. Newly synthesized virions 
are able to spurt the infection, penetrating into neighboring susceptible 
cells. In most of cases it is characteristic for acute viral infections.  
Persistent infection progresses much more slowly. It might be 
followed by low viral replication with slow budding from the infected 
cells. Thus, the host cells survive and can propagate. It is related with 
chronic viral infection 
Latent virus infection evolves, when the virus is continuously present 
inside the infected cells, but its reproduction is very slow or even ceased.  
Likewise, latent infection is established after the integration of the 
viral genome into the cell DNA with formation of provirus (integrative 
infection). In that case mature virus particles are not produced for a long 
time.  
Latent infection also corresponds to chronic viral disease. 
Transforming infection is promoted by particular type of viruses (e.g. 
Oncovirinae subfamily representatives, papillomaviruses, etc.) 
Transformation is mediated by complex chain of genetic events, caused by 
virus, which affect the genome of susceptible cells. The virus can initiate 
tumor growth in the infected organism. 
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Laboratory Diagnosis of Viral Infections.  
Methods for Virus Cultivation 
 
For laboratory diagnosis of viral diseases the indication and 
identification of certain virus present in clinical specimen is elaborated. 
Indication of viruses means the discovery of virus presence in the 
clinical material, whereas virus identification assumes the exact 
determination of virus species or type (primarily, viral serotype and viral 
genetic variant or genotype). 
Three basic groups of laboratory tests are used in clinical practice for 
indication and identification of viruses: 
– rapid (or express) tests allowing direct detection of viruses in 
clinical specimens; 
– isolation of viral culture; 
– serological tests that confirm the diagnosis of viral infection by 
detection of specific antibodies against viral antigens in patient’s serum. 
 
 
As current viral taxonomy is primarily based on genetic ground, the 
precise determination of viral genetic variant (genotype) is pivotal for 
correct identification of virus. For this purpose versatile molecular genetic 
tests like methods of nucleic acid sequencing, PCR and nucleic acid 
hybridization are commonly used. 
PCR is the most convenient and reliable as well as sensitive and 
specific genetic test with possibility of full automation that is available 
now for clinical practice. 
On the other hand, DNA microarray technologies based on parallel 
hybridization of multitude of nucleic acid probes placed in DNA biochip 
allow simultaneous testing of hundreds of clinical specimens for specific 
viral DNA or RNA. This creates excellent opportunities for mass screening 
of population for viral infections.  
Finally, highly sophisticated methods of nucleic acid sequencing play 
the role of the reference tests for precise identification of viruses. 
Serotype of virus is determined by reactions with specific antiviral 
antibodies, e.g. by neutralization tests, ELISA, immunofluorescence assay, 
complement fixation test, inhibition of hemagglutination, etc. 
PCR and molecular hybridization of nucleic acids as well as ELISA 
and immunofluorescence assay are the most commonly used methods for 
rapid detection of virus directly in clinical specimen. 
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Genetic tests made possible the identification of fastidious viruses that 
can’t be cultured in laboratory cell lines – PCR or nucleic acid probing 
reveals nucleic acids of these viruses directly in the host tissues. For 
instance, noncultivatable sarcoma Kaposi virus was detected in tissues of 
AIDS patients and was proven to be the herpes family representative 
(herpesvirus type 8) by methods of molecular genetic analyses. 
For isolation of virus cultures (as the viruses can propagate only 
inside the living cells) three main models are commonly used: laboratory 
cell cultures, chicken embryos and susceptible laboratory animals. 
The main aims of virus cultivation presume the efficient laboratory 
diagnosis of viral infections; investigation of pathogenesis of viral 
diseases; and laboratory design and trials of antiviral drugs and vaccines. 
The most simple and cheap model of virus propagation is their 
cultivation in embryonated chicken eggs under strictly controlled 
conditions. Virus-containing material can be inoculated in any 
compartment of the embryonated egg. 
Indication of viral growth in the fertile chick eggs is performed by 
estimation of embryo death, vessels impairment, production of pocks or 
plaques on the chorioallantoic membrane (e.g., it is characteristic for 
herpes, smallpox, or vaccinia viruses). 
Viruses, expressing hemagglutinins in their external coat, are shown 
to induce hemagglutination and hemadsorption phenomenons, clumping 
erythrocytes of different animal species. This is essential for ortho- and 
paramyxoviruses, certain types picornaviruses, and others. 
As the result, after cultivation in chicken embryo the indication of 
hemagglutinating virus is performed by hemagglutination test. In this case 
the twofold dilutions of the allantoic fluid are mixed with sensitive red 
blood cell suspension. During the incubation the virions interact with 
erythrocytes, mediating their aggregation. The surface viral hemagglutinins 
of virion can attach simultaneously to two and more separate red blood 
cells that promote erythrocyte clumping. 
The endpoint of hemagglutination test (or virus titer) is determined 
as the greatest dilution of the virus-containing material, which causes a 
clearly marked hemagglutination. 
Similarly virus indication by hemadsorption is performed using the 
microscopy of the mixture of virus-infected embryo cells with erythocytes. 
In latter case the eukaryotic infected cells, surrounded by adsorbed 
erythrocytes, are readily discernible in the smear. 
Identification of hemagglutinating virus in the chicken embryo is 
carried out by virus hemagglutination inhibition test. After primary 
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incubation of the virus-containing allantoic fluid with the dilutions of 
antiviral type-specific antibodies, the erythrocyte suspension is added. As 
antibodies block the viral hemagglutinins, the hemagglutination is 
inhibited, and the virus serotype is determined. 
Nevertheless, the most suitable and widespread model of virus 
investigation is the viral cultivation in cell (or tissue) cultures. 
All cell cultures are prepared from animal or human source. The tissue 
is minced into small pieces and homogenized. Then it is treated by 
proteolytic enzyme (mainly, by trypsin or collagenase) to disintegrate 
intercellular matrix. The cell suspension is placed into culture multiwell 
plate or flask with sterile nutrient complex medium, containing all 
necessary growth factors, such as amino acids, carbohydrates, vitamins, 
salts and sometimes fetal serum components and antibiotics to prevent 
bacterial growth. The cells propagate in the medium and finally form a 
single layer of the cells (cell monolayer), attached to the plastic surface. 
There are three main types of cell cultures: primary, secondary or 
diploid, and continuous. 
Primary cell cultures are obtained from different human and animal 
tissues (human skin fibroblasts, monkey kidney cells, etc.) They grow for 
1-3 weeks with final autolysis and culture death. In most of cases primary 
cultures undergo only 1-2 passages, thus they are not suitable for long-term 
cultivation. 
Cell passage (or subculture) means reinoculation of a small portion of 
basic cell culture grown in the medium into another well or flask with fresh 
nutrient medium for further propagation. Cell passaging substantially 
expands the survival time of laboratory cell lines. 
Diploid (or semi-continuous) cell cultures are designed for longer 
cultivation. The sources for diploid cell lines are fetal tissues (e.g., human 
diploid lung fibroblasts, human breast epithelial cells, etc.) They are also of 
limited survival, but can propagate for 40-50 or more passages. The nuclei 
of diploid cells retain their normal chromosome pattern. They can be used 
for cultivation of most viruses. 
And continuous cell cultures are originated from the almost immortal 
tumor cell lines (HeLa cells from human cervical cancer, HEp-2 from 
larynx carcinoma, McCoy cells, and many others.) Tumor cells can divide 
indefinitely long in vitro. These lines are appropriate for many viruses, but 
their genome might be not completely stable, rendering rare but 
cumulating chromosome aberrations. Also they can be occasionally 
contaminated by bacterial intracellular parasites (e.g., mycoplasmas) in 
course of long-time cultivation. 
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Viral indication and identification in the cell cultures is carried out 
by several methods. 
Viruses are indicated by their cytopathic effect. During cultivation the 
viruses impact on the cell life cycle resulting in changes of cell 
morphology and viability. This viral action is known as cytopathic effect. 
Different types of cytopathic effects exist – degeneration and 
destruction of monolayer, cell lysis or necrosis, plaque appearance, 
inclusion formation, cytoplasmic vacuolization, symplast, syncytium and 
giant cell formation. Many viruses develop a special cytopathic effect, 
which is used for viral indication. 
Inclusion formation is the characteristics of many viruses. RNA 
viruses (e.g. rhabdoviruses) usually form inclusions in the cell cytoplasm, 
while DNA-containing agents (e.g. herpesviruses) – in the nuclei of 
infected cells. However, the cells, infected with DNA-containing 
poxviruses, produce the specific inclusions (Guarniery bodies) in 
cytoplasm. Some viruses are shown to form inclusions both in the cell 
nucleus and cytoplasm (measles virus). Inclusions are the sites of virus 
intracellular replication. 
Different viruses can induce symplast and syncytium formation in the 
cell cultures because of virus-induced cell fusion activity. Giant 
polynuclear epithelial cells (symplasts) are formed after measles virus 
action. Respiratory syncytial virus and HIV exert the damage of infected 
cells by syncytium formation. 
Plaques appear after cell monolayer destruction and lysis, caused by 
virus. Plaques look like clear zones within the cell culture. This method is 
used for the determination of virus quantity, because each plaque is the 
result of single virus particle propagation within susceptible cells. Total 
virus count is calculated by multiplication of plaque quantity by the 
dilution of the sample. 
Indirect evaluation of viral cytopathic activity is performed by color 
reactions in the cell cultures. Test tubes, containing cell cultures, virus 
sample, and nutrient medium with indicator dye, are incubated for several 
days. During incubation the virus replicates within susceptible cells and 
destruct them. Control test tubes are free of virus, and the abundant growth 
of the cell culture is observed. In the control tubes the color of the indicator 
medium is changed due to the accumulation of products of cellular 
metabolism, resulting in the medium acidification and pH lowering. And 
vice versa, viral cytopathic activity blocks cell metabolism retaining the 
initial color of the medium. 
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Hemagglutination and hemadsorption are also used for 
hemagglutinin-containing virus indication in the infected cell cultures. 
Influenza and parainfluenza viruses are determined by these reactions. 
Viral identification in the cell and tissue cultures is based on virus 
neutralization reactions, promoted by specific antiviral antibodies, which 
block viral activity. The inhibition of virus hemagglutination and 
hemadsorbtion, neutralization of plaque and inclusion formation, 
neutralization of color reactions can be applied. 
And obviously, for precise indication and identification of viral 
isolates grown in cell culture lines, all genetic methods (like PCR or 
nucleic acid hybridization) or serological tests (immunofluorescence or 
ELISA test) are commonly used in clinical virology laboratories. 
Tissue and cell cultivation makes possible the rapid detection and 
diagnosis of viral infections. Also it is the suitable technology necessary to 
obtain the pure viral culture from cell lysate. It can be used for virus 
diagnosticum production or vaccine design. 
Sometimes the viruses are inoculated to propagate in the susceptible 
laboratory animals. For instance, Coxsackie viruses infect newborn 
“suckling” mice with characteristic disease development. Indication and 
identification of viruses in this model is similar with the above described. 
Serological testing allows to confirm the diagnosis of viral infections 
by detection of specific viral antibodies arisen in patient’s serum. A broad 
group of serological methods are currently used in laboratory practice – 
ELISA (the most common test), hemagglutination inhibition assay, 
radioimmunoassay, complement fixation test, neutralization test and some 
others.  
Identification of specific antibodies of IgM class indicates acute 
primary viral infection 
In many clinical situations serological paired sera test is elaborated, 
where patient’s antiviral antibodies are tested at least twice – early after the 
disease onset and next closer to patient’s recovery. The fourfold increase 
of the titers of specific antibodies gives the confirmation of current viral 
infection. 
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Chapter 14 
BACTERIOPHAGES 
 
 
Bacteriophages, the History of Discovery and Initial Characteristics 
 
Bacteriophages are viruses, which are specific parasites of bacteria. 
It is generally acknowledged that bacteriophage activity was described 
first by F. d'Herelle in 1917. He discovered the specific lysis of bacterial 
culture affected by non-cellular filtrate of dysentheria patients feces. 
However, the similar phenomenon was observed previously by 
N. Gamaleya in 1892 and F. Twort in 1915. 
Bacteriophages are ubiquitous in nature. They accompany bacteria in 
any place of their habitation: animal or human body, plants, water, soil, 
drainage waters, etc. For instance, phages are essential component of 
bacterioplankton, the bacteria found in the ocean. In this environment up 
to 2.5 x 10
8
 phages/ml have been found. 
Similar way bacteriophages are commonly isolated from different 
bacteria-containing foodstuffs (dairy products, fruits, etc.) 
In patients, suffering from various bacterial diseases, the phages are 
excreted by feces, urine, sputum, and saliva in the parallel with bacterial 
discharge. They are important epidemiological markers of the bacterial 
infection. 
 
 
Morphology of Phages 
 
Bacteriophages are typical viruses of complex structure. 
The majority of phages resembles spermatozoids in their shapes but 
filamentous and some other forms occur. Head of phage contains viral 
genome – DNA or RNA. 
The phage size usually varies from 20 to 200 nm. 
Main structural components of phages are nucleic acid (DNA or RNA) 
and proteins. Bacteriophage RNA is single-stranded. DNA may be single 
or double-stranded. Nucleic acids of phage are tightly packed into the 
phage’s head.  
Bacteriophages are composed of head, protein tail with hollow core 
and fibers, attached to tail basal plate. 
Phage head is of protein nature with icosahedral symmetry. It can be 
naked or covered with external envelope (supercapsid). Phage head can 
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carry spikes with receptor activity. Inner head proteins support DNA 
supercoiling. Phage’s tail of helical symmetry is covered with sheath, 
composed of contractile proteins, which provide tail contraction. They can 
be connected with calcium ions, and different enzymes (e.g., endolysins, 
ATPase or some others). 
Small amount of lipids are also present in phages envelope. 
Total protein content is about 50% of phage weight, nucleic acid 
content – 40-50% and lipids are about 1.5-3%. 
Well-studied is a group of T- (or type) phages of E. coli, as well as 
temperate E. coli lambda-phage, some filamentous phages (for instance, 
M13 phage) and many others. 
The differentiation of phages is based upon type of nucleic acid, 
phage’s morphology, chemical structure, and their interaction with the 
bacterial cell. 
As the result, all phages are divided into DNA- and RNA-containing.  
According to their morphology they are separated into several types: 
– DNA filamentous phages; 
– RNA-containing phages with rudimentary tails; 
– DNA phages with short tails; 
– DNA phages with long non-contractile tails; 
– DNA phages with long contractile tails. 
 
Phages are enough resistant to different physical and chemical factors 
(radiation, drying, pH fluctuations, or temperature). Nevertheless, they are 
rapidly inactivated by boiling, chemical disinfectants, UV-light. 
 
 
Interaction of Phages with Bacterial Cells 
 
There are four basic stages in phage-bacterial interaction that generally 
reflect the common steps of any viral replication cycle: adsorption, cell 
penetration, phage reproduction, and release of newly formed phage 
particles. 
Adsorption is provided by the attachment of receptor fiber proteins of 
the phage tail to the specific receptors on the bacterial cell wall. 
Reversible and irreversible phases of adsorption are indicated. The 
adsorption is accelerated by divalent cations (Ca
2+
 and Mg
2+
). 
Penetration is simulated by the action of phage enzymes. For 
instance, phages T4 of E. coli possess lysozyme-like enzyme endolysin, 
which degrades the minimal site of the bacterial cell wall. The tip of the 
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tail opens allowing viral DNA to move through the channel of the phage 
tail. Phage ATPase generates energy for tail contraction, and genomic 
nucleic acid is injected by into bacterial cell, passing through the cell wall 
and cytoplasmic membrane. The phage capsid remains outside the cell. 
Reproduction stage covers the period between the phage penetration 
and release of newly created phage particles. At the beginning of 
reproduction there is short-term eclipse phase, when phage biopolymers 
(genomic DNA and proteins of the coat) are synthesized.  
Phage DNA serves both as the template for replication of new phage 
DNA molecules and for transcription of matrix RNA, which encodes 
phage proteins. 
After the DNA penetration a number of “early” enzymes and other 
proteins are formed within the cell. They are generally termed as phage-
induced proteins. Their synthesis occurs due to the partial transcription of 
phage DNA by cellular polymerases. Some of these proteins (for instance, 
phage-induced nuclease) block bacterial cell DNA replication, and the 
phage switches bacterial intracellular machinery to its own purposes. 
As the result, the enzymes of bacterial cell actively supply the process 
of phage reproduction with energy and monomers for protein and nucleic 
acid synthesis. Bacterial ribosomal apparatus produces phage proteins. 
Then the assembly of structural components of phage (its head, tail 
and tail spikes, fibers) is activated. 
Late-induced enzymes provide the assembly of phage particles and 
phage release out of bacterial cell. 
Phage assembly is a complex process. After phage head formation 
DNA is packed into it, then the tail is attached with subsequent addition of 
tail spikes. 
Overall, for above mentioned T4-phage eclipse phase is finished 
within about 30 minutes; and new viable phage particles can be detected 
inside the bacterial cell. 
Phage release is initiated by late-induced enzymes with cell wall 
hydrolyzing activity (endolysins or murein hydrolases). They break down 
bacterial peptidoglycan layer with subsequent phage dissemination. 
Finally, hundreds of newly formed phage particles are liberated, and 
these virions are capable of infecting the neighbouring bacterial cells. 
 
 
 
 
 
 253 
Outcomes of Phage Infections 
 
The infectious process arisen in bacterial cells by specific 
bacteriophages can be resolved in various ways. 
Virulent phage infection leads to the burst maturation of new phages 
with further lysis of the bacterial cell. In this case the cycle of phage 
propagation lasts for 30-90 minutes. It is the variant of productive viral 
infection that is followed by host cell disruption with massive virion 
egress. 
Lysogenic infection or lysogeny is caused by temperate phages. 
These phages can integrate its DNA into the nucleoid of bacterial cell. 
Phage DNA then replicates as an integral part of the bacterial chromosome. 
Nucleoid-integrated bacteriophage is known as a prophage, while the 
bacterial cell infected with prophage is called a lysogenic cell, or lysogen. 
The well-known example of temperate bacteriophage is the phage 
lambda, which interacts with E. coli. 
Phage DNA integration into the bacterial chromosome is possible due 
to site-specific recombination between bacterial and phage genomes. Short 
nucleotide sequences in the DNA of phage and host nucleoid are 
homologous, allowing closest phage and bacterial DNA interaction 
(synapse) with subsequent genomes consolidation (for details see the 
Chapter of bacterial genetics). 
Being integrated, the phage DNA can remain in the prophage state for 
a long period of time. Its expression can enrich the host cell with some new 
properties. This bacterial cell state is known as lysogenic (or phage) 
conversion. Very often conversed bacterial cells become virulent after 
phage acquisition. For instance, Corynebacterium diphtheriae, Clostridium 
botulinum and Vibrio cholerae start to express extremely poisonous 
exotoxins. That is true also for beta-hemolytic streptococci, which acquire 
the ability to produce erythrogenic toxin that actively participate in scarlet 
fever, and for salmonellae that change LPS structure of cell wall due to 
phage infection. 
From the other hand, if prophage disappears from bacterial cell, the 
cell becomes avirulent. 
In the period of lysogeny the infected cell acquires the immunity to 
a certain type of phage. Repressor protein, encoded by one of integrated 
viral genes, blocks possible transformation of prophage into active virulent 
form. 
Bacteriophage activation with excision of viral genome (phage 
induction) is usually an accidental low-incidence process. It is occurred 
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after lysogenic bacterium exposure to ultraviolet light, irradiation, 
chemicals action, etc. In that case the prophage transforms into a mature 
vegetative phage. 
Sometimes after non-proper excision temperate bacteriophages can 
capture the bacterial genes surrounding phage nucleic sequence. In that 
case the phage becomes defective but able to transfer different host 
bacterial genes to other susceptible bacteria. 
This phenomenon is known as transduction, and it makes available 
the exchange of genetic material between bacterial cells. This results in 
great raise of bacterial population diversity, which is valuable for microbial 
evolution. Molecular transduction is actively used in genetic engineering. 
Filamentous phages can leave the infected cells without their 
destruction. All of them are of single-stranded DNA genome. Filamentous 
phages release is known as extrusion from the bacterial cell. In that case 
infected bacteria save their ability to cell division. Infected bacteria are 
called as carrier cells. 
Finally, about 50% of bacterial species are proven to carry special 
genetic region responsible for so-called bacterial “adaptive immune 
system”. This system maintains the specific protection of microbial cells 
against bacteriophage infection. For instance, it is essential for many 
aggressive human pathogens like M. tuberculosis or Y. pestis. 
Genome of these bacteria contains the number of genetic elements 
known as CRISPR cassettes (abbreviation “CRISPR” means “clustered 
regularly interspaced short palindromic repeats”). 
CRISPR cassette includes many short genetic spacers of similar 
length but of different DNA sequence interspersed between almost 
identical direct repeats of DNA. A single CRISPR cassette may contain 
more than 100 spacers. Every spacer harbors a short sequence of foreign 
DNA captured by bacterial cell during the previous infection with 
bacteriophage or plasmid.  
The genetic elements of this system control the acquired defensive 
reactions of bacterial cell against the invaded foreign nucleic acid of 
bacteriophage. Furthermore, the genetic information of invaded DNA is 
memorized in bacterial genome and becomes heritable. As the result, next 
entry of the same nucleic acid of bacteriophage leads to the activation of 
specific RNA-mediated enzymatic reactions that actively eliminate the 
extraneous nucleic acid of phage.  
The family of bacterial enzymes with integrase and nuclease activity 
generally termed as Cas proteins are responsible for uptake and 
degradation of phage nucleic acids. They are encoded by special bacterial 
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genetic locus cas (cas means CRISPR-associated) that borders with 
CRISPR genetic region. 
The details of functioning of bacterial CRISPR/Cas systems were 
presented earlier in the section of microbial genetics (Part 1 of the 
textbook). 
 
 
Production of Phage Culture 
 
To obtain virulent bacteriophages, the susceptible bacterial cells are 
infected by minimal amount of phage particles. During incubation at 37
0С 
for 18-24 h phage population propagates causing bacterial cell lysis. The 
remaining microbial fragments are removed from phage culture by 
centrifugation or filtration. The filtrate is tested for purity, sterility, and 
biological activity. 
 
Laboratory Determination of Bacteriophage Activity 
 
Bacteriophage presence in the investigated sample can be revealed by 
drop of the filtrated material on Petri dish with appropriate medium, pour 
plated with the susceptible bacterial culture. After incubation for 24-48 h at 
37
0С the infection of bacteria by phages results in a plaque formation, a 
clear area in the bacterial lawn. The plaque is formed due to phage lytic 
activity. 
Quantitative phage determination is possible by titration methods. 
Two main variations of these methods are based on phage titration in 
liquid or solid nutrient medium. 
In first case tenfold dilutions of the phage-containing material are 
prepared and then inoculated into liquid nutrient medium. The susceptible 
microbial culture is added to the broth. After incubation for 24-48 h at 
37
0С the growth inhibition is evaluated. The phage titer is established as 
the last dilution of the phage culture, which is able to cause complete 
inhibition of visible microbial growth. 
Similar agar titration method is performed as follows: mixture of 
susceptible bacterial culture with tenfold phage dilutions is poured on 
different Petri dishes with solid nutrient medium. After incubation for 24-
48 h at 37
oС the growth inhibition with plaque formation is estimated. The 
last phage dilution resulting in isolated plaque formation is considered to 
be the endpoint (titer) of the reaction. Total phage quantity is calculated by 
multiplication of last plaque count by the dilution of the sample. 
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Practical Applications of Phages in Biology and Medicine 
 
Practical applicability of bacteriophages in various fields of biology 
and medicine is based on their capacity to specific interaction with 
susceptible bacterial strains. 
First of all, bacteriophages are long time used for laboratory diagnosis 
of a large number of infectious diseases. 
Species-specific phages interact with bacteria of certain bacterial 
species, whereas type-specific phages can affect only particular variant of 
bacteria within the same species. This process is known as phagotyping. 
The specific phagotype of bacterial strain is proven to be a powerful 
epidemiological marker of the infection. Isolation of bacteria of the same 
phagotype from various human or animal hosts allows to trace the course 
of infection. 
Likewise, phagotyping is used for precise identification of bacterial 
isolates of a great number of microbial species (salmonella, shigellae, 
staphylococci, causative agents of plague, cholera, etc.) 
Also bacteriophages are being actively implemented now into medical 
treatment and prophylaxis of bacterial infections. This is primarily related 
with exuberant spread of multidrug resistant bacteria causing severe 
hospital-acquired infections (e.g., methicillin resistant Staphylococcus aureus 
strains, isolates of Salmonella typhimurium, Pseudomonas aeruginosa, 
Stenotrophomonas maltophilia, Acinetobacter baumannii, and others).  
Finally, phages vectors are widely used in genetic engineering for 
design of recombinant vaccines, hormones, cytokines and many other 
valuable biological products.  
Modern advanced vectors include complex genetic systems that 
contain DNA of various origins; for example, combined phage and plasmid 
DNA sequences. 
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Chapter 15 
CAUSATIVE AGENTS OF VIRAL RESPIRATORY INFECTIONS 
 
 
 
ORTHOMYXOVIRUSES 
 
 
The History of Discovery of Influenzaviruses 
 
Influenza is known from the Hippocrates era. Further flu-like 
epidemics were described in Middle Ages. Well-documented are influenza 
epidemics of 1890 and of 1900. Finally, the global influenza pandemic of 
1918-1919 (Spanish flu) caused the death of more than 20 million people. 
Viral etiology of influenza was established by W. Smith, C. Andrews, 
and R. Laidlaw, who isolated influenza type A virus in 1933.  
T. Francis and T. Magill isolated influenza type B virus in 1940, and 
type C influenza virus was discovered by R. Taylor in 1947. Previously 
circulated pandemic strains were ascertained later as influenza viruses by 
serological investigations; this conclusion was confirmed nowadays by 
genetic tests (PCR and others). 
Viruses of influenza type A pose the most serious threat for public 
health. They regularly cause seasonal influenza epidemics repeated in 
every 2-3 years, but also they can cause severe global pandemics of the 
disease. Influenza type В virus usually accounts for seasonal influenza 
outbreaks at time intervals of 3-6 years, and influenza С virus promotes 
only mild, sporadic forms of diseases. These differences rely upon the 
virus type A ability to undergo gene reassortment with subsequent change 
of viral antigenic structure. Thus, in several decades after the previous 
pandemic, a new subtype of influenza A arises in human circulation, 
resulting in new pandemic (e.g. H1N1 in 1918; H2N2 in 1957; H3N2 – 
Hong Kong flu – in 1968). H1N1 strain returned in 1977 (Russian flu). 
It was proven that all of pandemic strains are the reassortants between 
avian and human influenza viruses, except Hong Kong flu virus. 
Last global influenza pandemic later called as “swine flu” was 
declared by WHO in 2009. It originated from a newly emerged pandemic 
strain of H1N1 virus designated А/2009/Н1N1 (or pdm09 strain). This 
virus appeared to be quadruple reassortant of primary human, avian, and 
pig influenza viruses. 
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In 1997 the initial case of devastating human infection caused by 
avian influenza A virus (H5N1, avian flu) has been registered in Hong 
Kong. Since that time the multiple cases of H5N1 avian flu were observed 
in Southeast Asia with common fatality rate of more than 50%. 
Finally, the first human cases of avian flu engendered by novel highly 
pathogenic avian virus H7N9 were indicated in China in 2013. The 
lethality of epidemic outbreaks of this disease exceeded 25%. 
 
 
Classification of Influenza Viruses 
 
The family Orthomyxoviridae currently comprises 6 viral genera.  
The causative agents of influenza are placed into 3 separate genera 
Influenzavirus A, B and C, respectively, each harboring the single viral 
species of the same names (influenza A, B, or C viruses). 
Different viral types A, B, C are distinguished by their serological 
properties. 
A, B, and C type division of influenza viruses is based on antigenic 
variations of nucleocapsid NP viral structural proteins. They are distinct in 
all three types. Virus subtyping is performed according to antigenic 
differences of the surface glycoproteins hemagglutinin (H) and 
neuraminidase (N). Currently 18 subtypes of Н (Н1-Н18) and 11 of N 
(N1-N11) are described. They are combined in many variations. Influenza 
virus strains with five different HA (H1-H3, H5, and H7) and three N (Nl, 
N2, and N9) were isolated from humans. 
The strains of influenza viruses are marked by virus type, host, 
geographic origin, number and year of the strain isolation and by its H and 
N numbers, e.g., A/Hong Kong/03/68(H3N2). 
 
 
Structure of Viruses  
 
Influenza virus of A and B types contains single-stranded negative 
RNA, which is segmented into 8 fragments (RNA of type C viruses 
contains 7 fragments without neuraminidase gene). It is lipid enveloped 
virus of spherical shape. 
The diameter of viral particles varies in the range of 80-120 nm. Viral 
nucleocapsid is of helical symmetry. 
Influenza virus A carries at least 15 distinct proteins. 
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Type-specific nucleoprotein (NP) is tightly bound to viral RNA. Also 
the virion contains its own RNA polymerase.  
Viral matrix M1 protein scaffolds the outer coat of influenza virus; 
M2 structural proteins make numerous ionic channels in viral coat 
facilitating disassembly of virion. 
The viral particle is enwrapped by lipid envelope of host cell origin 
with external spikes. Different spikes contain two major glycoproteins – 
hemagglutinin (H) and neuraminidase (N).  
Viral H is a major viral receptor that binds to sialic acid residues of 
receptors of upper respiratory tract epithelial cells. It is able to agglutinate 
the erythrocytes of different species.  
Viral N is the sialidase enzyme that hydrolizes sialic acid in external 
mucous layer of respiratory tract, thus facilitating viral entry. Also this 
enzyme is essential for virion release, as it prevents viral particles self-
aggregation. Both of the proteins are of strong antigenic activity, causing 
neutralizing antibodies production. 
Certain viral non-structural proteins can be regarded as virulence 
factors of virus. 
For instance, protein PB1-F2 affects mytochondria and stimulates 
apoptosis of infected cells. Protein NS1 inhibits expression of interferons 
and other antiviral cytokines. Enzyme PА-Х with endonuclease activity 
destroys cellular mRNAs, thereby terminating cell protein synthesis. 
Segmented genomic RNA of influenza viruses encoding 
hemagglutinin and neuraminidase is capable of gene segment re-
assemblage, known as genetic reassortment. After possible mixed 
inoculation of the cell by the viruses of different types (e.g., H1N1 and 
H3N2) the reassortment can take place, resulting in new influenza virus 
subtype formation. 
Genetic reassortment ensures sharp viral genomic changes, called 
genetic shift. The shift usually occurs between the genomes of type A 
human and avian influenza viruses after possible coinfection. This 
coinfection may occur in the cells of pig host. It leads to the rapid creation 
of a new virus subtype.  
Influenza В and С viruses are deprived of antigenic shift because of 
little spread of related viruses in animals. 
Genetic drift means the minor genetic variations of viral protein-
encoding sequences, ensuing from the point mutations in these genes. It 
leads to gradual viral escape from the action of host specific antibodies. 
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Virion Resistance 
 
Influenza viruses are relatively stable to cooling and can survive at 
temperature 0-4
oC. They are inactivated at 65°C in 5-10 minutes. These 
viruses are sensitive to all disinfectants, ether and other organic solvents, 
UV light and to acidic pH. 
 
 
Viral Replication Cycle 
 
The replication cycle of influenza virus is rather short (about 6-8 h) 
being focused in the nucleus of infected cells.  
Viral attachment is promoted by interaction of hemagglutinin with 
cell-surface sialic acid. For successful binding hemagglutinin should be 
activated by local proteolysis with host enzymes localized in upper 
respiratory tract. 
 Receptor-mediated endocytosis provides virion internalization. After 
fusion of viral envelope with the cell membrane the uncoating activates. 
Acidification of the endosome compartment via M2 protein channells 
accelerates viral nucleoprotein release into the cytoplasm. 
At the first step of viral genomic RNA replication the positive-strand 
RNA copy is formed. The reaction is catalyzed by virus-encoded RNA 
polymerase. Positive strand serves as the template for subsequent protein 
synthesis. All of the genomic segments are sequentially transcribed. Two 
of newly appeared transcripts undergo splicing. 
Hemagglutinin and neuraminidase are produced in the cell 
endoplasmic reticulum. Then they are transported to the cell membrane for 
subsequent insertion. 
Nucleocapsids are assembled in the host cell nucleus and transferred 
to the cell membrane. They interact with hemagglutinin and neuraminidase 
that facilitates budding. 
Budding process accomplishes the maturation of nascent viruses and 
results in massive egress of progeny virions that rapidly infect the 
neighbouring cells. 
Because of short replication cycle, about 1000 virions are multiplied 
from 1 viral particle in first 8 h, and enormous number of 10
27
 virions 
arises to the end of the first day of the infection. This ensures the rapid 
onset and acute course of influenza. 
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Pathogenesis and Clinical Findings of Infection in Humans 
 
Influenza is the most common and severe human respiratory 
infection. According to WHO data, seasonal influenza epidemics affect 5-
10% of adult population and 20-30% of children. They result in 3-5 mln of 
severe disease cases annually followed by 250,000-500,000 deaths. 
Global pandemics of influenza involve up to 30-40% of human 
population with millions death cases. 
During influenza outbreak the source of infection is human (patient 
with the disease). The airborne (aerosol) mechanism of transmission is 
predominant for influenza virus. Occasionally the disease can be 
transmitted by direct contact. 
Incubation period depends on virus inoculation dose and lasts 1-3 
days. Respiratory epithelium is the primary target for viral infection. 
Short replication cycle of influenza virus provides the rapid spread of 
the infection within the epithelium of airways. Neuraminidase degrades the 
mucous layer of the respiratory tract, promoting viral dissemination. 
Subsequently the trachea, bronchi, bronchioli, and alveolar epithelial cells 
become involved into the process. Propagating viruses cause deep cellular 
destruction with subsequent epithelium desquamation. Also influenza 
viruses may affect endothelial cells resulting in damage of microcirculation 
blood vessels. 
Influenza is characterized by sudden onset with the headache, dry 
cough, high fever and muscular aches. Uncomplicated cases of illness are 
finished within 5-7 days. Children usually display more severe forms of the 
disease. 
Most frequent complication of influenza is pneumonia development. 
It can be primary viral, secondary bacterial, or combined. Secondary 
immunodeficiency, resulting in the defects of secretory IgA synthesis and 
phagocyte dysfunction, and the impairment of the ciliary clearance elevates 
the probability of bacterial complications. The combined viral-bacterial 
pneumonia occurs in 7-10 days of the disease onset and can increase 
greatly the influenza mortality rate especially in case of S. aureus 
infection. 
Rare but severe complication of influenza virus infection is virus-
induced encephalitis. 
Specific antibodies and cytotoxic cells appear in 12-15 days after the 
disease onset. After the disease the strong long-active subtype-specific 
immunity is formed. Antibodies to hemagglutinin and neuraminidase 
possess protective activity. Anti-ribonucleoprotein antibodies are type-
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specific. They are used for virus typing. Host interferon activity can inhibit 
influenza virus replication and accelerates the recovery. 
Passive immunity is maintained in newborns and infants for 6-8 
months after birth. 
Pathogenesis of avian flu caused by H5N1 or H7N9 virus is 
dramatically different from typical seasonal influenza A disease. 
Avian flu viruses, e.g. H5N1 strain, actively circulate in Southeast 
Asia amongst the aquatic birds (e.g., ducks, which are the natural 
reservoirs of infection). Periodically they cause devastating epizootics in 
poultry (primarily, chickens) resulting in destruction of most of their 
population. 
Humans become infected only after the long close contact with 
infected birds (e.g., the poultry workers or villagers working with infected 
flocks) or by alimentary route. Aerosol transmission or human-to-human 
transmission of avian influenza is not registered. 
Avian H5N1 pathogen is different from human influenza A viruses by 
the number of substantial traits. 
First, it reacts mainly with epithelial cells bearing the sialic receptors 
with α-2-3-glycosidic bonds; in humans these receptors are somewhere present 
only in the lower respiratory tract. As the result, airways of humans are 
poorly susceptible to H5N1 virus. However, if entered into deep airways, 
H5N1 ultimately causes viral pneumonia with damage of lung tissue. 
Second, hemagglutinin of H5N1 is activated by the vast number of 
non-specific proteases present in all human tissues that predisposes to 
systemic viral disease. 
And third, H5N1 infection triggers a massive production of 
proinfllammatory cytokines with cell death and tissue damage (systemic 
inflammatory response syndrome or SIRS). 
Hence, if started, H5N1 infection in humans manifests as severe 
pneumonia, followed by respiratory distress syndrome (RDS) and systemic 
virus infection with endothelial damage and multiorgan failure that often 
leads to patient’s death. 
From 1997 to 2016 WHO registered 854 human H5N1 infection cases 
with 450 deaths (about 50% fatality). 
If after the putative reassortment with seasonal influenza A virus 
H5N1 agent becomes capable of infecting humans by aerosol route with 
human-to-human transmission, H5N1 infection will pose a tremendous 
pandemic threat for human population. 
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Laboratory Diagnosis of Influenza 
 
Laboratory diagnosis of influenza is based on virus isolation and 
identification. 
Nasopharingeal washings and throat swabs are used for the 
examination. The specimens should be taken within 3 days after the 
disease onset. 
Rapid methods comprise immunofluorescence assay of nasal swabs 
for viral antigen detection and the identification of viral nucleic acid in 
patient's infected cells by reverse transcription PCR (RT-PCR). 
For viral cultivation the 9-10-day-old embryonated chicken eggs and 
primary monkey kidney cells are used. Inoculation is produced into the 
media, supplemented with antibiotics to suppress the concomitant bacterial 
flora, and with trypsin, which activates viral binding to the cell culture. 
After three or four days of culture influenza virus is detected by 
hemagglutination test (virus indication). If the result is negative, a second 
passage through the fresh culture is performed. 
Virus identification is accomplished by hemagglutination inhibition 
test with subtype-specific reference antisera to most prevalent viral strains. 
Also it can be made by neutralization of viral cytopathic effect. 
Serological method is used for retrospective influenza infection 
diagnostics to confirm the identification data of viral type and subtype. 
Antibodies to H-, N-, or M-proteins and viral nucleoprotein NP are 
produced in patients with influenza. 
For diagnosis confirmation paired sera tests are required because the 
patients can maintain some anti-influenza antibodies level due to previous 
influenza infections. Hemagglutination inhibition test and ELISA are 
mainly used. Positive test relies upon the fourfold rise of specific antibody 
titers. 
For identification of a new type of influenza virus the antibodies to 
viral NP antigens are evaluated. The previously mentioned reactions, as 
well as complement fixation test and neutralization test are used. 
 
 
Treatment and Prophylaxis of Influenza. Influenza vaccines  
 
Influenza is extremely contagious. For non-specific prophylaxis 
patient’s isolation, air decontamination, rooms ventilating and disinfection 
significantly prevent the spread of influenza. 
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Adamantan derivatives (amantadine hydrochloride and rimantadine) 
were introduced long ago for specific antiviral therapy of influenza type A. 
They should be administered only in 1-2 days after the disease onset. The 
drugs block M2 viral proteins thus preventing the step of virus uncoating. 
Hence, they are not so effective at the late stages of the disease. Also these 
medicals can be used for the urgent prophylaxis of influenza during 
epidemic period. Unfortunately, the rise of resistance of type A viruses to 
adamantan derivatives is common (e.g., pandemic “swine flu” 
А/2009/Н1N1 agent was totally resistant to these drugs). 
Inhibitors of neuraminidase (e.g., oseltamivir and zanamivir) prevent 
the release of type A viruses. Overall, the treatment with oseltamivir 
shortens the total course of influenza A case for about 1 day. 
As the result, vaccination is the only actual method to combat 
influenza epidemics. 
For specific prophylaxis various anti-influenza vaccines were 
elaborated. 
From the large number of vaccines the most efficient are live 
attenuated vaccines, inactivated split vaccines and subunit vaccines.  
All of them are combined polyvaccines containing at least 3-4 various 
antigens of influenza viruses. 
Live attenuated vaccines are usually produced by virus culture in 
embryonated eggs with subsequent virus purification. They confer 
protective type-specific immunity against the disease. Live vaccines can be 
administered locally by nasal spray. However, they are contraindicated for 
the persons suffering from egg protein allergy. 
“Split” vaccines include viral particles (virions) decomposed by 
detergents. Detergent treatment removes lipid envelope from complex 
viruses, thus exposing inner protein antigens to the immune cells on 
vaccination. Influenza split vaccines contain viral coats (capsids) with 
immunogenic outer proteins (namely, hemagglutinin and neuraminidase).  
The most advanced products are subunit vaccines. They are 
composed of different combinations of purified hemagglutinin and 
neuraminidase glycoproteins (e.g. Grippol or Fluorix vaccines). These 
vaccines are safe and strong effective. The latter makes possible the rapid 
change of vaccine composition according to current epidemic situation. 
The individual efficacy of anti-influenza vaccines is 60-90%. 
Vaccination coverage of population in the range of 70-80% (“herd” or 
community immunity) prevents the emergence of seasonal influenza 
epidemic. 
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Nevertheless, post-vaccination immunity lasts only for 6-10 months. 
Together with possible changes of antigenic composition of epidemic virus 
it requires the regular design of new versions of influenza vaccines and 
annual human revaccination. 
 
 
 
PARAMYXOVIRUSES 
 
 
The History of Discovery of Pathogenic Paramyxoviruses 
 
First representative of Paramyxoviridae family, measles virus, was 
detected in 1911 by J. Anderson and J. Goldberger. Then in 1934 
C. Johnson and E. Goodpasture isolated the causative agent of epidemic 
parotitis or mumps – mumps virus. And in 1956 R. Chanock discovered 
first human parainfluenza virus.  
Zoonotic Hendra virus was primarily isolated after infection outbreak 
in Australia in 1994. Similarly, zoonotic Nipah virus was first isolated in 
1998-1999 in Malaysia in the village of Nipah. Later both agents were 
proved to pertain to paramyxoviruses and placed into the same genus. 
These viruses are highly pathogenic for humans.  
 
Classification of Paramyxoviruses 
 
The family Paramyxoviridae pertain to the order Mononegavirales.  
Human pathogenic viruses belong to genera Respirovirus (with 
pathogenic species human parainfluenza virus 1 and 3), Rubulavirus 
(species are human parainfluenza viruses 2, 4, 5, and mumps virus), 
Morbillivirus, containing measles virus species, and genus Henipavirus 
with highly pathogenic species Hendra virus and Nipah virus. 
 
Structure of Paramyxoviruses  
 
All paramyxoviruses contain linear single-stranded negative-sense 
non-segmented RNA. 
These viruses are covered with the external lipid envelope of 
spherical shape. The size of virions is rather large (about 150-300 nm). 
Sometimes viral particles with the diameter of 400-700 nm can be found. 
Viral nucleocapsid displays the helical symmetry. 
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Paramyxoviruses contain nucleocapsid proteins bound to viral RNA. 
Internal protein L develops RNA polymerase activity. 
Three outer proteins are the structural components of the viral 
envelope. The matrix (M) protein supports envelope structure; other two 
glycoproteins are localized in the viral external spikes. The larger 
glycoprotein (HN) reveals both hemagglutinin and neuraminidase 
activities (in case of the measles virus – H-protein with hemagglutinin 
activity only). It promotes viral attachment to the susceptible cells. Another 
glycoprotein F (or fusion protein) provides membrane fusion and displays 
hemolytic and cytotoxic activities. 
 
 
Virion Resistance 
 
The viability of Paramyxoviridae virions is rather low. They generally 
stay infectious for several hours only. These viruses can withstand low-
temperature exposure for some time, but heating, the action of ether, 
organic solvents, disinfectants and UV light readily inactivate them. 
Measles virus is the most unstable agent – it is inactivated within 30 min at 
room temperature; hence, the disinfection is not performed in measles. 
 
 
Viral Replication Cycle 
 
The replication of paramyxoviruses occurs in the cytoplasm of 
infected cells. 
Their attachment to the host cells is mediated via hemagglutinin 
glycoprotein. For measles virus CD46 membrane molecule serves as the 
cell receptor. 
Extracellular proteases of tissues cleave viral F protein that triggers 
its fusion activity. It activates the direct fusion of the viral envelope with 
the cell membrane without endosome formation. Fusion is possible only at 
neutral pH of the extracellular environment; acidification inhibits virus 
penetration. 
Then envelope-free nucleocapsids are released into the cytoplasm. 
After uncoating viral RNA polymerase catalyzes the formation of 
mRNAs that encode viral proteins. 
In addition, viral polymerase produces the positive-strand RNA 
intermediate (antigenome) that serves as the template for synthesis of 
genomic (–) RNA. 
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Nucleocapsid assembly is performed in the cytoplasm. Maturating 
virions migrate towards the cell membrane and interact with HN- and F-
proteins. M protein promotes mature particle formation, joining the viral 
envelope with the nucleocapsid. Finally paramyxoviruses are released from 
the infected cells by budding. 
In case of intracellular protease presence, viral F protein is cleaved 
and activated progressively, resulting in fusion of the host cell membranes 
with symplast and syncytia formation. 
During the replication cycle acidophilic cytoplasmic inclusions 
appear within the cells. Measles virus can produce intranuclear inclusions. 
 
 
Human Infections Caused by Parainfluenza Viruses  
 
Pathogenesis, clinical findings and immunity 
According to antigenic structure there are 5 distinct serotypes of 
parainfluenza viruses corresponding to 5 viral species. 
Types 1-4 of parainfluenza viruses are able to cause respiratory 
diseases in infants and young children (parainfluenza disease). Type 5 is 
not pathogenic for humans. 
The source of infection is the sick person. 
Parainfluenza is transmitted by airborne mechanism or by direct 
contact. Incubation period varies within 2-7 days. Viruses propagate in the 
respiratory epithelium. 
Very often they induce mild upper respiratory tract infections. But in 
infants types 1 and 2 parainfluenza viruses provoke severe infections, 
affecting larynx and trachea. Larynx swelling and respiratory obstruction 
causes the croup syndrome (laryngotracheitis with obstruction and acute 
respiratory failure). Bronchial hyperreactivity takes part in croup 
pathogenesis. 
Type 3 parainfluenza virus is the predominant agent of lower 
respiratory tract inflammation, resulting in severe bronchiolitis and 
pneumonia. 
Type 4 of parainfluenza viruses is not so harmful; it causes inapparent 
or mild respiratory infections. 
Maternal antibodies can’t prevent infant’s parainfluenza infection. The 
immunity is predominantly mediated by growing secretory antibodies of 
IgA class that block local viral propagation. Nevertheless, reinfections 
readily occur. 
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Laboratory diagnosis 
The specimens are obtained from nasopharingeal washings, nasal and 
throat swabs, etc. 
For accelerated parainfluenza diagnostics various rapid methods are 
elaborated. Immunofluorescence assay of nasal swab and ELISA are 
frequently performed for primary virus detection. 
Also PCR is used for identification of parainfluenza species in clinical 
specimens. 
Virus isolation is made by inoculation of virus-containing material 
into the primary human cell lines or monkey kidney cell cultures. 
Parainfluenza viruses develop indistinct cytopathic effect but reveal 
the remarkable hemadsorption activity with guinea pig erythrocytes that is 
used for viral detection. 
Virus type identification is performed by hemadsorption or 
hemagglutination inhibition tests. 
Serological diagnosis is made with paired sera tests. 
Hemagglutination or hemadsorbtion inhibition tests and ELISA are 
adopted for clinical use. 
 
Principles of disease treatment and prophylaxis 
Potent antiviral agent ribavirin is used for treatment of severe clinical 
forms of parainfluenza infection. 
Effective parainfluenza vaccines are not designed yet. 
 
 
Mumps Virus Infection (or Epidemic Parotitis) 
 
Mumps (epidemic parotitis) is the specific highly contagious acute 
virus disease, which primarily affects parotid, sublingual, and 
submandibular salivary glands with subsequent involvement of other 
glandular organs and tissues (pancreas, ovaries, or testes), kidneys and 
central nervous system. Only 1 serotype of virus is known. 
 
Pathogenesis, clinical findings and immunity in mumps 
Mumps virus infects humans, predominantly young children. It is 
anthroponotic infections, humans are the only sources of infection. 
Disease transmission rate in unvaccinated children is near 50-70%. 
Mumps virus often gives epidemic outbreaks. 
The disease is contracted by airborne route. 
Incubation period varies from 2 to 3 weeks.  
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Primary viral replication is determined in nasal and upper respiratory 
tract epithelial cells. Then the virus spreads to the salivary glands and 
further to susceptible tissues and organs. 
The most typical symptoms of epidemic parotitis are the enlargement 
and swelling of the parotid gland.  
Systemic viral dissemination affects different inner organs and central 
nervous system because of viral ability to propagate within epithelial cells. 
Specific pancreatitis and orchitis that may cause sterility are 
developed. Meningitis and meningoencephalitis are the main complications 
on central nervous system in epidemic parotitis. 
During the disease course the virus is eliminated from the body 
mainly with saliva and urine. 
One-third of patients display inapparent forms of mumps. 
Post-infectious specific humoral immunity is lifelong and stable due 
to one antigenic type of virus. Antibodies appear to various viral antigens 
(HN-, F-proteins, nucleoproteins, etc.) They maintain immune response for 
many years. 
Newborn child is protected by maternal passive immunity within 6 
months. 
 
Laboratory diagnosis 
Laboratory examination is useful for diagnosis of inapparent forms of 
mumps and for differential diagnosis. 
For express diagnostics immunofluorescence assay with anti-mumps 
antibodies is used. 
For virus isolation the specimens are obtained from saliva, urine or 
cerebrospinal fluid. Inoculation is performed into primary monkey kidney 
cell cultures. Mumps virus displays characteristic cytopathic effect with 
cell rounding and giant cell formation. In the cell culture virus is detected 
by hemadsorption or hemagglutination. 
Mumps virus tidentification is performed by hemadsorption or 
hemagglutination inhibition tests. 
Serological diagnosis confirms acute mumps infection by ELISA 
detection of anti-mumps IgM-class antibodies. 
 
Principles of disease treatment and prophylaxis 
Treatment of the disease is solely symptomatic. 
High-effective attenuated live vaccine is used worldwide for mumps 
specific prophylaxis. Near to total coverage of children with anti-mumps 
vaccination lowered the disease incidence in most of states to the sporadic 
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events. Mumps vaccine can be applied as monovaccine, but in most of 
cases it is administered like triple MMR vaccine in combination with 
attenuated measles and rubella viruses. It confers high-grade long lasting 
immunity. 
 
 
Measles Virus Infection 
 
Measles is another example of acute respiratory but systemic viral 
disease. It is caused by specific virus of a single serotype that pertains to 
morbillivirus genus.  
Measles is extremely contagious – its transmission rate in 
unvaccinated persons is almost absolute – 95-100%. It is solely human 
anthroponotic illness.  
Measles virus usually gives outbreaks of the disease among children. 
 
Pathogenesis, clinical findings and immunity in measles 
Disease transmission is promoted by the airborne mechanism. 
Incubation period lasts from 9 to 18 days. 
Virus replicates in respiratory tract epithelium and moves to regional 
lymphatic nodes (primary viremia). After second propagation in the 
lymphoid tissue it spreads throughout the body and penetrates into 
epithelial cells in skin, conjunctiva, endothelium of vessels, respiratory 
tract, etc. 
Virus persists within circulating immune cells that facilitates viremia. 
Giant cells appearance and symplast formation is observed in tissue 
epithelial cells. Measles virus F-protein activates intercellular fusion. It 
permits direct viral spread across the epithelial layer and prevents virions 
against antibody neutralization. 
Prodromal phase lasts several days and it is shown to be highly 
contagious. Virus is excreted with biological fluids (urine, nasal secretion) 
and appears in blood. Filatov’s-Koplik’s spots are developed on the buccal 
epithelium in oral cavity of patients. The spots are the sites of intensive 
viral replication. This finding is proven to be the pathognomonic symptom 
of measles. 
Fever and maculopapular rash are the other main clinical findings of 
the disease. Eruptive phase lasts about five days. Rash development results 
from T cell cytotoxic activity, directed against virus-infected capillary 
endothelial cells. Rash descends from the face to the body and legs and 
dampens gradually within 1-2 weeks. 
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The main complications in measles are secondary bacterial 
pneumonia, otitis, and disorders of CNS (e.g., encephalitis). 
The extremely rare but potentially lethal late post-measles 
complication is subacute sclerosing panencephalitis. It may appear in 
many years after the infection regress because of immune system 
incapability to eliminate measles agent. The virus persists within CNS, 
causing gradual damage of neuronal structures with fatal consequences.  
Humoral immunity against measles develops in 10-14 days after the 
disease onset. It is maintained by circulating antibodies. The immunity is 
lifelong and stable that ensues from single antigenic type of virus. 
Maternal anti-measles antibodies passively protect newborns for 6 
months. They may develop modified mild clinical forms of measles. 
 
Laboratory diagnosis of measles 
Laboratory examination is necessary mainly for diagnosis of unclear 
measles cases. 
Material for investigation (nasopharyngeal swabs and blood samples) 
should be obtained from the last days of prodromal phase till 1-2 day of 
eruptive period. 
For detection of viral RNA reverse transcription PCR (or RT-PCR) 
may be used. 
Virus isolation is performed by specimen inoculation into monkey 
kidney cells, human amnion cells or HEp-2 cells. 
Virus is detected after 7-10 days of culture by characteristic cytopathic 
effects. Multinucleated giant cells (symplasts) and intranuclear and 
intracytoplasmic inclusions appear within the infected cells. 
Serological diagnosis is carried out with paired sera tests, where 
fourfold rise in antibody titer is observed. IgM class antibodies are the 
markers of the ongoing disease. Antibodies titers are evaluated by 
hemagglutination inhibition test, neutralization reaction and ELISA. 
 
Specific prophylaxis and treatment of measles 
Attenuated live measles vaccine is administered for active 
prophylaxis of the disease. Vaccination is considered to confer lifelong 
immunity with high efficacy. Live measles vaccine is predominantly used 
for vaccination in combination with attenuated mumps and rubella viral 
strains generally known as measles, mumps, and rubella vaccine, or 
MMR. 
The treatment of measles is supportive. If requires, infusion therapy 
and body detoxication is administered. 
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Characteristics of Hendra and Nipah Virus Infections 
 
In 1994 in Australia in Hendra suburb of the city of Brisbane the 
deadly outbreak of zoonotic influenza-like disease was primarily registered 
in horses that, in turn, infected contact humans with lethal outcomes. The 
causative agent was identified as a new parainfluenza virus (Hendra virus). 
Likewise, in 1998-1999 in Malaysia in the village of Nipah a novel 
zoonotic parainfluenza virus was isolated after the severe animal outbreak 
that also affected humans with high lethality (Nipah virus). 
Further outbreaks of Hendra and Nipah infections were repeatedly 
registered in Australia and Southeast Asia countries (Bangladesh, India, 
Malaysia, and Singapore). 
Zoonotic Hendra and Nipah parainfluenza viruses appeared to be 
highly pathogenic for humans. The primary sources and natural reservoirs 
of infections are the fruit bats that spread the viruses to other animals or 
humans. The diseases are contracted via the direct contact with infected 
animals or fomites; aerosol or oral transmission is also taken into account. 
In humans Hendra and Nipah infections are manifested as systemic 
viral disorders with encephalitis and severe pneumonia with acute 
respiratory failure. The lethality of disease outbreaks is very high in the 
range 40-60%. 
Laboratory diagnosis of infections is based on molecular genetic 
methods (PCR) and serological testing (ELISA). 
Human specific prophylaxis and treatment of these infections are not 
elaborated yet. In Australia the horses are immunized with vaccine against 
Hendra infection; experimental human Nipah vaccine is under clinical trial 
now. 
 
 
 
PNEUMOVIRUSES 
 
 
The History of Discovery 
 
J. Morris and R. Chanock isolated the primary representative of 
pneumoviruses – respiratory syncytial (or RS) virus in USA in 1956. 
First human metapneumovirus was isolated by A. Osterhaus and 
colleagues in 2001 after the infection outbreak in Netherlands. 
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For the longest time pneumoviruses were regarded as the members of 
Paramyxoviridae family. Only the latest ICTV release of virus taxonomy and 
nomenclature published in 2015 ultimately demarcated them and placed 
pneumoviruses into separate family. 
 
 
Classification of Pneumoviruses 
 
The family Pneumoviridae pertain to the order Mononegavirales.  
There are two genera in the family: Orthopneumovirus with human 
pathogenic species respiratory syncytial virus or RS virus, and 
Metapneumovirus with pathogenic species human metapneumovirus.  
 
 
Structure and Reproduction of Pneumoviruses  
 
The structure of pneumoviruses resembles to a certain extent the 
composition of paramyxoviruses but with the number of distinct traits. 
All pneumoviruses contain linear single-stranded negative-sense non-
segmented RNA. They are also covered with the external lipid envelope of 
spherical shape.  
Viral nucleocapsid displays the helical symmetry. nucleocapsid 
proteins are tightly bound to viral RNA. The virus carries RNA polymerase 
enzyme. 
The large glycoprotein receptor of pneumoviruses is devoid of 
hemagglutinin and neuraminidase activity, and it is called G protein. The 
fusion F protein of respiratory syncytial virus lacks hemolysin activity. 
Reproduction of pneumoviruses is generally similar to 
paramyxoviruses. RS virus binds to glycosaminoglycan receptors of 
respiratory epithelium, e.g. in lower respiratory tract. The infected cells 
produce characteristic cytopathic effect with syncytium formation 
mediated by viral F proteins. 
 
 
Infections, Caused by Pneumoviruses – Pathogenesis, Clinical 
Findings and Immunity  
 
Human respiratory syncytial virus is the prime cause of lower 
respiratory tract diseases in newborns and infants under the age of 2 years. 
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Respiratory syncytial infection is transmitted by airborne (aerosol) 
route. Incubation period varies for 2-8 days. Virus multiplies in 
nasopharyngeal epithelial cells with subsequent descending to lower 
respiratory tract (bronchioli, alveoli). 
Cell-mediated immunity limits the viral spread, thus viremia doesn’t 
occur. 
The adults usually display the symptoms of common cold infection, 
but in patients above 50 years with chronic obstructive pulmonary disease 
(COPD) or immunocompromised the course of infection might be severe. 
RS virus in infants often results in serious damage of lower airways, 
primarily affecting bronchioli and alveoli. The life-threatening 
complication of RSV infection is severe bronchiolitis with acute bronchial 
obstruction and pneumonia. 
Virus disintegrates respiratory epithelium with syncytium formation; 
the damage is intensified by immune cell-mediated reactions. Excessive 
cytokine production promotes virus-induced inflammation. However, RS 
virus blocks interferon synthesis by host epithelial cells. 
As RS infection provokes bronchial hyperreactivity, it predisposes to 
the development of bronchial asthma. 
Usually the patients recover completely after the RSV infection. 
Bronchiolitis and pneumonia in infants can cause lethal outcome without 
adequate therapy. 
Specific humoral and cellular immunity is unstable and of moderate 
grade. Mucous tissue IgAs are assumed to be responsible for protection. 
Nevertheless, the repeated exacerbations of RSV infection occur easily. 
Maternal antibodies defend the newborns against RSV infection during 
several months after birth. 
The first outbreak of respiratory infection caused by human 
metapneumovirus was registered in Netherlands, where the virus was 
primarily isolated in 2001. Since that time, metapneumoviral respiratory 
infections became regularly diagnosed in many countries. The disease 
affects the susceptible persons of all ages.  
Pathogenesis and clinical manifestations of these disorders are 
generally similar to RSV infection – human metapneumovirus damages 
lower respiratory tract resulting in bronchiolitis and pneumonia.  
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Laboratory Diagnosis of Respiratory Syncytial Infection 
 
For rapid diagnostics immunofluorescence assay or ELISA are 
commonly used for virus detection in nasopharyngeal secretions. Various 
kinds of RT-PCR tests are available for viral nucleic acid identification in 
clinical specimens. 
Nasopharyngeal washings, nasal and throat swabs are taken for virus 
isolation. 
The material is inoculated into continuous cell lines HeLa and HEp-2. 
Respiratory syncytial virus grows slowly, thus the cytopathic effects 
appear only at 10 day of culture – RSV induces giant cell and syncytium 
formation. Immunofluorescence test provides rapid virus identification in 
the cell culture. 
Viral indication in clinical specimen is the strong argument for RSV 
infection, because healthy persons are not able to carry respiratory 
syncytial virus. 
Serological diagnosis is helpful only for epidemiological 
investigations. 
 
 
Treatment and Prophylaxis of RSV Infection 
 
Ribavirin is recommended for antiviral therapy of RSV-mediated 
disorders. For urgent post-exposure prophylaxis of RSV infection in 
contact infants humanized antiviral monoclonal antibody (mAb 
“palivizumab”) is administered. Palivizumab is directed against F protein 
of RS virus. The efficacy of mAb prophylaxis is about 50-55%. 
Efficient anti-RSV vaccine is not available now. Different kinds of 
RSV vaccines are under the current laboratory and clinical trials. 
 
 
 
RUBELLA VIRUS 
 
The History of Rubella Virus Discovery 
 
Rubella virus (RV) is the causative agent of the same name rubella 
disease. The earliest description of rubella goes back to the 1700s, when 
the clinical manifestations of this illness were described by two German 
physicians, de Bergan in 1752 and Orlow in 1758. At this time it was 
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considered to be a derivative of measles, thus the disease became known as 
German measles. The illness was renamed “rubella” (Lat. – reddish) in 
1866 by H. Veale. 
Y. Hiro and S. Tasaka in 1938 established the viral etiology of the 
disease. In 1941 N. Gregg reported the devastating teratogenic effects of 
the virus. And finally, the isolation of rubella virus culture was elaborated 
by P.D. Parkman and T.H. Weller with F.A. Neva in 1962. 
 
 
Classification of Virus 
 
Rubella virus is placed into Togaviridae family. It is classified as the 
single species of the genus Rubivirus.  
Humans are the only known natural hosts for RV. 
 
 
Structure of Rubella Virus  
 
Rubella virion is a spherical particle about 60 nm in diameter. Virion 
envelope is composed of host-derived lipid bilayer with embedded spikes 
made up of E1 and E2 glycoproteins. 
Icosahedral internal capsid, or core, made of C proteins holds viral 
genome. Genome is composed of non-segmented single-stranded RNA of 
positive polarity.  
Viral genome encodes several enzymes, including replicase (RNA-
dependent RNA polymerase), protease and helicase. 
Virus possesses core protein antigen and surface external glycoprotein 
antigens E1 and E2, which develop hemagglutinating activity and can 
cause the synthesis of neutralizing antibodies. Only one serotype of virus 
exists. 
 
 
Virion Resistance 
 
The viability of rubella viruses beyond the human body is rather low. 
They stay infectious outside only for about 1 day. These viruses gradually 
lose infectivity under freezing; heating at 50-56
o
C kills them in 5-20 
minutes. They are readily inactivated by ether, organic solvents, 
disinfectants and UV light. Also they are sensitive to pH fluctuations 
losing the stability at pH levels less than 6.8 and above 8.0. 
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Viral Replication Cycle 
 
RV enters susceptible cells via endosomal uptake. Viral E1 and E2 
glycoproteins under endosome acidification stimulate the fusion of the 
viral envelope to the endosomal membrane. Uncoating occurs within the 
endosome, allowing next release of viral genomic RNA. Low pH of the 
endosome promotes not only virion envelope fusion but also triggers 
uncoating of the capsid protein. 
Virus-modified cytoplasmic endosome-lysosomal structures (termed 
as replication complexes) are the sites of RV replication. 
Viral genomic (+) RNA is translated on ribosomes creating early viral 
proteins (i.e., enzymes replicase, protease and helicase). Initially single 
polyprotein chain is formed that is further processed into final proteins by 
proteases. 
Replicase enzyme catalyzes the synthesis of genomic positive RNA 
through the stage of double-stranded RNA intermediate, containing both 
positive and negative RNA strands. Positive RNAs serve as templates for 
next synthesis of non-structural and capsid viral proteins. 
Replication complexes contain small vesicles, where viral 
morphogenesis takes place. 
After assembly virus is released out of the cell by budding. It is not 
followed by cell lysis. 
Overall, the duration of replication cycle of rubella virus is long and 
covers 36-46 hours. 
 
 
Pathogenesis, Clinical Findings and Immunity in Rubella 
 
Rubella affects unvaccinated individuals. The infection is transmitted 
via airborne route. Transmission rate for non-vaccinated exceeds 80-90%. 
Vertical “mother-to-child” transmission results in congenital rubella 
syndrome. 
Rubella is anthroponotic disease – the source of infection is solely 
human. 
The upper respiratory tract and nasopharyngeal lymphoid tissue are 
the first sites of viral replication. Next the virus migrates to regional lymph 
nodes.  
Incubation period of the disease lasts 2-3 weeks. 
The clinical manifestations of RV infection in adults are generally 
mild, and many infections are asymptomatic.  
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The first clinical sign of rubella is usually the appearance of a 
macropapular rash. Other symptoms typically include low-grade fever, 
lymphadenopathy, sore throat, etc. Lymphadenopathy is typical, involving 
the posterior cervical and occipital nodes. Rubella can cause complications 
with joint involvement such as transitory arthritis. 
However, the main threat for public health is the teratogenicity of 
rubella virus.  
Maternal infection early in pregnancy results in congenital rubella 
syndrome (CRS) in infants. The time the infection affects women during 
gestation can influence CRS outcome. The earlier in gestation the maternal 
infection occurs, the more severe is the damage to the fetus. Maternal 
infection during the first 8 weeks inevitably results in fetus disease. In this 
condition up to 100% of infected fetuses develop congenital defects.  
The virus penetrates all fetal tissues. RV is supposed to affect 
mitochondria, interfering cell respiration, and can cause apoptosis of 
infected cells. 
The risk of fetal infection and the severity of congenital abnormalities 
decreases after the first trimester; after 17 weeks gestation, the risk of 
developing any defects is low.  
The clinical manifestations of CRS vary significantly. The deafness is 
the most common. Other clinical features include cardiac disease, mental 
retardation, and ocular impairments such as cataracts and glaucoma. Non-
inflammatory necrosis is observed in affected organs due to viral action. 
After disease lifelong humoral IgG-mediated immunity arises. 
Maternal antibodies protect the newborns against rubella within 4-6 
months after birth. 
 
 
Laboratory Diagnosis of Rubella 
 
A leading test for detection of viral nucleic acids directly in clinical 
specimens (nasopharyngeal washings, blood, urine, fetal autopsy 
materials) is RT-PCR. 
Nasopharyngeal washings, nasal and throat swabs are taken for virus 
isolation. 
The virus is inoculated into monkey (e.g. Vero cells) or rabbit cell 
lines. Virus produces slight cytopathic effect. Immunofluorescence assay 
or ELISA can be used for virus detection in the cell cultures. 
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Serological diagnosis is confirmed by ELISA test. It might be carried 
out with paired sera, where fourfold elevation of antibody levels is 
observed. 
Rubella-specific IgM antibodies are detected with ELISA in the 
single specimen. 
 
 
Principles of Disease Treatment and Prophylaxis 
 
Rubella itself is a mild self-limited disease that doesn’t need specific 
treatment. 
A live rubella vaccine is commonly used for specific prophylaxis of 
rubella. It confers high-grade lifelong immunity with few side effects. 
Vaccination resulted in a substantial decrease in the number of cases of 
rubella and congenital rubella syndrome. Usually rubella vaccine is a 
constituent of multivalent respiratory disease vaccine, e.g. MMR (measles, 
mumps and rubella attenuated live vaccine). 
Vaccination coverage of population above 95% prevents the cases of 
rubella infection making conditions for virus elimination. 
 
 
CORONAVIRUSES 
 
 
The History of Discovery 
 
First human coronavirus was isolated by D. Tyrrell and M.L. Bynoe 
from patient with acute rhinitis in 1965. 
It was generally assumed earlier that coronaviruses cause only mild 
short-lasting respiratory or enteric diseases with complete patient’s 
recovery. But in 2002 the epidemics of new severe disease emerged in 
Southeast Asia, especially in China and Vietnam. The disorder primarily 
affected respiratory tract, resulting in fatal outcome near 10% of total 
disease cases. The disease was termed as “severe acute respiratory 
syndrome”, or SARS. In 2003 it was firmly established that the causative 
agent of SARS is the previously unknown new coronavirus (C. Urbani and 
coworkers, 2003). The virus was named as SARS coronavirus 
(SARS CoV) and placed into separate group of coronaviruses. 
Investigating SARS, Italian doctor Carlo Urbani contracted the infection 
and died.  
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Finally, in 2012 the severe disorder similar to SARS emerged in Saudi 
Arabia. Its agent, a novel coronavirus, was isolated by Egyptian virologist 
doctor Ali Mohamed Zaki. 
By analogy with SARS, the illness was termed as MERS (Middle East 
respiratory syndrome), and its causative agent was entitled as MERS 
coronavirus (MERS CoV). 
 
 
Classification of Coronaviruses 
 
The family Coronaviridae pertain to the order Nidovirales.  
The family comprises two subfamilies – Coronavirinae and 
Torovirinae. 
Coronavirinae subfamily contains 4 genera each of several species. 
To date 6 species of coronaviruses are registered, which are definitely 
pathogenic for humans. 
SARS and MERS coronavirus species pertain to genus 
Betacoronavirus. 
According to serological and genetic properties, 3 groups of 
coronaviruses are known; groups 1 and 2 harbor mammal pathogens; 
group 3 includes avian viruses. 
Human pathogens are present in both 1
st
 and 2
nd
 group; SARS and 
MERS coronaviruses pertain to group 2. 
 
Structure and Properties of Coronaviruses 
 
Coronaviruses carry single-stranded positive RNA. It is the largest 
viral RNA genome known.  
Coronaviruses produce the middle-size or large spherical particles 
with external lipoprotein envelope. Viral nucleocapsid is of helical 
symmetry. Matrix intermediate layer scaffolds the outer coat of 
coronaviruses. Glycoprotein spikes surround viral envelope resembling 
sun crown. 
Coronaviruses contain various proteins of nucleocapsid, matrix and 
outer coat that determine complex viral antigenic structure. Viruses of 
animal and human origin possess the number of common and specific 
antigenic determinants. 
External glycoprotein spikes are responsible for viral absorption and 
penetration into the host cells. They display hemagglutinating activity. 
The most studied is SARS coronavirus. 
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On the base of genomic analysis and electron microscopy data the 
main properties of SARS viruses were determined. 
SARS virus has 4 major structural proteins – inner nucleocapsid 
N protein, membrane M and envelope E proteins, and S protein of receptor 
spikes. 
Viral genome also encodes the number of viral enzymes including 
RNA-dependent RNA polymerase (replicase), helicase and proteases. 
Multiple non-structural accessory proteins play a role of virulence 
factors for SARS virus. They stimulate apoptosis of infected cells, inhibit 
the expression of interferons of I type, grossly activate proinflammatory 
cytokines, and cause deep disorders of blood coagulation and fibrinolysis. 
If cultured, coronaviruses are poorly adapted to laboratory animals and 
cell lines. Some strains can propagate in green monkey kidney cell cultures 
or Vero cells, and in suckling mice. 
 
 
Virion Resistance 
 
Coronaviruses are rather sensitive to external influences; ether, 
detergents and other disinfectants as well as heating above 56°C readily 
inactivate them. 
SARS CoV is relatively stable in comparison with other 
coronaviruses. It maintains viability in feces and urine for 2-4 days at room 
temperature. It easily withstands cooling being stable at least for 3 weeks 
at low temperature range. 
Heating at 56
oС kills virus within 15 min. As other coronaviruses, it is 
sensitive to all conventional disinfectants. 
 
 
Replication Cycle of SARS Coronavirus 
 
SARS virus enters epithelial cells of upper respiratory tract via 
binding of spike S proteins to specific cell membrane receptor angiotensin- 
converting enzyme 2 (ACE 2). S-glycoprotein mediates absorption and 
subsequent fusion of virus particles with susceptible cells. 
Uncoating is followed by translation of viral proteins from viral 
(+) RNA. Initial single polyprotein chain is produced that is eventually cut 
into mature proteins by viral protease.  
Newly formed viral replicase enzyme activates genomic RNA 
replication. Viral genome is transcribed through intermediate minus RNA 
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strand that serves as the template for final positive sense RNA synthesis. 
Viruses multiply in the cytoplasm of infected cells. After virion 
assemblage the viral particles are released out of the cells by budding that 
is promoted by M, E and N proteins. 
The death of infected epithelial cells is caused by direct viral 
cytopathic effects as well as by immune cell lysis. The latter results from 
immune reaction against viral antigens expressed upon infected cells  
 
 
Characteristics of Common Respiratory Coronaviral Infections 
 
Coronaviral infections are transmitted by airborne route. Known 
before 2002 coronaviruses cause up to 30% of all common acute 
respiratory infections and some gastrointestinal disorders. 
In adults respiratory infections are usually asymptomatic, or produce 
rhinitis and some other modest catarrhal manifestations. Secondary viremia 
leads to the infection of gastrointestinal tract resulting in diarrhea. 
Typically the infection course ceases in 5-7 days. 
The immunity is mostly humoral and type-specific. Virus-neutralizing 
antibodies confer the resistance to reinfection with the same type virus. 
 
Laboratory Diagnosis, Prophylaxis and Treatment of Coronaviral 
Infections 
 
Cell culturing is rarely applied due to poor viral propagation in the cell 
lines.  
For express analysis of nasal swabs or nasopharingeal washings 
immunofluorescence assay for viral antigens and PCR for identification of 
viral nucleic acid are elaborated. 
Serological testing is commonly used in routine laboratory diagnosis 
of coronaviral infections. Paired sera tests (e.g. indirect hemagglutination 
assay, or ELISA) are most preferable; they determine the 4-fold rise of 
specific antibodies in patient’s serum. 
Vaccination is not available for prophylaxis of coronaviral diseases. 
The infection needs only supportive treatment. 
 
Epidemiology, Pathogenesis and Clinical Findings of SARS 
 
At the end of 2002 the first cases of severe “atypical” pneumonia of 
unknown etiology have emerged in Guangdong Province of China. The 
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infection rapidly spread throughout the Southeast Asia involving humans 
in Hong Kong, Vietnam, and then in Canada and Europe. As the infection 
demonstrated high mortality rate (near to 10%) and great communicability 
by airborne route, the World Health Organization (WHO) declared a global 
alert for this disease, designated as “severe acute respiratory syndrome”. 
The epidemic was curbed during 2003; it resulted in more than 8000 
infection cases with 774 lethal outcomes.  
Overall, SARS was regarded as the first threatening epidemic of XXI 
century. 
The majority of investigators suppose SARS virus to originate from 
wild animal coronavirus via the chain of occasional mutations. In 2003 
Chinese researchers found the virus causing severe acute respiratory 
syndrome in masked palm civet – a feliform mammal species eaten as a 
delicacy in China. This agent is regarded now as the animal virus, 
apparently related with SARS. Thus, the particular animal species is 
possible source for initial SARS infection.  
Also it has been established that the long-term natural reservoirs for 
SARS virus are fruit bats. 
Nevertheless, the sources of infection in verified SARS cases were 
sick humans. The disease is contracted predominantly via airborne route. 
Human-to-human transmission is common. Household contact and 
contacts in health-care settings are also ascertained as the important routes 
of transmission. Oral transmission of the disease is possible as well. 
The healthcare workers and household members, who cared for 
patients with the disease, are regarded as the groups of highest risk of 
SARS acquisition. Special attention is to be paid on travellers returned 
from areas of infection outbreaks, especially from Southeast Asia. 
Incubation period lasts from 1 to 7-10 days.  
Specific cell membrane receptor for SARS virus angiotensin- 
converting enzyme 2 is present in high density on airways epithelium, 
endotheliocytes and enterocytes, which are the major primary targets for 
SARS infection. 
The disease has sharp onset with fever and myalgia. The virus affects 
respiratory system causing severe lung damage. Multiple virulent 
accessory proteins of SARS virus cause cell death and provoke systemic 
inflammatory response. Hematogenous dissemination of virus involves 
gastrointestinal tract that results in diarrhea. 
The fever may decline in a few days but on the 2-3 week of the illness 
many patients develop a secondary wave of fever with progressing 
respiratory failure. Since the viral replication slows down near the second 
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week of the illness, the life-threatening disease progression largely ensues 
from the activation of host autoimmune reactions. About 20% of patients 
manifest respiratory distress syndrome (RDS) with alveolar pulmonary 
edema that can cause the lethal outcome.  
Prognosis of SARS is deeply serious. Nevertheless, introduction of 
advanced methods of the disease treatmen substantially reduced the 
number of fatal outcomes. 
The infection confers strong high-grade immunity maintained by 
specific antiviral antibodies. They render high virus-neutralizing activity. 
 
 
 
Special Characteristics of MERS Infection Outbreaks 
 
As mentioned above, first outbreak of Middle East respiratory 
syndrome (MERS), followed by successful isolation of its agent MERS 
coronavirus (MERS CoV) was registered in 2012 in Saudi Arabia. 
According to WHO data, from 2012 to 2016 MERS infection spreaded 
from its intial focus in Middle East to Southeast Asia countries; the 
infection was also registered in Europe, United States, and African 
countries. On August, 2016 the total number of MERS cases was equal to 
1791. Case-fatality ratio of MERS is extremely high – about 35%.  
MERS virus and MERS disease to some extent are similar with SARS. 
Nevertheless, MERS infection demonstrates several distinct traits. 
MERS CoV is zoonotic virus supposed to originate from local animals 
(mainly, Arabian camels). Humans become infected by alimentary route 
and after close contact with sick animals or humans (hospital-acquired 
infection). 
MERS is manifested as severe systemic inflammatory disease that 
initially damages airways with development of respiratory distress 
syndrome and acute respiratory failure; this is followed by intestinal 
disorders and renal disfunction that may result in acute renal failure. 
Current MERS epidemic is not completely controlled yet, as the 
separate cases of infection repeatedly occur nowadays, e.g. in Saudi 
Arabia. Nevertheless, MERS infection is not regarded as global epidemic 
threat primarily because of low human-to-human transmission rate. 
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Laboratory Diagnosis of SARS 
 
Laboratory diagnosis of SARS infection is verified by PCR and 
serological reactions, e.g. by ELISA test. 
For PCR virus-containing specimens are taken from nasopharingeal 
washings, feces, and occasionally from urine.  
Laboratory handling of SARS clinical specimens should be performed 
in special biosafety facilities (BSL-2 – biosafety level 2). 
The diagnosis of SARS is confirmed by PCR in case of at least two 
positive repeated tests. 
For serological diagnosis ELISA test is elaborated. In patients the 
reaction is carried out with paired sera tests, where fourfold rise in 
antibody levels ultimately validates the infection. Healthy persons are 
negative for specific antibodies to SARS CoV. 
Virus culturing is produced in most advanced specialized laboratories 
using various cell lines (e.g., Vero cells). Virus isolation is confirmed by 
PCR. 
 
 
Principles of SARS Prophylaxis and Treatment  
 
Global alert from SARS infection requires strict measures to prevent 
international spread of the disease. It needs professional and public 
awareness, heightened surveillance with rapid case validation, patient 
isolation and management. Additional measures should be directed to 
control travellers departing from the areas of disease outbreak. 
International affiliation of scientific laboratories and institutions 
organized by WHO as Global Outbreak Alert and Response Network, joins 
collaborative forces to respond to SARS, MERS, or any other emerging 
infection threat. 
Vaccine for SARS prevention is not yet elaborated; nevertheless, the 
availability of complete genomic sequence of SARS agent makes possible 
to design effective vaccines and antiviral agents.  
Antiviral drug ribavirin is commonly used for treatment of SARS 
infection. To suppress immunopathological reactions aggravating the 
disease course steroid hormones (e.g. prednisolone or hydrocortisone) can 
be administered. The treatment of respiratory distress syndrome presumes 
the support of vital body functions including fluid resuscitation and 
artificial lung ventilation if required. 
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ADENOVIRUSES 
 
 
The History of Adenovirus Discovery 
 
These viruses were discovered by W. Rowe and coworkers in 1953. 
Primary investigation of adenoviruses revealed their ability to persist and 
develop the cytopathic effect in adenoids and tonsils, so they were named 
adenoviruses. 
 
 
Classification of Adenoviruses 
 
Adenoviruses pertain to the family Adenoviridae that encompasses 5 
distinct genera. Currently known 7 human pathogenic species (human 
adenviruses A-G) are included into genus Mastadenovirus, which contains 
adenoviruses, affecting mammals.  
From 100 adenoviral human serotypes known, above 50 serotypes are 
pathogenic for humans. They are clustered into several groups. 
 
 
Structure of Adenoviruses  
 
Adenoviruses are DNA-containing naked viruses. Viral DNA is the 
linear double-stranded molecule, which is attached to the protein at the 
end of genome. DNA is packed into the core of the virion. 
Virus size varies in the range of 70-100 nm. The virions are of 
icosahedral symmetry.  
Adenoviral capsid is composed of 252 capsomeres, where 12 
capsomers are pentons, (polyhedrons, based on pentagon structure) and 
other 240 are hexons (units, based on hexagons). Spike-like capsid 
structures, known as fibers, are connected with pentons. 
Fibers develop hemagglutinating activity, and pentons display 
cytopathic effect in the cell cultures. 
Pentons, hexons and fibers are the major antigens of adenoviruses, 
containing group- and type-specific epitopes on their surface. Fibers carry 
type-specific epitopes that are used for virus serotyping. 
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Virion Resistance  
 
Virions of adenoviruses are highly stable in the environment. Protein 
capsid protects them from unfavorable influences. They stay viable in 
water for weeks, on dry inanimate surface – up to 3 months 
Adenoviruses easily resist freezing. Heating at a temperature of 56
o
C 
inactivates them in 30 minutes; 60
o
C – in less than 10 minutes. They are 
insusceptible to ether and detergents, but destroyed by chlorine-containing 
disinfectants and formaldehyde. 
 
 
Viral Replication Cycle 
 
Adenoviruses propagate within epithelial cells. Viral attachment is 
promoted by fibers. They bind to the specific cell receptors. Viral 
penetration is facilitated by penton interaction with cellular integrins. 
Adenoviruses are transported rapidly from the endosomes towards the cell 
nucleus, where the uncoating is finished. 
About 20 early nonstructural proteins are synthesized, providing DNA 
replication. After DNA replication, the late proteins are translated. 
Capsomeres are self-assembled in the nucleus. The duration of 
adenovirus replication cycle is about 24 hours. 
 
 
Pathogenesis and Clinical Findings of Adenoviral Diseases in Humans 
 
Adenoviruses affect human epithelial cells, causing cell aggregation 
and enlargement usually without lysis. Moreover, they suppress immune 
defensive factors. For instance, adenoviruses inhibit interferon action by 
blocking interferon-induced genes transcription. Viral proteins also inhibit 
cytotoxic activity of TNF-alpha. Finally, they slow down HLA-Ag I class 
expression on the membranes of infected cell, preventing cell-mediated 
cytolysis. 
Adenoviruses are highly versatile in their pathogenicity. Various 
human serotypes affect respiratory and gastrointestinal tracts, eyes, and 
urinary bladder. They propagate in the epithelial cells and spread to 
regional lymph nodes, where they persist. The leading sites of adenoviral 
persistence are adenoids and tonsils. Also adenoviruses replicate in the 
epithelium of intestinal tract. 
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Adenoviral infections are spread by airborne and fecal-oral 
transmission. Infants and young children are the most susceptible to the 
infection. 
Infectious dose of adenoviruses is very low – dozens or even several 
viral particles. 
The sources of infections are sick or convalescent individuals. 
Shedding of adenoviruses after the infection may be long (for 3-6 weeks). 
About 50% of cases of human adenoviral infections are mild or 
asymptomatic. Nevertheless, they provoke a great number of acute and 
chronic human diseases. Among them are: 
 
– acute febrile pharyngitis; 
– pharyngoconjunctival fever; 
– acute respiratory diseases in children and adults; 
– adenoviral pneumonia; 
– adenoviral gastroenteritis; 
– eye infections; 
– acute hemorrhagic cystitis; 
– urethritis and cervicitis. 
 
Acute febrile pharyngitis resembles other similar viral respiratory 
infections. 
Pharyngoconjunctival fever manifests by the symptoms both of 
pharyngitis and conjunctivitis. It is often caused by adenoviruses of 
serotypes 3 and 7; outbreaks of pharyngoconjunctival fever are called 
“swimming pool conjunctivitis”. 
Adenoviruses of types 3 and 7 as well as the limited number of other 
serotypes cause adenoviral pneumonia. It comprises about 10% of all 
pneumonia cases affecting children. Lethality of adenoviral pneumonia in 
early postnatal period may exceed 5%. 
Adenoviruses of types 40 and 41 mainly affect gasrointestinal tract, 
being responsible for about 10% of cases of viral gastroenteritis in infants. 
Eye adenoviral infections include follicular conjunctivitis and 
epidemic keratoconjunctivitis. The latter is predominantly caused by 8, 19, 
and 37 viral types. 
Viruses of types 11 and 21 provoke acute hemorrhagic cystitis in 
children, while type 37 causes urethritis and cervicitis. 
Systemic adenoviral infection in infants leads to serious complications 
affecting parenchymatous organs (hepatitis, nephritis), heart (myocarditis), 
CNS (meningoencephalitis). 
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After most adenoviral diseases strong long-lasting immunity is 
developed. It is maintained by type-specific neutralizing antibodies. 
Group-specific antibodies can’t prevent the relapse of infection. 
 
 
Laboratory Diagnosis of Adenoviral Infections 
 
The clinical specimens are obtained from the throat swab or 
conjunctivall swab, from stool or urine. 
Nasal epithelial cells of patients can be examined directly by 
immunofluorescence test to reveal viral antigens in the infected cells. 
Virus isolation is carried out in different human cell lines – HeLa, 
HEp-2, etc. 
The indication is performed by cytopathic effect with rounding, 
enlargement, and grape-like clustering of impaired cells. 
Identification is made by viral cytopathic effect neutralization, or by 
inhibition of hemagglutination test. 
Molecular-based assays are broadly used for viral DNA 
identification. DNA hybridization and PCR can identify various groups of 
the adenoviruses. 
Fecal specimens can be directly examined by electron microscopy or 
by latex agglutination and ELISA tests for adenovirus presence. 
Serological testing is used to detect the growth of antiviral antibodies 
during the infection course. Latex agglutination and ELISA are usually 
performed in paired sera test, and the fourfold elevation of specific 
antibodies is regarded as positive test. Viral neutralization and 
hemagglutination inhibition tests can be applied as well. 
 
 
Principles of Disease Prophylaxis 
 
Non-specific prophylaxis of adenoviral infections is achieved by 
maintaining of asepsis conditions, sterilization of medical instruments, 
chlorination of swimming pools and wastewaters, etc. 
For specific prophylaxis formaldehyde-treated vaccine had the limited 
use in past. By now, the vaccine is not available. The novel types of 
adenovirus-specific vaccines are under the research, including type-
specific live vaccines. 
The treatment is supportive. Specific antiviral agents are not 
elaborated. 
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Chapter 16 
HUMAN ENTERIC VIRUSES: ROTAVIRUSES, PICORNAVIRUSES 
 
 
 
REOVIRUSES AND ROTAVIRUSES 
 
 
The History of Discovery  
 
First agents (later designated as reoviruses) were isolated in 1951 by 
US virologist W. Stanley from the feces of Australian child with fever, 
pneumonia and gastroenteritis. Further in 1959 A. Sabin termed them 
reoviruses (reo means respiratory enteric orphan viruses) as they were 
isolated from human airways and gastrointesinal tract without evident 
relations with certain human pathology. 
These viruses were placed into separate family Reoviridae. 
New members of this family – rotaviruses – were isolated by 
R. Bishop in 1973. They are common etiological agents of diarrheal 
diseases in infants. 
 
 
 
Classification of Viruses 
 
Reoviridae family currently comprises two subfamilies and 15 genera.  
The genus Rotavirus pertains to subfamily Sedoreovirinae. This genus 
embraces 8 viral species (Rotavirus A-H).  
Human infections are caused mainly by 3 species Rotavirus A, В and 
С, but more than 90% of infection cases are produced by Rotavirus A 
species members. 
Depending on variations of external capsid proteins VP7 (G-protein) и 
VP4 (Р-protein) and their genes, all rotaviruses are divided into multiple 
serotypes and genotypes.  
Other representatives of reoviruses, e.g. from genera Coltivirus and 
Orbivirus, are the transmissive zoonotic agents; in certain conditions they 
may also afflict humans. 
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Structure of Reoviruses and Rotaviruses  
 
Virion size is 70-100 nm in diameter. Viruses possess two capsid 
shells, made of proteins; each capsid is of icosahedral symmetry.  
Inner composition of viral particle has a triple-layered structure. 
Virion is devoid of lipid envelope (naked viruses).  
Reoviral genome consists of double-stranded RNA, composed of 10-
12 discrete segments. Rotaviruses contain 11 genome segments.  
Virion of rotaviruses looks like wheel (Lat. rota – wheel). 
Mature capsid of rotaviruses has 6 structural (VP1-VP7 except VP5) 
and 6 non-structural proteins (NSP1-NSP6). 
External capsid is composed of proteins VP4 (or G-protein) and VP7 
(or Р-protein). They play a role of viral receptors, binding to 
polysaccharides of enterocytes. 
Protein VP1 is RNA-dependent RNA polymerase. 
Certain non-structural proteins act as rotavirus virulence factors. The 
most active is viral enterotoxin NSP4 with multiple deleterious activities.  
NSP4 activates chloride secretion by enterocytes and increases 
intracellular Ca concentration; the latter results in cytoskeleton 
impairment, damage of tight junctions between enterocytes and stimulation 
of proinflammatory cytokine secretion. Taken together, this leads to 
secretory and inflammatory diarrhea. 
Protein VP3 inhibits interferon synthesis. 
Segmented genomic RNA of rotaviruses encoding superficial VP4 and 
VP7 proteins is capable of gene segment recombination, known as genetic 
reassortment or genetic shift.  
After possible coinfection of target cells by rotaviruses of different 
genotypes the reassortment can take place – it results in formation of 
recombinant virions with a new genome and new combination of VP4 and 
VP7 proteins within external coat. Recombination between human and 
animal rotaviruses is also possible. 
Genetic drift means the minor genetic variations of viral VP4- and 
VP7-encoding sequences, ensuing from the point mutations in their genes. 
This exerts viral evasion from the host immune response. 
Despite high genetic variability, human infections are caused by only 
limited number of genotypes and serotypes of rotaviruses. 
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Virion Resistance 
 
Reoviruses and rotaviruses are stable in the environment – outside the 
host they maintain viability for several months. Virions withstand pH 
changes in the range of 3.0-9.0; therefore, they are more resistant in gastric 
juice. Nevertheless, rotaviruses are inactivated by heating at 50
o
C for 
30 minutes. They are resistant to lipid solvents, but susceptible to 95% 
ethanol, phenol, chlorine, and glutaraldehyde. Limited treatment with 
proteolytic enzymes increases infectivity. 
 
 
Rotavirus Replication Cycle 
 
Viral particles attach via capsid receptors VP4 and VP7 to sialic acid 
residues and oligosaccharides of enterocyte membrane receptors. 
Viruses enter the cell by endocytosis that is followed by removal of 
external capsid. Reproduction of rotaviruses occurs in cytoplasm of 
infected cells. 
Core-associated viral RNA polymerase is activated. It transcribes 
mRNA molecules from the minus strand of each genome segment. 
Released mRNAs are translated into viral proteins and serve as templates 
for synthesis of negative-sense strands with subsequent double-stranded 
genome formation.  
At the same time viral polypeptides self-assemble to form the inner 
and outer capsid shells. 
Intensive reproduction and egress of progeny virions results in lysis of 
infected cells. 
Rotaviruses are the fastidious agents to culture. They don’t propagate 
in embryonated eggs or experimental animals. Nevertheless, group A 
human rotaviruses are adapted to certain cell lines. They grow if pre-
treated with trypsin that facilitates uncoating. Maturation of virions is 
incomplete and slow. Reoviruses produce the inclusion bodies in the 
cytoplasm of infected cells. 
 
 
Pathogenesis and Clinical Findings of Rotaviral Diseases 
 
Rotaviruses are the leading causative agents of gastroenteritis that 
predominantly affects infants and children before 5 years. 
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Acute rotaviral gastroenteritis with diarrhea is a most common disease 
that creates the significant burden on public health worldwide but 
especially in developing countries. According to WHO data, it accounts for 
at least 500,000 children lethal cases annually. 
Rotaviruses are ubiquitous. By age of 3 years, 90% of children have 
serum antibodies to one or more types of rotaviruses. 
The source of infection is sick human.  
Rotaviral infection is transmitted via fecal-oral mechanism with 
contact, foodborne and waterborne routs. The infant becomes infected 
predominantly by the direct contact with virus-contaminated fomites. 
Infectious dose of virus is very low – about 100 viral particles. 
Incubation period is short (1-2 days).  
Rotaviruses pass through the stomach being resistant to acidic gastric 
juice. They infect duodenal and intestinal epithelium by binding to 
intestinal villi. The viruses multiply in the cytoplasm of enterocytes and 
impair electrolyte trans-membrane transport. One of the rotavirus-encoded 
proteins, NSP4, is a viral enterotoxin, which triggers diarrhea activating 
intestinal chloride secretion. Also it causes direct damage of enterocytes 
and stimulates intestinal inflammation. Damaged cells may slough into the 
lumen of the intestine and release large quantities of virus, which sheds 
with feces.  
Typical symptoms of rotaviral infection include fever, abdominal pain, 
diarrhea and vomiting, resulting in severe dehydration. 
In infants and children, severe loss of electrolytes and fluids may be 
fatal without compensatory infusion therapy. Patients with milder cases 
have symptoms for 3-8 days and then recover completely. 
Viral excretion usually lasts 2-12 days. Normal function of intestine is 
restored only in 3-8 weeks after the disease. 
Local immunity factors, such as secretory IgAs, may be important in 
protection against rotavirus infection. 
 
 
Laboratory Diagnosis of Rotaviral Infection  
 
As all acute viral diarrheas are similar in clinical manifestations, the 
diagnosis of rotaviral infection rests on laboratory testing of infection 
origin. 
Rotaviruses are fastidious for culture; hence, laboratory diagnosis is 
based on virus detection in stool specimens taken early in the disease 
course. 
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Molecular genetic tests (e.g., RT-PCR) play a pivotal role in rapid and 
precise identification of rotaviral nucleic acids in clinical specimen.  
Virus in stool can be detected also by immune electron microscopy, or 
by ELISA.  
Serological diagnosis evaluates fourfold growth of antibodies by 
ELISA or latex-agglutination tests. 
 
 
Principles of Treatment and Prophylaxis of Rotavirus Infections 
 
Treatment of gastroenteritis is supportive, directed to correction of 
water and electrolyte loss. It includes fluids resuscitation and restoration of 
electrolyte balance either intravenously or orally. 
For specific prophylaxis of rotavirus infection two efficient live 
attenuated vaccines are applied (RV1 and RV5). They are successfully 
used in more than 80 countries. Mass vaccination of children substantially 
improves epidemiological situation with rotavirus infection worldwide. 
 
 
PICORNAVIRUSES 
 
The History of Picornavirus Discovery 
 
The investigation of picornaviruses has commenced as far back as in 
1908-1909, when К. Landsteiner and E. Popper demonstrated the viral 
nature of poliomyelitis. However, poliomyelitis virus was isolated only in 
1949 by J. Enders.  
In 1948 G. Dalldorf and G. Sickles discovered a new enterovirus 
during infection outbreak in the town of Coxsackie (USA); hence, it was 
designated as Coxsackie virus.  
First representatives of the numerous group of ECHO viruses were 
isolated and studied by M Ramos-Alvarez and A. Sabin in 1953-1956. 
 
 
Classification of Picornaviruses 
 
Picornaviruses pertain to the same name order Picornavirales and 
family Picornaviridae. This family comprises more than 30 viral genera. 
The genera of primary medical relevance are Enterovirus, Parechovirus, 
and Hepatovirus.  
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Most of pathogenic human viruses belong to genus Enterovirus. It 
embraces 12 species – 9 enteroviral species Enterovirus A-J (without I) 
and 3 rhinoviral species Rhinovirus A, B, C.  
By their antigenic variations enteroviruses are additionally divided 
into serogroups encompassing more than 100 serotypes. 
Species Enterovirus A contains serotypes of group A 
Coxsackieviruses. 
Species Enterovirus B includes group B Coxsackieviruses and more 
than 30 serotypes of ECHO-viruses.  
Species Enterovirus C comprises polioviruses of 1, 2, 3 serotypes, and 
the rest of serotypes of group A Coxsackieviruses. 
In addition, Enterovirus A, B, and C species harbor many enteroviral 
serotypes that are not included into certain viral serogroup.  
Rhinovirus A, B, and C species represent more than 150 serotypes. 
Parechovirus genus (species – parechoviruses А and В) has 14 
serotypes; some of them may affect humans. 
Hepatovirus genus has single serotype (“serotype 72”). 
Besides above mentioned agents, in rare cases the members of other 
picornaviral genera Cardiovirus and Kobuvirus may cause human 
pathology.  
Finally, the representatives of genus Aphthovirus cause foot-and-
mouth disease – severe highly contagious epizootic disorder affecting 
domestic and wild even-toed ungulates – e.g., cattle, sheep or swine. 
 
 
Structure and Properties of Picornaviruses 
 
Picornaviruses are single stranded positive-sense RNA-containing 
naked viruses.  
Virus size is very small (28-30 nm). Viral nucleocapsid possesses 
icosahedral symmetry. It is composed of 60 capsomers. Four structural 
proteins VP1-VP4 of enteroviruses are folded into capsomer unit. Capsid 
proteins of many picornaviruses possess hemagglutinin activity. 
VP4 is tightly bound to viral RNA. Also viral nucleocapsid has small 
inner Vpg protein.  
Slightly distinct parechovirus capsomers are composed of 3 viral 
proteins. These proteins develop major antigenic activity of enteroviruses. 
Virus culture of polioviruses is performed in various cell lines. They 
don’t propagate in experimental animals or embryonated eggs. 
Coxackieviruses are highly pathogenic for newborn (“suckling”) mice. 
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Virion Resistance 
 
Picornaviridae members are highly resistant viruses. They can 
withstand acidic pH, UV irradiation, long-term drying, etc. Viruses can 
survive in water for about 100 days, in milk for 90 days, in feces and in 
sewage for several months. 
Enteroviruses are sensitive to chlorine-containing disinfectants. 
Heating at 56° inactivates them in 30 min. 
 
 
Viral Replication Cycle 
 
Virus attachment is performed via specific receptors of host cell 
membrane. Polioviruses interact with their specific membrane receptor 
CD155, whereas many other enteroviruses and all rhinoviruses bind to 
intercellular adhesion molecule ICAM-1 (or CD54). Specific binding 
induces viral conformational change with subsequent viral penetration by 
endocytosis. Acidification of endosome facilitates viral uncoating and 
RNA release. All cycle of virus propagation takes place in cytoplasm of 
infected cells. 
Viral uncoating is followed by genomic (+) RNA translation, which 
results in large single polyprotein synthesis. It is rapidly cleaved into 
several structural and non-structural proteins, including RNA-dependent 
RNA polymerase (replicase) and viral protease. Subsequent RNA 
replication occurs through the stage of negative-sense RNA intermediate, 
which serves as template for viral genome synthesis. 
Viral self-assemblage starts from genomic RNA pack into capsid 
proteins. After complete maturation the progeny viruses are released from 
the host cells resulting in cell disintegration and lysis. 
Picornavirus replication cycle takes about 5-10 hours. 
 
 
 
Enteroviral Diseases in Humans  
 
Poliovirus infection – pathogenesis, clinical findings and immunity 
in poliomyelitis 
Structural properties of polioviruses are typical for enteroviruses. 
Polioviruses don’t contain hemagglutinin. 
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Poliomyelitis is an infectious disease that is manifested as severe 
central nervous system disorder that may result in flaccid paralysis. 
Poliomyelitis affects solely humans, which are the only known 
reservoir of infection (anthroponotic disease).  
Infection is transmitted via fecal-oral mechanism (waterborne and 
alimentary routes).  
Incubation period ranges 1-2 weeks. 
Primary viral replication is performed within tonsils, and then in 
Peyer's patches and intestine epithelial cells. The virus is excreted with 
stools prior to the disease onset.  
After propagation in the lymphoid and epithelial tissues it undergoes 
blood dissemination and reaches CNS along axons of peripheral nerves. 
Infection of CNS by polioviruses can result in deep destruction of 
spinal cord neurons (predominantly, motor neurons of anterior horns) and 
brain neurons with subsequent irreversible paralysis. Polioviruses don’t 
multiply in muscles in vivo. The impairment of innervation of striated 
muscles is secondary to the destruction of neurons. 
Despite active CNS involvement, most poliomyelitis cases are 
subclinical (inapparent) or mild. 
Clinical forms of poliomyelitis infection are the follows: 
– abortive poliomyelitis is the most common manifestation of the 
disease; the patient has only fever, malaise, headache, nausea, and recovers 
in a few days; 
– nonparalytic poliomyelitis that may result in aseptic viral 
meningitis; it is characterized by stiffness, back and neck pain and 
meningeal symptoms together with above manifestations;  
– paralytic poliomyelitis arises in about 1% of total disease cases; it 
results in flaccid paralysis due to motor neuron damage; maximal recovery 
may occur within 6 months after the infection, but residual paralysis lasts 
much longer.  
Nowadays the cases of poliovirus infection are predominantly 
registered as vaccine-associated poliomyelitis (VAP) after the 
immunization with live poliovaccine. 
Virus-neutralizing antibodies elevate soon after the exposure to 
infection. However, polioviruses located in brain and spinal cord are not 
influenced by high titers of blood antibodies.  
Post-infectious immunity is high-grade and long-lasting, but only 
type-specific. 
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Passive immunity is transferred from mother to newborn; nevertheless, 
the levels of maternal antibodies gradually decline during first 5-6 months 
after birth 
 
Laboratory diagnosis of poliomyelitis 
Throat swabs taken soon after the onset of illness, stool samples or 
rectal swabs are used as specimens for laboratory examination. 
Viral cultivation is made in WHO recommended genetically modified 
murine cell culture that expresses CD155 or in human rhabdomyosarcoma 
RD cultures.  
Cytopathic effects appear in 5-7 days on inoculation. Isolated virus is 
identified by neutralization tests with specific antisera that distinguish 3 
basic serotypes of polioviruses. 
For laboratory confirmation of cases of vaccine-associated 
poliomyelitis (or VAP) molecular genetic tests are applied (PCR and viral 
genome sequencing), as they are able to identify mutant viral strains 
within the same polio serotype. 
Serological testing is used to evaluate the growth of antibody titers 
during the course of the disease. 
 
Principles of treatment and prophylaxis of poliomyelitis 
In case of poliovirus infection only symptomatic treatment is 
available. Administration of human donor’s immunoglobuln containing 
antiviral antibodies may foster patient’s recovery. 
For specific prophylaxis both live- and killed-virus vaccines are 
commonly used. Inactivated polio vaccine (IPV or Salk’s vaccine) is 
prepared from the virus grown in cell cultures. Killed vaccine induces 
humoral antibodies, but doesn’t stimulate local intestinal immunity. 
Oral trivalent vaccine contains live attenuated virus (Sabin’s vaccine) 
grown in cultures. This polio vaccine multiplies in human intestinal 
epithelium. Live vaccine treatment produces not only IgM and IgG 
antibodies in the blood, but also secretory IgA antibodies in the intestine. 
As the result, live vaccine confers both systemic and local immunity. 
Oral vaccine is administered at least thrice because of 3 distinct 
serotypes of polioviruses. 
Extremely rare cases of vaccine-associated paralytic poliomyelitis 
(paralytic VAP) may occur in vaccinated with live poliovaccine resulted 
from possible vaccine strain mutations.  
The applications of genetic engineering create the opportunities for the 
development of a live poliovirus recombinant vaccine that can’t mutate to 
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virulent strain. Nevertheless, current strategy of polio vaccination in many 
countries (e.g., in Belarus) relies on administration of inactivated vaccine 
only to preclude virus human circulation and to escape putative VAP cases.  
The Global Polio Eradication Initiative governed by the World Health 
Organization (WHO) from 1988 strives for eradication of poliovirus on the 
Earth as it was done for smallpox virus. 
 
Coxackieviral Infections 
 
Special features of Coxsackie viruses 
Coxackieviruses are similar with other enteroviruses. They are divided 
into two groups, A and B with multiple serotypes spread among various 
enteroviral species. Most of Coxackie viruses possess hemagglutinin.  
 
Pathogenesis, clinical findings and immunity 
The incubation period of coxsackieviral infection ranges from 2 to 9 
days. 
Coxsackieviruses produce a great variety of disorders in humans: 
– herpangina or vesicular pharyngitis; 
– aseptic meningitis and  meningoencephalitis; 
– respiratory febrile diseases; 
– pleurodynia or epidemic myalgia; 
– hand, foot and mouth disease or vesicular stomatitis with exanthem; 
– acute hemorrhagic conjunctivitis; 
– generalized disease of infants; 
– various clinical forms of myocarditis and pericarditis; 
– hepatitis, pancreatitis. 
 
It is generally ascertained that group В coxsackieviruses attack 
presumably inner organs, whereas group A viruses affect central and 
peripheral nervous system and muscular system. 
Various diseases can be spread among humans via fecal-oral or 
airborne transmission. 
Virus has been recovered from the blood in the early stages of 
infection in humans. It is also found in the throat for a few starting days of 
infection and in the stools for up to 5-6 weeks. 
Coxsackie herpangina is a severe febrile pharyngitis. It is caused by 
certain group A viruses. There is an abrupt onset of fever and sore throat 
with discrete vesicles on the soft palate, pharynx, tonsils, or tongue. The 
disorder is self-limited and most common in young children. 
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Hand, foot and mouth disease also known as vesicular stomatitis with 
exanthem may affect persons of all ages but predominantly young children 
before 4-5 years. It is caused by group A Coxsackie viruses and by 
enterovirus serotype 71. 
This self-limited but contagious ailment is manifested by damage of 
skin and mucosa with ulcerations and eruptions of small vesicles in oral 
cavity, upon hands and feet. 
Pleurodynia, or epidemic myalgia, or Bornholm disease is provoked 
by group В viruses. It is followed by fever, chest and abdominal pain. The 
disease is also self-limited and recovery is complete; nevertheless, the 
relapses are common. 
Coxsackie myocarditis is a serious disease with acute inflammation of 
myocardium and pericardium (pericarditis). It can occur in adults as well 
as in children. Infection can be fatal in neonates. Coxsackie В virus 
infections are supposed to trigger host autoimmune response that leads to 
cardiomyopathies. 
Aseptic meningitis is similar with same disorders of picornavirus 
origin. Fever, malaise, headache, nausea, and abdominal pain are common 
clinical findings. The muscle weakness occurs, but the patients usually 
recover completely. 
Generalized disease of infants is followed by total coxsackie viremia, 
affecting baby’s heart, liver, and brain. The disease is caused by group В 
coxsackieviruses and has a serious prognosis. 
Seroepidemiological data links type 1 (insulin-dependent) diabetes 
mellitus with coxsackie В viruses. 
Immunity in Coxsackie infections is mediated by type-specific 
neutralizing antibodies that appear early and persist for years. Antibodies 
are transferred passively from mother to fetus, protecting newborns for 
about 6 months. 
 
 
Laboratory diagnosis of Coxsackie infections 
Specimens are taken from throat washings during the first several days 
of infection and from feces during the first few weeks. In cases of aseptic 
meningitis, the viruses can be recovered from cerebrospinal fluid as well as 
from intestine. 
Viral cultivation is performed by sample inoculation into cell cultures 
and by infection of suckling mice. In cell cultures a cytopathic effect 
evolves within 5-14 days. In suckling mice, signs of the disease appear 
usually within 3-8 days with group A strains and 5-14 days with group В 
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strains. The virus is identified by neutralization reaction or by 
hemagglutination inhibition test. 
Serological testing is performed in paired sera tests, where fourfold 
rise in antibody titer is observed. ELISA and hemagglutination inhibition 
tests are available. 
 
Principles of prophylaxis and treatment of infections 
There are no vaccines or antiviral drugs currently applied for 
prevention or treatment of diseases caused by coxsackieviruses. 
 
 
 
Infections, Caused by ECHO Viruses  
 
Special features of ECHO viruses 
Echoviruses (abbreviation of enteric cytopathogenic human orphan 
viruses) are grouped together as they infect human enteric tract and can be 
recovered from humans by inoculation into certain cell lines. More than 30 
serotypes are known, but not all of them affect humans. 
Echoviruses display typical traits of enteroviruses. Several echovirus 
strains possess hemagglutinin. 
 
 
Pathogenesis, clinical findings and immunity 
Echoviruses can cause different alimentary infections (e.g. 
gastroenteritis), aseptic meningitis, encephalitis, acute respiratory viral 
infections, generalized viral disease of newborns and other viral disorders 
usually with non-specific findings. 
Parechoviruses of serotype 1 cause literally the same disorders like 
group ECHO viruses. 
Pathogenesis is similar to other enteroviral diseases.  
Echoviruses must be regarded as causative agents in outbreaks of 
aseptic meningitis and in summer seasonal epidemics of viral disorders 
with fever and rash, especially in young children. 
Nowadays echoviruses are the major cause of aseptic meningitis in 
children. With the potential elimination of poliomyelitis in developed 
countries, the pathology of CNS associated with echoviruses is prevalent. 
Immunity maintained by neutralizing antibodies is long-term and 
type-specific. 
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Laboratory diagnosis 
It is difficult to diagnose an echoviral infection on clinical grounds. 
Isolation of virus is possible from throat swabs, stools, rectal swabs, 
and, in case of aseptic meningitis, from cerebrospinal fluid. 
For clinical specimen testing various rapid methods are employed. 
Immunofluorescence assay of throat swab and ELISA are used for primary 
virus detection. 
Viral cultivation is available in cell cultures (e.g. primary monkey 
kidney cells). If a viral agent is isolated, it is tested against the wide 
number of antisera against enteroviruses. Determination of viral type 
present is made by immunofluorescence or neutralization tests. Infection 
with two or more enteroviruses may occur simultaneously. 
As some echoviruses carry hemagglutinin, hemagglutination inhibition 
test is suitable in these cases for viral identification. 
For rapid identification of various enteroviral strains reverse 
transcription PCR (RT-PCR) is widely used. 
Serological diagnosis is impractical because of the many different 
viral types. 
 
Principles of infection treatment and prophylaxis 
Administration of immune globulin for infants with suspected 
enterovirus infections is of limited value. There are no antiviral drugs or 
vaccines available for the treatment or prevention of any echoviral disease. 
 
Other pathogenic enteroviruses 
Certain other serotypes of enteroviruses can cause human disorders. 
Enterovirus 68 accounts for bronchiolitis or pneumonia, being 
isolated from respiratory tract of children. 
Enterovirus 70 is the major cause of acute hemorrhagic conjunctivitis. 
Enterovirus 71 was revealed in patients with meningitis, encephalitis, 
and paralysis that resembles poliomyelitis. It can produce serious central 
nervous system disorders that may be fatal. Enterovirus 71 strains can 
cause the meningoencephalitis that affects brain stem neurons. Also type 
71 infection can result in pulmonary edema and hemorrhages with lethal 
outcome. 
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Chapter 17 
HEPATOTROPIC VIRUSES 
 
Viral hepatitis is a systemic disease primarily affecting the liver.  
The cases of viral hepatitis in children and adults are caused by one of 
the following hepatotropic viruses:  
hepatitis A virus (HAV), the etiologic agent of viral hepatitis type A 
(previously termed as infectious hepatitis);  
hepatitis В virus (HBV) that causes viral hepatitis В (known in past as 
“serum hepatitis”);  
hepatitis С virus (HCV) – the agent of the same name hepatitis C; 
hepatitis D virus (delta virus or HDV) – the agent of hepatitis D or 
delta hepatitis;  
hepatitis E virus (HEV), the agent of enterically transmitted 
hepatitis E. 
All above listed pathogens afflict humans only. 
Hepatotropic viruses produce acute or chronic inflammation of the 
liver, resulting in a clinical disease manifested by fever, gastrointestinal 
disorders, and symptoms of liver damage, e.g. jaundice. 
Some outsider viruses like GBV-C, TTV or SEN were accounted for a 
long time as putative causative agents of other hypothetical viral hepatites 
(e.g., hepatitis G or F). 
However, now it is evident that in spite of wide distribution of some 
pathogens in human population (like GBV-C pegivirus or TTV anellovirus) 
there are no firmly established associations between these viruses and liver 
disorders in humans.  
 
 
HEPATITIS A VIRUS 
 
The History of Virus Discovery 
 
Viral etiology of epidemic jaundice was not wide accepted by 
physicians until the middle of 20
th
 century, in spite of G. Findlay, 
J. Dunlop, and H. Brown data, published in 1931, where they proposed a 
virus as the most probable etiological agent of previously known “catarrhal 
jaundice”. This clinical syndrome was ascertained later as hepatitis A 
disease. 
Hepatitis A virus was discovered in 1973 by S.M. Feinstone and 
coworkers from the data of immune electron microscopy of patient’s feces.  
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Classification  
 
Hepatitis A virus (HAV) pertains to Picornaviridae family.  
Despite HAV shares some major characteristics with other genera of 
picornaviruses, it is sufficiently different and classified as the only species 
in the separate genus Hepatovirus. There are naturally occurring strains 
that infect nonhuman primates (three genotypes) as well as four genotypes 
that comprise human-infectious viruses. Only one serotype is known. 
 
 
Structure of Virus  
 
HAV is a 27-32 nm spherical particle with icosahedral symmetry, 
containing a linear single-stranded (+) RNA genome. 
Intact virions have nucleocapsid with RNA, covalently linked VPg 
protein, and a capsid of the coat proteins VP1-VP3. 
 
 
Virion resistance 
 
HAV demonstrates high virion stability. It withstand treatment with 
ether and acids (e.g., pH 1.0 for 2 hours), as well as heating (60°C for 
10 h). Outside the host it stays viable for months.  
The virus is destroyed by UV irradiation, autoclaving, boiling in water 
for 5 minutes, by treatment with formaldehyde or chlorine-containing 
disinfectants. 
 
Viral Replication Cycle 
 
HAV propagation assumes to be exclusive to hepatocytes and 
gastrointestinal epithelial cells. Viral replication is similar with other 
picornaviruses. Uncoating is followed by genomic (+) RNA translation 
with formation of structural and non-structural proteins, including RNA 
polymerase. It replicates viral RNA genome via a negative strand 
intermediate. Viral proteins are further produced from the genomic positive 
RNA strand. Virus particles appear in bile and blood, being released 
mainly across the apical hepatocyte membrane into the biliary canaliculus 
and across the basolateral membrane into the bloodstream. The mechanism 
of viral release and secretion is not known yet but it is usually not followed 
by hepatocyte necrosis. 
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Pathogenesis, Clinical Findings and Immunity of Hepatitis A 
 
The source of infection is sick person. The disease affects 
predominantly children or young adults. 
Hepatitis A transmission occurs via fecal-oral route (waterborne and 
foodborne infection) and by direct contact.  
Incubation period lasts in the range 10-50 days (average – about 1 
month).  
Primary replication of virus occurs in enterocytes and in regional 
lymph nodes. At the end of incubation period HAV enters the blood 
resulting in viremia. Viruses enter hepatocytes from systemic bloodstream 
or directly via the portal vein. 
Enterohepatic cycling of HAV is observed. After replication within 
hepatocytes the viruses are secreted into bile with subsequent excretion 
with feces. Otherwise, they undergo next reabsorbtion in the gut. The latter 
results in repeat viral uptake by hepatic cells. The enterohepatic cycle 
continues until specific antibodies eliminate virus. 
Disease onset is followed by fever, jaundice, bilirubin and 
aminotransferase elevation. 
In young children, acute HAV infection is very often asymptomatic. In 
contrast, elder children and adults demonstrate a range of clinical 
manifestations from mild infection to potentially fatal fulminant hepatic 
disease. 
Nevertheless, complete recovery occurs in majority of hepatitis A 
cases; chronicity is not observed. 
HAV infection stimulates both humoral and cellular immunity. 
IgM, IgG, and IgA antibodies directed against HAV proteins are 
induced and can usually be detected by the onset of clinical symptoms. 
They neutralize virus activity, facilitating recovery.  
By contrast, cell-mediated immunity provokes immune-mediated 
hepatocyte injury, aggravating hepatic inflammation. 
Post-infectious IgG-mediated humoral immunity provides lifelong 
protection against HAV infection. 
 
Laboratory Diagnosis of HAV Infection 
 
Liver biopsy permits a tissue diagnosis of hepatitis A. Tests for 
abnormal liver function, such as serum alanine aminotransferase (ALT) 
and bilirubin supplement the clinical, pathological, and epidemiological 
findings. 
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HAV can be detected in various clinical specimens (the liver biopsy, 
stool, bile, or blood) by various immunoassays (immunofluorescence test, 
ELISA), nucleic acid hybridization assays, or PCR.  
Peak levels of virus are detected in the stool about 1-2 weeks prior to 
the first liver enzyme abnormalities. 
Virus particles are detected by immune electron microscopy in fecal 
extracts of hepatitis A patients. Virus appears early in the disease and 
disappears within 2 weeks following the onset of jaundice. 
Serological diagnosis is most suitable for clinical use.  
Anti-HAV antibodies appear in the IgM fraction with peak near 2 
weeks after elevation of liver enzymes. Anti-HAV IgG antibodies follow 
the onset of disease and persist for decades.  
Thus, the detection of IgM anti-HAV antibodies in blood confirms the 
diagnosis of hepatitis A with specifity of 99%. ELISA is the method of 
choice for measuring HAV antibodies. 
 
 
Principles of Hepatitis A Treatment and Prophylaxis  
 
Subclinical and mild cases of viral hepatitis A don’t require treatment. 
Treatment of manifested cases is supportive, specific antiviral drugs are 
not available.  
For passive prophylaxis of exposed persons human immunoglobulin 
can be administered. 
For specific prophylaxis various cultural inactivated vaccines are 
commonly used. Children are immunized twice at 18 and 24 months. 
Vaccine-induced antibodies are long-living and persist in the least for 
20 years. Vaccination confers long-term protection against HAV; as the 
result, future eradication of this infection is possible now. 
 
 
 
HEPATITIS E VIRUS 
 
 
History of Discovery  
 
In 1981 Soviet virologist M.S. Balayan made an experiment of self-
infection, ingesting the infectious material collected from 9 soldiers with 
hepatitis of unclear origin. At 37
th
 day from the infection time point he 
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manifested typical symptoms of acute viral hepatitis. Laboratory testing 
revealed no markers of already known viral hepatites A or B. Nevertheless, 
immune electron microscopy of fecal specimens demonstrated the presence 
of novel hepatitis virus. This way hepatitis E virus (or HEV) was 
discovered. 
Meanwhile, some previous epidemics of fecal-orally transmitted 
hepatites were later proven to be hepatitis E disease. For instance, it was 
documented for New Delhi outbreak of 1955 (India), where 29,000 cases 
of hepatitis with jaundice were registered after sewage contamination of 
the drinking water supply.  
 
 
Classification  
 
Hepatitis E virus (HEV) pertains to Hepeviridae family, genus 
Orthohepevirus, and species Orthohepevirus А. This virus has 4 genotypes. 
Genotypes 1 and 2 are the solely human pathogens; genotypes 3 and 4 are 
isolated from humans and various animal species (swine, boars, rabbits, 
deers, etc.) 
Other members of genus Orthohepevirus infect only animals (zoonotic 
viruses). 
 
Structure of HEV 
 
HEV is a 27-34 nm spherical particle with icosahedral symmetry, 
containing a linear single-stranded (+) RNA genome. It is naked virus 
without lipid envelope. 
Three genetic regions of HEV (open reading frames, ORFs) encode 
viral proteins. One ORF codes for viral enzymes (RNA-polymerase, 
protease and helicase); two others encode viral capsid protein – major 
HEV antigen, and phosphoprotein, participating in viral infection. 
Only 1 serotype of virus is determined. 
Virion Resistance 
 
Generally HEV is less stable than hepatitis A virus. It is inactivated by 
heating at 60°C for 15-30 minutes. Also HEV is destroyed by chlorine-
containing disinfectants and formaldehyde. 
Nonetheless, the stability of HEV virions is quite enough for fecal-oral 
transmission. 
 
 308 
Viral Replication Cycle  
 
Virus attachment is performed via capsid protein binding to hepatic 
heparan sulfate and heat shock protein receptors. Viruses enter hepatocytes 
by endocytosis. All cycle of virus propagation takes place in cytoplasm of 
infected cells. 
Viral uncoating is followed by genomic (+) RNA translation, which 
results in early proteins synthesis (e.g., viral enzymes). Newly formed viral 
RNA polymerase (replicase) catalyzes viral (+) RNA replication through 
the stage of negative-sense RNA intermediate, which serves as template 
for viral genome synthesis. Later the structural proteins of HEV are 
translated. 
Viral self-assemblage depends on capsid proteins; viral 
phosphoprotein facilitates virion translocation and egress. After complete 
maturation the progeny viruses are released from hepatocytes by budding. 
 
 
Pathogenesis, Clinical Findings and Immunity of Hepatitis E 
 
Hepatitis E demonstrates 2 basic clinical forms, depending on viral 
genotype.  
HEV of 1-2 genotypes cause mass outbreaks of the disease in 
developing countries of Southeast Asia, Africa, and Latin America. This is 
mainly related with poor drinking water supply and sanitary control 
burdened with common deficiency of water resources. Less intensive 
outbreaks of infection may be registered in many countries all over the 
world.  
HEV of 3 and 4 genotypes cause sporadic cases of hepatitis E 
worldwide. Last 15 years a steady growth of this infection is observed in 
many developed world regions (United States, European countries, Russia, 
Japan, New Zealand, etc.) Now it is generally ascertained that this variant 
of the disease is typical zoonotic infection transmitted by alimentary route. 
Hence, hepatitis E caused by HEV of 1-2 genotypes is the disease with 
waterborne transmission. The sources of infection are humans. 
And hepatitis E caused by HEV of 3-4 genotypes is zoonotic infection 
with alimentary (foodborne) transmission primarily via ingestion of 
contaminated meat. The sources of infection are various animal species 
(mostly swine or boars). 
Incubation period lasts from 2 to 6 weeks. 
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The details of pathogenesis of hepatitis E are not completely 
elucidated. HEV enters the liver via portal vein and replicates in 
hepatocytes. Damage of liver cells is predominantly mediated by cellular 
autoimmune response directed against virus-infected host cells. 
The virus actively discharges from the body with feces especially in 
early stages of infection. 
Epidemic hepatitis E caused by HEV of 1-2 genotypes predominantly 
affects young individuals. Only 40% of patients display jaundice; the 
course of infection is usually moderate or mild. Lethality of epidemic 
outbreaks doesn’t exceed 1%. Complete recovery occurs in most of cases; 
chronicity is not observed. 
However, in case of infection of pregnant women at third trimester of 
pregnancy, severe and fulminant forms of the disease can develop with 
expected high fatality rate (20-30% and even more). The mechamisms of 
this clinical condition are not well-elucidated yet. 
Sporadic alimentary hepatitis E caused by HEV of 3-4 genotypes 
affects mainly elder persons with substantial comorbidity or under 
immunosuppression. The disease generally demonstrates more active 
course with jaundice in 75% of patients. If the patient had preliminary 
chronic liver disease (chronic hepatitis or cirrhosis), the fatality of HEV 
infection may be high (up to 70% in 1 year from infection onset). Chronic 
forms of hepatitis E can be observed in these patients. 
HEV infection confers both cellular and humoral post-infectious 
immunity. The protection maintains for several years. However, the levels 
of specific antibodies gradually decline, and HEV reinfection becomes 
possible. 
 
 
 
Laboratory Diagnosis 
 
Serological testing is primarily used for HEV laboratory diagnosis. 
Anti-HEV IgM antibodies are determined in patient’s sera by ELISA 
indicating acute disease. 
Molecular genetic tests (e.g. reverse transcriptase PCR) detect HEV 
RNA in patient’s feces. PCR and genetic sequencing identify genotypes of 
hepatitis E viruses. 
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Prophylaxis and Treatment of HEV Infection 
 
In most of cases viral hepatitis E needs only supportive symptomatic 
treatment. Ribavirin and interferon are used in immunocompromised 
patients. 
For specific prophylaxis several HEV recombinant vaccines were 
developed, based on viral capsid protein. One of them is registered in 
China for mass vaccination. 
 
 
 
HEPATITIS B VIRUS 
 
 
The History of Virus Discovery 
 
In the first half of XX century it has become evident that at least two 
viral agents are responsible for so-called “infectious jaundice”. As the 
result, F.O. MacCallum and D. J. Bauer proposed in 1947 the designation 
of hepatitis B for “serum-transmitted” hepatitis and hepatitis A for the 
disease transmitted via fecal-oral route. 
In 1967 B.S. Blumberg discovered a specific antigen in blood of an 
Australian aborigine that was later associated with acute hepatitis B and 
led to the development of specific tests for identification of HBV infection. 
Finally, viral etiology of hepatitis B was firmly established by 
D.S. Dane in 1968-1970 by electron microscopy with detection of HBV 
virions (referred to as Dane particles). Dane particles were shown to react 
with antiserum to Australian antigen. Next study found this antigen to be 
the surface component of HBV virion, thereby termed as hepatitis B 
surface antigen (or HBsAg). 
Classification of Virus 
 
Hepatitis B virus (HBV) pertains to Hepadnaviridae family, genus 
Orthohepadnavirus. 
This genus also harbors other viral species that infect animals (e.g., 
bats, woodchucks, squirrels, etc.) 
Hepatitis B virus cause acute and chronic viral hepatitis, often 
progressing to permanent carrier states, liver cirrhosis and hepatocellular 
carcinoma. 
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Viral Structure 
 
HBV is a 42 nm spherical particle with icosahedral symmetry, 
enveloped with external protein shell.  
HBV genome contains unique circular partly double-stranded DNA. 
Minus strand of DNA is almost a complete circle and carries overlapping 
genes that encode both structural proteins (pre-S, surface, and core 
proteins) and replicative proteins (polymerase with reverse transcriptase 
function and X-protein). The plus strand of DNA is shorter and variable in 
length. The gap in DNA must be completed at beginning of replication 
cycle. 
Partially different 8 genotypes of HBV are known to date (A to H). 
HBV contains 4 major antigens – HBs, HBc, HBe and HBx. 
Viral envelope is predominantly composed of HBsAg and some lipids. 
External shell surrounds a 27-nm inner nucleocapsid core that contains 
HbcAg. 
HbsAg particles exist in several forms – S (small), M (middle) and L 
(large). The latter two variants are composed of HbsAg and pre-S2 protein 
component or pre-S1 component. 
It is suggested that the pre-S proteins play an important role in the 
attachment of HBV to hepatocytes. In addition, pre-S2 attaches to 
polymerized human serum albumin. 
Core HBcAg is processed intracellularly to produce HBeAg, which 
appears in bloodstream. 
HBx protein is a small transcriptional transactivator, regulating viral 
transcription. It is suspected to participate in emergence of HBV-induced 
primary hepatocellular carcinoma. 
Also HBV genome encodes large polymerase (P) protein that 
develops DNA polymerase, reverse transcriptase, and RNase activities. 
 
Virion Resistance 
 
HBV virion is a stable particle. The dried virus remains viable for at 
least 1 week. HBV can be stored at -20°C for over 20 years; it is resistant 
to repeated freezing and thawing.  
HBV virion (but not HBsAg) is sensitive to high temperatures being 
inactivated at 100°C in 1 minute. Incubation at 60°C prolongs viral 
survival to 10 hours.  
HBsAg remains stable at pH 2.4 for up to 6 hours, but HBV infectivity 
is lost. 
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HBV is relatively sensitive to a number of disinfectants such as 
halides, glutaraldehyde and formaldehyde, 95% ethanol, phenol. For 
instance, sodium hypochlorite destroys HBV antigenicity within several 
minutes. 
 
 
 
HBV Replication Cycle 
 
HBV replication begins with binding of the virus to hepatocyte 
membrane with subsequent penetration and shedding of external shell. 
Virus core is transported to the nucleus, where the relaxed circular 
DNA is converted to a covalently closed circular DNA (cccDNA), which 
acts as the template for all viral RNA synthesis.  
DNA transcription results in pregenome RNA synthesis. Pregenomic 
RNA serves as a template for reverse transcription resulting in a negative 
strand DNA copy. The polymerase starts to synthesize positive DNA 
strand, but the process is not completed. Sometimes DNA becomes capable 
of integrating with cellular genome, but it usually doesn’t occur during the 
normal course of replication. 
Viral RNAs are translated on ribosomes yielding viral structural 
proteins. 
Viral cores become encapsidated with newly synthesized HbcAg, 
acquire HBsAg-containing envelopes in cytoplasm, and may exit the cell. 
Alternatively, cores may be reimported into the nucleus and initiate 
another round of replication in the same cell. 
 
 
 
Pathogenesis, Clinical Findings and Immunity of Hepatitis B 
 
HBV infection is grossly spread worldwide. According to WHO data, 
about 240 million people are chronically infected with hepatitis B. The 
estimated number of annual death cases due to hepatitis B complications 
(namely, cirrhosis and liver cancer) exceeds 680,000. 
Only mass human vaccination with efficient hepatitis B vaccine 
created the barrier against the infection, thereby preventing the 
development of disease complications.  
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Nevertheless, high prevalence of HBV infection creates a serious 
problem in certain world regions, e.g. in sub-Saharan Africa, South and 
East Asia, where 5-10% of the adults is chronically infected 
Hepatitis B is anthroponotic disease. The source of infection is 
human carrier of sick person. 
The infectious dose for HBV is low but not yet firmly established 
(usually less than 100 viral particles). 
The main routes of HBV transmission are: parenteral after medical 
manipulations via blood and its products (“artificial route”), sexual 
intercourse, and vertical transmission from mother to child. 
As the result, HBV infection is a substantial occupational hazard for 
healthcare workers due to the elevated risk of their exposure to infected 
blood and low infectious dose of the pathogen. 
Incubation period of hepatitis B is long and lasts from 1 to 6 months.  
When appeared in the bloodstream, HBV enters the liver, binds to 
membrane liver bile acid transporter protein (LBAT) by viral HBsAg and 
replicates within hepatocytes.  
It is generally assumed that HBV is not directly cytopathic to infected 
hepatocytes, but cytotoxic T cells attack the infected hepatic cells. Thus, 
cellular autoimmune reactions promote cytolysis of hepatocytes. 
Clinical findings of acute HBV infection include fever, nausea and 
vomiting, jaundice with dark urine and pale stools.  
In some cases extrahepatic autoimmune manifestations occur resulting 
in skin rashes, arthralgias or arthritis. Severe (fulminant) forms of 
hepatitis B develop in 1-2% of patients with lethality above 60%. 
The disease has a tendency to chronicity eventually observed in 5-
10% of cases. The risk of chronic infection is highest (up to 90%) for 
infants infected during pregnancy. 
Chronic HBV infection elevates the risk of hepatocellular carcinoma. 
Therefore, HBV is regarded as established biological carcinogen. 
Despite possible autoimmune injury of hepatocytes, T cell-mediated 
immunity is considered to be essential for patient recovery. Elimination of 
infected cells and inhibition of viral replication through the release of 
cytokines, e.g., γ-interferon and TNF-α, is a cornerstone of viral clearance 
during acute HBV infection. It is generally assumed that chronic infection 
is related to a weak T cell response to viral antigens.  
Binding of specific antibodies to viral envelope antigens also 
contributes to clearance of the virus. 
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Laboratory Diagnosis 
 
Viral DNA, antigens and antiviral antibodies are revealed in blood and 
liver biopsy specimens. HBsAg can be detected also in saliva, semen, 
vaginal secretions, etc. 
The most valuable tests are ELISA for detection of HBV antigens and 
antibodies and PCR for viral DNA. 
HBsAg indicates HBV infection – acute or chronic. HBsAg is usually 
detectable 2-6 weeks prior to clinical and biochemical signs of hepatitis. It 
persists throughout the clinical course of the disease but typically 
disappears by the 6
th
 month after exposure. 
HBeAg correlates with active HBV replication and high serum load 
with hepatitis B viruses 
Anti-HBs antibodies indicate past infection with immunity to HBV, or 
immune response to hepatitis B vaccine.  
High levels of IgM anti-HBc-specific antibodies are frequently 
determined at the onset of clinical illness.  
Anti-HBe antibodies are present in serum of persons with chronic 
HBV infection with low titers of HBV. 
Viral DNA detection by PCR correlates with active viral replication. 
 
 
Principles of Disease Treatment and Prophylaxis 
 
Hepatitis B is treated with reverse transcriptase inhibitors (e.g., 
lamivudine) and inhibitors of viral DNA synthesis (telbivudine). 
Recombinant interferon-alpha shows beneficial effect in the 
treatment of patients with chronic HBV infection. 
For passive post-exposure prophylaxis hepatitis B immune globulin 
is administered within 12 hours after percutaneous exposure to HBsAg-
positive blood, or after sexual intercourse with HBsAg-positive person. 
For active specific prophylaxis HBsAg recombinant vaccine is 
effectively used worldwide. HBV vaccination is an essential part of 
national immunization programs in many countries.  
Primary injection of vaccine is made during 12 h after birth; two 
boosters are conducted in 1 and 6 months. Full vaccination course confers 
specific immunity to 99% of persons.  
Pre-exposure prophylaxis with hepatitis В vaccine is conducted for all 
susceptible high-risk groups, including medical personnel. The protective 
immunity lasts for 10-15 years. 
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Non-specific prophylaxis includes the procedures that can limit the 
risk of infection to healthcare workers, laboratory personnel, and other 
susceptible individuals. All blood remnants, body fluids and contaminated 
materials should be treated as if they are infectious for HBV, HCV, HIV, 
and other parenteral viruses. The medical instruments are sterilized by 
autoclaving. 
 
 
 
HEPATITIS DELTA VIRUS 
 
 
The History of Virus Discovery 
 
From time to time highly severe (fulminant) hepatitis develops in 
patients with HBV infection. It has been demonstrated that fulminant HBV 
disease is associated predominantly with patient superinfection by new 
hepatitis D or hepatitis delta virus (HDV).  
HDV was first isolated from patients with severe hepatitis B by 
M. Rizetto in 1977. 
 
 
 
Classification and Structure of HDV 
 
HDV is not included into any viral family (unclassified virus). It is 
placed into separate genus Deltavirus with single species hepatitis delta 
virus.  
Hepatitis D virion is spherical particle with icosahedral symmetry, 
about 40 nm in size. Genome of HDV consists of very small circular 
negative single-stranded RNA, 1.7 kb in size. Genomic RNA encodes 
intrinsic HDV capsid antigen (HDAg or delta Ag). 
No homology exists between HBV and HDV genomes.  
HDV is a defected satellite virus (subviral agent) that reproduces only 
in presence of helper hepatitis B virus.  
HDV requires HBsAg of hepatitis B virus – together with host cell 
lipids HBsAg creates envelope for HDV virion. 
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Viral Replication Cycle  
 
HDV exploits the same membrane receptor as HBV (liver bile acid 
transporter protein or LBAT) to infect hepatocytes. After uncoating HDV 
nucleocapsid is transported into the cell nucleus, where genome replication 
occurs. 
HDV uses cellular RNA polymerases to create circular genomic RNA 
and linear mRNA for translation of protein HDAg.  
HDAg binds to viral genomic RNA transported into cytoplasm 
resulting in nucleocapsid formation. It acquires external coat from proteins 
of HBsAg of hepatitis B virus and releases via cytoplasmic membrane of 
hepatocytes. 
Thus, productive HDV infection is possible only in case of hepatocyte 
co-infection with HDV and HBV agents.  
 
 
Characteristics of HDV Infection 
 
As estimated, about 15-20 mln people are currently coinfected with 
HDV and HBV worldwide. HDV infection is often associated with the 
most severe forms of hepatitis in HBsAg-positive patients. Chronically 
infected individuals demonstrate high risk of progression to end-stage liver 
disease, resulting in cirrhosis and hepatic carcinoma. 
Intravenous drug abusers and persons, who received multiple 
hemotransfusions, are of high risk of HDV infection. 
The primary routes of transmission for HDV are similar to HBV, 
though HDV is not a sexually transmitted disease. Perinatal transmission 
of HDV is rare. 
The incubation period varies from 2 to 12 weeks. 
While HDV is absolutely dependent on a coexistent HBV infection, 
acute hepatitis D may develop either as a simultaneous infection 
(coinfection) with HBV or as a superinfection of patient with primary 
chronic HBV infection. 
Coinfection is similar to acute hepatitis B resulting in viral elimination 
in more than 90% of cases with complete recovery. 
By contrast, superinfection by HDV is frequently associated with 
severe acute (“fulminant”) hepatitis that, if recovered, results in chronic 
HDV disease (near 90% of cases). Fulminant hepatitis D is a life-
threatening disorder with fatality of 70-90%.  
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Laboratory Diagnosis 
 
Serological tests are used for hepatitis D diagnosis. Both HDAg and 
anti-delta IgM antibodies are determined by ELISA in case of acute 
delta infection. 
Also HDV RNA is discovered in patient’s serum by PCR. 
All markers of HDV replication decline to convalescence, but HDV 
antibodies may disappear within months or years. 
 
Treatment and Prophylaxis of hepatitis D 
 
Recombinant interferon-alpha is commonly used for treatment of 
delta hepatitis. Antiviral chemotherapy of HDV infection is currently not 
elaborated. 
In healthy individuals delta hepatitis can be fully prevented by 
vaccination of persons with hepatitis В vaccine. However, vaccination 
doesn’t protect chronic hepatitis В carriers from superinfection by HDV. 
 
 
 
HEPATITIS C VIRUS 
 
The History of Virus Discovery 
 
Long time accumulated clinical, epidemiological and laboratory data 
strongly indicated that it should be widespread hepatitis agent not related 
to HAV or HBV. Intensive attempts to identify enigmatic pathogen were 
protractedly unsuccessful until M. Houghton with colleagues, D. Bradley 
and H. Alter in 1985-1989 by the methods of molecular cloning isolated 
and then sequenced nucleic acid of a novel causitive agent of viral 
hepatitis, later designated as hepatitis C virus or HCV. 
 
 
Classification  
 
Hepatitis C virus (HCV) belongs to Flaviviridae family. Currently 
this family contains 4 viral genera. The genus with the most numerous 
viral species here is Flavivirus. It harbors at least 53 zoonotic viral species 
that pertain to arboviruses, contracted by arthropod vectors to animal and 
human hosts. 
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Genus Hepacivirus contains single species of hepatitis C virus.  
HCV demonstrates extreme genetic variability being divided into 7 
genotypes, each contains multiple genetic subtypes (totally more than 100). 
Subtype variations generate HCV quasispecies during the course of 
individual infection.  
HCV subtypes 1a and 1b have global distribution, they account for 
about 60% of total infection cases.  
 
 
 
Structure of HCV 
 
HCV is a positive single-stranded RNA virus of spherical shapes with 
lipid envelope, 60 nm in size. HCV virion has icosahedral symmetry. 
Viral particle has a core protein of nucleocapsid, two envelope 
glycoproteins E1 and E2.  
Proteins E1 and E2 promote HCV binding and fusion with membranes 
of hepatocytes facilitating viral entry. 
Viral genomic RNA encodes a number of non-structural proteins 
(NSP2- NSP5A and NSP5B) with multiple functions.  
They possess enzymatic activity (helicase, protease), inhibit host 
interferon production, suppress lymphocyte activation, or induce apoptosis 
of infected cells. 
Non-structural protein NSP5B is viral RNA polymerase. 
Hepatitis C viruses can’t propagate in laboratory cell lines except 
hepatocyte cultures. 
 
 
 
Virion Resistance  
 
HCV as all flaviviruses is relatively unstable in the environment. 
Nevertheless, in plasma, if exposed to room temperature or dried, the virus 
maintains viability at least for 16 h. Viral survival expands at low 
temperatures. 
Heating at 60-70
o
C for 10 minutes irreversibly inactivates virus. 
HCV is sensitive to UV light and all conventional disinfectants 
(halides, aldehydes, phenol, H2O2, detergents, ether, ethanol, etc.) 
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Viral Replication Cycle 
 
HCV infects hepatocytes, but it may replicate within lymphocytes and 
monocytes.  
Virus attachment is performed via binding of E1 and E2 viral proteins 
to broad group of cell membrane receptors. Viruses enter hepatocytes by 
endocytosis. Viral uncoating is facilitated with endosome acidification 
resulting in fusion of lipid envelope with endosomal membrane. 
All cycle of virus propagation occurs in cytoplasm of infected cells. 
Genomic (+) RNA translation results in primary polyprotein synthesis 
that further processed by viral and cellular proteases into mature viral 
proteins. 
Viral RNA polymerase NSP5B catalyzes genomic RNA replication 
through the stage of negative-sense RNA intermediate, which serves as 
template for genomic (+) RNA synthesis.  
Virion assembly and maturation is finalized by release of progeny 
viruses that leave hepatocytes by budding. 
 
 
Pathogenesis, Clinical Findings and Immunity in Hepatitis C 
 
Current infection by HCV demonstrates high prevalence throughout 
the world. According to WHO data, about 3% of human population are 
infected with HCV. Furthermore, some population subgroups (e.g., in 
Africa) have prevalence rates as high as 10%. Other high-prevalence areas 
are found in South America and Asia.  
It is estimated that totally there are more than 170 million HCV 
chronic carriers, who have elevated risk of progression of end-stage liver 
disease with cirrhosis, or hepatic carcinoma. 
Hepatitis C is solely anthroponotic disease. The source of infection is 
human (chronic patient or carrier). 
Incubation period usually lasts from 1 to 3-4 months.  
The main route of transmission is parenteral. The major risk groups 
are intravenous drug abusers that apply non-sterile syringes for drug 
injections, and persons, undergoing frequent massive blood transfusions. 
Sexual or vertical transmission is much more seldom (less than 5%). 
Most new infections with HCV are subclinical. Hospitalization is rare, 
and jaundice occurs in less than 25% of patients.  
Self-recovery after primary HCV infection greatly varies in the range 
near 20-40%. 
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The majority (more than 60%) of HCV patients develops primary 
chronic hepatitis, and many are at the risk of progressing towards chronic 
active hepatitis and cirrhosis (10-20%). About 40% of chronic liver disease 
is HCV-related. 
Also HCV infection substantially elevates the risk hepatocellular 
carcinoma’ i.e., HCV is a potent biological carcinogen. 
HCV is regarded to exert low or moderate cytopathic effect (e.g., liver 
steatosis) but hepatocytes are damaged by cellular autoimmune reactions. 
Many isolates of HCV are resistant to interferons, as viral proteins can 
block interferon-inducible antiviral cell proteins. 
In number of chronic HCV infections extrahepatic manifestations 
arise resulting in skin rashes, arthritis, progression of diabetes mellitus, etc. 
During the long course of chronic infection HCV undergoes active 
mutational process. It is essential for fast propagating RNA-containing 
viruses with error-prone replication with high mutation rate. 
This results in generation of a great number of mutant genetic variants 
(quasispecies or “mutant cloud”) arisen from primary HCV virus in the 
course of individual viral infection.  
The emergence of quasispecies is extremely significant in progression 
of viral disease. The ongoing pressure from the side of host immune 
system and the influence of antiviral drugs promote the selection of 
resistant viral mutants. This leads to creation of new genetic lines resistant 
to antiviral therapy and therefore, leads to the progression of viral disease. 
Overall, in many patients the immunity almost fails to prevent chronic 
infections by HCV. What’s more, the virus actively develops genetic 
variations during chronic infections resulting in change of viral antigenic 
structure. 
 
 
Laboratory Diagnosis of Hepatitis C 
 
Serological testing is commonly elaborated for diagnosis of HCV 
infection. ELISA determines antibodies to HCV but don’t distinguish 
between acute, chronic, or resolved infection. 
Nucleic acid-based assays (mainly, reverse transcriptase PCR) detect 
the presence of circulating HCV RNA. Quantitative real-time PCR is 
essential monitoring patients on antiviral therapy.  
Nucleic acid hybridization is used to determine genotypes of HCV 
isolates as well as for detection of viral RNA in liver biopsy specimens. 
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Principles of Disease Treatment and Prophylaxis 
 
Active specific prophylaxis of HCV infection by vaccination is not 
available now. Great difficulties in design of HCV vaccines are inevitable 
due to high genetic diversity of hepatitis C virus. 
Prior to 2013, combination therapy of hepatitis C patients with 
recombinant interferon-alpha and antiviral drug ribavirin was regarded as 
the method of choice for treatment of HCV infection. But only about 40-
80% of chronic HCV patients depending on HCV genotype responded to 
this therapy regimen that lasted up to 48 weeks. The treatment was also 
followed by serious side effects. The results were improved with 
administration of prolonged interferons conjugated with 
polyethyleneglycol (PEG-interferons). 
Fortunately, almost simultaneously in 2013/2014 novel highly 
efficient anti-HCV drugs were introduced into clinical practice that 
literally revolutionized the treatment of this life-threatening infection. 
With highest specificity they arrest the activity of viral proteins 
essential for HCV replication. In particular, simeprevir blocks viral 
protease action, sofosbuvir inhibits viral RNA polymerase NS5B, and 
ledipasvir inactivates non-structural protein NS5A, responsible for viral 
replication, assembly and egress.  
Taken in various combinations, they increased treatment success rate 
above 95% even for the most resistant 1 genotype of hepatitis C virus.  
The only serious obstacle still impeding the broad use of these life-
saving drugs is a very high cost of treatment course. 
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Chapter 18 
RETROVIRUSES:  
HUMAN IMMUNODEFICIENCY VIRUS (HIV)  
 
 
 
HUMAN IMMUNODEFICIENCY VIRUS 
 
 
The History of HIV Discovery 
 
Human immunodeficiency virus (HIV), supposed to be derived from 
primate lentiviruses, is the etiological agent of HIV infection with 
acquired immunodeficiency syndrome, or AIDS.  
The infection was first registered in 1981, and its causative retroviral 
agent was primarily isolated by the end of 1983 by French virologists 
F. Barrй-Sinoussi and L. Montagnier. To confirm the results of discovery, 
this viral isolate was sent to highly experienced US laboratory headed by 
R. Hallo that specialized in retrovirus study. At the end of 1983 the 
research group of F. Wong-Staal working under the guidance of R. Hallo 
reported about isolation of a new retrovirus – putative causative agent of 
AIDS. Further molecular genetic analysis demonstrated the identity of 
genomes of both viral agents. 
In 2008 F. Barrй-Sinoussi and L. Montagnier were awarded Nobel 
Prize in Physiology or Medicine for their pivotal discovery. 
In 1986 in West Africa F. Clavel and coworkers discovered another 
species of human immunodeficiency virus – HIV-2. 
 
 
Classification of Retroviruses 
 
Retroviridae family of RNA-containing viruses embraces 2 
subfamilies (Orthoretrovirinae and Spumaretrovirinae) with 7 viral genera.  
All the representatives of family Retroviridae contain unique reverse 
transcriptase enzyme, which synthesizes DNA copy of viral genome on 
the base of viral RNA template. 
HIV viruses (species HIV-1 and HIV-2) belong to subfamily 
Orthoretrovirinae and Lentivirus genus, which encompasses the viruses, 
capable of causing long-lasting slow viral infections.  
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Lentiviruses have been isolated from many living species, including 
20 different primate species.  
As some other RNA-containing viruses, HIV demonstrates 
outstanding genetic variability. HIV-1 is divided into genetic groups (M, 
N, O, and P). More than 90% of cases of HIV-infection are caused by 
representatives of M (main) viral group. 
Every genetic group contains multiple genetic subtypes. For instance, 
M group includes above 10 subtypes (A-K). Subtypes are able to cross-
recombination with formation of circulating recombinant forms of HIV. 
HIV-2 has 9 genetic groups (A-I). 
Subtype variations generate multiple HIV quasispecies during the 
course of HIV infection.  
 
 
Structure of HIV 
 
HIV viruses are spherical in shape 80-100 nm in diameter with 
cylindrical cone-shaped core. Virion is covered with lipid envelope, 
carrying receptor glycoproteins. Under lipid coat protein shell of p17 
protein is present. 
Viral genome is composed of single stranded positive-sense RNA. 
The genome is diploid that means the presence of two equal (+) RNA 
molecules. 
HIV contains three genes encoding viral structural proteins – gag, pol, 
and env.  
Viral env gene encodes major viral envelope proteins. Glycoprotein 
gpl20, product of env gene, contains binding domains for virus attachment 
to host CD4 molecules and coreceptors, and carries the main antigenic 
determinants that elicit neutralizing antibodies.  
Glycoprotein gp4l of env gene contains both a transmembrane domain 
that anchors the glycoprotein gp120 in the viral envelope and a fusion 
domain that facilitates virus penetration into target cells. Combination of 
gp41 and gp120 results in complex gp160 glycoprotein, integrated in the 
viral envelope. 
Viral pol gene codes for viral enzymes reverse transcriptase (p66), 
protease (p32), and integrase (p11).  
Gene gag (group specific antigen) encodes primary polyprotein with 
inner capsid peptides (e.g., p17 and p24). After translation viral 
polyprotein is cleaved by viral protease resulting in structural proteins. 
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Six additional genes encode proteins that regulate viral reproduction in 
vivo participating in pathogenesis of HIV infection: 
– Tat protein (product of tat gene) activates reverse transcription of 
viral RNA;  
– Rev protein (product of rev gene) regulates transcription of viral 
structural proteins;  
– Nef protein (product of nef gene) inhibits expression of CD and 
HLA molecules on membranes of infected cells; elicits chemokine 
production by macrophages that activate resting T cells resulting in 
productive HIV infections; 
– Vif protein (product of vif gene) suppresses synthesis of antiviral 
proteins; 
– Vpr protein (product of vpr gene) stimulates replication of viral RNA 
and transcription of viral protens; 
– Vpu protein (product of vpu gene) promotes virion release; 
– Vpx protein of HIV-2 (product of vpx gene) stimulates reverse 
transcription of HIV-2 RNA. 
 
 
Virion Resistance  
 
Despite generally low environmental resistance of retroviruses, in 
certain conditions and in high concentrations HIV maintains viability for a 
long time (e.g., above 10 days in blood in syringes at room temperature or 
at 4оС for 2-4 weeks). When dried in blood spots, HIV stays viable for 
several days.  
HIV remains infectious during long-term storage at low temperatures 
(-20оС and less). Virus is inactivated by heating at 60°C for 30 min and at 
100
оС for 1 min. 
HIV is sensitive to the most common disinfectants and antiseptics 
(household bleach, sodium hypochlorite and other halides, hydrogen 
peroxide, aldehydes, ethanol, detergents, and others). The virus is also 
killed by acidic or alkaline pH. 
 
 
Viral Replication Cycle 
 
Virus attachment is performed via gp120 receptor that binds to CD4 
molecules of lymphocytes, macrophages, and some other cell types. 
 325 
A highest density of membrane CD4 is essential for CD4
+
 T helper 
cells and T memory cells, but expression of CD4 on monocytes, 
macrophages, dendritic cells, glial cells, astrocytes and neurons of CNS, 
or enterocytes is enough for HIV adherence. 
A second co-receptor in addition to CD4 is necessary for HIV-1 to 
gain entry to the cells. It is required for fusion of the virus with the cell 
membrane. Virus first binds to CD4 and then to the coreceptor. These 
interactions cause conformational changes in the viral envelope that 
induces gp41-mediated membrane fusion and virus uptake.  
Host chemokine receptors serve as HIV co-receptors – CCR5 is the 
predominant co-receptor for macrophage-tropic strains of HIV, whereas 
CXCR4 is the co-receptor for lymphocyte-tropic strains of HIV. 
Uncoating of HIV occurs in cytoplasm. Here viral genomic RNA 
undergoes reverse transcription to complementary DNA by enzyme 
reverse transcriptase. 
Viral DNA is imported to the nucleus for integration to the host 
genome (provirus state). Incorporation of HIV DNA is catalyzed by viral 
integrase. 
HIV replication largely occurs in activated T cells and to a lesser 
extent in macrophages. They are stimulated by TNF-alpha and other 
proinflammatory cytokines followed by activation of cellular transcription 
factors (mainly, NF-κB) that trigger the transcription of viral RNA. 
After ribosomal translation primary viral polyproteins are processed 
by viral protease.  
Viral assembly (morphogenesis) takes place in the cytoplasm; progeny 
virions leave the cell by budding. 
Complete duration of HIV replication cycle averages 2.5 days. 
As it was mentioned above, HIV demonstrates highest genetic 
variability. Because of rapid viral proliferation and the error-prone mode 
of activity of HIV reverse transcriptase, every nucleotide of the HIV 
genome probably undergoes daily mutation. 
 
 
 
Epidemiology, Pathogenesis, Clinical Findings and Immunity in 
HIV Infection 
 
From its first case, HIV infection and AIDS has become a global 
epidemic, affecting different populations and all geographic regions. Once 
infected, individuals remain infected lifelong. Within a decade, if left 
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untreated, the vast majority of HIV-infected persons develop fatal 
opportunistic infections resulting from HIV-induced suppression of the 
immune system. 
The source of infection is HIV-infected person. 
The most common route of transmission is sexual intercourse (homo- 
and heterosexual contacts) that accounts for more than 70% of infection 
spread.  
Next follows parenteral transmission (artificial route) that 
predominantly includes intravenous drug use. Occasionally the infection 
is contracted after medical manipulations, predominantly, blood 
transfusions. 
Mother-to-child or vertical transmission occurs during pregnancy or 
childbirth, and through breastfeeding with maternal milk. 
Transmission of HIV-2 is 10-20 times less frequent than HIV-1 in the 
same conditions of exposure to virus. 
HIV infection affects CD4-bearing cell populations. 
The main target of virus action is the subset of T helper lymphocytes, 
which express CD4 phenotypic marker on their surface.  
It was determined that HIV co-receptor CXCR4 is carried by “naive” 
T cells, whereas another co-receptor CCR5 is expressed predominantly by 
macrophages and dendritic cells as well as by activated T lymphocytes and 
memory T cells.  
After viral entry reverse transcription of viral genomic RNA leads to 
complementary DNA synthesis and its further integration with cell genome 
resulting in provirus state. 
Proviruses remain long-time associated with affected cells, but under 
the number of external and internal stimuli viral replication is activated. 
Various cytokines (e.g., TNF-alpha or IL-10) induce HIV transcription in 
both macrophages and T cells. 
Chronic activation of the TNF-signaling pathway enhances HIV-1 
transcription. Viral propagation within T helpers causes cell death due to 
multiple devastating effects of virus: 
– cytopathic effect on T cells with syncytium formation; 
– direct and TNF-mediated apoptosis of T cells; 
– pyroptosis, or inflammatory T cell death via activation of caspase-1; 
– death of infected T cells under the attack of cytotoxic T cells and 
NK cells; 
– general inhibition of hematopoiesis. 
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Monocytes and macrophages play a substantial role in the 
dissemination of HIV infection. Unlike CD4
+
 T lymphocytes, monocytes 
are relatively refractory to the cytopathic effects of HIV, and the virus can 
be transported to various organs and tissues (such as the lungs and brain). 
Infection of glial cells, astrocytes and neurons of CNS is followed by 
permanent neuropsychiatric disorders in patients with HIV infection. 
Progressive decline of T helpers leads to profound attrition of the 
immune system that affects basic functions of cytotoxic T cells, natural 
killer cells, impairs secretion of cytokines, etc. 
As the final result, a tremendous variety of opportunistic infections 
arises in HIV-infected person due to deep immunosuppression, caused by 
HIV. 
Typical course of untreated HIV infection spans about a decade. 
Stages of HIV infection include: 
– incubation period; 
– acute infection; 
– clinical latency; 
– persistent generalized lymphadenopathy; 
– AIDS development; 
– death of patient resulted from AIDS-associated diseases. 
 
During incubation in 24 h after exposure HIV invades dendritic cells 
at the portal of entry; in 24-48 h infected dendritic cells migrate into 
regional lymph nodes; in 4-11 days HIV appears in blood resulting in 
viremia; and in 3-4 weeks first clinical signs of infection arise. 
Acute infection is characterized with dissemination of virus to 
lymphoid organs. An acute mononucleosis-like syndrome develops in 
many patients (50-75%) 3-6 weeks after primary infection. There is a 
significant drop of circulating CD4 T cells at early time. An immune 
response to HIV occurs 1 week to 3 months after infection, plasma viremia 
declines, and the number of CD4 cells restores. However, the immune 
response is unable to clear the infection completely, and HIV-infected cells 
persist within the lymph nodes. 
The period of clinical latency may last for as long as 10 years. During 
this time, there is a high level of ongoing viral replication.  
Coming next persistent generalized lymphadenopathy is 
characterized with gradual enlargement of different groups of lymph 
nodes. 
And eventually, the patient will develop clinically manifested disease 
with opportunistic infections or neoplasms. They emerge due to severe 
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immune system failure resulting in acquired immunodeficiency syndrome, 
or AIDS. 
The predominant sources of morbidity and lethality among AIDS 
patients are opportunistic infections, induced by pathogenic agents that 
rarely cause serious diseases in immune-competent individuals. 
The most common opportunistic infections in AIDS patients are 
caused by: 
bacterial pathogens – Mycobacterium tuberculosis, Mycobacterium 
avium-intracellulare, Listeria monocytogenes, salmonella species, 
streptococcus species and many others;  
viruses – cytomegalovirus (CMV), varicella-zoster virus, herpes 
simplex viruses, adenoviruses, etc.;  
protozoans – Toxoplasma gondii, Cryptosporidium spp.; 
fungi – Candida albicans, Cryptococcus neoformans, Histoplasma 
capsulatum, and Pneumocystis jirovecii. 
Tuberculosis is the major AIDS-associated disease in HIV-infected 
persons. It develops at least in 30-40% of HIV-infected individuals being 
the major cause of patient’s death (25-40% of total AIDS lethality). Global 
spread of HIV and tuberculosis co-infection is sometimes called as 
“Syndemic”. 
Severe AIDS-indicator diseases are also associated with 
mycobacterioses, systemic candidiasis, CMV- and varicella-zoster viral 
infections, pneumocystis pneumonia and T. gondii infection.  
AIDS patients exhibit a marked predisposition to the development of 
cancer. AIDS-associated tumors include lymphomas, Kaposi's sarcoma, 
(vascular neoplasm, caused by herpesvirus type 8, thought to be of 
endothelial origin), cervical cancer, etc. 
Neurological abnormalities are common in AIDS affecting 40-90% 
of patients. They are manifested by HIV encephalopathy, peripheral 
neuropathies, and most serious, AIDS dementia complex.  
HIV-infected persons develop both humoral and cell-mediated 
immunity against the virus. Antibodies to a number of viral antigens (p24, 
gp41, gpl20) develop soon after infection, but they can’t stop infection 
progressing. Cellular responses (cytotoxic T cells and natural killers) can 
destroy virus-infected cells. 
Nevertheless, immune response to HIV isn’t able to eliminate virus. 
AIDS consequences, predominantly opportunistic infections and CNS 
disorders, lead to inevitable death of AIDS patient. 
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Evident devastating nature of HIV infection multiplied by its rapid 
spread has posed a tremendous threat to global health security. 
In 2005 Joint United Nations Programme on HIV/AIDS (UNAIDS) in 
its annual special report characterized HIV infection as “...one of the most 
destructive epidemics in recorded history”. 
On the peak of AIDS pandemic (1996-2005) a total number of HIV-
infected persons became closer to 40 million, about 2-3 million people 
annually died from AIDS-associated diseases, and the annual number of 
individuals newly infected with HIV exceeded 4 million. 
According to WHO data, more than 34 million people died from the 
start of AIDS pandemic. 
In September 2000 Member States of United Nations at the 
Millennium Summit adopted United Nations Millennium Declaration. It 
included 8 crucial international development aims – the Millennium 
Development Goals (MDG).  
The Goal 6 claimed “...to halt and begin to reverse the spread of 
HIV/AIDS by 2015”. It was appended in 2006 with a new AIDS target 
“...to achieve universal access to antiretroviral medicines for people in 
need by 2010”. 
As the result, only owing to outstanding joint efforts of national 
governments and global international organizations working under the 
aegis of UNAIDS (WHO, UNESCO, UNDP, UNICEF, World Bank and 
others) it has become possible to break down the progression of HIV 
pandemic. 
This great success was largely related with expanding availability of 
highly efficient antiretroviral therapy for HIV-infected people. 
In July 2015 the report of UNAIDS entitled “How AIDS changed 
everything” with preface of UN General Secretary Ban Ki-moon stated: 
“The world has achieved the AIDS targets of Millennium Development 
Goal 6. The epidemic has been halted and reversed”. 
It has been confirmed by the next data – the number of persons newly 
infected with HIV globally declined by 35% in 2000–2014; the number of 
people dying from HIV-related diseases declined by 41% since 2004, the 
peak epidemic year; and almost 16 million people acquired HIV treatment. 
Current number of HIV-infected individuals is equal now to 
36.9 million. 
UNAIDS report has also emphasized a future challenging objective as 
essential part of the sustainable development goal – ending the AIDS 
epidemic by 2030. 
 330 
Despite undoubt achievements in the combat with HIV infection, a lot 
of issues haven’t been solved yet.  
First of all, a total number of HIV-infected persons still remains great. 
The most of suffering people (estimated 25.8 million) live in Sub-Saharan 
Africa, the region “most heavily affected by the epidemic”. An estimated 
5 million HIV-infected people live in Asia and the Pacific region.  
Second, antiretroviral treatment should cover at least 60-80% of all 
HIV-infected persons to maintain positive tendency of global HIV decline.  
And finally, certain world regions demonstrate increasing trends in 
HIV spread; among them are the countries of Eastern Europe and Central 
Asia, including Russian Federation, Ukraine, and Belarus. 
 
 
Laboratory Diagnosis of HIV Infection 
 
Diagnosis of HIV infection is established only on the base of highly 
specific and sensitive laboratory tests that detect specific antiviral 
antibodies or viral nucleic acid in clinical specimens (primarily, patient’s 
blood or serum). 
Serological testing is the most suitable in clinical practice to 
determine HIV infection. Antibodies to HIV are evaluated by enzyme-
linked immunosorbent assay (ELISA). If properly performed, these tests 
have a sensitivity and specificity exceeding 98%. 
The first positive ELISA test of a serum sample must be confirmed by 
a repeat testing.  
If the repeat ELISA is reactive, a confirmatory test is performed. The 
most wide used confirmation assay is the western blot technique, in which 
antibodies to various HIV proteins of specific molecular weights should be 
simultaneously detected. Antibodies to viral core protein p24 or envelope 
glycoproteins gp41, gpl20, or gpl60 are most commonly assessed. 
Simple and rapid tests for detecting HIV antibodies are based on latex-
agglutination. 
The majority of individuals display seroconversion (reveal antibodies) 
within 2 months after viral exposure. HIV infection for longer than 6 
months without a detectable antibody response is very rare. 
Amplification assays such as the real-time reverse transcriptase PCR 
and hybridization tests are also commonly used to detect viral RNA in 
clinical specimens. HIV RNA level (viral load) is an important predictive 
marker of disease progression and valuable tool to monitor the efficacy of 
antiviral therapy. 
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Other auxiliary laboratory tests for AIDS diagnosis include various 
methods of assessment of immune status. CD4
+
 T helper subset count is 
evaluated by flow cytometry or immunofluorescence with monoclonal 
anti-CD4 antibodies. 
CD4
+
 cell count (normal level – 800-1000 cells/μL of blood) shows 
direct correlation with AIDS progression – falling below 500 cells/μL 
predisposes to development of opportunistic infections; the decline less 
than 200 cells/μL corresponds to AIDS. 
Diagnosis of AIDS-associated opportunistic infections rests on rapid 
molecular tests (e.g., PCR) followed by pathogen isolation and 
identification. 
 
Principles of HIV Treatment and Prophylaxis 
 
Practical implementation of HIV chemotherapy with combinations of 
various antiretroviral drugs, referred to as highly active antiretroviral 
therapy (HAART), literally revolutionized the treatment of HIV-infected 
persons. 
HAART suppresses viral replication below the limits of detection in 
plasma and decreases the viral load in lymphoid tissues that leads to the 
recovery of immune response. 
However, HAART has failed to cure HIV infection. DNA copy of 
viral genome is harbored within long-living infected cells, including 
memory CD4
+
 T cells and probably macrophages and seminal cells. When 
HAART is discontinued or there is a treatment failure, virus production 
reactivates. Thus, the treatment should last lifelong. 
Nonetheless, if HIV patients strictly follow treatment regimens, their 
life expectancy comes closer to average lifespan of human population. 
Antiretroviral drugs with various mechanisms of action are included 
into HAART treatment scheme: 
– nucleoside inhibitors of HIV reverse transcriptase (lamivudine, 
abacavir, azidothymidine and many others); 
– non-nucleoside inhibitors of HIV reverse transcriptase (efavirenz, 
nevirapine); 
– HIV protease inhibitors (indinavir, nelfinavir, ritonavir); 
– HIV integrase inhibitors (raltegravir, elvitegravir); 
– inhibitors of HIV entry and fusion: 
  – maraviroc – inhibits binding of gp120 to human CCR5 co-receptor; 
  – enfuvirtide – binds to HIV gp41 receptor, thereby blocking viral fusion. 
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Initial HAART schedule presumes administration of 2 nucleoside 
inhibitors of HIV reverse transcriptase and one drug from other 
antiretroviral groups (e.g., HIV protease inhibitor). 
Whereas monotherapy usually results in the rapid emergence of drug-
resistant mutants of HIV, combination therapy, which targets multiple 
steps in virus replication, prevents the emergence of HIV quasispecies. 
Post-exposure prophylaxis of HIV infection (PEP) is administered 
after occasional contact with biological fluids of HIV-infected persons 
(unprotected sexual intercourse, accidental needlestick injury, scalpel cut, 
infected blood transfusion, etc.) To be maximum effective, PEP must be 
initiated without any delay (within first 72 hours after the exposure). 
Modern schemes based on HAART are currently used including HIV 
integrase inhibitors. After primary PEP it is recommended to continue 
antiretroviral therapy at least for 4 weeks. The repeat laboratory testing of 
affected persons is performed up to 6 months after exposure. 
Specific prophylaxis of HIV infection is not created yet. A safe and 
effective vaccine is the best tool of controlling the AIDS pandemic. 
Recombinant viral envelope glycoproteins are the most likely candidates 
for vaccine. 
Unfortunately, vaccine development is extremely difficult because 
HIV mutates rapidly; furthermore, the virus stays integrated within genome 
of many infected cells and thereby not completely eliminated by host 
immune response. 
Non-specific prophylaxis presumes the maintainance of a lifestyle that 
minimizes or eliminates the high-risk factors of HIV spread. This is 
directly related with the success of educational projects offering behavioral 
changes. 
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Chapter 19 
HERPESVIRUSES AND HERPES VIRAL INFECTIONS 
 
 
The History of Discovery of Herpes Viruses  
 
Herpetic infections (Gr. herpes means “to creep or crawl”) are the 
commonest among humans. They follow humankind throughout all its 
history. It is generally ascertained that more than 90% of human population 
are infected with herpesviruses. 
The main representatives of herpesiviruses were identified in 
XX century. At first, A. Lowenstein discovered herpes simplex virus in 
1919. Then in 1925 K. Kundratitz confirmed the link between varicella 
and zoster infections; H. Ruska in early 1940s found this virus by electron 
microscopy, and finally the varicella-zoster agent was isolated in 1952 by 
T. Weller. 
In 1955-1956 M. Smith obtained the culture of human 
cytomegalovirus (CMV).  
In 1964 M. Epstein, B. Achong, and Y. Barr established a new herpes 
virus isolated from Burkitt’s lymphoma cells that was later termed as 
Epstein-Barr virus (EBV). Further in 1968 W. Henle and G. Henle 
identified Epstein-Barr virus as the causative agent of infectious 
mononucleosis. 
First lymphotropic human herpesvirus type 6 was primarily isolated in 
1986 by S.Z. Salahuddin and coworkers in laboratory of R. Gallo; another 
herpesviral species of type 6 was revealed by the group of K. Yamanishi in 
1988.  
Next lymphotropic human herpesvirus of type 7 was described by 
N. Frenkel and coworkers in 1990.  
The most recently found Kaposi’s sarcoma-associated herpesvirus or 
human herpesvirus 8 was first detected in 1994 by Y. Chang, P. Moore, 
and colleagues. 
 
 
Classification of Herpesviruses 
 
Herpesviruses are placed into order Herpesvirales and Herpesviridae 
family; the latter comprises multiple viral genera and species of human and 
animal herpesviruses. To date, 8 types of human herpesviruses are known. 
Family Herpesviridae is divided into 3 subfamilies. 
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Subfamily Alphaherpesvirinae includes genus Simplexvirus with 
species human alphaherpesvirus 1 (herpes symplex virus type 1) and 
human alphaherpesvirus 2 (herpes symplex virus type 2) as well as genus 
Varicellovirus with species human alphaherpesvirus 3 or varicella-zoster 
virus of type 3. 
Subfamily Betaherpesvirinae comprises genera Cytomegalovirus 
(species human betaherpesvirus 5, or type 5, or CMV) and Roseolovirus 
(species human betaherpesvirus 6A and 6B of type 6). 
Finally, one more subfamily Gammaherpesvirinae contains genus 
Lymphocryptovirus with species human gammaherpesvirus 4 known as 
type 4 or Epstein-Barr virus (EBV) and genus Rhadinovirus with species 
human gammaherpesvirus 8 also known as herpesvirus type 8 or Kaposi’s 
sarcoma-associated herpesvirus (KSHV). 
 
 
 
Structure of Herpesviruses 
 
Herpesviruses are double-stranded linear DNA-containing enveloped 
viruses. 
Herpesvirus size is large (about 150-200 nm). The mature virion is of 
spherical shape.  
Viral nucleocapsid exhibits icosahedral symmetry. It is composed of 
162 capsomers. Viral envelope is derived from nuclear membrane of the 
infected cell and carries viral glycoprotein spikes. 
The protein coat between the capsid and envelope is termed as 
tegument. 
There is generally low DNA relatedness between various species of 
herpesviruses except for herpes simplex types 1 and 2 with 50% sequence 
homology, and herpesviruses of 6 and 7 types, which show limited (30-
50%) genomic DNA similarity. DNA homology predisposes to antigenic 
cross-reactivity between related herpesviruses. 
Genomic DNA of herpesviruses is large. Typical herpesviral genome 
encodes above 100 viral proteins.  
More than 35 polypeptides are included into the structure of mature 
virion. Mutiple glycoproteins of spikes, protruding outside the envelope 
(e.g., gB and gD proteins of herpes simplex virus) promote virion binding 
to cell receptors. Some glycoproteins (e.g., gG protein) confer virus 
antigenic specificity 
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A number of virus-specific enzymes (e.g., DNA polymerase and 
thymidine kinase) are synthesized in infected cells, but they are not 
incorporated into the virus particles. 
 
 
 
Viral Replication Cycle 
 
Primary virus binding to target cells largely occurs via interaction of 
envelope glycoproteins with membrane glycosaminoglycans, e.g., heparan 
sulfate. Viral entry is promoted by next binding of spike glycoproteins 
(like gD) to a number of special high-affinity membrane receptors 
(herpesvirus entry mediators). 
The virus enters the cell by fusion with the cell membrane. The capsid 
is transported to a nuclear pore. Then uncoating occurs, and DNA 
becomes associated with the nucleus.  
Viral DNA is transcribed by cellular RNA polymerase II. 
At first immediate-early and early viral proteins are translated that 
serve for viral replication and genome expression. 
A large number of enzymes involved in DNA synthesis is produced. 
They are subjected to inhibition by specific antiviral drugs.  
Viral host shutoff protein arrests cellular protein synthesis degrading 
host mRNAs. 
Next late proteins are translated. Most of them are structural proteins 
of herpesviruses.  
Encasing of newly synthesized viral DNAs into empty nucleocapsids 
occurs in the cell nucleus. 
Maturation accomplishes by budding of nucleocapsid complexes 
through nuclear membrane. Enveloped progeny virions are then released 
by exocytosis from the infected cells. 
The duration of replication cycle of herpesviruses varies greatly – 
from 8-16 h for herpes simplex viruses to over 70 h for cytomegalovirus. 
Productive infection is followed by cell death with lysis. On the other 
hand, herpesviruses stay dormant inside infected cells resulting in long-
lasting latent infection. In herpes symplex viruses this state is maintained 
by synthesis of viral latency associated transcript RNA (LAT). It 
influences normal cell life cycle and slows down viral replication. 
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Resistance of Herpesviruses 
 
The resistance of herpesviruses is low or moderate. When dried upon 
inanimate surfaces, these agents survive from several hours to 7 days 
(cytomegaloviruses), or from few hours to weeks (herpes simplex viruses). 
HSV-2 is more sensitive than HSV-1.  
Epstein-Barr virus is the most labile pathogen; it can’t be isolated from 
environmental objects due to the rapid loss of viability. 
Herpesviruses are readily inactivated by pH<4, UV irradiation or 
sunlight, and by heating (30 min at 60-80°C). 
Viruses are sensitive to most disinfectants (e.g., sodium hypochlorite, 
povidone-iodine and other halides, phenol, aldehydes, ethanol, 
isopropanol, and others).  
 
 
 
HERPES VIRAL INFECTIONS IN HUMANS 
 
 
Infections, Caused by Herpes Simplex Viruses of Types 1 and 2 
 
Special features of herpes simplex viruses 
There are two distinct herpes simplex viruses: type 1 and type 2 
(HSV-1, HSV-2). Their genomes exhibit substantial homology. These two 
viruses demonstrate serological cross-reactivity. 
Herpes simplex viruses express at least 11 structural glycoproteins 
with versatile biological functions (from gB to gM). 
Glycoproteins gD and gB are the viral receptors, responsible for 
adherence and viral entry. Glycoproteins gD and gB also stimulate the 
production of virus-neutralizing antibodies. 
Several proteins impact host immune responses – protein gС is a 
complement-binding factor, and gE acts as Fc receptor for human IgG.  
Glycoprotein gG is serotype-specific antigen allowing discrimination 
between HSV-1 (gG-1) and HSV-2 (gG-2).  
The HSV growth cycle proceeds rapidly being completed in 8-16 h.  
 
Pathogenesis, clinical findings and immunity 
Infection with herpes simplex viruses is common among human 
population.  
The viruses propagate rapidly being highly cytolytic.  
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HSV-1 is usually associated with oropharyngeal lesions and causes 
recurrent attacks of herpes labialis or “fever blisters”.  
HSV-2 primarily infects the genital mucosal tissues resulting in 
genital herpes. 
Total spectrum of herpes simplex-associated diseases ranges from 
local gingivostomatitis and conjunctivitis to severe genital disease, 
encephalitis, and generalized infections of newborns and 
immunocompromised adults.  
Herpes simplex viruses produce latent infection in neural tissues with 
periodical exacerbations. Recurrences of infections are common. 
HSVs are transmitted through mucosal surfaces or skin lesions (intact 
skin is not permeable for virus).  
HSV-1 is spread by airborne (aerosole) route or by direct contact 
with infected saliva. In most of cases the infection locally affects the 
oropharynx.  
HSV-2 is usually transmitted by sexual intercourse like other kinds of 
sexually transmitted diseases. 
Neonatal herpes occurs after intra- or postnatal infections with either 
HSV-1 or HSV-2 (vertical transmission). 
Viral replication primarily occurs at the site of entry. Within infected 
cells HSV inhibits the expression of HLA-I class molecules, thereby 
impairing presentation of viral Ags and making difficult elimination of 
infected cells by immune system. 
Further HSVs invade local nerve endings and undergo retrograde 
axonal transport to dorsal root ganglia, where after several replications 
latency is established.  
Oropharyngeal HSV-1 infections result in viral persistence in the 
trigeminal ganglia, whereas genital HSV-2 persists within infected sacral 
ganglia. 
Herpes simplex viruses stay latent within infected ganglia lifelong.  
Various triggering stimuli like axonal injury, UV irradiation, fever, 
stresses and many other challenges induce viral replication. The 
mechanisms of viral activation are not well-elucidated yet. 
The viruses move along axons to their peripheral sites within the skin 
or mucous membranes, where viral replication reoccurs. 
Many of HSV-1 infections are asymptomatic. Symptomatic diseases 
demonstrate short incubation period (about 3-5 days), and clinical 
manifestations last for 2-3 weeks. 
Gingivitis is the most common lesion in infants, primary infections in 
adults result in pharyngitis or tonsillitis. 
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Recurrent HSV-1 infections are commonly manifested as cold sores 
(fever blisters) near the lips. 
Primary eye HSV-1 infection leads to severe keratoconjunctivitis. 
Genital disease is usually caused by HSV-2. This clinical variant is 
characterized by vesicular and ulcerative lesions of genitalia, which are 
very painful. Viral discharge lasts near 3 weeks. 
Relapses of genital herpes are common but milder. 
Herpetic encephalitis is seldom but life-threatening form of herpes 
simplex infections. 
The most severe generalized forms of herpetic infections develop in 
immunocompromised patients, resulting from HSV dissemination. 
Neonatal herpes demonstrates variable clinical manifestations, but in 
many cases it progresses into systemic infection with viremia and viral 
encephalitis. HSV-2 causes the most severe infections. 
Cell-mediated immunity (e.g., T cytotoxic and natural killer cells) as 
well as host interferon responses are pivotal for efficient control of primary 
and recurrent HSV infections. 
During primary herpetic infection short-term IgM antibodies are next 
followed by IgG and IgA antibodies that stay for a long period. Specific 
antibodies don’t abolish reactivation of a latent virus but may reduce 
disease manifestations. 
 
 
Laboratory diagnosis 
The specimens for examination are taken from viral herpetic lesions; 
throat washings and cerebrospinal fluid can be used as well. 
PCR assays are most commonly used for viral identification. 
Viral cultivation is performed in primary tissue cultures. HSVs are 
further identified by immunofluorescence or neutralization tests. 
The diagnostic value of serological testing is limited. Elevation of 
specific antibodies in 4-7 days after primary infection with a peak in 2-4 
weeks is detected by ELISA. 
 
 
Principles of treatment and prophylaxis of herpesviral infections 
A number of efficient antiviral agents is used for treatment of HSV 
infections. Among them are acyclovir and valacyclovir. Both inhibit viral 
DNA synthesis. Topical acyclovir applications are effective in herpes 
labialis. 
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However, antivirals don’t influence on latent HSVs that stay within 
sensory ganglia.  
Experimental vaccines of various types are being developed. 
Nevertheless, there is no efficient HSV vaccine in current clinical practice. 
 
 
Varicella-zoster Herpesvirus Infections 
 
Special features of varicella-zoster virus (VZV) 
Human herpesvirus type 3 or varicella-zoster agent is a typical 
herpesvirus. 
The same virus causes chickenpox (varicella) and zoster (shingles). 
Viral isolates from the patients with these diseases exhibit no significant 
genetic variation. 
Chickenpox develops in case of exogenous VZV infection, whereas 
shingles emerges after reactivation of endogenous latent virus. 
VZV propagates in cultures of human embryonic cell lines and 
produces chracteristic intranuclear inclusions. 
 
Pathogenesis, clinical findings and immunity of VZV infections 
Varicella is a primary VZV infection. 
Communicability of varicella is very high. It is solely anthroponotic 
disease. Almost all unvaccinated humans acquire the infection. 
Varicella-zoster infections are transmitted via airborne (aerosole) 
route. The sources of infections are sick persons with varicella or zoster 
disease. 
The portal of viral entry is the mucosal epithelium of upper respiratory 
tract or eye conjunctiva.  
The incubation period of varicella lasts for 10-21 days.  
The virus circulates in blood resulting in viremia, undergoes multiple 
cycles of replication, and eventually localizes in the skin. Viral infection 
induces the formation of giant multinucleated cells with characteristic 
nuclear inclusions. 
Malaise and fever are the earliest symptoms, followed by next 
vesicular rashes appearance. It arises upon whole body surfaces on the 
skin of face, trunk, limbs, buccal mucosa, etc. 
Varicella complications are rare. The virus may affect inner organs 
and brain with encephalitis. Immunocompromised patients are at increased 
risk of various complications of varicella. 
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Primary VZV infection is believed to confer lifelong immunity to 
varicella. 
After the disease viral latency is established followed by VZV 
persistency within vertebral and cranial nerve ganglia. 
Exacerbations of herpes zoster infection or shingles are stipulated by 
reactivation of dormant VZVs. The disease is triggered by various factors, 
which are not well-defined: body cold, UV irradiation, stresses, injuries, 
flare-up of systemic diseases, etc. 
The disease usually occurs in adults over 50 years of age. 
It is considered that insufficient immune surveillance permits 
reemergence of viral replication in ganglia, causing intensive inflammation 
of dorsal roots and pain. Virus migrates down the nerves to the skin and 
mucosa and induces vesicle formation. 
The skin lesions of zoster are the same as in varicella but much more 
painful. The disease onset is followed by severe pain in the area of 
innervation of affected sensory nerves and ganglia. After exacerbation a 
chain of vesicles arises over the skin along the afflicted nerve. The most 
common complication of zoster is postherpetic neuralgia. The pain may 
last for weeks or months. It is typical for ophthalmic zoster. 
Zoster can emerge in the presence of relatively high levels of 
neutralizing antibody to varicella. Thus, cell-mediated immunity is 
regarded as the most important defense barrier in combat against varicella-
zoster infection. 
The repeated attacks of HZV infections are rare in immunocompetent 
individuals. 
Overall, immunocompromised persons are the most predilected for 
zoster infections. Recurrent shingles is a common AIDS-indicator disease. 
 
Laboratory diagnosis 
In most cases the diagnosis of varicella and shingles is established on 
clinical grounds. 
Laboratory testing confirms the viral origin of diseases. 
Microscopy of smears of scrapings or swabs from the vesicles reveals 
multinucleated giant cells with nuclear inclusions. These are absent in 
nonherpetic vesicles. 
Varicella-zoster specific antigens are determined by 
immunofluorescence method or ELISA.  
Viral DNA can be detected in vesicle fluid, in extracts of crusts, or in 
biopsy materials by PCR. 
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Virus isolation is performed from vesicle fluid in embryonal human 
cell cultures within 3-7 days. Viral identification is made by 
immunofluorescence, neutralization tests and PCR. 
Serological examination detects elevation of specific antibodies in the 
patient’s serum mainly by ELISA test. 
 
Principles of treatment and prophylaxis of VZV infections 
Varicella is usually a mild disease and requires no treatment, except 
complicated forms of infection in immunocompromised patients. 
Several antiviral agents are effective against VZV including acyclovir, 
valacyclovir, famcyclovir, and interferons. 
An efficient live attenuated varicella vaccine is available now for 
specific prophylaxis of the disease. It greatly reduces the number of 
infection cases and confers stable and long-lasting immunity. 
 
 
Infections, Caused by Epstein-Barr virus 
 
Special features of Epstein-Barr virus 
The structure of Epstein-Barr virus (EBV, or human herpesvirus 
type 4) is generally similar to other herpesviruses but with certain specific 
morphological traits. 
EBV genome harbors about 100 genes encoding three groups of viral 
antigens: latent phase antigens, which maintain the state of viral latency; 
early antigens – nonstructural proteins, required to promote productive 
viral replication, and late antigens, which are the structural components of 
viral capsid (capsid antigens) and viral envelope (membrane antigens). 
As the result, EBV life cycle may result in productive infection with 
lytic replication or come to latency. 
Specific viral antigens VCA (viral capsid antigen) and EBNA (EBV 
nuclear antigen) are worthy for diagnosis of infection. 
EBV has only two target cells for replication – human lymphocytes 
(primarily, B cells) and epithelial cells.  
By means of supercapsid glycoproteins EBV binds to specific 
membrane receptors of B lymphocytes – first to CD21 (or receptor for the 
C3d component of complement) and then to B-cell HLA class II molecules. 
This stimulates virus entry by endocytosis. 
Epithelial cells capture EBV via membrane integrin receptors instead of 
CD21. 
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Upon infection of human В cells, EBV triggers their polyclonal 
activation with proliferation and blast transformation.  
After active replication the virus converts to latency. Within small 
portion of memory B cells EBV persists lifelong. 
EBV latency is maintained by presence of viral DNAs as circular 
episomes within infected B cells. It is considered, that some part of viral 
DNA might be integrated with human genome. 
EBV demonstrates marked oncogenic potential especially for 
lymphoid cells.  
 
Pathogenesis, clinical findings and immunity 
Epstein-Barr virus is a ubiquitous herpesvirus that is the causative 
agent of acute infectious mononucleosis, nasopharyngeal carcinoma, 
Burkitt's lymphoma, and some other lymphoproliferative disorders 
(lymphomas). 
Infectious mononucleosis is a typical acute EBV infection. It has 
subclinical or mild course in children before the age of 10 and manifested 
disease in adolescents and young adults. 
Incubation period usually lasts for about 30-50 days. 
The infection affects humans only. The disease is mainly transmitted 
by infected saliva (e.g., by kissing) and initiates infection in the 
oropharynx. The virus invades В lymphocytes and epithelial cells of 
pharynx and salivary glands and disseminates throughout the body.  
EBV activates growth program of B cells resulting in their polyclonal 
blast transformation and intensive proliferation followed by active 
replication of virus. Infected blasting B cells are recognized and massively 
destroyed by activated CD8
+ 
cytotoxic T cells (T killers) that finally curb 
the infection. 
As the result, some part of viruses switches lytic cycle to latency and 
stays in memory B cells (and, probably, epitheliocytes) until the 
reactivation of virus occurs.  
Clinical illness is characterized by the triad of symptoms – fever, sore 
throat and lymphadenopathy. Enlargement of cervical lymph nodes, 
spleno- and hepatomegaly are the characteristic findings in the disease.  
There is a substantial increase in the number of circulating white blood 
cells, represented by atypical mononuclears. Most of them are activated 
CD8
+ 
cytotoxic T cells.  
The typical illness is self-limited and lasts 2-4 weeks. After clinical 
recovery asymptomatic individuals may shed the virus for many months. 
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Reactivations of EBV latent infections can occur but usually not 
manifested.  
Severe recurrent infections may develop in immunosuppressed 
patients, e.g., after allogeneic transplantation. 
Burkitt's lymphoma (a tumor of the jaw in African children and young 
adults) is considered to be associated with Epstein-Barr virus. Most of 
these tumors in Africa (> 90%) contain EBV DNA and viral antigens. 
It is supposed that EBV virus may be involved at an early stage in 
Burkitt's lymphoma by immortalizing В cells. Malaria is regarded as 
cofactor that promotes EBV-induced cell transformation. Finally, specific 
chromosome translocations appear that affect immunoglobulin genes and 
deregulate c-myc proto-oncogene expression. 
Nasopharyngeal carcinoma is the malignant tumor of epithelial cells 
that predominantly occurs in males of Chinese origin. EB virus DNA is 
commonly detected in nasopharyngeal carcinoma cells, and the patients 
demonstrate high levels of antibody to EBV. The tumor is poorly 
differentiated and aggressive, being infiltrated with lymphocytes.  
Finally, Epstein-Barr virus is supposed to participate in pathogenesis 
of other lymphoproliferative disorders, such as Hodgkin’s disease (i.e., 
lymphogranulomatosis), and some B cell lymphomas. 
EBV infections elicit an intensive immune response both antibody- 
and cell-mediated. IgG antibodies against VCA and EBNA viral antigens 
circulate lifelong. However, cell-mediated reactions remain crucial for the 
control of infection. Active synthesis of interferons by affected cells 
facilitates viral clearance. 
 
 
Laboratory diagnosis of EBV infections 
Every case of EBV infection (e.g., infectious mononucleosis) needs 
laboratory confirmations. 
PCR is the method of choice to detect EBV nucleic acid in clinical 
specimens (saliva, blood, or biopsies of lymphoid tissues). 
Viral antigens can be detected in patient’s samples by 
immunofluorescence. 
EBV isolation is rarely performed due to the difficulties of viral 
culture. 
Serological testing is commonly used in clinical practice. The 
detection of IgM anti-VCA antibodies confirms acute EBV infection. 
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Principles of infection treatment and prophylaxis 
Prophylaxis is non-specific. Various kinds of experimental vaccines 
are being developed now. 
The treatment of infectious mononucleosis is symptomatic. 
Valacyclovir demonstrates some clinical benefit in cases of manifested 
disease. 
 
Cytomegalovirus Infections 
 
Special features of cytomegalovirus 
Cytomegalovirus (CMV, human herpesvirus type 5) is also commonly 
spread in human population.  
Nowadays CMV agent is a global leading cause of congenital 
infections, followed by childhood hearing loss and neurodevelopmental 
delay with mental retardation. 
Cytomegaloviruses exhibit a number of characteristic traits: 
– viruses are strictly adapted to human host; CMV propagates only in 
human cells; 
– CMVs contain the largest genome of human herpesviruses with 
marked genetic variability; 
– viruses demonstrate slow replication rate; the length of viral 
replication cycle is over 70 h, this leads to long incubation period of CMV 
infection;  
– high variety of clinical manifestations affecting various organs and 
tissues with special emphasis to CNS; 
– generally low pathogenicity for immunocompetent individuals; 
– propagating within immune cells, CMVs suppress cell-mediated 
immune response; 
– lifelong persistency with repeated subclinical reactivations; 
– evident teratogenicity resulting in high rate of congenital 
abnormalities; 
– CMV produces characteristic cytopathic effect in cell cultures – the 
affected cells become enlarged, nuclear cytoplasmic inclusions appear. 
 
Pathogenesis, clinical findings and immunity in CMV infections 
CMV infection is largely a social health problem. In developing 
countries and resource-limited communities the contraction of the infection 
occurs in early childhood primarily due to infected breast milk feeding, 
poor living conditions (overcrowdness) and generally low attention of 
health authorities to CMV burden.  
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In industrialized countries the prevalence of CMV infection in women 
of childbearing age exceeds 50%, whereas in developing countries it 
usually above 90%. 
Three main clinical groups of infections are caused by CMV: 
– congenital disorders in newborns and infants;  
– generalized (systemic) viral infections and CMV pneumonia in 
immunocompromised individuals (e.g., in AIDS patients); 
– CMV infections in graft recipients after organ transplantation. 
 
Humans are the only known hosts and sources of infection for 
cytomegalovirus. 
Airborne and oral transmissions are the most common in 
cytomegalovirus spread.  
It can also be transmitted vertically from mother to child, by contact 
route via contaminated fomites, by organ transplantation, via blood 
transfusion, or by sexual intercourse. 
CMV infection in immunocompetent adults is usually mild or 
subclinical disease.  
Incubation period lasts about 30-40 days. Manifested disease reveals 
mononucleosis-like syndrome with viremia, fever, lymphocytosis, and 
moderate hepatitis.  
The virus is capable of invading virtually any type of host cells – 
endotheliocytes, leukocytes, epithelial cells, fibroblasts, parenchymatous 
cells of inner organs. CMV inhibits apoptosis of infected cells maintaining 
viral survival. During infection CMV actively sheds with saliva, genital 
secretions and urine, breast milk.  
After 2-4 weeks the symptoms of the disease decline, as the virus is 
actively eliminated by reactions of humoral and cell-mediated immunity, 
and CMV comes into state of latency.  
Latent infection is lifelong. The virus persists in CD14
+ 
monocytes 
and bone marrow progenitors. The genome of virus stays as episome 
within infected cells. 
Reactivations of virus may be common but host immune response 
withstands viral propagation, preventing infection recurrence. Reactions of 
cell-mediated immunity are mandatory for efficient protection.  
Congenital and perinatal CMV infections are characterized by CMV 
transmission across placenta in pregnancy, during delivery, and with 
infected breast milk after birth.  
Cytomegalic disease of newborns often demonstrates systemic severe 
course with encephalitis and CNS damage. Lethality may achieve 30%.  
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The most common complications are sensorineural hearing loss 
(deafness), ocular abnormalities, and infant neurodevelopmental delay with 
mental retardation. 
Severe generalized CMV infections develop in AIDS (AIDS indicator 
disease). They affect at least 15% of AIDS patients. CMV accounts for 
death of 10-20% of individuals with AIDS. 
Finally, CMV produces life-threatening infections after organ 
transplantations, being one of the substantial causes of death of graft 
recipients.  
 
 
Laboratory diagnosis of CMV infections 
Laboratory confirmation of CMV infection is of great value due to its 
non-specific clinical manifestations. 
Specimens of throat washings, urine, saliva, blood, or autopsy 
materials are taken for examination. 
For rapid cytomegalovirus detection immunofluorescence assay, 
ELISA and PCR are used.  
PCR is the most reliable laboratory test in routine clinical practice for 
CMV identification. 
Virus isolation is performed in human embryonated cell lines (e.g. 
fibroblast culture). In 1-2 weeks swollen cells with large intranuclear 
inclusion bodies (known as “owl’s eye”) are detected under microscopy. 
Rapid identification of CMV isolates in cell cultures is made by 
immunofluorescence and PCR. 
In serological testings specific anti-CMV antibodies are detected by 
ELISA. Detection of antibodies of IgM class indicates primary CMV 
infection. 
 
 
 
Principles of treatment and prophylaxis of CMV infection 
Ganciclovir, a nucleoside structurally related to acyclovir, is used 
successfully to treat life-threatening cytomegaloviral infections in 
immunosuppressed patients. Donor’s high-titer CMV immune globulin can 
be administered for pregnant women with active CMV infection. 
Specific prophylaxis by vaccination is still not available for 
prevention of cytomegalovirus infection. Several candidate vaccines 
undergo clinical trials. 
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Non-speciic prophylaxis includes the maintenance of high personal 
hygienic conditions. Isolation of newborns with systemic CMV from other 
infants helps to prevent infection spread. Screening for cytomegalovirus 
infection is mandatory for graft donors and recipients. 
 
 
Herpesviruses of Types 6, 7, and 8 in Human Pathology 
 
T-lymphotropic human herpesvirus type 6 (HHV-6) comprising two 
closely related viral species 6A and 6B is ubiquitous in human population. 
After the decline of protective maternal antibodies it rapidly infects infants 
– more than 90% of children above the age of 1 year and adults are 
seropositive for antiviral antibodies. 
Despite the virus can infect a broad range of human cells, the main 
targets for HHV-6 infection are activated CD4
+ 
T lymphocytes. 
Primary acute infection of HHV-6 affects children of 6 months to 3 
years of age. Viral transmission occurs predominantly via oral secretions 
(saliva). 
Typical febrile disease is known as exanthema subitum (or roseola 
infantum) that is followed by fever and skin rashes. The disease is self-
limited. 
It is generally ascertained now that HHV-6 may account at least for 
10-20% of all febrile illnesses at this age.  
After primary infection the virus comes into latency and persists 
lifelong in macrophages, bone marrow progenitors or CNS cells. The 
unique feature of latent HHV-6 genome is to make covalent linkages with 
host chromosomes. 
Reactivations of virus are almost totally asymptomatic. Severe 
recurrent HHV-6 infections may develop after allogeneic transplantation in 
graft recipients. 
Similarly, T-lymphotropic human herpesvirus type 7 (HHV-7) also 
appears to be a ubiquitous viral agent, which most infections arise in 
childhood. Persistent infections are established in salivary glands; the virus 
can be isolated from saliva of infected individuals.  
The distinct relations between HHV-7 and human disorders remain to 
be established. HHV-7 as well as HHV-6 may have concern to the 
development of human chronic fatigue syndrome.  
Last human herpesvirus, called Kaposi’s sarcoma-associated 
herpesvirus (KSHV) or human herpesvirus type 8, was first detected in 
1994 in Kaposi’s sarcoma biopsies of AIDS patients.  
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This virus is lymphotropic. Viral replication is very slow. It influences 
cellular genetic elements responsible for cell proliferation and host 
immune response (cytokine production, chemokine receptor expression, 
etc.) Human herpesvirus 8 seems to account for Kaposi’s sarcoma, 
vascular tumor of mixed cellular origin in AIDS patients. 
KSHV is not as ubiquitous as other herpesviruses, affecting about 5-
10% of human population. It might be sexually transmitted among 
homosexual men, e.g. following HIV infection. Also the virus can be 
transmitted via solid organ transplantations. 
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Chapter 20 
CAUSATIVE AGENTS OF ZOONOTIC VIRAL INFECTIONS 
 
 
 
ARTHROPOD-BORNE AND RODENT-BORNE VIRUSES:  
GENERAL CHARACTERISTICS  
 
Most of zoonotic viruses that may affect humans are the members of 
2 ecological groups – arboviruses and roboviruses. 
Arboviruses (or arthropod-borne viruses) comprise a broad ecological 
group of viruses transmitted to animal and human hosts by arthropod 
vectors. 
Similarly, rodent-borne viruses (or roboviruses) fall into ecological 
group of zoonotic viruses transmitted from rodents to susceptible humans.  
That kind of division is not related with any viral taxonomic category. 
These groups embrace highly diverse viral representatives but sharing the 
number of common characteristics of their natural circulation and spread. 
Numerous arbo- and roboviruses pertain to a vast line of viral families 
namely Arenaviridae, Bunyaviridae, Togaviridae, Filoviridae, Flaviviridae, and 
some others. 
Many of them cause the severest human infections manifested by two 
clinical syndromes – viral fevers and viral encephalitis. 
Most clinically relevant representatives of arthropod-borne and rodent-
borne viruses are listed in Table 10. 
 
Table 10 
Main arthropod-borne and rodent-borne viruses that cause human diseases 
 
Viral 
genera 
Viral 
representatives  
 
 
Clinical disease 
Infection 
source or 
vector 
Basic 
properties 
 
Family Bunyaviridae 
Genus 
Hantavirus 
 
Hantaan virus 
 
 
Sin Nombre virus  
 
Hemorrhagic fever 
with renal syndrome 
 
Hantavirus 
pulmonarysyndrome 
 
 
Rodent borne 
 
 
 
 
 
ss (–) RNA 
segmented 
Helical or 
icosahedral 
Enveloped 
Genus  
Nairovirus  
 
Crimean-Congo 
hemorrhagic fever 
virus 
 
 
Hemorrhagic fever 
Arthropod 
borne:  
ticks 
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Genus 
Phlebovirus 
 
Rift Valley fever 
virus 
 
Sandfly fever Naples 
virus 
Rift Valley fever 
 
 
Sandfly fever 
Arthropod 
borne: 
mosquitoes, 
ticks,  
sandflies 
 
Genus 
Orthobunyavirus 
 
California 
encephalitis virus 
 
Encephalitis, 
fever  
Arthropod 
borne: 
mosquitoes 
 
Family Togaviridae 
Genus 
Alphavirus 
 
Eastern and western 
equine encephalitis 
viruses  
Venezuelan equine 
encephalitis virus  
 
Chikungunya virus,  
O'nyong-nyong virus, 
and many others 
 
 
Encephalitis 
 
 
 
Hemorrhagic fevers  
 
 
 
 
Arthropod 
borne: 
mosquitoes 
 
 
 
ss (+) RNA 
Icosahedral 
Enveloped 
 
Family Flaviviridae 
Genus  
Flavivirus 
Tick-borne 
encephalitis virus 
St. Louis encephalitis 
virus 
Japanese encephalitis 
virus 
Murray Valley 
encephalitis virus 
 
Yellow fever virus 
Dengue virus 
West Nile virus 
Omsk hemorrhagic 
fever virus 
 
Zika virus 
 
 
 
 
 
Encephalitis 
 
 
 
 
 
 
Hemorrhagic fevers 
 
 
 
Putative 
teratogenicity 
 
 
 
 
 
 
Arthropod 
borne: 
mosquitoes, 
ticks 
 
 
 
 
 
 
 
ss (+) RNA 
Icosahedral 
Enveloped 
 
Family Arenaviridae 
Genus 
Mammarenavirus 
Lymphocytic 
choriomeningitis 
virus. 
 
Lassa virus 
Guanarito,  
Junin, Machupo, 
Sabia, Lujo viruses 
 
Fever, meningitis 
 
 
 
Hemorrhagic fevers  
 
 
 
 
Rodent borne 
 
 
 
ss (–) RNA 
segmented, 
ambisense 
Enveloped 
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Family Filoviridae 
Genus  
Ebolavirus 
Zaire ebolavirus 
Sudan ebolavirus 
Bundibugyo 
ebolavirus 
Taп Forest ebolavirus 
 
 
Hemorrhagic fevers 
 
 
 
Presumptively 
bat- or rodent-
borne 
 
 
ss (–) RNA 
Helical 
Enveloped 
Genus 
Marburgvirus 
 
Marburg virus 
 
Hemorrhagic fever  
 
 
The note: single-stranded nucleic acid is designated as ss. 
 
Certain viral human pathogens from arthropod-borne and rodent-borne 
ecological groups are discussed below. 
 
 
 
FLAVIVIRUSES: TICK-BORNE ENCEPHALITIS VIRUS 
 
 
The History of Virus Discovery 
 
Tick-borne encephalitis virus (TBEV) was discovered in 1937 by 
Soviet virologists L. Zilber, M. Chumakov, and E. Levkovich during their 
Far East expedition. 
 
 
Classification  
 
Tick-borne encephalitis virus (TBEV) pertains to Flaviviridae family 
and genus Flavivirus. The genus encompasses 53 zoonotic viral species 
that pertain to arboviruses, contracted by arthropod vectors to animal and 
human hosts. 
 
 
Structure of Virus 
 
TBEV is a middle- or small size virus (20-40 nm) of spherical shapes 
with lipid envelope. TBE virion has icosahedral symmetry. 
Viral genome consists of positive single-stranded non-segmented 
RNA. 
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Viral particle has a RNA-bound nucleocapsid C protein and envelope 
proteins M and E  
External E glycoproteins make viral spikes with receptor functions, 
promoting viral binding to the cells. They possess hemagglutinating 
activity. 
Genomic RNA encodes a number of non-structural proteins (NSP) 
with enzymatic activity (helicase, protease, RNA polymerase). 
TBE virus has 3 distinct genetic subtypes: European, Siberian, and Far 
Eastern.  
All TBE viruses form similar common antigenic complex. 
 
 
Virion Resistance  
 
TBE virus as all flaviviruses is moderately resistant to the external 
influences. Nevertheless, it remains long stable at low temperatures. Virus 
maintains viability at least for 10 days at 16-18
o
C. 
Within contaminated dairy products (milk) it may stay viable for 2 
months. 
Heating at 60
o
C for 10 min and boiling for 2 min irreversibly 
inactivates virus. 
Virus is sensitive to UV light and all conventional disinfectants 
(halides, aldehydes, phenol, H2O2, detergents, ethanol, etc.) 
 
 
Viral Replication Cycle 
 
TBEV infects various types of cells, including leukocytes, 
endotheliocytes, hepatocytes, and neurons.  
The virus attachs to the host membrane receptors by spikes and enter 
the cells by endocytosis. Viral uncoating is facilitated with endosome 
acidification resulting in fusion of lipid envelope with endosomal 
membrane. Viral nuclecapsid passes into cytoplasm, where uncoating and 
further replication occurs. 
Genomic (+) RNA translation results in primary polyprotein synthesis 
that further processed by viral and cellular proteases into mature viral 
proteins. 
Newly formed viral RNA polymerase enzyme activates genomic RNA 
replication. Viral genome is transcribed through intermediate minus RNA 
strand that serves as the template for final positive sense RNA synthesis. 
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Virion assembly and maturation is followed by egress of progeny 
viruses that leave the cell by budding. Active viral propagation results in 
destruction of infected cells. 
Virus is easily cultured in embryonated chicken eggs, various 
continuous (Vero and BHK cells) or primary cell lines, and in experimental 
animals (mice) under intracerebral inoculation. 
 
Pathogenesis, Clinical Findings and Immunity in Tick-Borne 
Encephalitis 
 
Tick-borne encephalitis is endemic zoonotic disease registered in the 
areas of habitations of tick vectors. The broad endemic regions of infection 
cover Far East, Siberia, Urals, Central Asia, Northern, Central and Eastern 
Europe. The disease cases were indicated from France to Japan. The 
largest number of cases is regularly reported from Russian Federation – 
5,000 to 13,000 annually. 
Each of genetic subtypes of viruses – European, Siberian, and Far 
Eastern – prevails in its corresponding geographical areas.  
Belarus is also an endemic country for TBE caused by European 
subtype of virus. Above 110 cases of the disease were registered in 2014. 
The sources of infection are the numerous species of wild and 
domestic animals (primarily, rodents, hares, ungulates, predators, birds and 
many others, totally about 130 species).  
The infection has a predominant vector-borne route of transmission 
via the bites of infected ticks. 
The main vector for Siberian and Far Eastern virus subtypes is tick 
species Ixodes persulcatus, for European subtype – Ixodes ricinus.  
According to local data, about 15% of tick vectors are infected by 
TBEV. Tick vectors have the transovarial transmission of virus 
Rare alimentary transmission was occasionally registered in past via 
contaminated non-pasteurized goat or cow milk. 
The disease is characterized with spring-summer seasonality. 
Incubation period of tick-borne encephalitis averages 1-2 weeks. 
According to seroprevalence studies, it has been established that about 
90% of cases may be subclinical or asymptomatic. 
After tick bite the virus enters the blood and lymph. It may primarily 
propagate in the site of bite and infect leukocytes and endotheliocytes. 
Hematogenous and lymphogenous dissemination spreads the pathogen 
throughout the body; the virus appears in spleen and liver and finally 
reachs CNS.  
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Viral propagation causes degeneration of neurons in spinal cord and 
brain followed by meningeal damage. The most suffering are the motor 
neurons of brainstem, cervical and upper thoracic parts of spinal cord.  
In case of manifested TBE disease the onset is sharp with fever, 
headache and vomit. 
Meningeal symptoms, sensory and coordination disorders and 
muscular pareses are observed. In severe cases the patients develop acute 
flaccid paralysis that predominantly affects the muscles of neck, shoulders, 
and upper limbs. The muscular weakness and paralysis may stay long after 
the end of acute disease course. Progression of the disease may be fatal.  
The most severe are the clinical cases caused by Far Eastern subtype 
of virus. They demonstrate lethality of 20-40% and the high rate of poorly 
resolving neurologic sequelae. 
The disease, caused by European virus subtype, has a milder course 
usually followed by complete recovery with lethality less than 1-2%. 
Post-infectious immunity is long-term and stable. Virus-neutralizing 
antibodies maintain their protecting levels for a long time. 
 
 
 
Laboratory Diagnosis of TBE  
 
Clinical specimens of patient’s blood, serum, cerebrospinal fluid or 
autopsy materials are taken for examination. 
For rapid detection of virus immunofluorescence assay, ELISA and 
RT-PCR are elaborated.  
Serological testing is actively used in routine laboratory practice. 
Anti-TBEV IgM antibodies are determined in patient’s sera by ELISA 
indicating acute disease. The elevation of specific antibodies in the course 
of infection is determined in paired sera tests by hemagglutination 
inhibition assay, ELISA, or neutralization tests in the cell cultures. 
Virus isolation is made by inoculation of filtrates of virus-containing 
specimens into various cell lines. TBE virus is detected in cell cultures by 
immunofluorescence test and PCR. 
Animal experimental infection is performed by intracerebral 
inoculation of mice followed by animal postmortem examination with 
identification of virus (immunofluorescence assay, ELISA, or PCR).  
Infectivity of ticks is determined by immunofluorescence and ELISA.  
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Prophylaxis and Treatment of Tick-borne Encephalitis  
 
Specific antiviral treatment of tick-borne encephalitis is not 
elaborated. As the result, the treatment is largely symptomatic (infusion 
and detoxication therapy, neurological support). Passive protection with 
antiviral immune globuline might be worthy at early course of the disease. 
Specific prophylaxis is performed by vaccination with inactivated 
cell culture-derived TBE vaccines.  
The persons from the professional groups of risk of tick exposure that 
work in the endemic areas are vaccinated (e.g., forest workers, hunters, 
laboratory personnel, operating with infectious materials, etc.) In 
hyperendemic areas mass vacination of population should be conducted. 
Post-exposure prophylaxis of individuals subjected to infected tick 
attack is performed by specific antiviral immune globuline being efficient 
within 2-3 days after the exposure.  
Non-specific prophylaxis is primarily based on tick control measures 
achieved by broad use of chemical acaricidal agents in endemic areas. This 
substantially reduces the total number of living vectors, and therefore, the 
risk of infection. 
Personal protection against tick bites should be maintained as well. 
 
 
 
FILOVIRUSES: CAUSATIVE AGENTS OF  
EBOLA HEMORRHAGIC FEVER  
 
 
The History of Ebolavirus Discovery and Current Epidemiological 
Situation 
 
Severe hemorrhagic fevers caused by filoviruses (Lat. filum – thread) 
are the endemic diseases of West and Equatorial Africa, where they were 
met long ago. 
First filovirus was isolated in 1967 in Marburg (Germany) by 
R. Siegert and coworkers after the laboratory outbreak of hemorrhagic 
fever in Yugoslavia and Germany. Primarily infected laboratory personnel 
have operated with monkey cell cultures, delivered from Uganda (Africa). 
From 31 affected people 7 died. 
The isolated agent was designated as Marburg virus and the disease 
was referred to as “Marburg hemorrhagic fever”.  
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Subsequently the limited outbreaks of the disease were repeatedly 
registered in Africa, the last occured in 2014. 
In 1976 a great outbreak of a new hemorrhagic fever emerged in 
Sudan and Zaire that involved more than 600 people with 430 fatality 
cases. Outbreak onset was located in Yambuku village near the Ebola 
River. 
Initially presumed Marburg virus as the causitive agent of epidemic 
was further rejected after the thorough study of a novel isolated pathogen 
termed as ebolavirus (S. Pattyn and coworkers, Belgium, 1976; K. Johnson 
and coworkers, USA, 1976).  
In 1982 both Marburg and Ebola agents were placed into newly 
formed viral family Filoviridae. Later it has become known that Ebola 
disease is caused by closely related several species of ebolaviruses. 
Since 1975 the outbreaks of Ebola hemorrhagic fever were regularly 
registered in Central and West Africa. 
In December 2013 a new epidemic of Ebola virus disease emerged in 
Guinea; the infection rapidly spread to the neighbouring countries (Liberia, 
Sierra Leone and others) and moved outside the initial region. The single 
cases of infection were diagnosed in United States, European countries and 
in a number of African states).  
Due to its serious community health threat in 2014 WHO constituted 
Ebola disease outbreak as Public Health Emergency of International 
Concern (PHEIC).  
To April 2016, more than 28,800 cases of Ebola virus disease were 
indicated (above 15,000 of them were laboratory confirmed) that resulted 
in 11,325 death cases. Therefore, outbreak lethality reached almost 40%. 
Only after intensive united efforts of international organizations and 
national state authorities the Ebola epidemic was terminated. Last cases of 
the disease were officially registered in March, 2016. 
On March 29, 2016, WHO ended the state of the Public Health 
Emergency of International Concern for the Ebola outbreak in West 
Africa. 
 
Classification of Filoviruses 
 
The family Filoviridae pertain to the order Mononegavirales.  
The causative agents of Ebola virus disease (EVD) and Marburg 
virus disease (hemorrhagic fevers) pertain to genera Ebolavirus and 
Marburgvirus, respectively. Genetic similarity between two genera is 
moderate – less than 50%. 
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Marburgvirus genus has a single viral species Marburg virus. 
Genus Ebolavirus harbors 5 closely related viral species Zaire 
ebolavirus, Sudan ebolavirus, Bundibugyo ebolavirus, Taп Forest 
ebolavirus, and Reston ebolavirus, where first four species cause 
hemorrhagic fevers in humans. The most severe disease is related with 
Zaire ebolavirus. 
 
 
 
Structure of Ebolaviruses 
 
All ebolaviruses contain linear single-stranded negative-sense non-
segmented RNA. The viruses look like long cylindrical thread-like 
structures about 80 nm in breadth and 600-1000 nm in length. 
These viruses are covered with the external lipid envelope. Viral 
nucleocapsid displays the helical symmetry. 
Ebolaviruses contain nucleocapsid proteins bound to viral RNA. 
Internal protein L develops RNA polymerase activity. 
GP glycoproteins are the outer structural components of the viral 
envelope. During reproduction, GP proteins are largely produced in soluble 
form (sGP).  
The matrix viral proteins (VP) support envelope structure 
 
 
 
Virion Resistance 
 
The viability of ebolaviruses is moderate. Within aerosol droplets they 
retain infectivity at least for 1-2 hours, when dried – for several days. 
Sunlight and UV radiation readily inactivate them. 
These viruses can withstand low-temperature exposure. Dried blood 
spots with ebolaviruses remain viable at 4
o
C for 3-4 weeks. 
Heating at 60
o
C for 30-60 min and boiling for 5 min irreversibly 
inactivates virus. 
Viruses are sensitive to most of conventional disinfectants (halides, 
aldehydes, phenol, detergents, ethanol, etc.) For ebolaviruses WHO 
recommends surface disinfection with household bleach (sodium 
hypochlorite). 
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Viral Replication Cycle 
 
The target cells for ebolavirus replication are the all cells of 
monocyte/macrophage lines, dendritic cells, endotheliocytes, adrenal cells, 
hepatocytes. 
Viral attachment to the host cells is mediated via GP proteins binding 
to numerous membrane receptors (lectins and many others) 
Specific binding induces viral penetration by endocytosis. 
Acidification of endosome facilitates viral uncoating and RNA release. 
The replication of ebolaviruses occurs in the cytoplasm of infected 
cells. 
At first viral mRNAs are transcribed on genomic (–) RNA matrix. 
mRNAs are next translated on cellular ribosomes resulting in viral 
proteins.  
New genomic (–) RNAs are reproduced by viral RNA polymerase via 
the step of (+) RNA intermediate that serves as the template for progeny 
genome synthesis. 
Nucleocapsid assembly is performed at the inner part of cytoplasmic 
membrane. Maturating virions migrate across the cell membrane, where 
they are covered with lipid envelope. Finally ebolaviruses are released 
from the infected cells by budding. 
Filoviruses are characterized with high reproduction rate. Massive 
egress of nascent virions results in destruction of infected cells.  
Culture of ebolaviruses is performed only in specially organized and 
highly equipped national centers (laboratories) that maintain 
biocontainment precautions at biosafety level 4 (BSL-4) as the highest 
level of biosafety precautions.  
BSL-4 is created for rapidly transmitted microbial pathogens, which 
cause diseases with highest fatality rate (like ebolaviruses). 
In BSL-4 conditions ebolaviruses can be readily cultured within 
continuous cell lines (Vero cells or others), or by inoculation in laboratory 
animals (guinea pigs, hamsters, mice, or primates). 
 
 
Pathogenesis, Clinical Findings and Immunity in Ebola Virus Disease 
 
Hemorrhagic Marburg and Ebola fevers are extremely dangerous, 
highly contagious and fatal zoonotic viral infections. 
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Both agents stay in WHO Risk Group 4 pathogens and US list of 
“Biological Select Agents or Toxins” being present in Tier 1 of this list 
(the highest rank of public threat). 
The sources of infection in cases of Ebola disease outbreaks are sick 
animals (primates, swine, or certain species of antelopes) or sick humans, 
primarily taking care on patients with Ebola.  
Fruit bats and less likely rodents seem to be the animal reservoirs that 
harbor ebolaviruses in natural conditions.  
The infection is transmitted predominantly via direct or indirect 
contact of human susceptible host with infected excretions of sick animals 
or humans. 
Also the disease is contracted by alimentary route after the ingestion 
of infected meat.  
High concentration of viruses is observed in patient’s blood, and in 
sufficient amounts in feces, vomits, breast milk, or sperm that is enough 
for transmission. In this vein Ebola infection can be transmitted by sexual 
intercourse still over 3 months after clinical recovery. 
Aerosol spread of infection is only possible in cases of great 
concentration of virus in droplets. Direct air droplet human-to-human 
transmission of Ebola disease is not registered. 
The virus is not transmitted by arthropod vectors. 
Medical workers treating patients with Ebola, as well as other 
caregiving persons are at the highest risk of infection. In Africa the 
infection spread is maintained by traditional burial rituals with unprotected 
contacts with the deceased.  
Incubation period varies from 2 to 21 days (an average of 6-10 days). 
The causative agent usually enters the body through skin lesions or 
cuts. Also it can penetrate conjunctiva. The virus propagates in regional 
lymph nodes. Hematogenous and lymphogenous dissemination spreads 
ebolaviruses throughout the body; they appear in all inner organs and 
tissues. 
The main targets for ebolaviruses are the cells of innate immunity 
(monocytes, macrophages, dendritic cells, neutrophils), endothelial cells, 
and the cells of parenchymatous organs.  
Extensive viral reproduction results in massive cell death, activates 
systemic inflammation with parallel deep suppression of antiviral immune 
responses.  
The viruses activate apoptosis of lymphocytes, monocytes and 
macrophages. 
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Soluble sGP protein arrests neutrophil activation. Structural 
VP proteins inhibit the secretion of both types of interferons. 
In 2-3 days the viruses affect vascular endothelium all over the body’s 
tissues resulting in generalized vasculitis.  
Hard damage of hepatocytes and endothelial cells leads to 
disseminated intravascular coagulation (DIC) that entails hypotension and 
collapse. As the result of systemic infection, hemorrhagic and necrotic 
lesions emerge in all organs and tissues. This is followed by massive 
internal bleedings and tissue edema resulting in hypovolemic shock with 
possible fatal outcome. 
The infection has acute onset with fever above 38
o
C and extensive 
pain syndrome (headaches, abdominal and chest pain, muscular and joint 
pain). At 5-7 days of the disease about 50% of patients exhibit skin rash, 
followed by internal bleedings and mucosal hemorrhages.  
Hematemesis, hemoptisis, and post-injection bleedings can be 
observed. 
The development of hemorrhages and hypovolemic shock seriously 
worsenes the prognosis of Ebola virus disease. 
The lethality of Ebola outbreaks is very high – it varies from 20 to 
90% (average at 50%). 
The recovery is slow, the convalescents produce long time shedding of 
virus. Hearing and vision disorders are common. 
Post-infectious humoral immunity renders the high levels of specific 
antiviral antibodies but their role in protection against reinfections remains 
unclear. 
Due to their prominent virulence, rapid and severe disease course, and 
high fatality of infection, ebolaviruses are generally ascertained as the 
potential agents of bioterrorism and biological warfare.  
 
 
Laboratory Diagnosis of Ebola Virus Disease  
 
Taking into account an extreme danger of Ebola infection all 
manipulations with ebolavirus agents should be performed in laboratories 
maintaining biosafety level 4 (BSL-4) as the highest grade of 
biocontainment precautions.  
The specimens are taken from patient’s blood and autopsy materials 
Laboratory diagnosis of infection is verified by RT-PCR and other 
molecular genetic tests detecting viral nucleic acids. 
Viral antigen is determined by immunochromatography. 
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Isolation of ebolaviruses is not routinely used because of high 
demands to biosafety. The virus is cultured in various cell lines with its 
further identification by PCR. 
For serological diagnosis ELISA test is elaborated detecting antiviral 
IgM and IgG antibodies. 
 
 
Principles of Prophylaxis and Treatment of Ebola Virus Disease 
 
A substantial threat of Ebola virus disease requires strict measures in 
order to prevent the emergence and spread of the infection. It needs to keep 
professional and public awareness, heightened infection surveillance with 
rapid case validations, patient isolation and management. Additional 
measures should be directed to control travellers visiting the areas of 
disease outbreaks. 
Vaccines for specific prophylaxis of Ebola infection will be soon 
introduced into clinical practice as several genetically engineered vaccines 
from Russia, USA, and Great Britain manufacturers are starting clinical 
trials now. 
There is still no specific antiviral treatment for Ebola disease. Positive 
result is achived by administration of the sera of convalescent patients with 
high titers of specific antiviral antibodies. 
Extensive supportive treatment greatly amends the disease prognosis. 
The prevention of hypovolemic shock and DIC development, the 
maintenance of vital body functions including active fluid resuscitation 
with correction of electrolyte disbalance and coagulation disorders favor 
the outcome of Ebola infection. 
 
 
ARENAVIRUSES: CAUSATIVE AGENT OF  
LASSA HEMORRHAGIC FEVER 
 
The History of Arenavirus Discovery 
 
First arenavirus – a causative agent of lymphocytic choriomeningitis – 
was isolated in 1933 by R. Lilly and C. Armstrong in USA. 
Further it has been discovered that most of arenaviruses are the 
severest zoonotic pathogens that in some situations may cause acute 
hemorrhagic fevers in humans with high fatality rate. These infections are 
endemic in various regions of Africa and Latin America. 
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Arenavirus known as Junнn virus, a causative agent of Argentine 
hemorrhagic fever was discovered in 1958 by A. Parodi; Machupo virus, 
the agent of Bolivian hemorrhagic fever was found by K. Johnson in 1963; 
Lassa virus, the agent of Lassa hemorrhagic fever was isolated in Nigeria 
by J. Frame in 1969; Guanarito virus of Venezuelan hemorrhagic fever – 
by R. Salas in 1991; and Lujo virus of hemorrhagic fever – by W.I. Lipkin 
in Africa in 2008. 
 
 
Classification of Arenaviruses  
 
The viral members of family Arenaviridae, pathogenic for mammals, 
are assigned to genus Mammarenavirus.  
The most dangerous for humans are numerous species – the agents of 
viral hemorrhagic fevers like Lassa virus or Junнn, Machupo, Guanarito, 
Lujo, and some other less common viruses. 
According to their geografical location these pathogens are divided 
into the Old World viruses and the New World viruses. 
Lassa virus is responsible for most of endemic cases of arenaviral 
hemorrhagic fevers. 
Besides these agents, the virus of lymphocytic choriomeningitis may 
also cause human disorders (e.g., fever or meningoencephalitis). Also it 
demonstrates evident teratogenic potential. 
The name of arenaviruses originated from Lat. arena – sand, as these 
agents hold in their envelope sand-like granular inclusions – captured 
cellular ribosoms – visible by electron microscopy. 
 
 
Structure of Arenaviruses 
 
Arenaviruses are polymorphic enveloped viral particles 50-300 nm in 
size. 
Genome of arenaviruses comprises 2 segments (small S and large L) 
of linear single-stranded ambisense (–) RNA.  
The ambisense nature of genomic RNA indicates that synthesis of 
viral proteins is based on either genomic or its complementary antigenomic 
RNA templates.  
Every segment of viral genomic RNA codes for 2 viral proteins. 
L segment is responsible for synthesis of L protein (RNA polymerase) 
and matrix Z protein. 
 363 
S segment encodes NP nucleoprotein and GP glycoprotein of viral 
spikes. The molecule of GP is further proteolyzed into GP1 (receptor 
protein) and GP2 (fusion protein). 
Nucleoprotein NP and matrix Z protein inhibit the synthesis of 
interferons by infected cells, thus promoting viral dissemination. 
 
 
Virion Resistance 
 
Outside the host arenaviruses stay alive 15-30 minutes to several 
hours; their survival increases at low humidity conditions. 
The viruses are sensitive to UV radiation and sunlight.  
Heating at 60
o
C for 30-60 min irreversibly destroys arenaviruses. 
They are readily inactivated by all conventional disinfectants. 
 
 
Viral Replication Cycle 
 
Viral attachment to host cells is promoted by binding of receptor 
GP1 protein to various membrane molecules (e.g., transferrin receptor) 
present on many types of human cells. 
Specific binding induces viral endocytosis. Acidification of endosome 
activates GP2 protein that stimulates uncoating and viral entry into 
cytoplasm with genomic RNA release. 
The replication of arenaviruses is performed in the cytoplasm of 
infected cells. 
After synthesis of viral genomic RNAs by viral RNA polymerase and 
translation of viral proteins capsid assembly is performed at the inner part 
of cytoplasmic membrane. Viral self-assemblage is mediated by matrix 
Z protein. Occasionally viral particles may capture cellular ribosomes. 
Virions are released through the cell membrane, being covered with 
lipid envelope. Viral egress occurs by budding. 
Culture of arenaviruses similar to isolation of other causative agents 
of acute hemorrhagic fevers (e.g., filoviruses) is performed only in 
reference centers (laboratories) that operate at highest biosafety level 4 
(BSL-4).  
In BSL-4 conditions arenaviruses can be isolated in various cell lines 
(e.g., Vero cells), or by inoculation into laboratory animals (guinea pigs, or 
primates). 
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Pathogenesis and Clinical Findings of Lassa Hemorrhagic Fever  
 
From all arenaviral diseases Lassa hemorrhagic fever seems to be the 
most life-threatening infection. Being localized in endemic regions of West 
Africa (e.g., in Nigeria, Liberia, Guinea and some other countries) it affects 
up to 300,000 people annually resulting in a number of human deaths 
about 5,000-10,000.  
The incidence of other arenaviral hemorrhagic fevers (e.g., Junнn, 
Machupo, Guanarito, or Lujo diseases) is substantially lower.  
Lassa virus belongs to the arenaviruses of the Old World. 
Lassa hemorrhagic fever is a typical zoonotic endemic disease. It 
pertains to ecological group of rodent-borne infections. 
The main source of infection is a certain species of endemic African 
rodent (Natal multimammate rate or Mastomys natalensis). These animals 
continuously excrete the viruses with feces and urine. 
The mechanisms of development of Lassa hemorrhagic fever share a 
number of common traits with other hemorrhagic fever diseases (e.g., 
caused by filoviruses). 
The infection is transmitted predominantly by contact route; 
foodborne and dust aerosol transmission are also possible. 
Infectious dose for Lassa hemorrhagic fever is extremely low – it is 
estimated as 1-10 viral particles. 
Incubation period lasts 1-2 weeks. 
Despite the high virulence of the infectious agent, more than 80% of 
infection cases are mild or subclinical, indicating the natural resistance of 
local human communities. 
Lassa virus usually enters the host through the mucosal or skin lesions. 
The virus propagates in regional lymph nodes. Hematogenous 
dissemination results in viremia. The levels of viremia correspond to 
disease severety. 
The main targets for Lassa viruses are the cells of innate immunity 
(primarily, monocytes, macrophages, and dendritic cells). 
The basic mechanism of the development of systemic viral infection is 
the prominent ability of arenaviruses to inhibit cellular and humoral 
reactions of antiviral immunity. 
Viral nucleoprotein NP and matrix Z protein inhibit the synthesis of 
interferons and activation of macrophages and dendritic cells. This blocks 
the presentation of viral antigens to immune lymphocytes and sharply 
diminishes cytokine secretion. 
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In conditions of immune insufficiency arenaviruses rapidly spread 
throughout the body, affecting parenchymatous organs and other tissues. 
The viruses affect endothelial cells with deep microcirculation 
disorders.  
Lassa disease manifests with fever and ulcerative pharingitis, followed 
by cough and vomiting. It progresses towards generalized hemorrhagic 
syndrome resulting in multiple organ dysfunctions with severe hepatitis, 
myocarditis, viral pneumonia, encephalitis, and renal failure. 
The lethality in hospitalized patients is about 15-20%; amongst 
pregnant women – more than 80%. Hearing loss is a common neurologic 
sequela. 
Convalescence is slow; the virus sheds for 1-3 months after the 
recovery. 
 
Laboratory Diagnosis of Arenaviral Infections  
 
All manipulations with Lassa viruses and other arenaviral agents are 
elaborated in laboratories of biosafety level 4 (BSL-4).  
The specimens are taken from patient’s blood, urine, sputum, 
cerebrospinal fluid, nasopharyngeal washes, and autopsy materials. 
The virus is most rapidly identified by RT-PCR or other molecular 
genetic tests. 
For detection of viral antigens immunofluorescence or ELISA tests 
are elaborated. 
Isolation of arenaviruses is conducted in various cell lines or by 
inoculation into laboratory animals followed by viral identification with 
ELISA or PCR. 
For serological diagnosis ELISA test is elaborated detecting specific 
antiviral antibodies of IgM class. 
 
 
Principles of Prophylaxis and Treatment of Arenaviral Infections  
 
Antiviral drug ribavirin is commonly used for treatment of arenaviral 
hemorrhagic fevers. If administrated on the 1
st
 week of the disease, it 
substantially reduces lethality. 
Administration of the sera of convalescent patients with high titers of 
specific antiviral antibodies facilitates the recovery. 
Other treatments presume the support of vital body functions of 
respiratory and cardiovascular system. 
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Common prophylaxis measures are non-specific and similar to other 
cases of hemorrhagic fevers. 
Various kinds of vaccines for prevention of Lassa fever are actively 
developed now. A first example of efficient live arenaviral vaccine against 
Argentine hemorrhagic fever caused by Junнn virus has been introduced 
already into clinical practice. 
 
 
 
RABDOVIRUSES – RABIES VIRUS 
 
 
The History of Virus Discovery 
 
Rabies disease is well-known since antiquity. It is a zoonotic acute 
infection of central nervous system that is inevitably fatal.  
First breaking success in the fight against rabies was achieved in 1884 
by Louis Pasteur and his outstanding colleagues Emile Roux, Charles 
Chamberland, and Louis Thuillier, who created efficient antirabies 
vaccine. Since that time this mortal disease began to retreat.  
V. Babes in 1887 and A. Negri in 1903 described specific inclusion 
bodies in neurons of animals, dead from rabies. These inclusions were 
referred to as Babes-Negri bodies.  
The viral etiology of rabies was proved in 1903 by P. Remlinger, 
E. Riffat-Bay, and A. di Vestea, who isolated rabies virus. 
Although the number of human cases is small, rabies is a major public 
health problem because it is broadly spread among animal reservoirs. 
 
 
 
Classification of Rabies Virus 
 
This virus pertains to the order Mononegavirales, family 
Rhabdoviridae, genus Lyssavirus, and species rabies virus. 
To date 7 genotypes and 5 serotypes of rabies virus are established. 
Overall, lyssaviruses demonstrate the lowest genetic variability in 
comparison with other rhabdoviruses. 
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Structure of Virus 
 
Rabies viruses are the rod- or bullet-shaped particles of about 
75x180 nm. Type of symmetry of virions is helical.  
Viruses are surrounded by lipid envelope with protruding spikes. 
Ribonucleocapsid is confined inside the envelope. Viral genome includes 
single-stranded, non-segmented negative-sense RNA. 
Genomic RNA encodes 5 structural proteins. 
Nucleocapsid proteins N (nucleoprotein), P (phosphoprotein), and 
L (RNA polymerase) account for replication of viral genome and viral 
mRNA transcription. 
Matrix M protein is located under lipid envelope; it takes active part in 
viral budding. 
Supercapsid glycoprotein G makes spikes in lipid envelope. It plays an 
essential role in rabies pathogenesis.  
First, it specifically binds to nicotinic acetylcholine receptors 
(nAChR) on membranes of neurons and muscle cells promoting viral 
attachment and membrane fusion. Also protein G stimulates apoptosis of 
infected cells. 
Furthermore, superficially located protein G activates host immune 
response in the course of infection. It elicits the synthesis of virus-
neutralizing antibodies.  
According to structural variations of G proteins, rabies virus is divided 
into 5 serotypes. However, all viral serotypes are enough similar and 
induce the formation of cross-reactive neutralizing antibodies. Thus, it 
became possible to use only 1 serotype of vaccine virus for rabies 
vaccination.  
When freshly isolated in the laboratory from external source, the viral 
strain is designated as rabies street virus. These viruses show long and 
variable incubation periods (usually 21-60 days in dogs) and regularly 
produce cytoplasmic inclusion bodies. Sequential brain-to-brain passages 
in rabbits primarily made by L. Pasteur yielded a "fixed" virus. This 
pathogen lost the ability to multiply in extraneural tissues. Fixed mutant 
virus propagates rapidly, and its incubation period has been shortened to 4-
6 days. Inclusion bodies are found rarely in this infection. 
 
 
 
 
 
 368 
Virion Resistance  
 
Rhabdoviruses demonstrate generally low resistance. Rabies virus is 
inactivated rapidly by exposure to ultraviolet radiation or sunlight, and by 
heating (1 hour at 50°C or 1 minute at 100оС)., 
Nevertheless, it remains long-time infectious at low temperatures, e.g. 
it stays viable at 4°C for weeks. 
Rabies virus is sensitive to the commonly used biocides (e.g., sodium 
hypochlorite and other halides, detergents, aldehydes, ethanol, ether, and 
others). The virus loses viability at рН<3 or рН>10. 
 
Viral Replication Cycle 
 
Rabies virus attaches to cells via its glycoprotein spikes. Spike 
G protein binds to nicotinic acetylcholine receptor (nAChR) facilitaing 
viral entry by endocytosis. Molecules of nAChR are expressed on the 
membranes of neurons and muscle cells, so these cells are the primary 
targets for virus. 
Acidification of endosome content activates G proteins. It results in 
envelope-membrane fusion and viral penetration into cytoplasm followed 
by uncoating. 
Rabies virus replication occurs in cytoplasm of infected cells. 
Single-stranded RNA genome is transcribed by virion-associated RNA 
polymerase L to mRNA. Messenger RNAs code for five structural virion 
proteins: nucleoprotein (N), polymerase (L), phosphoprotein (P), matrix 
(M), and receptor glycoprotein (G). 
Negative-sense genomic RNA is transcribed via complementary 
positive-sense RNA intermediate. Newly synthesized genomic RNAs 
associate with N, L, and P proteins with formation of ribonucleocapsids. 
They further interact with matrix M proteins in cytoplasm. 
The nascent virions acquire an envelope and external spikes, when 
released by budding through the cell plasma membrane, where G proteins 
were primarily embedded. 
Rabies virus is readily cultured in brain tissues of laboratory mice, 
syrian hamsters, or rabbits; the infected animals display encephalitis with 
paralysis. 
Also the virus is adapted to various cell lines (Vero cells, BHK 
cultures and others). Acidophylic inclusions (Babes-Negri bodies) are 
detected in cytoplasm of infected cells.  
Cytopathic effect of rabies virus is not observed. 
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Pathogenesis, Clinical Findings and Immunity in Rabies 
Rabies is acute zoonotic neuroinfection developing after the bite of a 
rabid animal and followed by progressive CNS damage with lethal 
encephalitis. 
Without urgent vaccination rabies disease demonstrates 100% fatality. 
Rabies virus has a broad host range. All warm-blooded animals, 
including mammals, can be infected.  
Susceptibility of many mammalian species is very high (e.g. foxes, 
wolves, racoons and raccoon dogs, cats, rats and many others.)  
Recovery from infection in animals is extremely rare except certain 
bats species. For instance, vampire bats may transmit the virus for months 
without any signs of disease. 
Thus, the source of infection is a rabid animal. 
The virus is usually transmitted to humans via the rabid animal bite 
or by contact with infected saliva through the skin or mucosal lesions. 
Incubation period varies strongly depending on host’s immune status, 
the amount of inoculum, and the distance the virus should move from the 
point of inoculation to the central nervous system. The shortest incubation 
period (about 7-10 days) is observed in patients bitten on the face, head or 
neck; the longest occurs in cases of bites on feet (1-3 months). Moreover, 
some documented cases of rabies had the incubation period of more than 
10 years. Thus, rabies is regarded as slow viral infection. 
When entered into the tissues, rabies virus binds to nicotinic 
acetylcholine receptor (nAChR) on the membranes of neurons and 
neuromuscular junctions. 
Next pathogenesis of infection follows two basic ways.  
If the virus locally multiplies in muscle tissue at the site of inoculation, 
it may stay long and propagate in primary location up to 2 months. 
By contrast, if the virus binds to neuronal transport proteins dynein or 
neurotropin in axoplasm of peripheral nerves, it undergoes fast retrograde 
axonal transport that delivers virus directly to bodies of neurons in spinal 
cord and brain. The velocity of viral movement is equal to 50-
100 mm/daily that substantially shortens the incubation period. 
Next the virus multiplies in the nuclei of CNS in spinal cord, 
brainstem, hippocampus, thalamus, cerebellum and other CNS parts. 
The progeny viruses spread further through peripheral nerves to the 
salivary glands and other tissues. The highest concentration of rabies virus 
is observed in submaxillary salivary gland. Viruses are also found in 
skeletal muscles, retina and cornea, heart, kidneys and other inner organs. 
However, rabies virus is not isolated from patient’s blood. 
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The virus produces characteristic eosinophilic cytoplasmic inclusions, 
Babes-Negri bodies, within infected neurons. This finding is 
pathognomonic on rabies. 
The disease manifests as acute fulminant fatal encephalitis.  
During the acute neurologic phase the patients demonstrate deep 
neurologic disorders. Patients exhibit hydrophobia (fear of water), 
photophobia (fear of light), aerophobia, noise phobia. They feel a 
profound thirst; their swallowing is impaired. Severe sympathetic 
hyperactivity results in hypersalivation, increased perspiration and 
lacrimation. The patients often show aggressiveness. 
In case of paralytic forms of infection initial local paralysis progresses 
into generalized disease. 
The late phase of rabies is followed by coma and death, usually 2-7 
days after the disease onset. The major cause of death is respiratory 
paralysis. 
 
 
Laboratory Diagnosis of Rabies 
 
All the animals indicated as “rabid or suspected rabid” should be 
sacrificed immediately for laboratory examination of nervous tissue. Other 
animals should be observed for 10 days. If they demonstrate any signs of 
encephalitis, or unusual behavior, they should be killed and the neural 
tissues examined. 
Post-mortem diagnosis of rabies is highly specific. 
The specimens of brain tissues taken from died animals or patients are 
used for laboratory diagnosis. The virus is most rapidly identified by 
immunofluorescence or immunoperoxidase staining using antirabies 
antibodies. 
Cytological examination of slides reveals Babes-Negri bodies in the 
neurons of brain or spinal cord of affected person.  
Reverse transcription-PCR can be used to detect rabies virus genome 
in brain tissue. 
For viral isolation the tissue samples are inoculated intracerebrally 
into suckling mice. Infection in mice results in encephalitis and next death. 
Animal CNS tissues are examined for viral antigen or Babes-Negri bodies.  
Similarly the virus can be inoculated into laboratory cell lines with 
further identification by immunofluorescence, cytology, ELISA or PCR. 
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Antemortem (intravital) diagnosis of rabies is applied in cases of 
atypical infections in humans and, more often, for rapid diagnosis of 
animal infection needs to urgent vaccination of affected individuals.  
Tissue biopsies of bite sites and back of neck skin, buccal and corneal 
epithelium, cerebrospinal fluid or saliva are examined by immuno-
fluorescence or PCR.  
Detection of serum specific antibodies by ELISA might be helpful in 
monitoring of humoral response in vaccinated persons. 
 
 
Principles of Rabies Prophylaxis and Treatment 
 
There is still no treatment for clinical rabies.  
Thus, post-exposure rabies prophylaxis is lifesaving intervention and 
should be initiated without any delay. The medications include rabies 
vaccination, administration of rabies immune globulin if required, and 
perfect surgical management of bite wounds. 
If the vaccine or specific antibodies are timely administered, virus 
propagation arrests, and the virus can’t invade the central nervous system. 
Passively administered antibodies lower the concentration of virus, 
providing additional time for a vaccine to stimulate active antibody 
production, thereby preventing viral entry to CNS. 
All the vaccines for humans contain inactivated rabies virus. The most 
commonly administered is human diploid cell vaccine.  
Vaccine is injected 5-6 times into deltoid muscle. It confers long-term 
immunity, postvaccinal complications are rare. 
Live attenuated vaccine can be used for animal vaccination. 
For passive post-exposure prophylaxis specific immunoglobulins are 
administered. 
Equine rabies immunoglobulin is obtained from horses 
hyperimmunized with rabies vaccine virus. 
Human anti-rabies immunoglobulin is a globulin fraction prepared 
from the plasma of vaccinated humans. It renders fewer side effects in 
comparison with equine antibodies. 
Passive prophylaxis is administered prior to vaccination in case of 
multiple bites on upper limbs, neck, or head, where the incubation period 
is short. 
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Chapter 21  
PRIONS AND PRION DISEASES 
 
 
General Characteristics of Prion Agents 
 
Prions are the novel unique class of infectious agents completely 
different from all microbial pathogens known before. The name “prion” 
abbreviates from words “proteinaceous infectious particle”, thus 
emphasizing the protein nature and infectivity of these unusual pathogenic 
agents.  
Prion diseases afflict humans as well as various animal species 
causing slow but severe progressing neurodegenerative disorders with 
characteristic spongioform degeneration in central nervous system 
(transmissible spongiform encephalopathies or TSEs). 
 
 
The History of Discovery 
 
As far as in 1939 the cases of strange disease of sheep marked by 
severe itching of animals were described. Thereafter, the disease was 
named as “scrapie”, and its infectious nature was proven further by direct 
experimental infection of goats. 
Later in the 1950s, C. Gajdusek and coworkers first demonstrated 
another strange neurodegenerative disorder spread among some tribes 
inhabiting New Guinea island. The disease, called kuru, was transmitted 
throughout the population of the island by ritual cannibalism, being 
ultimately fatal.  
Further the distinct similarities between above mentioned diseases and 
some other known human and animal disorders, e.g. sporadic form of 
Creutzfeldt-Jakob disease (CJD), or bovine spongiform encephalopathy 
(BSE) were noticed. In the early 1980s all these clinical data together with 
the number of evident laboratory findings allowed future Nobel Prize 
Laureate S. Prusiner to propound a prion hypothesis for explanation of 
origin of these diseases. 
Owing to the discovery of prions made by S. Prusiner in 1982 it 
became obvious that not only DNA-containing agents can provoke 
diseases but the products of gene expression, proteins, are able to cause the 
disease emergence and progression. Prions differ from bacteria and 
viruses, as they are lack of any type of nucleic acids, DNA or RNA, being 
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solely of protein nature. Prions resist inactivation by procedures that 
modify polynucleotides, e.g. treatment with DNAse or RNAse. They are 
also extremely stable to heating. 
 
 
Pathogenesis of Prion Diseases 
 
Actual identification of prion molecules has become possible only 
after cloning of their specific gene PRNP (PRioN Protein gene), located 
within 20
th
 chromosome. This gene codes for normal cell glycoprotein 
PrP
C
 (the letter C in abbreviation means common or cellular). The gene is 
typically expressed in neurons and glial cells of CNS, as well as in 
leukocytes and some other cell elements. PrP
C
 molecule is supposed to 
play a role in signal transmission regulating synaptic activity. PRNP gene 
is evolutionary stable structure. It expresses not only in humans, but also in 
other mammalian species, birds, etc. 
The infection arises after alteration of initial non-pathogenic form of 
PrP
C
 protein. The latter event ensues from PRNP gene mutations that are 
characteristic for hereditary prion diseases, e.g. Gerstmann-Straussler-
Scheinker syndrome (GSS), fatal familial insomnia (FFI), or sporadic 
form of Creutzfeldt-Jakob disease. Also the disease can start after 
acquisition of infectious prion molecules from external source. This is 
essential for epidemic bovine spongiform encephalopathy (BSE) or “mad 
cow disease” in cattle and suspected for emergence of a “new variant” of 
Creutzfeldt-Jakob disease in humans. 
Pathogenic form of prion protein PrP
Sc
 (Sc means scrapie) originates 
from initial PrP
C
 molecule after conformational change of its structure. 
Once appeared, pathogenic prion PrP
Sc
 spreads its abnormal conformation 
to surrounding intact PrP
C
 molecules as autocatalytic chain reaction. 
It is well-determined that the animals, which are lack of PrP gene (for 
instance, experimental “knock-out” mice) are not affected by prions. They 
can’t express pathogenic PrPSc molecules. 
Generated prions are tough units, resistant to proteases, formaldehyde 
treatment and heating. They display distinct ability to self-aggregation 
forming amyloid protein deposits in brain tissue. This leads to the 
progression of neurodegenerative disorders of CNS. 
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General Manifestations of Prion Diseases 
 
Prion diseases are generally characterized by severe non-inflammatory 
damage of neuronal tissue with spongioform degeneration and atrophy, 
neuronal loss, vacuolization, astrogliosis, progression of amyloid plaques.  
Familial and sporadic (hereditary) forms of prion diseases in humans 
are rare (about 1 case per million of population in a year).  
Infectious prion diseases are more common; in addition, some other 
neurodegenerative disorders of unknown origin are supposed now to be of 
prion nature.  
Prion diseases that can afflict humans comprise a number of disorders. 
Among them are above mentioned Creutzfeldt-Jakob disease (sporadic, 
mixed and iatrogenic forms), Gerstmann-Straussler-Scheinker syndrome, 
fatal familial insomnia, and kuru disease. 
Kuru and iatrogenic Creutzfeldt-Jakob disease are the infectious 
forms of human prion illnesses; the others are hereditary disorders. Human 
prion infections are contracted by alimentary route or by medical 
manipulations (e.g., after organ and tissue transplantations). 
Every disease is characterized by some specific clinical and 
morphological traits. For instance, sporadic Creutzfeldt-Jakob disease 
gradually starts at the age of 50-60 years. First symptoms are not very 
specific; the patients demonstrate general asthenia, sleeplessness, 
headache, dizziness, and memory disorders. Progression of dementia is 
followed by motor dysfunction with cerebellar ataxia, myoclonic spasms, 
pyramidal and extrapyramidal disturbances, etc. The disease becomes fatal 
in one-two years.  
Rare iatrogenic form of Creutzfeldt-Jakob disease usually occurs after 
organ transplantations, non-sterile medical manipulations, after cellular 
and tissue therapy, etc. Its incubation period lasts for more than 10 years  
A great public interest to prion diseases was renewed after epidemic 
of bovine spongiform encephalopathy (BSE) or “mad cow disease” 
occured in Great Britain in 1986-1998. The disease affected about 200,000 
cattle.  
During the epidemic course more than 30 cases of a “new variant” of 
Creutzfeldt-Jakob disease were registered in humans. The onset of the 
disease developed young and adult persons 15-40 years old. It was strongly 
supposed that the illness contracted by alimentary route after ingestion of 
infected beef. Similar disorders were determined in animals (cats, zoo apes 
and others) kept with beef meet feeding. 
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Post-mortal examination of the patients died from “new variant” of 
Creutzfeldt-Jakob disease revealed alterations of brain tissue typical for 
spongiform encephalopathy in cattle. 
Clinical findings are common with other prion diseases (psychotic 
reactions, dementia, cerebellar ataxia, myoclonic cramps, etc.) The 
insidious progression of CNS disorders leads to lethal outcome. 
Kuru disease is only of historical interest now as the disease 
transmission is possible only by acts of ritual cannibalism that was 
eliminated among affected tribes long time ago.  
Gerstmann-Straussler-Scheinker syndrome is a seldom disease. It is 
a familial or sporadic disorder that occurs mostly in the 4
th
-5
th
 decade. 
Cerebellar ataxia and concomitant motion disturbances are common. The 
illness lasts several years to patient’s death.  
Fatal familial insomnia is inherited by autosomal dominant type. It is 
characterized by untreatable insomnia together with hyperthermia, 
tachycardia, progressing ataxia, myoclonic cramples, atrophy of the 
thalamus and other brain structures, memory loss. Mental disorders are 
followed by endocrine dysfunction with abnormal production of melatonin, 
prolactin, somatotropic hormone, etc. The disease predominantly afflicts 
young people. 
Finally, a number of commonly spread diseases with still unknown 
pathogenesis show distinct similarity with prion disorders. For instance, 
prion hypothesis is relevant for Alzheimer’s disease – widespread mental 
disorder of elderly that is followed by severe dementia. The same principle 
concerns Parkinson’s disease and serum amyloidosis. 
The observed variations in the course and clinical manifestations of 
prion diseases are supposed to be dependent on existence of different 
strains of infectious prion molecules.  
 
 
Laboratory Diagnosis of Prion Diseases 
 
Laboratory confirmation of prion origin of the disease is the subject of 
great difficulties. It can be made by intracerebral inoculation of suckling 
mice or hamsters with postmortem material taken from the brain. The 
laboratory animals render some symptoms of prion infection in 150 days 
and even longer after primary inoculation.  
Cytological examination of brain tissue of died animals reveals the 
injury of the brain tissue characteristic for prion disease (spongioform 
degeneration and atrophy, vacuolization, amyloid plaques, etc.). 
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Detection of prion molecules with highly specific monoclonal 
antibodies using various immunological tests (immunohistochemistry, 
western blotting, or ELISA) expanded the opportunities of diagnosis of 
prion infections. Nevertheless, conventional immunoassays are still less 
sensitive for diagnosis of minute amounts of prion molecules. 
Quite recently ultra-sensitive prion assays based on highly 
sophisticated laboratory procedures and equipment were introduced into 
practice. They allow to detect negligible amounts of prions directly in 
clinical specimens, e.g. in blood of infected organisms (antemortem tests). 
Among them are immuno-quantitative PCR, protein misfolding cyclic 
amplification and the most novel SOFIA test (surround optical fiber 
immunoassay). The latter test is capable of detecting as low as 1 attogram 
(10
-18
 g) of prion substance. 
 
 
Prophylaxis and Treatment of Prion Diseases 
 
Non-specific prophylaxis is the only method known to date that is 
used for prevention of transmission of prion diseases. As the prion 
molecules show striking resistance to heating and chemical disinfectants 
the carcasses of dead animals should be burnt. 
Efficient prophylaxis of iatrogenic form of Creutzfeldt-Jakob disease 
needs the tight control of medical sterilization and requires thorough 
selection of donor’s tissues for transplantation. 
Drug treatment of prion disorders is not yet elaborated. Promising new 
direction in this field implies the drug intervention into molecular 
pathogenesis of prion disorders, e.g. inhibition of remodeling of normal 
PrP
C
 into deleterious PrP
Sc
. 
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Chapter 22 
INFECTIOUS DISEASES WITH SPECIFIC LESIONS  
IN ORAL CAVITY 
(For students of Dentistry faculty) 
 
 
Tuberculosis 
 
Tuberculosis is one of the most severe threats for human health at the 
beginning of XXI century. The current increase of new tuberculosis cases 
is about 2% per year, but the raise of multidrug resistant (MDR) 
tuberculosis and extensively drug-resistant tuberculosis (XDR) is much 
more rapid.  
Therefore, the global spread of MDR tuberculosis is a problem of 
great medical and social importance. 
The main sources of infection are persons with active tuberculosis.  
Tuberculosis of oral cavity is a seldom clinical situation among 
common lesions of oral cavity. Nevertheless, every case of oral ulceration 
requires stringent differential diagnosis for tuberculosis. 
Tuberculous oral injuries can be primary or secondary to pulmonary 
disease; the latter are much more frequent.  
Oral lesion in tuberculosis can resemble stellated ulcer. In many cases 
it affects the dorsum of tongue. The ulceration is usually painful.  
Less often the lesions might be found on gingiva, lips, buccal mucosa, 
palate, or floor of mouth. 
Laboratory diagnosis of disease is based on microscopy of specimen, 
taken from oral lesion, and isolation of M. tuberculosis on selective media. 
Ziehl-Neelsen acid-fast bacilli stain or fluorescent microscopy with 
auramine stain is used.  
In most of cases oral tuberculosis is secondary to pulmonary disease, 
that’s why sputum culture must be examined. 
Specific treatment of tuberculosis grounds on long-term regimen of 
combined antimicrobial chemotherapy. It lasts up to 6 months. The list of 
first-line drugs comprises isoniazid, rifampin, pyrazinamide, ethambutol, 
and streptomycin. If necessary, oral mycobacterial lesions are subjected to 
surgical treatment. 
 
 
 
 
 378 
Actinomycosis 
 
The patients with actinomycosis of orofacial area comprise up to 80% 
of all infection cases. The main causative agents of the disease are 
Actinomyces israelii and A. gerencseriae. They are commonly associated 
with Aggregatibacter actinomycetemcomitans and propionibacteria. 
In relatively large amounts actinomycetes reside in dental plaques of 
clinically healthy individuals. Also they are present in soil, contaminate 
herbs and grains. In this vein actinomycosis contraction occurs from 
endogenous or exogenous microbial infection. 
The disease transmission is possible by airborne, contact or rarely by 
alimentary route. After initial contact with skin or oral mucosa the bacteria 
activate their lymphogenous or hematogenous spread into deep tissues. 
They can reach adipose tissue, muscles and fascia resulting in formation of 
long-term granulomatous and poorly healing abscesses. In case of 
progression the abscesses enlarge and may open spontaneously with 
purulent discharge. 
Primary actinomycosis is readily complicated by secondary infection 
predominantly of anaerobic genesis.  
Microbiological examination starts from microscopy of purulent 
discharges taken from inflammatory abscess lesions. Round-shaped 
branched microcolonies of actinomycetes are indicated. Their inner 
structure resembles mycelium – fungus-like branched network of hyphae. 
Successful treatment of actinomycosis requires high-dose 
administration of antimicrobial drugs for which the bacteria retain 
sensitivity: beta-lactams, macrolides, or doxycycline. 
 
 
Diphtheria 
 
Diphtheria is the severe infectious disorder caused by toxigenic 
Corynebacterium diphtheriae.  
Bacterial exotoxin plays the principal role in the pathogenesis of 
disease, blocking intracellular protein synthesis in tissues and organs. 
Diphtheria is manifested by characteristic fibrinous inflammation 
with growing vascular permeability. It results in formation of tight 
“pseudomembranes” covering the tonsils, pharynx, or larynx. 
Proteinaceous pseudomembranes contain fibrin that is firmly attached to 
innermost tissues. 
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Diphtheria is anthroponotic disease. Patients with diphtheria and 
carriers are the main sources of infection. The disease is communicated by 
airborne route. 
Exotoxin traverses the mucous membranes and causes the destruction 
of epithelium with inflammatory response and microcirculatory and 
coagulation disorders. The expanding necrotic pseudomembranes impede 
normal airflow. Any attempt to remove the pseudomembrane results in 
bleeding. Pseudomembrane respiratory obstruction (or diphtheritic croup) 
can cause patient suffocation. The regional neck lymph nodes enlarge and 
neck swelling progresses resulting in total neck edema (“bull neck”).  
Toxin absorption leads to distant toxic action with tissue damage, 
parenchymatous degeneration, fatty infiltration and necrosis in 
myocardium, liver, kidneys, and adrenals, sometimes accompanied by 
hemorrhages. The toxin also produces nerve damage often followed by 
paralysis of the soft palate, eye muscles, or limbs. 
In dental practice the most common is the local form of diphtheria 
where pseudomembranes cover patient’s tonsils. 
Toxic and hypertoxic clinical forms are characterized with burst 
progression of the disease resulting in toxic shock that may cause patient 
death in two-three days. 
Laboratory diagnosis of diphtheria depends on rapid determination of 
diphtherial exotoxin and isolation of toxigenic bacteria. 
The presence of exotoxin in clinical specimen (primarily, in tonsillar 
pseudomembranes) is detected by enzyme-linked immunosorbent assay 
(ELISA test) or by immunoprecipitation. The toxigenicity of 
С. diphtheriae culture can be shown also by incorporation of bacteria into 
cell culture monolayers. Toxin diffuses into cells monolayer and causes 
cell destruction. Finally, PCR is used as the most sensitive, rapid and 
specific method for determination of gene encoding diphtheria toxin. 
The treatment of diphtheria basically rests on the early administration 
of specific antitoxic antibodies that block toxin action. 
Specific prophylaxis is afforded by active immunization. Usually 
combined DPT (or diphtheria-pertussis-tetanus) vaccine or combined 
tetanus-diphtheria toxoids are used. All the children must gain the 
repetitive course of diphtheria toxoid immunizations followed by several 
boosters in every 10 years. 
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Scarlet Fever 
 
Scarlet fever is acute streptococcal infection caused by group A 
Streptococcus pyogenes that produce pyrogenic exotoxins A, B and C. The 
symptoms of the disease ensue from systemic toxin action. Toxins display 
superantigenic activity with massive production of proinflammatory 
cytokines. This results in fever, generalized rash, and skin desquamation. 
The disease profoundly impairs cardiovascular system especially 
microcirculation. 
Scarlet fever transmission occurs by air-droplet route. The illness 
affects predominantly children. It begins from sharp raise of temperature, 
vomiting and throat pain. In 1-2 days characteristic skin rash appears and 
moves down from face to trunk and limbs. The patient demonstrates bright 
red cheeks and chin with a typical pale area around the mouth. The rash 
stays for several days and then gradually fades with skin desquamation (or 
peeling). 
Almost all cases of scarlet fever are followed with specific oral lesions 
such as “strawberry” tongue with elevated deep-red lingual papillae and 
inflamed uvula. 
Clinical diagnosis of the disease is supported by isolation of group A 
streptococci from patient’s throat swab. Microbial culturing is performed 
on number of special media for streptococci (blood or serum agar).  
Scarlet fever is efficiently treated with antibiotics. Beta-lactams are 
the most commonly used antimicrobials here because of retained 
sensitivity of S. pyogenes to this group of drugs. 
 
 
Anthrax 
 
Anthrax is the severe zoonotic disease caused by toxigenic 
B. anthracis. Herbivores can become infected with anthrax by grazing in 
pastures that are contaminated with spores. Contact with animals 
(butchering, skinning, or exposure to hides or wool), and consumption of 
contaminated meat are the risk factors for infection in humans.  
Depending on the site of the infection, anthrax cases display different 
clinical manifestations – cutaneous anthrax, inhalation anthrax (or wool-
sorter's disease) and gastrointestinal disease. 
In dental practice cutaneous anthrax may be observed. Here the 
spores of bacilli are introduced into the skin. Germination occurs within 
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hours, and vegetative cells produce anthrax toxin. The disease usually 
develops within 1-7 days after entry. 
A red macule emerges at the site of inoculation. The lesion 
subsequently comes into a papular-vesicular stage that is followed by 
ulceration with a blackened necrotic eschar or anthrax carbuncle 
(malignant pustule) surrounded by brawny edema. This lesion is painless. 
A regional lymphadenitis is commonly seen in these patients. Eventually 
eschar dries, loosens, and separates; spontaneous healing occurs in 80 to 
90% of untreated cases. However, in severe cases bacterial dissemination 
leads to septicemia with high mortality rate. 
Anthrax diagnosis relies on clinical findings and disease 
epidemiology with subsequent microbiological confirmation. It includes 
microscopy of samples taken from primary skin lesions and bacterial 
isolation. 
The patients are hospitalized and treated with antibiotics 
(fluoroquinolones or beta-lactams) and specific immunoglobulin. 
 
Syphilis 
Primary syphilitic lesions in oral cavity may inflict buccal and 
gingival mucosa, lips or perioral skin. They emerge in affected individuals 
after oral sex. The rates of other routes for disease transmission (via 
personal things such as tooth brushes, or by direct contact, or after medical 
manipulations) are negligibly low. 
After sexual intercourse the causative agent of syphilis T. pallidum 
invades the skin or mucosals through their minimal lesions. Infectious dose 
for it is extremely low: as little as 1-5 microbial cells can trigger the 
illness. 
Incubation period depends on inoculated dose. A large inoculum, e.g., 
about 10
7
 bacterial cells, results in disease appearance in 5-7 days. 
After approximately 1 month of incubation a hard chancre, essential 
tissue lesion of primary syphilis, appears. It is followed by regional 
lymphadenopathy. 
Chancre evolves at the primary site of microbial entry. Its orofacial 
localization often occurs on lip vermilions and oral mucosa. Hard chancre 
is a painless ulcer about 0.5-3 cm with sharp margins, clean base, 
induration, and sometimes with purulent discharge. 
In most cases chancre heals spontaneously within about 6 weeks. 
Nevertheless, in several weeks the disease comes into stage of secondary 
syphilis, which results from lymphogenous and hematogenous microbial 
dissemination. 
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Secondary syphilis is the systemic inflammatory process characterized 
by skin rash, headaches, fever, malaise, lymphadenopathy, mucosal 
lesions, and CNS disorders. It lasts from 2-3 months to more than 1 year. 
Cutaneous or mucosal syphilitic eruptions or syphilides harbor great 
amount of spirochetes, being highly infectious.  
In oral cavity secondary mucosal lesions appear as the erythematous 
and maculo-papular syphilides. They render oval-shaped grayish-white 
elements on mucosal surface followed by periostitis.  
If not treated, after latent period of various length (about 1 year or 
even more) the disease progresses into tertiary syphilis. 
Tertiary syphilis affects various body’s organs and tissues, especially 
cardiovascular system and CNS. Specific slow-growing indurative injuries 
(or gummas) emerge in tissues and parenchimatous organs resulting in 
necrosis with subsequent connective tissue proliferation. 
These lesions rarely appear in mouth. If arisen, they form growing 
nodules (tubercular syphilides) and gummas. When progressed, the lesions 
undergo deep necrosis with degradation of underlying soft tissues and 
bones, for instance, resulting in perforation of the soft palate.  
Congenital syphilis in infants issues from vertical disease 
transmission in untreated women with a rate of 70 to 100% for primary 
syphilis.  
The infected infants may be asymptomatic or show the numerous 
manifestations of early and late congenital disorder with multiple dental 
abnormalities. Herein they render screwdriver-shaped incisors with 
notched incisal edges (Hutchinson's incisors). Mulberry deformation of 
molars is observed. 
Overall, Hutchinson's triad of abnormalities in congenital syphilis 
comprises lymphadenopathy and hepatomegaly accompanied with skeleton 
and teeth lesions. 
Laboratory diagnosis of syphilis rests on microscopical examination 
of specimens taken from primary or secondary syphilitic lesions and/or 
serological tests for specific antibodies.  
Serological testing is the mainstay of laboratory diagnosis for latent, 
secondary, and tertiary syphilis. It confirms the presence of anti-
treponemal antibodies in patient sera by means of highly specific 
serological reactions, e.g., T. pallidum immobilization test and ELISA test. 
The treatment of the disease is based on high sensitivity of 
T. pallidum to beta-lactam antibiotics. Penicillin G and its derivatives 
remain to be the drugs of choice for syphilis treatment. 
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Gonococcal Infection 
 
Gonococcal stomatitis can arise in newborns infected from sick 
mothers in the course of delivery. In adults oral gonococcal infection 
usually follows urogenital infection in persons practicizing orogenital 
contacts.  
Mucosal tissue, tonsils, pharynx and upper larynx are involved into 
inflammatory process. Inflammatory manifestations result in erythematous 
edema, suppurative erosions and ulcerations of oral mucosa. 
Laboratory diagnosis of gonococcal infections is carried out by 
microscopy of the materials obtained from urogenital excretions and lesion 
discharges. 
Antimicrobial treatment is performed by antibiotics with proven 
efficacy against gonococci because of high levels of resistance essential for 
these bacteria. Combinations of azithromycin with gentamycin or 
fluoroquinolones are preferentially used. Local treatment of specific 
oropharyngeal lesions with antiseptics can be applied. 
 
 
Oral Candidiasis 
 
Oral candidiasis (or candidal stomatitis, oropharyngeal candidiasis 
and moniliasis) is the specific oral mycosis caused by yeast-like fungi of 
Candida genus. 
More than 50% of disease cases is related with commonly spread 
fungi Candida albicans; other causative species for candidiasis in 
descending rate are C. tropicalis, C. glabrata, C. parapsilosis, or C. krusei. 
C. albicans pertain to the normal representatives of oral microflora, 
where they can be found in modest amounts. However, in some specified 
conditions these fungal members exert serious opportunistic infections 
rendering local or severe systemic disease.  
C. albicans are dimorphic fungi. In mouth they are often present as 
yeast forms or blastospores with questionable virulence whereas mould-
like fungal hyphal forms are capable of invading host tissues. Transition 
between these two phases largely depends on changes of environmental 
conditions.  
In addition candidae create pseudohyphae – long filaments composed 
of oval fungal cells that are closely attached on their poles. It occurs due to 
incomplete separation of cells after division. 
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Overall, all the details of transformation of oral saprophytic candida 
into aggressive fungal pathogens are not yet clear completely.  
It is considered that candidal strains with enhanced capacity to 
adhesion and colonization are generally more pathogenic. In particular, the 
strains with high expression of certain adhesins (e.g., hyphal wall protein 1 
or extracellular mannoprotein) are referred to as more active pathogens. 
Similarly, pathogenic fungi produce large amounts of hydrolytic enzymes 
such as proteases, phospholipases and hyaluronidase. 
Oral candidiasis is regarded as the most frequent opportunistic 
infection of oral cavity that affects humans. Likewise, it is the most typical 
form of candidal infection and the most common form of oral mycosis.  
Candidiasis affects newborns and infants, but most of all – 
inmunocompromised persons, namely patients with HIV infection and 
acquired immunodeficiency syndrome (AIDS); patients with cancer under 
cytostatic chemotherapy; patients, treated with antibiotics of broad 
spectrum of action with deep oral or intestinal dysbiosis.  
Primary carriage of C. albicans predisposes to its further opportunistic 
infection.  
Candidal infection is divided into acute and chronic, primary and 
secondary. 
Primary oral candidiasis originates from resident fungi and affects 
oral cavity and perioral area. By contrast, secondary disease emerges after 
spread of disseminated candidal infection that occupies the mouth and 
other body compartments. 
Nevertheless, dissemination of oral candidiasis to other body sites (or 
invasive infection) is generally seldom situation. It happens predominantly 
in immunocompromised patients.  
There are 3 main forms of oral candidiasis:  
1) pseudomembranous;  
2) erythematous; 
3) hyperplastic. 
Pseudomembranous candidiasis, or thrush, demonstrates white 
pseudomembranous spots upon oral mucosa that contain epithelial and 
fungal cells mixed with fibrin and cellular decay. The covering film is 
easily removed showing red mucosal bottom. These lesions usually affect 
tongue, palate and buccal epithelium. 
Chronic pseudomembranous candidiasis arises mainly in 
immunocompromised persons, e.g., HIV patients. 
Erythematous form of the disease exposes typical smooth and 
reddened lesions, which are located mainly upon the tongue dorsum or 
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palate. The lesions are usually painful. Substantial loss of lingual papillae 
(or depapillation) is common here. 
In most of cases this fungal infection is the result of long-term 
antibiotic treatment or corticosteroid therapy. That’s why it is often named 
as “antibiotic induced stomatitis” or “antibiotic sore mouth”.  
Erythematous illness covers up to 60% of total oral candidiasis if 
taken with related clinical forms such as angular stomatitis and denture-
related stomatitis. The latter is associated with chronic erythematous 
candidiasis. 
Hyperplastic candidiasis is a seldom form of disease with the 
incidence of about 5%.  
Candida-associated lesions are the oral injuries caused by candida 
fungi in association with other pathogenic microorganisms. Two basic 
forms are known – angular cheilitis and denture related stomatitis. 
Angular cheilitis is the infection-based inflammation at mouth angles. 
About 20% of disease is caused solely by candidal species, whereas 60% 
originate from association of C. albicans and S. aureus. This pathology 
renders angular soreness and erythematous inflammation that may result in 
angular fissuring. The syndrome affects elderly adults and often 
accompanies denture related stomatitis 
Denture related stomatitis is a low or moderate inflammatory 
complication that affects edentulous elderly adults wearing oral appliances 
(dentures). 
It is generally ascertained that more than 50-60% of denture-wearing 
individuals exhibit denture related stomatitis.  
Dominating causative agents in this pathology are candida fungi 
(above 90% of total number of cases). Thus the disease is commonly 
termed as “Candida-associated denture induced stomatitis” or CADIS. 
Mucosal surface under dentures demonstrates highest grades of fungal 
colonization in comparison with normal unaffected mucosa. It creates 
acidic, moist and relatively anaerobic surrounding that promotes further 
candidal growth. In addition, poor adjustment of oral prostheses causes 
micro-injuries of gingival mucosa. 
Candidae easily attach to the surface of damaged tissues and 
polymeric surface of dentures with their multiple pits and fissures. 
Microbial adherence and colonization stimulates local inflammation. This 
leads to continuous irritation of oral mucosa resulting in erythematous 
lesions. 
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Chronic denture related stomatitis creates the stable reservoir for 
candidal infection that in worsen conditions may expand to other areas of 
oral cavity. 
Diagnosis of oral candidiasis grounds on clinical findings but requires 
laboratory confirmation of fungal infection. 
Specimens are taken from lesion sites by oral smears, swabs or 
rinsing. 
Microbial smears are examined by Gram stain demonstrating gram-
positive candidal cells with pseudohyphae.  
Fungal culture is made on Sabouraud medium. 
Oral rinse examinations help to discriminate between “normal” 
candidal carriage and oral candidiasis. About 7,000-7,500 colony-forming 
units of candidae per 1 ml of oral rinse can be found in disease condition. 
Treatment of oral candidiasis presumes administration of topical anti-
fungal drugs, such as miconazole, nystatin, levorin, or amphotericin B. 
Severely immunocompromised patients, e.g., with candidiasis in 
AIDS, need systemic anti-fungal therapy with oral or intravenous drugs 
(amphotericin B, azoles or others). 
Proper oral hygiene strongly reduces candidal propagation in oral 
cavity. It presumes adequate toothbrushing, smoking cessation, oral rinsing 
after inhalation steroid use, and regular denture disinfection with denture 
cleaner preparations (e.g., chlorhexidine or sodium hypochlorite). 
 
 
General Characteristics of Viral Infections, Affecting Oral Cavity 
 
Viral lesions are considered among the most common in current dental 
practice. 
Numerous viral infections cause specific alterations within oral cavity. 
For instance, in severe influenza course hyperemia and cyanosis of 
oral mucosa are typical. Infectious mononucleosis is followed by tonsillitis 
with multiple petechial rashes that covers oral mucosa. Likewise, 
oropharyngeal lesions are common in parainfluenza infection, in rubella, 
rhinoviral and adenoviral diseases. Manifestations in viral hemorrhagic 
fevers comprise severe hemorrhagic rash, cheilitis, angular stomatitis, 
catarrhal gingivitis. 
Herpes simplex virus, vesiculovirus and herpes zoster virus, 
Coxsackie A viruses, virus of vesicular stomatitis are able to cause 
infections with similar alterations in oral cavity. Primary lesion here is 
vesicle that is gradually changed into ulcerative erosion or aphtha. 
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Herpetic Oral Lesions: Herpes Simplex Infection 
 
Viral infection, caused by 1
st
 type of herpes simplex virus (HSV-1) is 
the most common viral disease in humans. By sensitive laboratory tests 
herpes simplex persistency is detected among 90% of adult population. 
Infants in the age range from 6 month to 3 years are grossly 
susceptible to this infection. Large outbreaks of acute herpetic stomatitis 
emerge in child care settings. 
The main clinical presentations of infection are acute (primary) 
herpetic gingivostomatitis and chronic herpes labialis (or cold sores) with 
its recurrent exacerbations.  
Acute herpetic gingivostomatitis occurs as initial (primary) herpetic 
infection. It is caused by HSV-1 and in rare cases by HSV-2 that is 
common for genital infection.  
Incubation period lasts for 4-5 days. It is followed by fever and 
appearance of characteristic lesions – pin-head vesicles, localized on lips, 
tongue and gingival or buccal mucosa. Soon the vesicles become eroded 
forming painful ulcerations.  
Usually isolated viral lesions heal spontaneously in several days 
without scarring. Clinical recovery occurs in 1-3 weeks.  
Nonetheless, in course of primary infection the virus invades local 
nerve endings and moves by retrograde axonal flow to dorsal root ganglia, 
where the latency is established.  
Chronic herpes labialis (or cold sores) results from repetitive 
exacerbations of latent HSV-1 infection. In most of cases various 
exogenous stimuli (fever, UV irradiation, physical or emotional stress, 
axonal injury, etc.) activate viral replication. The virus moves along axons 
back to the peripheral site; and replication proceeds at the skin or mucous 
membranes. The vesicles commonly affect perioral area, lip vermilions and 
their borders, sometimes – soft and hard palate, tongue or buccal 
epithelium. Many recurrences are asymptomatic. 
Clinical diagnosis of herpetic infection is confirmed with laboratory 
testing of specimens taken from herpetic lesions. Immunofluorescence 
analysis and PCR are the standard reactions in this condition. Serological 
testing states the elevated levels of specific antiviral antibodies of IgM 
class. 
In mild or moderate cases acute herpetic gingivostomatitis doesn’t 
require treatment. Severe or complicated manifestations can be treated 
with topical applications of acyclovir on the background of adequate oral 
hygiene.  
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Herpangina 
 
Herpangina (also known as mouth blisters or vesicular pharyngitis) is 
typically caused by Coxsackie group A viruses. In few cases it can be 
triggered by Coxsackie group B infection and echoviral infection. All these 
viruses are the members of Enterovirus genus and Picornaviridae family. 
Coxsackie herpangina is a severe febrile pharyngitis. It affects 
predominantly babies and young children. 
There is an abrupt onset of fever and sore throat with discrete vesicles 
on the posterior half of the palate, pharynx, tonsils, or tongue. The vesicles 
progress into ulcerations that heal spontaneously in 7-8 days. 
The disorder is self-limited and resolves in 1-2 weeks. 
Diagnosis rests on clinical findings; virus isolation is usually not 
required.  
The treatment of herpangina is symptomatic; specific antiviral therapy 
is absent.  
 
 
Oral Lesions in Measles  
 
Measles is an example of extremely contagious acute respiratory viral 
infection. It is caused by specific morbillivirus of a single serotype. 
Measles is a human illness that usually affects children. 
Virus replicates in respiratory tract epithelium and moves to regional 
lymphatic nodes (primary viremia). After second propagation in the 
lymphoid tissue it spreads throughout the body penetrating endothelium of 
vessels and epithelial cells in skin, conjunctiva, respiratory tract, and oral 
cavity. 
Characteristic lesions of oral cavity in measles are known as 
Filatov’s-Koplik's spots. They appear upon the buccal mucosa two to three 
days earlier than the measles rash. The spots are the sites of intensive viral 
replication with formation of giant cells. 
Koplik's spots can be discerned as firm white lesions on the buccal 
epithelium opposite to the lower 1
st
 and 2
nd
 molars. They are highly 
specific for the disease, sometimes described as “grains of salt on a wet 
background”. 
As Koplik's spots emerge at the beginning of measles, their discovery 
makes possible timely isolation of contact individuals thus preventing 
further disease spread. 
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Oral Manifestations of HIV Infection  
 
Severe immune suppression that follows progressive HIV infection 
results in development of acquired immune deficiency syndrome, or 
AIDS. Similar with other body compartments, HIV dampens immune 
response within oral cavity. This creates conditions for local oral 
manifestations of opportunistic infections and tumors.  
Before the clinical implementation of highly active antiretroviral 
therapy (or HAART) in 1996, oral lesions were registered in 50% of 
individuals infected with HIV and in about 80% of persons with AIDS. 
Since that time the course of HIV infection has become more benign but 
the oral lesions remain to be common in this patients. 
In 1992 the EC-Clearinghouse on oral problems related to HIV 
infection and WHO Collaborating Centre on Oral manifestations of the 
immunodeficiency virus worked out the classification of oral 
manifestations of HIV infection. Later, in 2002, an international workshop 
confirmed the validity of this classification and recommended it for 
practical use.  
Classification data summarizing oral lesions associated with 
HIV/AIDS are present in Table 11. 
The most common oral lesions in HIV/AIDS are the results of 
candidal infection. They occur at least in 40-60% of AIDS patients. The 
main causative agent is Candida albicans; it often associates with 
С. tropicalis, C. parapsilosis and others. Erythematous and hyperplastic 
candidiasis, chronic pseudomembranous disease, and angular stomatitis 
are typical in AIDS. 
Viral infections in HIV/AIDS rapidly progress in condition of severe 
cellular immune deficiency. The viruses from Herpesviridae family play 
pivotal role in genesis of viral complications in AIDS.  
Among them are herpes simplex and herpes zoster viruses, herpesvirus 
type 4 or Epstein-Barr virus, cytomegalovirus (herpesvirus type 5), and 
herpesvirus type 8 or Kaposi's sarcoma-associated herpesvirus. 
Active reproduction of Epstein-Barr virus in epithelial cells of tongue 
exerts its specific lesion, known as hairy leukoplakia. It follows about 
50% of HIV infection cases. 
Hairy leukoplakia represents white wrinkled lesions from lateral sides 
of tongue that are not painful. In most of cases it doesn’t need specific 
treatment. Re-emergence of hairy leukoplakia in the same patient may 
indicate the failure of HIV specific therapy. 
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Table 11 
Oral lesions, associated with HIV/AIDS 
 
 
Group 1.  
Lesions strongly 
associated with HIV 
infection 
 
 
Group 2. 
Lesions less commonly 
associated with HIV 
infection 
 
Group 3. 
Lesions seen in HIV 
infection 
 
 
 
 
Candidiasis 
 
Hairy leukoplakia 
 
Kaposi’s sarcoma 
 
Non-Hodgkin’s lymphoma 
 
Periodontal diseases:  
linear gingival erythema, 
necrotizing ulcerative 
gingivitis,  
necrotizing ulcerative 
periodontitis 
 
 
Bacterial infections: 
 
Mycobacterium avium-
intracellularae 
Mycobacterium tuberculosis 
Necrotizing (ulcerative) 
stomatitis 
Salivary gland disease 
Dry mouth due to 
decreased salivary flow 
Unilateral/bilateral 
swelling of salivary glands 
Non-specific ulcerations 
 
Viral infections: 
 
Herpes simplex virus 
Human papillomavirus 
Condyloma acuminatum 
Varicella-zoster virus 
 
Bacterial infections: 
 
Actinomyces israelii 
Escherichia coli 
Klebsiella pneumonia 
Cat-scratch disease 
Bacillary angiomatosis 
 
Fungal infection  
other than candidiasis: 
 
Cryptococcus neoformans 
Geotrichum candidum 
Histoplasma capsulatum 
Mucoraceae fungi 
Aspergilus flavus 
 
Neurological disturbances: 
Facial palsy 
Trigeminal neuralgia 
 
Herpesvirus type 8 causes angioproliferative tumor Kaposi’s sarcoma. 
It affects one third of patients with AIDS. About 40% of them demonstrate 
oral lesions. This vascular tumor renders multiple red-violet macules, 
papules or nodules mainly upon hard palate. 
Repetitive herpes zoster infections are also common in AIDS patients. 
Deep immune suppression in patients with AIDS-related complex and 
AIDS activates numerous opportunistic pathogens resulting in severe 
mixed bacterial, fungal and viral infections.  
Among the most common are tenacious periodontal disorders of 
polymicrobial origin. 
Usually periodontal damage starts from linear gingival erythema or 
HIV-associated gingivitis. It may progress further into necrotizing 
ulcerative gingivitis and necrotizing ulcerative periodontitis. 
Linear gingival erythema looks like narrow red band surrounding the 
marginal gum. If not controlled, it stimulates progression of necrotizing 
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ulcerative gingivitis with deep damage of papillary gingival area and 
necrotizing ulcerative periodontitis with dental attachment loss and 
destruction of alveolar bone. 
Periodontal pathology in AIDS arises from the joint action of typical 
oral pathogens, such as gram-negative obligate anaerobes Porphyromonas 
gingivalis, Tannerella forsythia, Prevotella intermedia, Treponema 
denticola, Fusobacterium nucleatum, Actinomyces naeslundii, and others. 
Aggregatibacter actinomycetemcomitans, candidae fungi, and viruses are 
also the active participants of AIDS-associated periodontal diseases. 
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